Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
GRCh37/hg19 Xq27.3(chrX:143637961-144285954)x3			not provided	Benign(Last reviewed: Jun 12, 2015)	no assertion criteria provided	VCV000617216	X	143637961 - 144285954			617216	608552		
Single allele			Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Mar 2, 2016)	no assertion criteria provided	VCV000236260					236260	237816		
GRCh37/hg19 15q11.2-26.3(chr15:20733395-102511616)x4	AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAL|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APBA2|APH1B|AQP9|AQR|ARPIN|ARHGAP11A|ARHGAP11B|ARID3B|ARIH1|ARNT2|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATP10A|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C15orf65|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1|CHRFAM7A|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYFIP1|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|EPB42|ETFA|EXD1|FAH|FAM174B|FAM189A1|FAM214A|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FBN1|FBXL22|FBXO22|FBXO22-AS1|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L1|GOLGA6L2|GOLGA6L6|GOLGA8A|GOLGA8B|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HERC2|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IPW|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOC100128979|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAGEL2|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR211|MIR9-3|MKRN3|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDN|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NIPA1|NIPA2|NMB|NOP10|NOX5|NPAP1|NPTN|NR2E3|NR2F2|NRG4|NSMCE3|NTRK3|NUSAP1|NUTM1|OAZ2|OCA2|ODF3L1|OIP5|ONECUT1|OR4F15|OR4F4|OR4F6|OR4M2|OR4N4|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PGPEP1L|PHGR1|PIAS1|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|POTEB|POTEB2|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNORD115-1|SNORD116-1|SNRPA1|SNRPN|SNUPN|SNURF|SNX1|SNX22|SNX33|SORD|SPATA5L1|SPATA8|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THBS1|THSD4|TICRR|TIPIN|TJP1|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TUBGCP5|TYRO3|UACA|UBAP1L|UBE2Q2|UBE3A|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS18|VPS33B|VPS39|WDR61|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH		See cases	Pathogenic	no assertion criteria provided	VCV000395145	15	20733395 - 102511616			395145	382038		
GRCh38/hg38 15q11.2-14(chr15:25033869-37204304)x1	ACTC1|APBA2|AQR|ARHGAP11A|ARHGAP11A-SCG5|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|AVEN|CDIN1|CHRFAM7A|CHRM5|CHRNA7|DPH6|DPH6-DT|EMC4|EMC7|FAM189A1|FAN1|FMN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GJD2|GJD2-DT|GOLGA6L7|GOLGA8A|GOLGA8B|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8K|GOLGA8M|GOLGA8N|GOLGA8O|GOLGA8Q|GOLGA8R|GOLGA8T|GREM1|GREM1-AS1|HERC2|IPW|KATNBL1|KLF13|LINC00929|LINC02249|LINC02250|LINC02252|LINC02256|LINC02346|LINC02352|LINC02853|LOC100130111|LOC100132202|LOC100996413|LOC101928042|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC108004527|LOC110120842|LOC110120858|LOC110120936|LOC110121498|LOC112272580|LOC112272581|LOC112272582|LOC112272583|LOC113939943|LOC145845|LOC283710|LOC645202|LPCAT4|MEIS2|MIR1233-1|MIR1233-2|MIR211|MIR3942|MIR4509-2|MIR4509-3|MIR4510|MIR4715|MIR8063|MTMR10|NANOGP8|NOP10|NSMCE3|NUTM1|OCA2|OTUD7A|PGBD4|PWAR1|PWAR4|PWAR6|RYR3|RYR3-DT|SCG5|SCG5-AS1|SLC12A6|SNHG14|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|TJP1|TRE-TTC2-2|TRPM1|UBE3A|ZNF770		See cases	Pathogenic(Last reviewed: Jan 28, 2013)	no assertion criteria provided	VCV000155138	15	25279016 - 37496505	15	25033869 - 37204304	155138	164892		
NM_000026.4(ADSL):c.674T>C (p.Met225Thr)	ADSL	M225T, M161T	Adenylosuccinate lyase deficiency	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000002468	22	40755283	22	40359279	2468	17507	rs119450945	NC_000022.11:40359278:T:C
GRCh37/hg19 15q11.2-13.3(chr15:23213406-32446830)x1	APBA2|CHRNA7|GABRA5|GABRB3|TRPM1|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|ARHGAP11B|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|PWAR4|PWARSN|TJP1|CHRFAM7A|MIR211|SNORD116-1|PWAR6|GABRG3|IPW		not provided	Pathogenic(Last reviewed: May 30, 2019)	no assertion criteria provided	VCV000815688	15	23213406 - 32446830			815688	803897		
GRCh37/hg19 15q11.1-13.3(chr15:20179527-32998070)x3	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SCG5|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|ARHGAP11A|FAN1|CYFIP1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|OR4N4|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|OR4M2|MIR211|GOLGA8N|GOLGA8J|GOLGA8M|GOLGA6L6|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|POTEB2|PWAR6|POTEB		not provided	Pathogenic(Last reviewed: May 31, 2018)	no assertion criteria provided	VCV000685306	15	20179527 - 32998070			685306	672898		
Single allele	APBA2|ATP10A|CYFIP1|FAM189A1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|NPAP1|MKRN3|NDN|NIPA1|NIPA2|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TUBGCP5|UBE3A		Neurodevelopmental delay|Seizures|Ventricular septal defect|Esophageal atresia	Pathogenic(Last reviewed: May 1, 2019)	no assertion criteria provided	VCV000638670	15	22676913 - 30137106			638670	626445		
GRCh37/hg19 15q11.2-13.3(chr15:22383299-32917689)	APBA2|PWRN1|PWRN2|TJP1|FAM189A1|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|ARHGAP11A|FAN1|CYFIP1|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|OR4N4|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8N|GOLGA8J|GOLGA8M|GOLGA8O|GOLGA8H|KLF13|NPAP1|SNORD116-1|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625714	15	22383299 - 32917689			625714	614018		
GRCh37/hg19 15q11.2-13.2(chr15:22835967-30371774)x4	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NSMCE3|PWAR1|ATP10A|NIPA2|TUBGCP5|NIPA1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Oct 14, 2011)	no assertion criteria provided	VCV000614542	15	22835967 - 30371774			614542	605878		
GRCh37/hg19 15q11.2-13.3(chr15:22770421-33098520)x3,4	APBA2|CHRNA7|GABRA5|OCA2|GABRB3|GABRG3|IPW|TRPM1|NDN|SCG5|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|ARHGAP11A|FAN1|CYFIP1|FAM189A1|NPAP1|GREM1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8N|GOLGA8J|GOLGA8M|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Mar 21, 2018)	no assertion criteria provided	VCV000564150	15	22770421 - 33098520			564150	555334		
GRCh37/hg19 15q11.2-13.3(chr15:22770421-32439524)x4	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|CYFIP1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|MIR211|SNORD116-1|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|PWAR6		not provided	Pathogenic(Last reviewed: Jun 3, 2019)	no assertion criteria provided	VCV000564149	15	22770421 - 32439524			564149	555333		
GRCh37/hg19 15q11.2-13.3(chr15:22770421-32421780)x2,3	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|CYFIP1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	VCV000564148	15	22770421 - 32421780			564148	555332		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-31073668)x3,4	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Nov 9, 2017)	no assertion criteria provided	VCV000564147	15	22770421 - 31073668			564147	555331		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-30386398)x1	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8J|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000564146	15	22770421 - 30386398			564146	555330		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29214721)x3	APBA2|ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Likely pathogenic(Last reviewed: Nov 11, 2014)	no assertion criteria provided	VCV000442621	15	22770421 - 29214721			442621	436283		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-30369944)x4	APBA2|ATP10A|CYFIP1|FAM189A1|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jul 18, 2014)	no assertion criteria provided	VCV000442241	15	22770421 - 30369944			442241	435903		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-31122895)x4	APBA2|ARHGAP11B|ATP10A|CHRFAM7A|CYFIP1|FAM189A1|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8H|GOLGA8J|GOLGA8M|HERC2|IPW|MAGEL2|NPAP1|MKRN3|NDN|NIPA1|NIPA2|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Aug 10, 2015)	no assertion criteria provided	VCV000442097	15	22770421 - 31122895			442097	435759		
GRCh37/hg19 15q11.1-13.2(chr15:20071673-30737344)x4	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|NIPA2|CHRFAM7A|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|OR4N4|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|OR4M2|GOLGA8J|GOLGA8M|GOLGA6L6|PWRN1|PWRN2|SNORD116-1|POTEB2|PWAR6|POTEB		See cases	Pathogenic(Last reviewed: Oct 25, 2016)	criteria provided, single submitter	VCV000402122	15	20071673 - 30737344			402122	389094		
GRCh37/hg19 15q11.2-14(chr15:22770421-33707835)x3	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|RYR3|SCG5|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|ARHGAP11A|FAN1|CYFIP1|FAM189A1|NPAP1|GREM1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8N|GOLGA8J|GOLGA8M|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397372	15	22770421 - 33707835			397372	384265		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-31073669)x4	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397126	15	22770421 - 31073669			397126	384019		
GRCh37/hg19 15q11.2-13.3(chr15:23282829-32446830)x1	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|CHRFAM7A|ARHGAP11B|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396463	15	23282829 - 32446830			396463	383356		
GRCh37/hg19 15q11.2-13.3(chr15:22770421-31760986)x1	APBA2|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|CYFIP1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396071	15	22770421 - 31760986			396071	382964		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-30386398)x4	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8J|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000395941	15	22770421 - 30386398			395941	382834		
GRCh37/hg19 15q11.2-13.1(chr15:23300138-29338429)x3	APBA2|ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000394379	15	23300138 - 29338429			394379	381272		
GRCh37/hg19 15q11.1-13.3(chr15:20190548-32917801)x4	APBA2|ARHGAP11A|ARHGAP11B|FAM189A1|ATP10A|CHRFAM7A|CHRNA7|CYFIP1|FAN1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|HERC2|IPW|KLF13|MAGEL2|MIR211|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OR4N4|OTUD7A|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TRPM1|TUBGCP5|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000394315	15	20190548 - 32917801			394315	381208		
GRCh37/hg19 15q11.1-13.3(chr15:20190548-32917857)x4	APBA2|ARHGAP11A|ARHGAP11B|ATP10A|CHRFAM7A|CHRNA7|CYFIP1|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|HERC2|IPW|KLF13|MAGEL2|MIR211|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OR4N4|OTUD7A|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TRPM1|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253558	15	20190548 - 32917857			253558	248006		
GRCh37/hg19 15q11.1-13.3(chr15:20190548-32386089)x4	APBA2|ARHGAP11B|ATP10A|CHRFAM7A|CHRNA7|CYFIP1|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|GOLGA8H|GOLGA8J|GOLGA8M|HERC2|IPW|KLF13|MAGEL2|MIR211|OR4N4|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OTUD7A|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TRPM1|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253536	15	20190548 - 32386089			253536	247984		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-30361733)x3	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAM189A1|NPAP1|LINC02249|MAGEL2|NSMCE3|ATP10A|CHRFAM7A|SNORD107|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L7|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580|LOC112272581		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000160989	15	22698522 - 30653936	15	23319714 - 30361733	160989	170833		
GRCh38/hg38 15q11.2-13.2(chr15:23328044-30094350)x4	APBA2|ATP10A|ATP10A-DT|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8J|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 14, 2014)	no assertion criteria provided	VCV000155312	15	22770421 - 30386553	15	23328044 - 30094350	155312	165066		
GRCh38/hg38 15q11.2-13.2(chr15:23328044-30023809)x1	APBA2|ATP10A|ATP10A-DT|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 4, 2013)	no assertion criteria provided	VCV000155159	15	22770422 - 30316012	15	23328044 - 30023809	155159	164913		
GRCh38/hg38 15q11.2-13.2(chr15:23319714-30527306)x4	APBA2|ATP10A|ATP10A-DT|CHRFAM7A|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8J|GOLGA8M|GOLGA8R|GOLGA8S|GOLGA8T|HERC2|IPW|LINC00929|LINC02249|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC100996413|LOC102723623|LOC106736464|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Nov 14, 2012)	no assertion criteria provided	VCV000154724	15	22765628 - 30819509	15	23319714 - 30527306	154724	164478		
GRCh38/hg38 15q11.2-13.2(chr15:23328044-30077815)x1	APBA2|ATP10A|ATP10A-DT|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 3, 2013)	no assertion criteria provided	VCV000153771	15	23276605 - 30370018	15	23328044 - 30077815	153771	163522		
GRCh38/hg38 15q11.1-13.3(chr15:19840581-32621939)x4	APBA2|ARHGAP11A|ARHGAP11A-SCG5|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|CHRNA7|CYFIP1|FAM189A1|FAM30B|FAM30C|FAN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA6L6|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8K|GOLGA8M|GOLGA8N|GOLGA8O|GOLGA8Q|GOLGA8R|GOLGA8S|GOLGA8T|HERC2|IPW|KLF13|LINC00929|LINC01193|LINC02203|LINC02249|LINC02250|LINC02256|LINC02346|LINC02352|LOC100130111|LOC100132202|LOC100996413|LOC101927079|LOC101928042|LOC102723623|LOC102724971|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC110121498|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283683|LOC283710|LOC645202|MAGEL2|MIR1268A|MIR211|MIR3118-2|MIR3118-3|MIR3118-4|MIR4508|MIR4509-1|MIR4509-2|MIR4509-3|MIR4715|MIR5701-1|MIR5701-2|MIR5701-3|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OR4N4|OR4N4C|OTUD7A|POTEB|POTEB2|POTEB3|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000151938	15	20045834 - 32914140	15	19840581 - 32621939	151938	161689		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-32217731)x3	APBA2|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|CHRNA7|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8S|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8Q|GOLGA8R|GOLGA8T|HERC2|IPW|KLF13|LINC00929|LINC02249|LINC02250|LINC02346|LINC02352|LOC100130111|LOC100132202|LOC100996413|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283710|LOC645202|MIR4715|MAGEL2|MIR211|MIR4508|MIR4509-2|MIR4509-3|MKRN3|MTMR10|NDN|NPAP1|NSMCE3|OCA2|OTUD7A|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000150806	15	22765637 - 32509932	15	23319714 - 32217731	150806	160557		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-31175232)x3	APBA2|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8Q|GOLGA8R|GOLGA8S|GOLGA8T|HERC2|IPW|LINC00929|LINC02249|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC100996413|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC106736480|LOC106783506|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR211|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|MTMR10|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000150213	15	22765637 - 31467435	15	23319714 - 31175232	150213	159964		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-32607357)x3	APBA2|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|CHRNA7|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8K|GOLGA8M|GOLGA8N|GOLGA8O|GOLGA8Q|GOLGA8R|GOLGA8S|GOLGA8T|HERC2|IPW|KLF13|LINC00929|LINC02249|LINC02250|LINC02256|LINC02346|LINC02352|LOC100130111|LOC100132202|LOC100996413|LOC101928042|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283710|LOC645202|MAGEL2|MIR211|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|MTMR10|NDN|NPAP1|NSMCE3|OCA2|OTUD7A|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000149631	15	22765637 - 32899558	15	23319714 - 32607357	149631	159382		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-32384654)x1	APBA2|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|GOLGA8G|CHRNA7|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8Q|GOLGA8R|GOLGA8S|GOLGA8T|HERC2|IPW|KLF13|LINC00929|LINC02249|LINC02250|LINC02346|LINC02352|LOC100130111|LOC100132202|LOC100996413|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283710|LOC645202|MAGEL2|MIR211|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|MTMR10|NDN|NPAP1|NSMCE3|OCA2|OTUD7A|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|UBE3A		See cases	Pathogenic(Last reviewed: Apr 16, 2012)	no assertion criteria provided	VCV000149258	15	22765628 - 32676855	15	23319714 - 32384654	149258	159009		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-30073921)x4	APBA2|ATP10A|ATP10A-DT|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 26, 2012)	no assertion criteria provided	VCV000148557	15	22765628 - 30366124	15	23319714 - 30073921	148557	158308		
GRCh38/hg38 15q11.2-13.2(chr15:23319714-30361733)x4	APBA2|ATP10A|ATP10A-DT|CHRFAM7A|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8J|GOLGA8M|GOLGA8S|GOLGA8T|HERC2|IPW|LINC00929|LINC02249|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jun 5, 2011)	no assertion criteria provided	VCV000148504	15	22765628 - 30653936	15	23319714 - 30361733	148504	158255		
GRCh38/hg38 15q11.1-13.2(chr15:20480943-30217181)x3	APBA2|ATP10A|ATP10A-DT|CYFIP1|FAM189A1|FAM30C|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA6L6|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8J|GOLGA8M|GOLGA8S|GOLGA8T|HERC2|IPW|LINC00929|LINC01193|LINC02203|LINC02249|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC101927079|LOC102723623|LOC102724971|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC283683|LOC645202|MAGEL2|MIR1268A|MIR3118-2|MIR3118-3|MIR3118-4|MIR4508|MIR4509-1|MIR4509-2|MIR4509-3|MIR4715|MIR5701-1|MIR5701-2|MIR5701-3|MKRN3|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OR4N4|OR4N4C|POTEB|POTEB2|POTEB3|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Sep 16, 2011)	no assertion criteria provided	VCV000147837	15	20686196 - 30509384	15	20480943 - 30217181	147837	157588		
GRCh38/hg38 15q11.2-13.2(chr15:23319714-30073876)x4	APBA2|ATP10A|ATP10A-DT|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Aug 30, 2010)	no assertion criteria provided	VCV000146726	15	22765637 - 30366079	15	23319714 - 30073876	146726	156477		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-30361733)x4	APBA2|ATP10A|ATP10A-DT|CHRFAM7A|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8J|GOLGA8M|GOLGA8S|GOLGA8T|HERC2|IPW|LINC00929|LINC02249|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000146447	15	22698522 - 30653936	15	23319714 - 30361733	146447	156198		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-30073921)x3	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|SNORD107|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L7|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580|LOC112272581		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059391	15	22863854 - 30366124	15	23319714 - 30073921	59391	73986		
GRCh38/hg38 15q11.2-13.3(chr15:23319714-32607498)x4	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|FAM189A1|NPAP1|LINC02249|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|CHRFAM7A|ARHGAP11B|SNORD107|PWAR1|OTUD7A|GOLGA6L2|LOC283710|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|MIR211|LINC00929|GOLGA8N|LOC645202|GOLGA8S|GOLGA8J|GOLGA8T|GOLGA8K|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA8Q|GOLGA8O|GOLGA6L7|GOLGA8H|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|LINC02256|LOC100996413|GOLGA8R|LOC101928042|PWRN3|GABRG3-AS1|LOC102723623|ARHGAP11B-DT|LINC02352|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059370	15	22698322 - 32899699	15	23319714 - 32607498	59370	73965		
GRCh38/hg38 15q11.2-13.2(chr15:23319714-30109283)x1	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAM189A1|NPAP1|MAGEL2|NSMCE3|ATP10A|SNORD107|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|GOLGA8J|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L7|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580|LOC112272581		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058581	15	22669052 - 30401486	15	23319714 - 30109283	58581	73176		
GRCh38/hg38 15q11.2-13.2(chr15:22144677-30349193)x1	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|LINC02249|MAGEL2|NSMCE3|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|GOLGA6L1|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L7|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|MIR1268A|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058577	15	22432628 - 30641396	15	22144677 - 30349193	58577	73172		
GRCh38/hg38 15q11.1-13.3(chr15:20002460-32121422)x3	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|CYFIP1|FAM189A1|NPAP1|LINC02249|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|SNORD107|TUBGCP5|NIPA1|PWAR1|SNORD115-1|OTUD7A|LOC283683|GOLGA6L2|OR4N4|LOC283710|GOLGA6L1|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|MIR211|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|GOLGA8J|GOLGA8T|GOLGA8M|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|GOLGA8Q|LINC02203|GOLGA6L7|GOLGA8H|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|MIR5701-2|MIR5701-1|SNORD116-30|SNORD115-46|POTEB|LOC100996413|GOLGA8R|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|ARHGAP11B-DT|LINC02352|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|FAM30B|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058569	15	20207713 - 32413623	15	20002460 - 32121422	58569	73164		
GRCh38/hg38 15q11.1-13.2(chr15:20002460-30349193)x3	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|FAM189A1|NPAP1|LINC02249|MAGEL2|NSMCE3|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|GOLGA8J|GOLGA8T|GOLGA8M|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|LINC02203|GOLGA6L7|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|MIR5701-2|MIR5701-1|SNORD116-30|SNORD115-46|POTEB|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|FAM30B|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058568	15	20207713 - 30641396	15	20002460 - 30349193	58568	73163		
GRCh38/hg38 15q11.1-13.1(chr15:19879749-28918517)x3	APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|GOLGA8M|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|LINC02203|GOLGA6L7|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|MIR5701-2|MIR5701-1|SNORD116-30|SNORD115-46|POTEB|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|FAM30B|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058531	15	20085002 - 29210720	15	19879749 - 28918517	58531	73126		
GRCh38/hg38 15q11.2-13.3(chr15:23319714-32607357)x3	APBA2|CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|FAM189A1|NPAP1|LINC02249|KLF13|MAGEL2|MTMR10|NSMCE3|ATP10A|CHRFAM7A|ARHGAP11B|SNORD107|PWAR1|LOC283710|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|MIR211|LINC00929|GOLGA8K|GOLGA8N|LOC645202|GOLGA8S|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|GOLGA8Q|GOLGA8O|GOLGA6L7|GOLGA8H|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|LINC02256|LOC100996413|GOLGA8R|LOC101928042|PWRN3|GABRG3-AS1|LOC102723623|ARHGAP11B-DT|LINC02352|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|OTUD7A|GOLGA6L2		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057412	15	22698522 - 32899558	15	23319714 - 32607357	57412	72007		
GRCh37/hg19 15q11.2-26.3(chr15:22770422-102429112)	ARHGAP11A|ARHGAP11B|ARID3B|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAL|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APBA2|APH1B|AQP9|AQR|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATP10A|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C15orf65|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1|CHRFAM7A|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYFIP1|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|EPB42|ETFA|EXD1|FAH|FAM174B|FAM189A1|FAM214A|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FGF7|FBN1|FBXL22|FBXO22|FBXO22-AS1|FEM1B|FES|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L2|GOLGA8A|GOLGA8B|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HERC2|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IPW|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOC100128979|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAGEL2|MAN2A2|MAN2C1|MAP1A|MAP2K1|MAP2K5|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR211|MIR9-3|MKRN3|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MTFMT|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDN|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NIPA1|NIPA2|NMB|NOP10|NOX5|NPAP1|NPTN|NR2E3|NR2F2|NRG4|NSMCE3|NTRK3|NUSAP1|NUTM1|OAZ2|OCA2|ODF3L1|OIP5|ONECUT1|OR4F15|OR4F6|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PGPEP1L|PHGR1|PIAS1|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNORD115-1|SNORD116-1|SNRPA1|SNRPN|SNUPN|SNURF|SNX1|SNX22|SNX33|SORD|SPATA5L1|SPATA8|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THBS1|THSD4|TICRR|TIPIN|TJP1|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TUBGCP5|TYRO3|UACA|UBAP1L|UBE2Q2|UBE3A|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS18|VPS33B|VPS39|WDR61|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH		See cases	Pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000442892	15	22770422 - 102429112			442892	436554		
GRCh38/hg38 15q13.2-13.3(chr15:30629714-32569425)x3	ARHGAP11B|CHRNA7|FAN1|GOLGA8K|GOLGA8O|KLF13|LINC02256|LINC02352|LOC106736469|LOC106736476|LOC106736477|LOC110121498|LOC112272582|LOC283710|MIR211|MTMR10|OTUD7A|TRPM1		See cases	Pathogenic(Last reviewed: Nov 14, 2012)	no assertion criteria provided	VCV000154725	15	30921917 - 32861626	15	30629714 - 32569425	154725	164479		
GRCh38/hg38 15q13.2-13.3(chr15:30361674-32414682)x3	ARHGAP11B|ARHGAP11B-DT|CHRFAM7A|CHRNA7|FAN1|GOLGA8H|GOLGA8K|GOLGA8Q|GOLGA8R|KLF13|LINC02352|LOC100996413|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272582|LOC283710|MIR211|MTMR10|OTUD7A|TRPM1		See cases	Pathogenic(Last reviewed: Sep 26, 2012)	no assertion criteria provided	VCV000148179	15	30653877 - 32706883	15	30361674 - 32414682	148179	157930		
GRCh38/hg38 15q13.2-13.3(chr15:30361674-32222779)x3	ARHGAP11B|ARHGAP11B-DT|CHRFAM7A|CHRNA7|FAN1|GOLGA8H|GOLGA8Q|GOLGA8R|KLF13|LINC02352|LOC100996413|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272582|LOC283710|MIR211|MTMR10|OTUD7A|TRPM1		See cases	Uncertain significance(Last reviewed: Jun 14, 2011)	no assertion criteria provided	VCV000146427	15	30653877 - 32514980	15	30361674 - 32222779	146427	156178		
GRCh38/hg38 15q11.2-13.3(chr15:23328044-32151843)x3	ARHGAP11B-DT|APBA2|ARHGAP11B|ATP10A|ATP10A-DT|CHRFAM7A|CHRNA7|FAM189A1|FAN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8S|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8Q|GOLGA8R|GOLGA8T|HERC2|IPW|KLF13|LINC00929|LINC02249|LINC02250|LINC02346|LINC02352|LOC100130111|LOC100132202|LOC100996413|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283710|LOC645202|MIR4715|MAGEL2|MIR211|MIR4508|MIR4509-2|MIR4509-3|MKRN3|MTMR10|NDN|NPAP1|NSMCE3|OCA2|OTUD7A|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|UBE3A		See cases	Pathogenic(Last reviewed: Oct 22, 2013)	no assertion criteria provided	VCV000155586	15	23282829 - 32444044	15	23328044 - 32151843	155586	165340		
NM_030632.3(ASXL3):c.3106C>T (p.Arg1036Ter)	ASXL3	R1036*	Bainbridge-Ropers syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000429913	18	31322918	18	33742954	429913	422219		NC_000018.10:33742953:C:T
Single allele	ATP10A|NPAP1|CYFIP1|SNURF|GOLGA6L2|SNORD115-1|SNORD116-1|PWRN2|MAGEL2|TUBGCP5|NIPA1|PWAR1|NDN|SNRPN|NIPA2|PWRN1|GABRB3|PWARSN|PWAR6|UBE3A|OCA2|MKRN3|PWAR4|IPW|GABRA5|GABRG3|PWAR5|HERC2		Angelman syndrome	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000974577	15	22833416 - 28566671			974577	962874		
GRCh37/hg19 15q11.2-13.1(chr15:22816713-28530182)	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625832	15	22816713 - 28530182			625832	614136		
GRCh37/hg19 15q11.2-13.1(chr15:23810184-28525505)	ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Prader-Willi syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625718	15	23810184 - 28525505			625718	614022		
GRCh37/hg19 15q11.2-13.1(chr15:23683783-28530182)	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625717	15	23683783 - 28530182			625717	614021		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28561671)	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625716	15	23615768 - 28561671			625716	614020		
GRCh37/hg19 15q11.2-13.1(chr15:22770994-29050198)	ATP10A|CYFIP1|GABRA5|IPW|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625713	15	22770994 - 29050198			625713	614017		
Single allele	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		Autistic disorder of childhood onset	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545173			15	23319712 - 28800324	545173	535437		
GRCh37/hg19 15q11.2-13.1(chr15:23810397-29213787)	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Autistic disorder of childhood onset|Prominent forehead|Long face|Strabismus|Short attention span|Delayed speech and language development|Intellectual disability|Generalized joint laxity	Pathogenic(Last reviewed: Jan 1, 2017)	criteria provided, single submitter	VCV000523251	15	23810397 - 29213787			523251	514167		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28823722)x3	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Likely pathogenic(Last reviewed: Jul 14, 2015)	no assertion criteria provided	VCV000443973	15	22770421 - 28823722			443973	437635		
GRCh37/hg19 15q11.2-13.1(chr15:23615769-28561097)x3	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Aug 15, 2014)	no assertion criteria provided	VCV000443863	15	23615769 - 28561097			443863	437525		
GRCh37/hg19 15q11.2-13.1(chr15:23290786-28545601)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Feb 15, 2018)	no assertion criteria provided	VCV000443862	15	23290786 - 28545601			443862	437524		
GRCh37/hg19 15q11.2-13.1(chr15:23286571-28540415)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Sep 1, 2015)	no assertion criteria provided	VCV000443860	15	23286571 - 28540415			443860	437522		
GRCh37/hg19 15q11.2-13.1(chr15:23290862-28958779)x3	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Likely pathogenic(Last reviewed: May 18, 2015)	no assertion criteria provided	VCV000443641	15	23290862 - 28958779			443641	437303		
GRCh37/hg19 15q11.2-13.1(chr15:23615769-28953483)x3	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Likely pathogenic(Last reviewed: Feb 1, 2016)	no assertion criteria provided	VCV000443510	15	23615769 - 28953483			443510	437172		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28660038)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jul 6, 2015)	no assertion criteria provided	VCV000443375	15	22770421 - 28660038			443375	437037		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28561671)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jun 23, 2014)	no assertion criteria provided	VCV000443143	15	22770421 - 28561671			443143	436805		
GRCh37/hg19 15q11.2-13.1(chr15:23615769-28163991)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	VCV000443030	15	23615769 - 28163991			443030	436692		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28534245)x3	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: May 16, 2014)	no assertion criteria provided	VCV000442976	15	23620191 - 28534245			442976	436638		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28958779)x3	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Nov 3, 2014)	no assertion criteria provided	VCV000442845	15	23620191 - 28958779			442845	436507		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28415107)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jun 16, 2014)	no assertion criteria provided	VCV000442844	15	22770421 - 28415107			442844	436506		
GRCh37/hg19 15q11.2-13.1(chr15:23615769-28561671)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Aug 5, 2015)	no assertion criteria provided	VCV000442664	15	23615769 - 28561671			442664	436326		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28540415)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Dec 31, 2014)	no assertion criteria provided	VCV000442410	15	23620191 - 28540415			442410	436072		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29009042)x3	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	VCV000442380	15	22770421 - 29009042			442380	436042		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28709715)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Aug 13, 2015)	no assertion criteria provided	VCV000442317	15	23620191 - 28709715			442317	435979		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28561670)x4	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: May 16, 2014)	no assertion criteria provided	VCV000442248	15	22770421 - 28561670			442248	435910		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28526410)x3	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Likely pathogenic(Last reviewed: Aug 26, 2015)	no assertion criteria provided	VCV000442180	15	22770421 - 28526410			442180	435842		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28539975)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Apr 2, 2015)	no assertion criteria provided	VCV000442072	15	23620191 - 28539975			442072	435734		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28540415)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Feb 5, 2015)	no assertion criteria provided	VCV000441794	15	23615768 - 28540415			441794	435456		
GRCh37/hg19 15q11.2-13.1(chr15:23625784-28540345)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Sep 16, 2014)	no assertion criteria provided	VCV000441725	15	23625784 - 28540345			441725	435387		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29062203)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jul 21, 2014)	no assertion criteria provided	VCV000441588	15	22770421 - 29062203			441588	435250		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28534359)x1	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Aug 27, 2015)	no assertion criteria provided	VCV000441569	15	23620191 - 28534359			441569	435231		
GRCh37/hg19 15q11.2-13.1(chr15:23707452-28406650)x1	ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000395546	15	23707452 - 28406650			395546	382439		
GRCh37/hg19 15q11.2-13.1(chr15:23707452-28406650)x3	ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000395545	15	23707452 - 28406650			395545	382438		
GRCh37/hg19 15q11.2-13.1(chr15:22815306-28406650)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000395128	15	22815306 - 28406650			395128	382021		
GRCh37/hg19 15q11.2-13.1(chr15:23487423-28406650)x3	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000395075	15	23487423 - 28406650			395075	381968		
GRCh37/hg19 15q11.2-13.1(chr15:22698522-28406650)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000394779	15	22698522 - 28406650			394779	381672		
GRCh37/hg19 15q11.1-13.1(chr15:20190548-28406650)	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000394240	15	20190548 - 28406650			394240	381133		
GRCh37/hg19 15q11.2-13.1(chr15:20733395-28406650)x3	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic	no assertion criteria provided	VCV000393841	15	20733395 - 28406650			393841	380734		
GRCh37/hg19 15q11.2-13.1(chr15:22815306-28406709)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253603	15	22815306 - 28406709			253603	248051		
GRCh37/hg19 15q11.2-13.1(chr15:22698522-28406709)x1	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253497	15	22698522 - 28406709			253497	247945		
GRCh37/hg19 15q11.2-13.1(chr15:20733395-28406709)x3	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253444	15	20733395 - 28406709			253444	247892		
Single allele	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236373	15	23624148 - 28790734			236373	237928		
Single allele	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA6L6|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236372	15	20044342 - 28924405			236372	237927		
Single allele	ATP10A|CYFIP1|GOLGA6L1|GOLGA6L2|GOLGA6L6|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OR4M2|OR4N4|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236371	15	20306549 - 26208861			236371	237926		
Single allele	ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|OCA2|PWAR1|PWAR4|SNORD115-1|UBE3A		Autism spectrum disorder	Pathogenic(Last reviewed: Oct 12, 2015)	criteria provided, single submitter	VCV000236370	15	25334522 - 28369712			236370	237925		
GRCh38/hg38 15q11.2-13.1(chr15:23370622-28300209)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 18, 2014)	no assertion criteria provided	VCV000155677	15	23615769 - 28545355	15	23370622 - 28300209	155677	165431		
GRCh38/hg38 15q11.2-12(chr15:24051424-27222420)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|MIR4715|NPAP1|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 10, 2014)	no assertion criteria provided	VCV000155649	15	24296571 - 27467567	15	24051424 - 27222420	155649	165403		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28294829)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 10, 2014)	no assertion criteria provided	VCV000155635	15	22770421 - 28539975	15	23328044 - 28294829	155635	165389		
GRCh38/hg38 15q11.2-13.1(chr15:23444168-28277347)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 22, 2013)	no assertion criteria provided	VCV000155599	15	23689315 - 28522493	15	23444168 - 28277347	155599	165353		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28478308)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000155416	15	22770421 - 28723454	15	23328044 - 28478308	155416	165170		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28713633)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jun 25, 2013)	no assertion criteria provided	VCV000155412	15	22770421 - 28958779	15	23328044 - 28713633	155412	165166		
GRCh38/hg38 15q11.2-13.1(chr15:23370622-28389912)x1	ATP10A|ATP10A-DT|GABRA5|HERC2|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jun 4, 2013)	no assertion criteria provided	VCV000155376	15	23615769 - 28635058	15	23370622 - 28389912	155376	165130		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28683584)x4	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 19, 2013)	no assertion criteria provided	VCV000155224	15	22770421 - 28928730	15	23328044 - 28683584	155224	164978		
GRCh38/hg38 15q11.2-13.1(chr15:23422864-28460005)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	VCV000155118	15	23668011 - 28801348	15	23422864 - 28460005	155118	164872		
GRCh38/hg38 15q11.2-13.1(chr15:23422864-28446314)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	VCV000155116	15	23668011 - 28691460	15	23422864 - 28446314	155116	164870		
GRCh38/hg38 15q11.2-13.1(chr15:23398620-28280314)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 24, 2012)	no assertion criteria provided	VCV000154787	15	23643767 - 28525460	15	23398620 - 28280314	154787	164541		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Oct 9, 2012)	no assertion criteria provided	VCV000154728	15	22765628 - 28912057	15	22358243 - 28481444	154728	164482		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28314256)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 28, 2012)	no assertion criteria provided	VCV000154699	15	22765628 - 28559402	15	23319714 - 28314256	154699	164453		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000154646	15	22765628 - 29085896	15	22358243 - 28481444	154646	164400		
GRCh38/hg38 15q11.2-13.1(chr15:23370621-28578576)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 10, 2014)	no assertion criteria provided	VCV000154084	15	23615768 - 28823722	15	23370621 - 28578576	154084	163835		
GRCh38/hg38 15q11.2-13.1(chr15:23375044-28300358)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Nov 5, 2013)	no assertion criteria provided	VCV000153993	15	23620191 - 28545504	15	23375044 - 28300358	153993	163744		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28300358)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 22, 2013)	no assertion criteria provided	VCV000153934	15	23286571 - 28545504	15	23328044 - 28300358	153934	163685		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28464569)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 22, 2013)	no assertion criteria provided	VCV000153884	15	22770421 - 28709715	15	23328044 - 28464569	153884	163635		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28315123)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 18, 2013)	no assertion criteria provided	VCV000153815	15	22770421 - 28560269	15	23328044 - 28315123	153815	163566		
GRCh38/hg38 15q11.2-13.1(chr15:23370621-28414765)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Aug 2, 2013)	no assertion criteria provided	VCV000153630	15	23615768 - 28659911	15	23370621 - 28414765	153630	163381		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28836775)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 24, 2014)	no assertion criteria provided	VCV000153283	15	22770421 - 29081921	15	23328044 - 28836775	153283	163034		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|PWAR4|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	VCV000152733	15	22765628 - 28976193	15	22358243 - 28481444	152733	162484		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28300209)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 11, 2013)	no assertion criteria provided	VCV000152316	15	23286571 - 28545355	15	23328044 - 28300209	152316	162067		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28446314)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Nov 26, 2012)	no assertion criteria provided	VCV000152057	15	22765628 - 28691460	15	23319714 - 28446314	152057	161808		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28154050)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000151937	15	23569415 - 28399196	15	23328044 - 28154050	151937	161688		
GRCh38/hg38 15q11.2-13.1(chr15:21581401-28332641)x3	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8S|HERC2|IPW|LINC00929|LINC02203|LINC02250|LINC02346|LOC101927079|LOC102723623|LOC102724971|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|MAGEL2|MIR1268A|MIR3118-4|MIR4508|MIR4509-1|MIR4715|MIR5701-3|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|OR4M2|OR4N4|OR4N4C|POTEB|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000151934	15	22304596 - 28577787	15	21581401 - 28332641	151934	161685		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28578576)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Feb 16, 2015)	no assertion criteria provided	VCV000151766	15	22770421 - 28823722	15	23328044 - 28578576	151766	161517		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|NPAP1|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Oct 9, 2012)	no assertion criteria provided	VCV000151535	15	22765628 - 28940098	15	22358243 - 28481444	151535	161286		
GRCh38/hg38 15q11.2-13.1(chr15:23375044-28300209)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jun 22, 2015)	no assertion criteria provided	VCV000151262	15	23620191 - 28545355	15	23375044 - 28300209	151262	161013		
GRCh38/hg38 15q11.2-13.1(chr15:23370621-28289312)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 31, 2014)	no assertion criteria provided	VCV000151256	15	23615768 - 28534458	15	23370621 - 28289312	151256	161007		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28638603)x4	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8G|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000151222	15	22652060 - 28883749	15	23328044 - 28638603	151222	160973		
GRCh38/hg38 15q11.2-13.1(chr15:23999707-28314256)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MIR4715|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jul 2, 2012)	no assertion criteria provided	VCV000150851	15	24244854 - 28557186	15	23999707 - 28314256	150851	160602		
GRCh38/hg38 15q11.2-13.1(chr15:23410917-28446301)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000150488	15	23656064 - 28691447	15	23410917 - 28446301	150488	160239		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28446301)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000150279	15	23300254 - 28691447	15	23319714 - 28446301	150279	160030		
GRCh38/hg38 15q11.2-13.1(chr15:23462288-28446301)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA8F|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000149915	15	23707435 - 28691447	15	23462288 - 28446301	149915	159666		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|PWAR4|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jul 18, 2014)	no assertion criteria provided	VCV000149075	15	22765628 - 29006852	15	22358243 - 28481444	149075	158826		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x4	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Nov 27, 2012)	no assertion criteria provided	VCV000149074	15	22765628 - 29006852	15	22358243 - 28481444	149074	158825		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x4	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Nov 11, 2011)	no assertion criteria provided	VCV000148881	15	22765628 - 28912057	15	22358243 - 28481444	148881	158632		
GRCh38/hg38 15q11.2-12(chr15:23319714-25980547)x3	ATP10A|ATP10A-DT|GOLGA6L2|GOLGA8S|IPW|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|UBE3A		See cases	Pathogenic(Last reviewed: Nov 4, 2011)	no assertion criteria provided	VCV000148846	15	23179889 - 26225694	15	23319714 - 25980547	148846	158597		
GRCh38/hg38 15q11.2-13.1(chr15:23422864-28280314)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: May 7, 2012)	no assertion criteria provided	VCV000148318	15	23668011 - 28525460	15	23422864 - 28280314	148318	158069		
GRCh38/hg38 15q11.2-13.1(chr15:23523934-28280314)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Mar 21, 2011)	no assertion criteria provided	VCV000148195	15	23769081 - 28525460	15	23523934 - 28280314	148195	157946		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28314256)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: May 6, 2011)	no assertion criteria provided	VCV000148004	15	22765628 - 28557186	15	23319714 - 28314256	148004	157755		
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28694952)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA8F|GOLGA8G|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000147960	15	23707452 - 28940098	15	23462305 - 28694952	147960	157711		
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28314256)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000147819	15	23707452 - 28557186	15	23462305 - 28314256	147819	157570		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28280314)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 14, 2010)	no assertion criteria provided	VCV000147648	15	22784523 - 28525460	15	23319714 - 28280314	147648	157399		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28314256)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Oct 19, 2010)	no assertion criteria provided	VCV000146597	15	22698522 - 28557186	15	23319714 - 28314256	146597	156348		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|NPAP1|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: May 27, 2010)	no assertion criteria provided	VCV000146448	15	22698522 - 29085896	15	22358243 - 28481444	146448	156199		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x4	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|NPAP1|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Jan 27, 2011)	no assertion criteria provided	VCV000146278	15	22698522 - 28940098	15	22358243 - 28481444	146278	156029		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275167)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000146185	15	23300238 - 28520313	15	23319714 - 28275167	146185	155936		
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28275167)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Aug 5, 2011)	no assertion criteria provided	VCV000146184	15	23707452 - 28520313	15	23462305 - 28275167	146184	155935		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28154050)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000145987	15	22860857 - 28399196	15	23328044 - 28154050	145987	155738		
GRCh38/hg38 15q11.2-13.1(chr15:23410917-28275170)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Aug 30, 2010)	no assertion criteria provided	VCV000145389	15	23656064 - 28520316	15	23410917 - 28275170	145389	155140		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000145368	15	22765637 - 29085888	15	22358243 - 28481444	145368	155119		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|PWAR4|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Sep 21, 2012)	no assertion criteria provided	VCV000145366	15	22765637 - 29085888	15	22358243 - 28481444	145366	155117		
GRCh38/hg38 15q11.2-13.1(chr15:23462288-28694922)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA8F|GOLGA8G|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100132202|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jul 30, 2010)	no assertion criteria provided	VCV000145322	15	23707435 - 28940068	15	23462288 - 28694922	145322	155073		
GRCh38/hg38 15q11.2-13.1(chr15:23439508-28154050)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Apr 30, 2011)	no assertion criteria provided	VCV000145034	15	23684655 - 28399196	15	23439508 - 28154050	145034	154785		
GRCh38/hg38 15q11.2-13.1(chr15:23462288-28314291)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jun 30, 2010)	no assertion criteria provided	VCV000144667	15	23707435 - 28557186	15	23462288 - 28314291	144667	154418		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28347620)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: May 30, 2010)	no assertion criteria provided	VCV000144600	15	23353638 - 28592766	15	23319714 - 28347620	144600	154351		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275170)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: May 30, 2010)	no assertion criteria provided	VCV000144586	15	22765637 - 28520316	15	23319714 - 28275170	144586	154337		
GRCh38/hg38 15q11.2-13.1(chr15:23462288-28275170)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: May 30, 2010)	no assertion criteria provided	VCV000144574	15	23707435 - 28520316	15	23462288 - 28275170	144574	154325		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x4	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000144122	15	22698522 - 29030517	15	22358243 - 28481444	144122	153873		
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28275167)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 19, 2014)	no assertion criteria provided	VCV000033733	15	23707452 - 28520313	15	23462305 - 28275167	33733	42398		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000033590	15	22698522 - 29030517	15	22358243 - 28481444	33590	42255		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000033584	15	22698522 - 29085896	15	22358243 - 28481444	33584	42249		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28275167)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000032921	15	23656936 - 28520313	15	23411789 - 28275167	32921	41586		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28446314)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000032878	15	22698522 - 28691460	15	23319714 - 28446314	32878	41543		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28275167)x3	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Feb 4, 2013)	no assertion criteria provided	VCV000032168	15	23656936 - 28520313	15	23411789 - 28275167	32168	40833		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275167)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: May 27, 2010)	no assertion criteria provided	VCV000032126	15	23300238 - 28520313	15	23319714 - 28275167	32126	40791		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28275167)x3	ATP10A-DT|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD115-21|SNORD115-22|SNORD115-13|SNORD115-14|SNORD115-47|LOC112272578|LOC112272579|TRE-TTC2-2|SNORD115-9|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-48|SNORD115-24|SNORD115-27|PWAR6|MIR4508|LINC02346|SNORD116-28|SNORD116-29|PWRN3|GABRG3-AS1|SNHG14|MIR4715|SNORD116-30|SNORD115-46|SNORD115-15|SNORD115-16|SNORD115-17|PWRN4|LINC02250|SNORD107|PWAR1|GABRA5|GOLGA6L2|SNORD116-4|SNORD116-5|SNORD116-6|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-23|SNORD115-25|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD116-1|SNORD116-2|SNORD116-3|HERC2|SNORD116-19|PWRN1|PWRN2|SNORD115-4|SNORD115-5|SNORD115-6|SNORD116-23|SNORD115-2|SNORD116-26|SNORD115-12|SNORD116-27|SNORD115-3|SNORD116-24|SNORD116-25|SNORD115-7|SNORD115-8|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD116-9|SNORD116-11|SNORD116-12|SNORD116-13|GABRB3|GABRG3|IPW|NDN|OCA2|SNORD116-10|SNRPN|UBE3A|MKRN3|PWAR5|SNORD116-14|SNORD116-15|SNORD116-16|SNURF|NPAP1|MAGEL2|ATP10A|SNORD115-32|SNORD115-28|SNORD115-45|SNORD108|SNORD109A|SNORD115-43|SNORD115-44|SNORD116-7|SNORD116-8|SNORD109B|SNORD115-1|SNORD64|PWAR4|LOC112272580|SNORD115-10|SNORD115-11		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000160797	15	23656936 - 28520313	15	23411789 - 28275167	160797	170641		
NM_015570.4(AUTS2):c.3169G>A (p.Gly1057Ser)	AUTS2	G1057S, G1033S	Chromosome 15q11-q13 duplication syndrome|not provided	Uncertain significance(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000386816	7	70255371	7	70790385	386816	371356	rs1057522609	NC_000007.14:70790384:G:A
NM_001323289.2(CDKL5):c.463+8A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV001169545	X	18600078	X	18581958	1169545	1159507		NC_000023.11:18581957:A:G
NM_001323289.2(CDKL5):c.145+5AT[14]	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV001169508	X	18582646 - 18582647	X	18564526 - 18564527	1169508	1159506		NC_000023.11:18564526:ATATATATATATATATATATATAT:ATATATATATATATATATATATATATAT
NM_001323289.2(CDKL5):c.145+5AT[10]	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV001168486	X	18582647 - 18582650	X	18564527 - 18564530	1168486	1159505		NC_000023.11:18564526:ATATATATATATATATATATATAT:ATATATATATATATATATAT
NM_001323289.2(CDKL5):c.2256A>G (p.Arg752=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001165618	X	18631375	X	18613255	1165618	1159511		NC_000023.11:18613254:A:G
NM_001323289.2(CDKL5):c.1422C>T (p.Pro474=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001165315	X	18622466	X	18604346	1165315	1159509		NC_000023.11:18604345:C:T
NM_001323289.2(CDKL5):c.2022C>G (p.Ser674=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign/Likely benign(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001165086	X	18627008	X	18608888	1165086	1159510		NC_000023.11:18608887:C:G
NM_001323289.2(CDKL5):c.1088A>G (p.Asn363Ser)	CDKL5	N363S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Mar 18, 2020)	criteria provided, single submitter	VCV001164539	X	18622132	X	18604012	1164539	1159508		NC_000023.11:18604011:A:G
NM_001323289.2(CDKL5):c.555C>T (p.Gly185=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV001160525	X	18606074	X	18587954	1160525	1150624		NC_000023.11:18587953:C:T
NM_001323289.2(CDKL5):c.2152+10C>T	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 4, 2019)	criteria provided, single submitter	VCV001158467	X	18627700	X	18609580	1158467	1150630		NC_000023.11:18609579:C:T
NM_001323289.2(CDKL5):c.234A>G (p.Ala78=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV001158321	X	18593562	X	18575442	1158321	1150622		NC_000023.11:18575441:A:G
NM_001323289.2(CDKL5):c.1389G>A (p.Lys463=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV001158179	X	18622433	X	18604313	1158179	1150627		NC_000023.11:18604312:G:A
NM_001323289.2(CDKL5):c.858C>T (p.Tyr286=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001155753	X	18616614	X	18598494	1155753	1150626		NC_000023.11:18598493:C:T
NM_000330.4(RS1):c.184+3151C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001153917	X	18671622	X	18653502	1153917	1150635		NC_000023.11:18653501:G:A
NM_001323289.2(CDKL5):c.1827T>C (p.His609=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001150297	X	18622871	X	18604751	1150297	1150628		NC_000023.11:18604750:T:C
NM_001323289.2(CDKL5):c.2679C>G (p.Pro893=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001149266	X	18646673	X	18628553	1149266	1150631		NC_000023.11:18628552:C:G
NM_001323289.2(CDKL5):c.810A>G (p.Leu270=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001145320	X	18613533	X	18595413	1145320	1150625		NC_000023.11:18595412:A:G
NM_001323289.2(CDKL5):c.2040G>A (p.Lys680=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001144637	X	18627026	X	18608906	1144637	1150629		NC_000023.11:18608905:G:A
NM_001323289.2(CDKL5):c.480G>T (p.Leu160=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001142508	X	18602399	X	18584279	1142508	1150623		NC_000023.11:18584278:G:T
NM_000330.4(RS1):c.326+1190T>C	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001140537	X	18664121	X	18646001	1140537	1129584		NC_000023.11:18646000:A:G
NM_001323289.2(CDKL5):c.2497-6_2497-3del	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV001139847	X	18646480 - 18646483	X	18628360 - 18628363	1139847	1129578		NC_000023.11:18628359:CTTTCTTTC:CTTTC
NM_001323289.2(CDKL5):c.1947T>C (p.Pro649=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001133509	X	18626933	X	18608813	1133509	1129572		NC_000023.11:18608812:T:C
NM_001323289.2(CDKL5):c.1968G>A (p.Glu656=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: May 22, 2020)	criteria provided, single submitter	VCV001132556	X	18626954	X	18608834	1132556	1129573		NC_000023.11:18608833:G:A
NM_001323289.2(CDKL5):c.2067A>G (p.Pro689=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Mar 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001131537	X	18627605	X	18609485	1131537	1129575		NC_000023.11:18609484:A:G
NM_001323289.2(CDKL5):c.2031A>G (p.Thr677=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 24, 2020)	criteria provided, single submitter	VCV001130933	X	18627017	X	18608897	1130933	1129574		NC_000023.11:18608896:A:G
NM_001323289.2(CDKL5):c.1287A>G (p.Pro429=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV001129930	X	18622331	X	18604211	1129930	1129571		NC_000023.11:18604210:A:G
NM_001323289.2(CDKL5):c.2152+9A>C	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV001128122	X	18627699	X	18609579	1128122	1129576		NC_000023.11:18609578:A:C
NM_001323289.2(CDKL5):c.2244C>T (p.Asn748=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 9, 2019)	criteria provided, single submitter	VCV001125161	X	18631363	X	18613243	1125161	1129577		NC_000023.11:18613242:C:T
NM_001323289.2(CDKL5):c.21T>C (p.Gly7=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV001117209	X	18525237	X	18507117	1117209	1108211		NC_000023.11:18507116:T:C
NM_000330.4(RS1):c.184+3124T>C	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001117061	X	18671649	X	18653529	1117061	1108222		NC_000023.11:18653528:A:G
NM_001323289.2(CDKL5):c.603T>C (p.Leu201=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign/Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV001112123	X	18606122	X	18588002	1112123	1108212		NC_000023.11:18588001:T:C
NM_001323289.2(CDKL5):c.1413C>T (p.Asp471=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001110742	X	18622457	X	18604337	1110742	1108215		NC_000023.11:18604336:C:T
NM_001323289.2(CDKL5):c.1649G>A (p.Arg550Gln)	CDKL5	R550Q	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV001110449	X	18622693	X	18604573	1110449	1108216		NC_000023.11:18604572:G:A
NM_001323289.2(CDKL5):c.1317A>G (p.Arg439=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001107826	X	18622361	X	18604241	1107826	1108214		NC_000023.11:18604240:A:G
NM_001323289.2(CDKL5):c.1086C>T (p.Ala362=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV001106381	X	18622130	X	18604010	1106381	1108213		NC_000023.11:18604009:C:T
NM_001323289.2(CDKL5):c.1989G>A (p.Ser663=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV001099625	X	18626975	X	18608855	1099625	1108217		NC_000023.11:18608854:G:A
NM_000330.4(RS1):c.326+1160T>C	CDKL5|RS1	Q913R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 10, 2020)	criteria provided, single submitter	VCV001093995	X	18664151	X	18646031	1093995	1086509		NC_000023.11:18646030:A:G
NM_001323289.2(CDKL5):c.2668C>A (p.Arg890=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jan 19, 2020)	criteria provided, single submitter	VCV001091899	X	18646662	X	18628542	1091899	1086503		NC_000023.11:18628541:C:A
NM_001323289.2(CDKL5):c.1233C>T (p.Ala411=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001087727	X	18622277	X	18604157	1087727	1086502		NC_000023.11:18604156:C:T
NM_001323289.2(CDKL5):c.1213CTT[1] (p.Leu406del)	CDKL5	L406del	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001087069	X	18622257 - 18622259	X	18604137 - 18604139	1087069	1086501		NC_000023.11:18604136:CTTCTT:CTT
NM_001323289.2(CDKL5):c.2579_2582dup (p.Leu862fs)	CDKL5	L862fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001075877	X	18646570 - 18646571	X	18628450 - 18628451	1075877	1065259		NC_000023.11:18628450:CCAGCC:CCAGCCAGCC
NM_001323289.2(CDKL5):c.554+4A>G	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001073273	X	18602477	X	18584357	1073273	1065254		NC_000023.11:18584356:A:G
NM_001323289.2(CDKL5):c.1584dup (p.Ser529fs)	CDKL5	S529fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001072905	X	18622626 - 18622627	X	18604506 - 18604507	1072905	1065256		NC_000023.11:18604506:CC:CCC
NM_001323289.2(CDKL5):c.513C>G (p.Tyr171Ter)	CDKL5	Y171*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001072862	X	18602432	X	18584312	1072862	1065251		NC_000023.11:18584311:C:G
NM_001323289.2(CDKL5):c.1053_1056dup (p.Leu353fs)	CDKL5	L353fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jun 28, 2020)	criteria provided, single submitter	VCV001072660	X	18622096 - 18622097	X	18603976 - 18603977	1072660	1065255		NC_000023.11:18603976:AGGC:AGGCAGGC
NM_001323289.2(CDKL5):c.1976_1977del (p.Val659fs)	CDKL5	V659fs	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001072616	X	18626960 - 18626961	X	18608840 - 18608841	1072616	1065258		NC_000023.11:18608839:TGTG:TG
NM_001323289.2(CDKL5):c.194G>C (p.Arg65Pro)	CDKL5	R65P	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001072615	X	18593522	X	18575402	1072615	1065250		NC_000023.11:18575401:G:C
NM_001323289.2(CDKL5):c.532C>G (p.Arg178Gly)	CDKL5	R178G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001071237	X	18602451	X	18584331	1071237	1065253		NC_000023.11:18584330:C:G
NM_001323289.2(CDKL5):c.1927C>T (p.Gln643Ter)	CDKL5	Q643*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV001070908	X	18622971	X	18604851	1070908	1065257		NC_000023.11:18604850:C:T
NC_000023.10:g.(?_18534398_18600033del	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001070861					1070861	1058210		
NC_000023.10:g.(?_18582587)_(18627700_?)dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 23, 2020)	criteria provided, single submitter	VCV001070860	X	18582587 - 18627700			1070860	1058211		
NC_000023.10:g.(?_18525211)_(18528980_?)dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV001070859	X	18525211 - 18528980			1070859	1058209		
NM_001323289.2(CDKL5):c.527G>A (p.Trp176Ter)	CDKL5	W176*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001070360	X	18602446	X	18584326	1070360	1065252		NC_000023.11:18584325:G:A
NM_001323289.2(CDKL5):c.2606del (p.Asn869fs)	CDKL5	N869fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV001070205	X	18646596	X	18628476	1070205	1065260		NC_000023.11:18628475:AAAAA:AAAA
NM_001323289.2(CDKL5):c.256T>G (p.Tyr86Asp)	CDKL5	Y86D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001067592	X	18593584	X	18575464	1067592	1056750		NC_000023.11:18575463:T:G
NM_001323289.2(CDKL5):c.146-2A>C	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001067367	X	18593472	X	18575352	1067367	1056749		NC_000023.11:18575351:A:C
NM_001323289.2(CDKL5):c.404-2_412del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001067235	X	18600008 - 18600018	X	18581888 - 18581898	1067235	1056751		NC_000023.11:18581887:CAGATATAAAAC:C
NM_001323289.2(CDKL5):c.601_603del (p.Leu201del)	CDKL5	L201del	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001062746	X	18606118 - 18606120	X	18587998 - 18588000	1062746	1052364		NC_000023.11:18587997:TTCTT:TT
NM_001323289.2(CDKL5):c.2070C>G (p.His690Gln)	CDKL5	H690Q	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001061053	X	18627608	X	18609488	1061053	1052367		NC_000023.11:18609487:C:G
NM_001323289.2(CDKL5):c.1910C>G (p.Ala637Gly)	CDKL5	A637G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001058049	X	18622954	X	18604834	1058049	1052366		NC_000023.11:18604833:C:G
NM_001323289.2(CDKL5):c.238C>T (p.Arg80Cys)	CDKL5	R80C	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001053624	X	18593566	X	18575446	1053624	1052362		NC_000023.11:18575445:C:T
NM_001323289.2(CDKL5):c.217G>A (p.Val73Met)	CDKL5	V73M	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001052408	X	18593545	X	18575425	1052408	1052361		NC_000023.11:18575424:G:A
NM_001323289.2(CDKL5):c.436A>G (p.Asn146Asp)	CDKL5	N146D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001052159	X	18600043	X	18581923	1052159	1052363		NC_000023.11:18581922:A:G
NM_001323289.2(CDKL5):c.761A>G (p.His254Arg)	CDKL5	H254R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2020)	criteria provided, conflicting interpretations	VCV001051353	X	18613484	X	18595364	1051353	1052365		NC_000023.11:18595363:A:G
NM_001323289.2(CDKL5):c.2556G>A (p.Pro852=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Jun 29, 2020)	criteria provided, conflicting interpretations	VCV001046637	X	18646550	X	18628430	1046637	1035440		NC_000023.11:18628429:G:A
NM_001323289.2(CDKL5):c.379C>G (p.His127Asp)	CDKL5	H127D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV001046503	X	18598064	X	18579944	1046503	1035435		NC_000023.11:18579943:C:G
NM_000330.4(RS1):c.185-3127del	CDKL5|RS1	P950fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001045972	X	18668579	X	18650459	1045972	1035442		NC_000023.11:18650458:CCC:CC
NM_001323289.2(CDKL5):c.1027A>G (p.Ser343Gly)	CDKL5	S343G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001043238	X	18622071	X	18603951	1043238	1035438		NC_000023.11:18603950:A:G
NM_000330.4(RS1):c.184+3173C>T	CDKL5|RS1	R1010K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001040769	X	18671600	X	18653480	1040769	1035443		NC_000023.11:18653479:G:A
NM_001323289.2(CDKL5):c.2014A>T (p.Thr672Ser)	CDKL5	T672S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001040215	X	18627000	X	18608880	1040215	1035439		NC_000023.11:18608879:A:T
NM_001323289.2(CDKL5):c.412C>G (p.Pro138Ala)	CDKL5	P138A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001038592	X	18600019	X	18581899	1038592	1035436		NC_000023.11:18581898:C:G
NM_001323289.2(CDKL5):c.424T>G (p.Leu142Val)	CDKL5	L142V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001037382	X	18600031	X	18581911	1037382	1035437		NC_000023.11:18581910:T:G
NM_001323289.2(CDKL5):c.1404C>G (p.Ser468Arg)	CDKL5	S468R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001026357	X	18622448	X	18604328	1026357	1014854		NC_000023.11:18604327:C:G
NM_001323289.2(CDKL5):c.915T>C (p.Arg305=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001025252	X	18616671	X	18598551	1025252	1014852		NC_000023.11:18598550:T:C
NM_000330.4(RS1):c.185-3110G>C	CDKL5|RS1	P944A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001024601	X	18668562	X	18650442	1024601	1014860		NC_000023.11:18650441:C:G
NM_001323289.2(CDKL5):c.1602A>C (p.Arg534Ser)	CDKL5	R534S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Aug 15, 2020)	criteria provided, single submitter	VCV001022264	X	18622646	X	18604526	1022264	1014855		NC_000023.11:18604525:A:C
NM_001323289.2(CDKL5):c.554+5G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001020776	X	18602478	X	18584358	1020776	1014850		NC_000023.11:18584357:G:A
NM_001323289.2(CDKL5):c.1273C>T (p.Pro425Ser)	CDKL5	P425S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001020368	X	18622317	X	18604197	1020368	1014853		NC_000023.11:18604196:C:T
NM_001323289.2(CDKL5):c.794T>C (p.Ile265Thr)	CDKL5	I265T	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 22, 2020)	criteria provided, single submitter	VCV001018419	X	18613517	X	18595397	1018419	1014851		NC_000023.11:18595396:T:C
NM_000330.4(RS1):c.184+3152G>A	CDKL5|RS1	A1017V	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001017245	X	18671621	X	18653501	1017245	1014861		NC_000023.11:18653500:C:T
NC_000023.10:g.(?_18671542)_(18671664_?)del	CDKL5|RS1		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001015176	X	18671542 - 18671664			1015176	1001921		
NM_001323289.2(CDKL5):c.2236G>A (p.Gly746Arg)	CDKL5	G746R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001013832	X	18631355	X	18613235	1013832	1014857		NC_000023.11:18613234:G:A
NM_001323289.2(CDKL5):c.377G>C (p.Cys126Ser)	CDKL5	C126S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001009865	X	18598062	X	18579942	1009865	999705		NC_000023.11:18579941:G:C
NM_001323289.2(CDKL5):c.1076G>C (p.Gly359Ala)	CDKL5	G359A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001006373	X	18622120	X	18604000	1006373	999707		NC_000023.11:18603999:G:C
NM_001323289.2(CDKL5):c.593G>A (p.Gly198Asp)	CDKL5	G198D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 23, 2020)	criteria provided, single submitter	VCV001006298	X	18606112	X	18587992	1006298	999706		NC_000023.11:18587991:G:A
NM_001323289.2(CDKL5):c.2171A>T (p.Asp724Val)	CDKL5	D724V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001004575	X	18631290	X	18613170	1004575	999709		NC_000023.11:18613169:A:T
NM_001323289.2(CDKL5):c.1337C>T (p.Ser446Leu)	CDKL5	S446L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 17, 2020)	criteria provided, single submitter	VCV001003060	X	18622381	X	18604261	1003060	999708		NC_000023.11:18604260:C:T
NM_001323289.2(CDKL5):c.135G>T (p.Lys45Asn)	CDKL5	K45N	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001000784	X	18582632	X	18564512	1000784	999703		NC_000023.11:18564511:G:T
NM_001323289.2(CDKL5):c.282+5G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV000999655	X	18593615	X	18575495	999655	999704		NC_000023.11:18575494:G:A
NM_001323289.2(CDKL5):c.2581C>T (p.Pro861Ser)	CDKL5	P861S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000998581	X	18646575	X	18628455	998581	999710		NC_000023.11:18628454:C:T
NM_001323289.2(CDKL5):c.2066C>T (p.Pro689Leu)	CDKL5	P689L	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000972202	X	18627604	X	18609484	972202	959218		NC_000023.11:18609483:C:T
NM_001323289.2(CDKL5):c.2153-64_2153-5delinsG	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000971254	X	18631208 - 18631267	X	18613088 - 18613147	971254	960978		
NM_001323289.2(CDKL5):c.878dup (p.Asn293fs)	CDKL5	N293fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000970805	X	18616632 - 18616633	X	18598512 - 18598513	970805	959217		NC_000023.11:18598512:AA:AAA
NM_001323289.2(CDKL5):c.2152+5G>T	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 27, 2019)	criteria provided, single submitter	VCV000969068	X	18627695	X	18609575	969068	960977		NC_000023.11:18609574:G:T
NM_001323289.2(CDKL5):c.2256_2263del (p.Arg752fs)	CDKL5	R752fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV000969040	X	18631373 - 18631380	X	18613253 - 18613260	969040	959219		NC_000023.11:18613252:AGACAACCAG:AG
NM_001323289.2(CDKL5):c.103A>C (p.Thr35Pro)	CDKL5	T35P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000968754	X	18582600	X	18564480	968754	959216		NC_000023.11:18564479:A:C
NM_001323289.2(CDKL5):c.282+1G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 12, 2019)	criteria provided, single submitter	VCV000963731	X	18593611	X	18575491	963731	960372		NC_000023.11:18575490:G:A
NM_001323289.2(CDKL5):c.375G>C (p.Trp125Cys)	CDKL5	W125C	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000962951	X	18598060	X	18579940	962951	951693		NC_000023.11:18579939:G:C
NM_001323289.2(CDKL5):c.1673G>A (p.Arg558His)	CDKL5	R558H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000962204	X	18622717	X	18604597	962204	951697		NC_000023.11:18604596:G:A
NM_001323289.2(CDKL5):c.524G>C (p.Arg175Thr)	CDKL5	R175T	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Oct 31, 2019)	criteria provided, single submitter	VCV000957873	X	18602443	X	18584323	957873	951694		NC_000023.11:18584322:G:C
NM_001323289.2(CDKL5):c.212A>G (p.Asn71Ser)	CDKL5	N71S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 20, 2019)	criteria provided, single submitter	VCV000957648	X	18593540	X	18575420	957648	951692		NC_000023.11:18575419:A:G
NM_001323289.2(CDKL5):c.2195T>A (p.Val732Glu)	CDKL5	V732E	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000957096	X	18631314	X	18613194	957096	951698		NC_000023.11:18613193:T:A
NM_001323289.2(CDKL5):c.680T>C (p.Leu227Pro)	CDKL5	L227P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000955434	X	18606199	X	18588079	955434	951695		NC_000023.11:18588078:T:C
NM_001323289.2(CDKL5):c.853A>G (p.Arg285Gly)	CDKL5	R285G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000954584	X	18616609	X	18598489	954584	951696		NC_000023.11:18598488:A:G
NM_000330.4(RS1):c.184+3231A>C	CDKL5|RS1		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000949413	X	18671542	X	18653422	949413	941293		NC_000023.11:18653421:T:G
NM_001323289.2(CDKL5):c.2682dup (p.Pro895fs)	CDKL5	P895fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000947226	X	18646675 - 18646676	X	18628555 - 18628556	947226	929639		NC_000023.11:18628555:A:AA
NM_001323289.2(CDKL5):c.2026del (p.His676fs)	CDKL5	H676fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000947188	X	18627011	X	18608891	947188	929637		NC_000023.11:18608890:CC:C
NM_001323289.2(CDKL5):c.2389G>C (p.Asp797His)	CDKL5	D797H	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV000946638	X	18643260	X	18625140	946638	929638		NC_000023.11:18625139:G:C
NM_000330.4(RS1):c.326+1106del	CDKL5|RS1	Q931fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000944491	X	18664205	X	18646085	944491	929640		NC_000023.11:18646084:AA:A
NM_000330.4(RS1):c.185-3261C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jun 9, 2019)	criteria provided, single submitter	VCV000944458	X	18668713	X	18650593	944458	941292		NC_000023.11:18650592:G:A
NM_000330.4(RS1):c.185-3128G>A	CDKL5|RS1	P950S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000938954	X	18668580	X	18650460	938954	939515		NC_000023.11:18650459:C:T
NM_000330.4(RS1):c.184+3136A>T	CDKL5|RS1	H1022Q	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 26, 2020)	criteria provided, single submitter	VCV000938714	X	18671637	X	18653517	938714	939517		NC_000023.11:18653516:T:A
NM_001323289.2(CDKL5):c.2437A>G (p.Thr813Ala)	CDKL5	T813A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000937086	X	18643308	X	18625188	937086	939510		NC_000023.11:18625187:A:G
NM_001323289.2(CDKL5):c.2135T>C (p.Val712Ala)	CDKL5	V712A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000936799	X	18627673	X	18609553	936799	939509		NC_000023.11:18609552:T:C
NM_001323289.2(CDKL5):c.1386A>C (p.Glu462Asp)	CDKL5	E462D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000936459	X	18622430	X	18604310	936459	939507		NC_000023.11:18604309:A:C
NM_001323289.2(CDKL5):c.1909G>C (p.Ala637Pro)	CDKL5	A637P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV000935438	X	18622953	X	18604833	935438	939508		NC_000023.11:18604832:G:C
NM_000330.4(RS1):c.185-3212G>A	CDKL5|RS1	L978F	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000934650	X	18668664	X	18650544	934650	939516		NC_000023.11:18650543:C:T
NM_001323289.2(CDKL5):c.2714G>A (p.Gly905Asp)	CDKL5	G905D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000934074	X	18646708	X	18628588	934074	940548		NC_000023.11:18628587:G:A
NM_000330.4(RS1):c.185-3221G>A	CDKL5|RS1	R981*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 4, 2020)	criteria provided, conflicting interpretations	VCV000930627	X	18668673	X	18650553	930627	920000		NC_000023.11:18650552:C:T
NM_001323289.2(CDKL5):c.38T>C (p.Phe13Ser)	CDKL5	F13S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000929426	X	18525254	X	18507134	929426	917738		NC_000023.11:18507133:T:C
NM_001323289.2(CDKL5):c.59G>T (p.Gly20Val)	CDKL5	G20V	CDKL5 disorder|Angelman syndrome|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000918032	X	18525275	X	18507155	918032	906351		NC_000023.11:18507154:G:T
NM_001323289.2(CDKL5):c.290T>C (p.Leu97Pro)	CDKL5	L97P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000870171	X	18597975	X	18579855	870171	858369		NC_000023.11:18579854:T:C
NM_001323289.2(CDKL5):c.744+1G>A	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000863429	X	18606264	X	18588144	863429	852972		NC_000023.11:18588143:G:A
NM_001323289.2(CDKL5):c.398A>C (p.His133Pro)	CDKL5	H133P	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 17, 2019)	criteria provided, single submitter	VCV000863243	X	18598083	X	18579963	863243	849854		NC_000023.11:18579962:A:C
NM_001323289.2(CDKL5):c.154G>T (p.Glu52Ter)	CDKL5	E52*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000861338	X	18593482	X	18575362	861338	849853		NC_000023.11:18575361:G:T
NM_001323289.2(CDKL5):c.1382A>T (p.Asn461Ile)	CDKL5	N461I	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000858782	X	18622426	X	18604306	858782	849860		NC_000023.11:18604305:A:T
NM_001323289.2(CDKL5):c.2376+4dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Nov 20, 2019)	criteria provided, single submitter	VCV000858055	X	18638088 - 18638089	X	18619968 - 18619969	858055	852483		NC_000023.11:18619968:AA:AAA
NM_001323289.2(CDKL5):c.116T>G (p.Val39Gly)	CDKL5	V39G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Feb 7, 2020)	criteria provided, single submitter	VCV000857803	X	18582613	X	18564493	857803	849852		NC_000023.11:18564492:T:G
NM_001323289.2(CDKL5):c.2197_2204dup (p.Arg735fs)	CDKL5	R735fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 15, 2019)	criteria provided, single submitter	VCV000857515	X	18631314 - 18631315	X	18613194 - 18613195	857515	849864		NC_000023.11:18613194:GTCAACTAG:GTCAACTAGTCAACTAG
NM_001323289.2(CDKL5):c.408A>G (p.Ile136Met)	CDKL5	I136M	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Apr 16, 2019)	criteria provided, single submitter	VCV000857028	X	18600015	X	18581895	857028	849855		NC_000023.11:18581894:A:G
NM_001323289.2(CDKL5):c.1755_1756del (p.Ser586fs)	CDKL5	S586fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000856634	X	18622798 - 18622799	X	18604678 - 18604679	856634	849862		NC_000023.11:18604677:TGT:T
NM_001323289.2(CDKL5):c.420T>A (p.Asn140Lys)	CDKL5	N140K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV000853249	X	18600027	X	18581907	853249	849856		NC_000023.11:18581906:T:A
NM_000330.4(RS1):c.184+3170G>A	CDKL5|RS1	A1011V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Mar 3, 2019)	criteria provided, single submitter	VCV000850649	X	18671603	X	18653483	850649	849874		NC_000023.11:18653482:C:T
NM_001323289.2(CDKL5):c.2464C>T (p.Arg822Cys)	CDKL5	R822C	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV000846246	X	18643335	X	18625215	846246	849865		NC_000023.11:18625214:C:T
NM_001323289.2(CDKL5):c.877_881dup (p.His294fs)	CDKL5	H294fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000845526	X	18616632 - 18616633	X	18598512 - 18598513	845526	849859		NC_000023.11:18598512:AATCA:AATCAAATCA
NM_001323289.2(CDKL5):c.58G>A (p.Gly20Ser)	CDKL5	G20S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000844687	X	18525274	X	18507154	844687	849851		NC_000023.11:18507153:G:A
NM_001323289.2(CDKL5):c.1883del (p.Ser628fs)	CDKL5	S628fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV000840609	X	18622927	X	18604807	840609	849863		NC_000023.11:18604806:G:
NM_001323289.2(CDKL5):c.608A>G (p.Glu203Gly)	CDKL5	E203G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Apr 30, 2019)	criteria provided, single submitter	VCV000839936	X	18606127	X	18588007	839936	849857		NC_000023.11:18588006:A:G
NM_001323289.2(CDKL5):c.1485dup (p.Lys496fs)	CDKL5	K496fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000838071	X	18622527 - 18622528	X	18604407 - 18604408	838071	849861		NC_000023.11:18604407:CC:CCC
NM_000330.4(RS1):c.326+1151T>C	CDKL5|RS1	H916R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 23, 2019)	criteria provided, single submitter	VCV000837329	X	18664160	X	18646040	837329	849870		NC_000023.11:18646039:A:G
NM_001323289.2(CDKL5):c.464-1G>C	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV000834731	X	18602382	X	18584262	834731	851950		NC_000023.11:18584261:G:C
NM_001323289.2(CDKL5):c.783A>G (p.Arg261=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000834468	X	18613506	X	18595386	834468	849858		NC_000023.11:18595385:A:G
NM_001323289.2(CDKL5):c.988G>A (p.Gly330Ser)	CDKL5	G330S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 15, 2019)	criteria provided, single submitter	VCV000833743	X	18622032	X	18603912	833743	822222		NC_000023.11:18603911:G:A
NM_001323289.2(CDKL5):c.724C>A (p.Pro242Thr)	CDKL5	P242T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV000833683	X	18606243	X	18588123	833683	822221		NC_000023.11:18588122:C:A
NC_000023.11:g.(?_18628351)_(18628607_?)del	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000832153	X	18646471 - 18646727			832153	821576		
NC_000023.11:g.(?_18595328)_(18595448_?)del	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 5, 2019)	criteria provided, single submitter	VCV000831965	X	18613448 - 18613568			831965	821575		
NC_000023.11:g.(?_18506933)_(18604888_?)del	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 12, 2019)	criteria provided, single submitter	VCV000831097	X	18525053 - 18623008			831097	821573		
NC_000023.11:g.(?_18506933)_(18510874_?)del	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000830999	X	18525053 - 18528994			830999	821572		
NM_000330.4(RS1):c.184+3119G>A	CDKL5|RS1	T1028M	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 8, 2020)	criteria provided, conflicting interpretations	VCV000810524	X	18671654	X	18653534	810524	798249	rs762576315	NC_000023.11:18653533:C:T
NM_001323289.2(CDKL5):c.65G>A (p.Gly22Glu)	CDKL5	G22E	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2020)	criteria provided, conflicting interpretations	VCV000803714	X	18528940	X	18510820	803714	792184	rs1602232972	NC_000023.11:18510819:G:A
NM_001323289.2(CDKL5):c.396C>T (p.Val132=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000797246	X	18598081	X	18579961	797246	786767	rs1602271730	NC_000023.11:18579960:C:T
NM_001323289.2(CDKL5):c.2241C>T (p.Thr747=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV000795612	X	18631360	X	18613240	795612	786769	rs753606345	NC_000023.11:18613239:C:T
NM_001323289.2(CDKL5):c.231A>G (p.Glu77=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000794736	X	18593559	X	18575439	794736	786766	rs1602269399	NC_000023.11:18575438:A:G
NM_001323289.2(CDKL5):c.2217A>G (p.Leu739=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000794336	X	18631336	X	18613216	794336	786768	rs1602292116	NC_000023.11:18613215:A:G
NM_001323289.2(CDKL5):c.2277-7C>T	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000762115	X	18637980	X	18619860	762115	776793	rs1245961569	NC_000023.11:18619859:C:T
NM_001323289.2(CDKL5):c.291C>G (p.Leu97=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000761781	X	18597976	X	18579856	761781	773940	rs138125282	NC_000023.11:18579855:C:G
NM_000330.4(RS1):c.185-3124G>A	CDKL5|RS1		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000757158	X	18668576	X	18650456	757158	773943	rs1602315522	NC_000023.11:18650455:C:T
NM_001323289.2(CDKL5):c.291C>T (p.Leu97=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV000748686	X	18597976	X	18579856	748686	758415	rs138125282	NC_000023.11:18579855:C:T
NM_001323289.2(CDKL5):c.1701G>A (p.Thr567=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000725105	X	18622745	X	18604625	725105	743269	rs751738489	NC_000023.11:18604624:G:A
NM_001323289.2(CDKL5):c.909G>A (p.Leu303=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000705311	X	18616665	X	18598545	705311	694850	rs1159901195	NC_000023.11:18598544:G:A
NM_001323289.2(CDKL5):c.933A>G (p.Ala311=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 4, 2020)	criteria provided, single submitter	VCV000701541	X	18616689	X	18598569	701541	689451	rs1348754333	NC_000023.11:18598568:A:G
NM_001323289.2(CDKL5):c.554+10C>T	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV000701388	X	18602483	X	18584363	701388	690267	rs755385076	NC_000023.11:18584362:C:T
NM_001323289.2(CDKL5):c.1614G>A (p.Thr538=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV000700635	X	18622658	X	18604538	700635	689453	rs147300538	NC_000023.11:18604537:G:A
NM_001323289.2(CDKL5):c.1452C>A (p.Thr484=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000698120	X	18622496	X	18604376	698120	689452	rs760623086	NC_000023.11:18604375:C:A
NM_001323289.2(CDKL5):c.1768G>A (p.Glu590Lys)	CDKL5	E590K	not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Feb 25, 2021)	criteria provided, conflicting interpretations	VCV000680382	X	18622812	X	18604692	680382	656757	rs372629988	NC_000023.11:18604691:G:A
NM_001323289.2(CDKL5):c.2345C>G (p.Ser782Ter)	CDKL5	S782*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 24, 2018)	criteria provided, single submitter	VCV000662018	X	18638055	X	18619935	662018	649906	rs1555954074	NC_000023.11:18619934:C:G
NM_001323289.2(CDKL5):c.1600A>G (p.Arg534Gly)	CDKL5	R534G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000661864	X	18622644	X	18604524	661864	649899	rs749639424	NC_000023.11:18604523:A:G
NM_001323289.2(CDKL5):c.99+9A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000660635	X	18528983	X	18510863	660635	653782	rs1602233003	NC_000023.11:18510862:A:G
NM_001323289.2(CDKL5):c.53T>A (p.Val18Asp)	CDKL5	V18D	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Dec 13, 2018)	criteria provided, single submitter	VCV000659752	X	18525269	X	18507149	659752	649896	rs1602230515	NC_000023.11:18507148:T:A
NM_001323289.2(CDKL5):c.2444G>T (p.Ser815Ile)	CDKL5	S815I	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000659279	X	18643315	X	18625195	659279	649909	rs1449425691	NC_000023.11:18625194:G:T
NM_001323289.2(CDKL5):c.454T>C (p.Cys152Arg)	CDKL5	C152R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 22, 2018)	criteria provided, conflicting interpretations	VCV000658951	X	18600061	X	18581941	658951	649897	rs1602272932	NC_000023.11:18581940:T:C
NM_001323289.2(CDKL5):c.1948G>A (p.Gly650Arg)	CDKL5	G650R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000658591	X	18626934	X	18608814	658591	649901	rs1602289171	NC_000023.11:18608813:G:A
NM_001323289.2(CDKL5):c.2243A>C (p.Asn748Thr)	CDKL5	N748T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV000657569	X	18631362	X	18613242	657569	649903	rs748459878	NC_000023.11:18613241:A:C
NM_001323289.2(CDKL5):c.1922G>T (p.Ser641Ile)	CDKL5	S641I	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000656692	X	18622966	X	18604846	656692	649900	rs1602287027	NC_000023.11:18604845:G:T
NM_001323289.2(CDKL5):c.2272C>T (p.Pro758Ser)	CDKL5	P758S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000654804	X	18631391	X	18613271	654804	649904	rs1210870589	NC_000023.11:18613270:C:T
NM_001323289.2(CDKL5):c.2326_2327del (p.Lys776fs)	CDKL5	K776fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000652635	X	18638036 - 18638037	X	18619916 - 18619917	652635	649905	rs1602295727	NC_000023.11:18619915:AA:
NM_001323289.2(CDKL5):c.2785C>T (p.Gln929Ter)	CDKL5	Q929*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000648838	X	18646779	X	18628659	648838	649910	rs1602300816	NC_000023.11:18628658:C:T
NM_001323289.2(CDKL5):c.1177A>G (p.Thr393Ala)	CDKL5	T393A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jan 25, 2020)	criteria provided, single submitter	VCV000648587	X	18622221	X	18604101	648587	649898	rs1187227979	NC_000023.11:18604100:A:G
NM_001323289.2(CDKL5):c.2426A>G (p.His809Arg)	CDKL5	H809R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000647375	X	18643297	X	18625177	647375	649908	rs1602298609	NC_000023.11:18625176:A:G
NM_001323289.2(CDKL5):c.2013C>T (p.Gly671=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000645940	X	18626999	X	18608879	645940	649902	rs1602289218	NC_000023.11:18608878:C:T
NM_001323289.2(CDKL5):c.2821del (p.Tyr941fs)	CDKL5	Y941fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2019)	criteria provided, conflicting interpretations	VCV000643438	X	18646815	X	18628695	643438	649911	rs1602300837	NC_000023.11:18628694:T:
NM_001323289.2(CDKL5):c.2408C>T (p.Thr803Met)	CDKL5	T803M	Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000642554	X	18643279	X	18625159	642554	649907	rs1005844306	NC_000023.11:18625158:C:T
NM_000330.4(RS1):c.184+3158_184+3167del	CDKL5|RS1	V1013fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000642094	X	18671606 - 18671615	X	18653486 - 18653495	642094	649912	rs1363899499	NC_000023.11:18653485:AGGTAAACCAAG:AG
NM_001323289.2(CDKL5):c.1579C>T (p.Pro527Ser)	CDKL5	P527S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2019)	criteria provided, conflicting interpretations	VCV000590134	X	18622623	X	18604503	590134	580760	rs1275389347	NC_000023.11:18604502:C:T
NM_000330.4(RS1):c.184+3143G>T	CDKL5|RS1	T1020K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Jan 18, 2019)	criteria provided, conflicting interpretations	VCV000590093	X	18671630	X	18653510	590093	580917	rs757994307	NC_000023.11:18653509:C:A
NM_001323289.2(CDKL5):c.480G>C (p.Leu160=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|History of neurodevelopmental disorder	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000588018	X	18602399	X	18584279	588018	580887	rs750878642	NC_000023.11:18584278:G:C
NM_001323289.2(CDKL5):c.282+1G>T	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000582020	X	18593611	X	18575491	582020	572370	rs1569213054	NC_000023.11:18575490:G:T
NM_001323289.2(CDKL5):c.638G>A (p.Gly213Glu)	CDKL5	G213E	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Feb 23, 2018)	criteria provided, single submitter	VCV000577127	X	18606157	X	18588037	577127	572376	rs1569215629	NC_000023.11:18588036:G:A
NM_001323289.2(CDKL5):c.2142del (p.Tyr716fs)	CDKL5	Y716fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000576176	X	18627680	X	18609560	576176	573755	rs1569220925	NC_000023.11:18609559:C:
NM_001323289.2(CDKL5):c.2502G>T (p.Gln834His)	CDKL5	Q834H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000573507	X	18646496	X	18628376	573507	573760	rs1334119558	NC_000023.11:18628375:G:T
NM_001323289.2(CDKL5):c.2682_2683insGGAA (p.Pro895fs)	CDKL5	P895fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000573189	X	18646675 - 18646676	X	18628555 - 18628556	573189	574440	rs1569225454	NC_000023.11:18628555:A:AGGAA
NM_001323289.2(CDKL5):c.1116T>A (p.Ala372=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000570060	X	18622160	X	18604040	570060	574380	rs148302590	NC_000023.11:18604039:T:A
NM_001323289.2(CDKL5):c.1198A>C (p.Asn400His)	CDKL5	N400H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Jun 28, 2018)	criteria provided, single submitter	VCV000569644	X	18622242	X	18604122	569644	574382	rs921600020	NC_000023.11:18604121:A:C
NM_001323289.2(CDKL5):c.1286C>T (p.Pro429Leu)	CDKL5	P429L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000569630	X	18622330	X	18604210	569630	575376	rs377263491	NC_000023.11:18604209:C:T
NM_001323289.2(CDKL5):c.1891A>G (p.Ile631Val)	CDKL5	I631V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000568711	X	18622935	X	18604815	568711	574438	rs1569219817	NC_000023.11:18604814:A:G
NM_001323289.2(CDKL5):c.26T>C (p.Val9Ala)	CDKL5	V9A	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000568435	X	18525242	X	18507122	568435	574377	rs1569197962	NC_000023.11:18507121:T:C
NM_001323289.2(CDKL5):c.583T>G (p.Trp195Gly)	CDKL5	W195G	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000567323	X	18606102	X	18587982	567323	572373	rs1569215594	NC_000023.11:18587981:T:G
NM_001323289.2(CDKL5):c.934A>G (p.Lys312Glu)	CDKL5	K312E	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000565624	X	18616690	X	18598570	565624	572379	rs1569218064	NC_000023.11:18598569:A:G
NM_001323289.2(CDKL5):c.868C>T (p.Gln290Ter)	CDKL5	Q290*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jul 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000560971	X	18616624	X	18598504	560971	552253	rs1569218019	NC_000023.11:18598503:C:T
NC_000023.11:g.(?_18564457)_(18581970_?)del	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000533400	X	18582577 - 18600090	X	18564457 - 18581970	533400	534520		
NM_001323289.2(CDKL5):c.464-9A>G	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV000533399	X	18602374	X	18584254	533399	535117	rs374030184	NC_000023.11:18584253:A:G
NM_001323289.2(CDKL5):c.2493C>T (p.Thr831=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Dec 20, 2017)	criteria provided, single submitter	VCV000533398	X	18643364	X	18625244	533398	535122	rs1555954758	NC_000023.11:18625243:C:T
NM_001323289.2(CDKL5):c.1590A>C (p.Pro530=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000533397	X	18622634	X	18604514	533397	535121	rs891117762	NC_000023.11:18604513:A:C
NM_001323289.2(CDKL5):c.1038C>T (p.Ile346=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV000533396	X	18622082	X	18603962	533396	534683	rs754663076	NC_000023.11:18603961:C:T
NM_000330.4(RS1):c.185-3121C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, single submitter	VCV000533395	X	18668573	X	18650453	533395	534778	rs368344738	NC_000023.11:18650452:G:A
NM_001323289.2(CDKL5):c.987C>T (p.Ala329=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Likely benign(Last reviewed: Mar 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000533394	X	18622031	X	18603911	533394	534772	rs142665931	NC_000023.11:18603910:C:T
NM_000330.4(RS1):c.326+1093_326+1094del	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000533393	X	18664217 - 18664218	X	18646097 - 18646098	533393	534694	rs1555957573	NC_000023.11:18646096:TCT:T
NM_001323289.2(CDKL5):c.2541G>A (p.Ser847=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign/Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533392	X	18646535	X	18628415	533392	534690	rs781774964	NC_000023.11:18628414:G:A
NM_001323289.2(CDKL5):c.1692T>C (p.His564=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000533391	X	18622736	X	18604616	533391	534686	rs765011302	NC_000023.11:18604615:T:C
NM_001323289.2(CDKL5):c.725del (p.Pro242fs)	CDKL5	P242fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000533390	X	18606243	X	18588123	533390	535120	rs1555950494	NC_000023.11:18588122:CC:C
NM_001323289.2(CDKL5):c.614_617dup (p.Asp206fs)	CDKL5	D206fs	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 15, 2017)	criteria provided, single submitter	VCV000533389	X	18606131 - 18606132	X	18588011 - 18588012	533389	535119	rs1555950465	NC_000023.11:18588011:AGCGA:AGCGAGCGA
NM_001323289.2(CDKL5):c.973A>G (p.Asn325Asp)	CDKL5	N325D	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000533388	X	18616729	X	18598609	533388	534680	rs756721244	NC_000023.11:18598608:A:G
NM_001323289.2(CDKL5):c.1213C>G (p.Leu405Val)	CDKL5	L405V	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000533387	X	18622257	X	18604137	533387	534773	rs1555951984	NC_000023.11:18604136:C:G
NM_001323289.2(CDKL5):c.200_201del (p.Leu67fs)	CDKL5	L67fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 28, 2018)	criteria provided, single submitter	VCV000533386	X	18593525 - 18593526	X	18575405 - 18575406	533386	534765	rs1555949011	NC_000023.11:18575404:CTCTC:CTC
NM_001323289.2(CDKL5):c.508G>T (p.Glu170Ter)	CDKL5	E170*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Oct 31, 2017)	criteria provided, single submitter	VCV000533384	X	18602427	X	18584307	533384	535118	rs1555950066	NC_000023.11:18584306:G:T
NM_001323289.2(CDKL5):c.100-7C>T	CDKL5		not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000518418	X	18582590	X	18564470	518418	508960	rs752279222	NC_000023.11:18564469:C:T
NM_001323289.2(CDKL5):c.1122T>A (p.Ala374=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000517837	X	18622166	X	18604046	517837	507981	rs141452495	NC_000023.11:18604045:T:A
NM_001323289.2(CDKL5):c.1098C>T (p.Phe366=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Benign/Likely benign(Last reviewed: Dec 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000516565	X	18622142	X	18604022	516565	508096	rs777079786	NC_000023.11:18604021:C:T
NM_000330.4(RS1):c.326+1114C>T	CDKL5|RS1		History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000516455	X	18664197	X	18646077	516455	508000	rs369383134	NC_000023.11:18646076:G:A
NM_001323289.2(CDKL5):c.2109A>T (p.Leu703=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Jun 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000514228	X	18627647	X	18609527	514228	508099	rs761789190	NC_000023.11:18609526:A:T
NM_000330.4(RS1):c.185-3221G>C	CDKL5|RS1	R981G	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512938	X	18668673	X	18650553	512938	508488	rs374054249	NC_000023.11:18650552:C:G
NM_001323289.2(CDKL5):c.2680G>A (p.Ala894Thr)	CDKL5	A894T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000512529	X	18646674	X	18628554	512529	508487	rs763110247	NC_000023.11:18628553:G:A
NM_000330.4(RS1):c.184+3198C>T	CDKL5|RS1	V1002I	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000511046	X	18671575	X	18653455	511046	508623	rs987192406	NC_000023.11:18653454:G:A
NM_001323289.2(CDKL5):c.1527G>A (p.Ala509=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign/Likely benign(Last reviewed: May 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000509971	X	18622571	X	18604451	509971	508483	rs369561849	NC_000023.11:18604450:G:A
NM_001323289.2(CDKL5):c.404-9A>G	CDKL5		not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000508473	X	18600002	X	18581882	508473	508481	rs1037467164	NC_000023.11:18581881:A:G
NM_001323289.2(CDKL5):c.2086G>A (p.Ala696Thr)	CDKL5	A696T	not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507662	X	18627624	X	18609504	507662	507990	rs374518046	NC_000023.11:18609503:G:A
NM_001323289.2(CDKL5):c.786C>A (p.Tyr262Ter)	CDKL5	Y262*	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000489166	X	18613509	X	18595389	489166	482246	rs1555951146	NC_000023.11:18595388:C:A
NM_000330.4(RS1):c.326+1115G>A	CDKL5|RS1	T928M	History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Jan 23, 2017)	criteria provided, conflicting interpretations	VCV000464817	X	18664196	X	18646076	464817	471436	rs951430019	NC_000023.11:18646075:C:T
NM_000330.4(RS1):c.326+1182C>T	CDKL5|RS1	G906S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000464816	X	18664129	X	18646009	464816	471435	rs369009993	NC_000023.11:18646008:G:A
NM_001323289.2(CDKL5):c.2652C>T (p.Gly884=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign(Last reviewed: Aug 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000464815	X	18646646	X	18628526	464815	472114	rs201473442	NC_000023.11:18628525:C:T
NM_001323289.2(CDKL5):c.2490G>C (p.Gln830His)	CDKL5	Q830H	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000464814	X	18643361	X	18625241	464814	471841	rs1485485459	NC_000023.11:18625240:G:C
NM_001323289.2(CDKL5):c.244del (p.Arg82fs)	CDKL5	R82fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: May 2, 2017)	criteria provided, single submitter	VCV000464813	X	18593572	X	18575452	464813	471428	rs1555949041	NC_000023.11:18575451:A:
NM_001323289.2(CDKL5):c.2345C>A (p.Ser782Ter)	CDKL5	S782*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000464812	X	18638055	X	18619935	464812	471434	rs1555954074	NC_000023.11:18619934:C:A
NM_001323289.2(CDKL5):c.2220A>G (p.Pro740=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000464811	X	18631339	X	18613219	464811	472113	rs142079769	NC_000023.11:18613218:A:G
NM_001323289.2(CDKL5):c.1731G>A (p.Met577Ile)	CDKL5	M577I	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000464810	X	18622775	X	18604655	464810	472112	rs757573258	NC_000023.11:18604654:G:A
NM_001323289.2(CDKL5):c.1519C>T (p.Gln507Ter)	CDKL5	Q507*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000464809	X	18622563	X	18604443	464809	471431	rs1555952052	NC_000023.11:18604442:C:T
NM_001323289.2(CDKL5):c.1246G>T (p.Glu416Ter)	CDKL5	E416*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000464808	X	18622290	X	18604170	464808	470650	rs1555951991	NC_000023.11:18604169:G:T
NM_001323289.2(CDKL5):c.825+5G>A	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000452763	X	18613553	X	18595433	452763	446600	rs1555951149	NC_000023.11:18595432:G:A
NM_000330.4(RS1):c.185-3137C>A	CDKL5|RS1	A953S	not specified|not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2020)	criteria provided, conflicting interpretations	VCV000434667	X	18668589	X	18650469	434667	430762	rs767312604	NC_000023.11:18650468:G:T
NM_001323289.2(CDKL5):c.1684A>G (p.Thr562Ala)	CDKL5	T562A	History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 10, 2020)	criteria provided, conflicting interpretations	VCV000434666	X	18622728	X	18604608	434666	430760	rs376341076	NC_000023.11:18604607:A:G
NM_001323289.2(CDKL5):c.1564T>G (p.Leu522Val)	CDKL5	L522V	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)	criteria provided, conflicting interpretations	VCV000434664	X	18622608	X	18604488	434664	430759	rs781427744	NC_000023.11:18604487:T:G
NM_001323289.2(CDKL5):c.350A>G (p.Tyr117Cys)	CDKL5	Y117C	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2018)	criteria provided, conflicting interpretations	VCV000432427	X	18598035	X	18579915	432427	426443	rs1189749755	NC_000023.11:18579914:A:G
NM_001323289.2(CDKL5):c.1234A>G (p.Lys412Glu)	CDKL5	K412E	CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000423898	X	18622278	X	18604158	423898	411223	rs770340766	NC_000023.11:18604157:A:G
NM_001323289.2(CDKL5):c.1064G>A (p.Arg355Gln)	CDKL5	R355Q	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000423478	X	18622108	X	18603988	423478	411221	rs189400843	NC_000023.11:18603987:G:A
NM_001323289.2(CDKL5):c.1945-5T>C	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Aug 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000423121	X	18626926	X	18608806	423121	411227	rs1064796245	NC_000023.11:18608805:T:C
NM_001323289.2(CDKL5):c.2546C>T (p.Ser849Leu)	CDKL5	S849L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2019)	criteria provided, conflicting interpretations	VCV000422765	X	18646540	X	18628420	422765	411231	rs1064795982	NC_000023.11:18628419:C:T
NM_001323289.2(CDKL5):c.743G>T (p.Arg248Leu)	CDKL5	R248L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Apr 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000422559	X	18606262	X	18588142	422559	411214	rs1064795857	NC_000023.11:18588141:G:T
NM_001323289.2(CDKL5):c.854G>A (p.Arg285Lys)	CDKL5	R285K	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000422272	X	18616610	X	18598490	422272	411215	rs1064795672	NC_000023.11:18598489:G:A
NM_001323289.2(CDKL5):c.950A>G (p.His317Arg)	CDKL5	H317R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000420833	X	18616706	X	18598586	420833	411218	rs756537286	NC_000023.11:18598585:A:G
NM_001323289.2(CDKL5):c.1795A>G (p.Thr599Ala)	CDKL5	T599A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000419920	X	18622839	X	18604719	419920	411226	rs761662406	NC_000023.11:18604718:A:G
NC_000023.10:g.(?_18525055)_(18528974_?)dup	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jul 9, 2016)	criteria provided, single submitter	VCV000417421	X	18525055 - 18528974	X	18506935 - 18510854	417421	403990		
NM_001323289.2(CDKL5):c.145+5AT[13]	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000414804	X	18582646 - 18582647	X	18564526 - 18564527	414804	404159	rs745969938	NC_000023.11:18564526:ATATATATATATATATATATATAT:ATATATATATATATATATATATATAT
NM_001323289.2(CDKL5):c.2022del (p.Phe675fs)	CDKL5	F675fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 10, 2016)	criteria provided, single submitter	VCV000408123	X	18627007	X	18608887	408123	404163	rs1060501860	NC_000023.11:18608886:CC:C
NM_001323289.2(CDKL5):c.7A>T (p.Ile3Phe)	CDKL5	I3F	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 21, 2016)	criteria provided, single submitter	VCV000408122	X	18525223	X	18507103	408122	404186	rs138539908	NC_000023.11:18507102:A:T
NM_001323289.2(CDKL5):c.826-2A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Nov 8, 2016)	criteria provided, single submitter	VCV000408121	X	18616580	X	18598460	408121	404509	rs1060501859	NC_000023.11:18598459:A:G
NM_001323289.2(CDKL5):c.1930C>T (p.Leu644Phe)	CDKL5	L644F	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2019)	criteria provided, conflicting interpretations	VCV000393097	X	18622974	X	18604854	393097	379152	rs1057524785	NC_000023.11:18604853:C:T
NM_001323289.2(CDKL5):c.2573G>A (p.Arg858His)	CDKL5	R858H	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000392468	X	18646567	X	18628447	392468	379159	rs759083770	NC_000023.11:18628446:G:A
NM_001323289.2(CDKL5):c.886A>G (p.Thr296Ala)	CDKL5	T296A	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000383412	X	18616642	X	18598522	383412	379262	rs751995225	NC_000023.11:18598521:A:G
NM_000330.4(RS1):c.185-3189C>T	CDKL5|RS1	R970Q	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000381696	X	18668641	X	18650521	381696	379266	rs570887192	NC_000023.11:18650520:G:A
NM_001323289.2(CDKL5):c.2106C>T (p.His702=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Aug 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000378930	X	18627644	X	18609524	378930	380008	rs1057520416	NC_000023.11:18609523:C:T
NM_000330.4(RS1):c.185-3213A>C	CDKL5|RS1	L978R	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377651	X	18668665	X	18650545	377651	379272	rs143243059	NC_000023.11:18650544:T:G
NM_001323289.2(CDKL5):c.1730T>C (p.Met577Thr)	CDKL5	M577T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000377647	X	18622774	X	18604654	377647	378025	rs749822712	NC_000023.11:18604653:T:C
NM_001323289.2(CDKL5):c.192T>G (p.Leu64=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely benign(Last reviewed: May 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377645	X	18593520	X	18575400	377645	378006	rs145496868	NC_000023.11:18575399:T:G
NM_001323289.2(CDKL5):c.2465G>A (p.Arg822His)	CDKL5	R822H	not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000377094	X	18643336	X	18625216	377094	363972	rs376429571	NC_000023.11:18625215:G:A
NM_000330.4(RS1):c.185-3260C>T	CDKL5|RS1	G994R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Epileptic encephalopathy	Conflicting interpretations of pathogenicity(Last reviewed: Mar 6, 2020)	criteria provided, conflicting interpretations	VCV000375543	X	18668712	X	18650592	375543	362354	rs866859766	NC_000023.11:18650591:G:A
NM_001323289.2(CDKL5):c.462T>C (p.Phe154=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000373584	X	18600069	X	18581949	373584	360556	rs898874642	NC_000023.11:18581948:T:C
NM_001323289.2(CDKL5):c.2520C>T (p.Arg840=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Nov 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373525	X	18646514	X	18628394	373525	360605	rs1037569177	NC_000023.11:18628393:C:T
NM_001323289.2(CDKL5):c.1006C>T (p.Gln336Ter)	CDKL5	Q336*	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Pathogenic(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000373086	X	18622050	X	18603930	373086	360565	rs1057518203	NC_000023.11:18603929:C:T
NM_001323289.2(CDKL5):c.1338A>T (p.Ser446=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000288260	X	18622382	X	18604262	288260	272497	rs139329419	NC_000023.11:18604261:A:T
NM_001323289.2(CDKL5):c.2152+10C>G	CDKL5		not specified|not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2019)	criteria provided, conflicting interpretations	VCV000287225	X	18627700	X	18609580	287225	271462	rs763466606	NC_000023.11:18609579:C:G
NM_001323289.2(CDKL5):c.2469C>T (p.Pro823=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2020)	criteria provided, conflicting interpretations	VCV000287145	X	18643340	X	18625220	287145	271382	rs369377144	NC_000023.11:18625219:C:T
NM_001323289.2(CDKL5):c.2151A>G (p.Arg717=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2020)	criteria provided, conflicting interpretations	VCV000286706	X	18627689	X	18609569	286706	270943	rs886043453	NC_000023.11:18609568:A:G
NM_001323289.2(CDKL5):c.2466C>G (p.Arg822=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|not specified	Benign/Likely benign(Last reviewed: Nov 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000258979	X	18643337	X	18625217	258979	257791	rs146488512	NC_000023.11:18625216:C:G
NM_001323289.2(CDKL5):c.2445C>T (p.Ser815=)	CDKL5		CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000258978	X	18643316	X	18625196	258978	257790	rs371902632	NC_000023.11:18625195:C:T
NM_001323289.2(CDKL5):c.145+5AT[11]	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Benign(Last reviewed: Aug 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000239511	X	18582647 - 18582648	X	18564527 - 18564528	239511	243784	rs745969938	NC_000023.11:18564526:ATATATATATATATATATATATAT:ATATATATATATATATATATAT
NM_000330.4(RS1):c.185-3176C>T	CDKL5|RS1	V966I	CDKL5 disorder|not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000210646	X	18668628	X	18650508	210646	208993	rs747799506	NC_000023.11:18650507:G:A
NM_001323289.2(CDKL5):c.1722G>A (p.Pro574=)	CDKL5		History of neurodevelopmental disorder|not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2020)	criteria provided, conflicting interpretations	VCV000210643	X	18622766	X	18604646	210643	208990	rs371603866	NC_000023.11:18604645:G:A
NM_001323289.2(CDKL5):c.1002T>C (p.Ala334=)	CDKL5		History of neurodevelopmental disorder|not provided|not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Conflicting interpretations of pathogenicity(Last reviewed: Aug 17, 2020)	criteria provided, conflicting interpretations	VCV000210642	X	18622046	X	18603926	210642	208989	rs756986206	NC_000023.11:18603925:T:C
NM_001323289.2(CDKL5):c.2243A>G (p.Asn748Ser)	CDKL5	N748S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 9, 2020)	criteria provided, conflicting interpretations	VCV000194499	X	18631362	X	18613242	194499	191662	rs748459878	NC_000023.11:18613241:A:G
NM_001323289.2(CDKL5):c.800A>G (p.Asn267Ser)	CDKL5	N267S	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000193651	X	18613523	X	18595403	193651	190814	rs794726990	NC_000023.11:18595402:A:G
NM_001323289.2(CDKL5):c.2046+1G>A	CDKL5		Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Likely pathogenic(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000189568	X	18627033	X	18608913	189568	187620	rs786204976	NC_000023.11:18608912:G:A
NM_001323289.2(CDKL5):c.1247_1248del (p.Glu416fs)	CDKL5	E416fs	Inborn genetic diseases|CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Epileptic encephalopathy|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000189554	X	18622289 - 18622290	X	18604169 - 18604170	189554	187611	rs786204967	NC_000023.11:18604168:AGAG:AG
NM_000330.4(RS1):c.185-3208C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189535	X	18668660	X	18650540	189535	187630	rs140944590	NC_000023.11:18650539:G:A
NM_001323289.2(CDKL5):c.2673G>A (p.Gln891=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified|not provided	Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189534	X	18646667	X	18628547	189534	187627	rs373448935	NC_000023.11:18628546:G:A
NM_001323289.2(CDKL5):c.2389G>A (p.Asp797Asn)	CDKL5	D797N	not provided|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not specified	Benign/Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189533	X	18643260	X	18625140	189533	187624	rs140313320	NC_000023.11:18625139:G:A
NM_000330.4(RS1):c.184+3171C>T	CDKL5|RS1	A1011T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2020)	criteria provided, conflicting interpretations	VCV000166822	X	18671602	X	18653482	166822	177440	rs727503848	NC_000023.11:18653481:G:A
NM_001323289.2(CDKL5):c.2388C>T (p.Ser796=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 17, 2020)	criteria provided, conflicting interpretations	VCV000166821	X	18643259	X	18625139	166821	177566	rs727503847	NC_000023.11:18625138:C:T
NM_001323289.2(CDKL5):c.146-1G>A	CDKL5		CDKL5 disorder|not provided|Early infantile epileptic encephalopathy 2	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000158179	X	18593473	X	18575353	158179	170097	rs587783399	NC_000023.11:18575352:G:A
NM_001323289.2(CDKL5):c.1071C>T (p.Asp357=)	CDKL5		not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Likely benign(Last reviewed: May 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000158176	X	18622115	X	18603995	158176	170103	rs144204039	NC_000023.11:18603994:C:T
NM_000330.4(RS1):c.185-3207G>A	CDKL5|RS1	P976L	CDKL5 disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156694	X	18668659	X	18650539	156694	166548	rs587783161	NC_000023.11:18650538:C:T
NM_000330.4(RS1):c.326+1159C>G	CDKL5|RS1	Q913H	not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Jan 25, 2020)	criteria provided, conflicting interpretations	VCV000156693	X	18664152	X	18646032	156693	166547	rs587783160	NC_000023.11:18646031:G:C
NM_001323289.2(CDKL5):c.2555C>T (p.Pro852Leu)	CDKL5	P852L	not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Jun 17, 2020)	criteria provided, conflicting interpretations	VCV000156690	X	18646549	X	18628429	156690	166544	rs587783156	NC_000023.11:18628428:C:T
NM_001323289.2(CDKL5):c.1818A>G (p.Gln606=)	CDKL5		not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Benign/Likely benign(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156686	X	18622862	X	18604742	156686	166540	rs587783154	NC_000023.11:18604741:A:G
NM_001323289.2(CDKL5):c.1721C>T (p.Pro574Leu)	CDKL5	P574L	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign/Likely benign(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156685	X	18622765	X	18604645	156685	166539	rs199897804	NC_000023.11:18604644:C:T
NM_001323289.2(CDKL5):c.1636G>A (p.Gly546Arg)	CDKL5	G546R	Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Aug 25, 2019)	criteria provided, single submitter	VCV000156684	X	18622680	X	18604560	156684	166538	rs587783153	NC_000023.11:18604559:G:A
NM_001323289.2(CDKL5):c.2360_2363del (p.Lys787fs)	CDKL5	K787fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Aug 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156651	X	18638068 - 18638071	X	18619948 - 18619951	156651	166505	rs587783123	NC_000023.11:18619947:AAAGAA:AA
NM_001323289.2(CDKL5):c.1455_1460del (p.Ala486_Lys487del)	CDKL5		not specified|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2020)	criteria provided, conflicting interpretations	VCV000156642	X	18622495 - 18622500	X	18604375 - 18604380	156642	166496	rs587783114	NC_000023.11:18604374:CCAAGGCCAA:CCAA
NM_001323289.2(CDKL5):c.404-2A>G	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: May 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000156599	X	18600009	X	18581889	156599	166453	rs587783080	NC_000023.11:18581888:A:G
NM_001323289.2(CDKL5):c.2047-1G>A	CDKL5		not provided|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000156077	X	18627584	X	18609464	156077	165873	rs267608650	NC_000023.11:18609463:G:A
NM_001323289.2(CDKL5):c.100-2A>G	CDKL5		not provided|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000156073	X	18582595	X	18564475	156073	165869	rs267608423	NC_000023.11:18564474:A:G
NM_001323289.2(CDKL5):c.902_903dup (p.Leu302fs)	CDKL5	L302fs	Angelman syndrome|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 13, 2014)	no assertion criteria provided	VCV000143838	X	18616654 - 18616655	X	18598534 - 18598535	143838	153570	rs267608546	NC_000023.11:18598534:AGAGA:AGAGAGA
NM_001323289.2(CDKL5):c.659T>C (p.Leu220Pro)	CDKL5	L220P	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000143830	X	18606178	X	18588058	143830	153562	rs267608511	NC_000023.11:18588057:T:C
NM_001323289.2(CDKL5):c.587C>T (p.Ser196Leu)	CDKL5	S196L	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|Epileptic encephalopathy	Pathogenic(Last reviewed: Feb 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143827	X	18606106	X	18587986	143827	153559	rs267608501	NC_000023.11:18587985:C:T
NM_001323289.2(CDKL5):c.578A>G (p.Asp193Gly)	CDKL5	D193G	Early infantile epileptic encephalopathy 2|CDKL5 disorder|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143826	X	18606097	X	18587977	143826	153558	rs267608500	NC_000023.11:18587976:A:G
NM_001323289.2(CDKL5):c.532C>T (p.Arg178Trp)	CDKL5	R178W	Early infantile epileptic encephalopathy 2|Intellectual disability|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143823	X	18602451	X	18584331	143823	153555	rs267608493	NC_000023.11:18584330:C:T
NM_001323289.2(CDKL5):c.513C>A (p.Tyr171Ter)	CDKL5	Y171*	Early infantile epileptic encephalopathy 2|CDKL5 disorder|not provided	Pathogenic(Last reviewed: Mar 9, 2021)	reviewed by expert panel	VCV000143822	X	18602432	X	18584312	143822	153554	rs267608490	NC_000023.11:18584311:C:A
NM_001323289.2(CDKL5):c.380A>G (p.His127Arg)	CDKL5	H127R	Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143818	X	18598065	X	18579945	143818	153550	rs267608468	NC_000023.11:18579944:A:G
NM_000330.4(RS1):c.184+3190C>A	CDKL5|RS1	R1004S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|not specified	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143815	X	18671583	X	18653463	143815	153547	rs267608667	NC_000023.11:18653462:G:T
NM_000330.4(RS1):c.185-3188G>A	CDKL5|RS1	R970*	Atypical Rett syndrome|CDKL5 disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143812	X	18668640	X	18650520	143812	153544	rs267608665	NC_000023.11:18650519:C:T
NM_000330.4(RS1):c.185-3134G>A	CDKL5|RS1	R952*	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|not specified	Benign/Likely benign(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143811	X	18668586	X	18650466	143811	153543	rs202153551	NC_000023.11:18650465:C:T
NM_001323289.2(CDKL5):c.2635_2636del (p.Leu879fs)	CDKL5	L879fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000143809	X	18646629 - 18646630	X	18628509 - 18628510	143809	153541	rs61753251	NC_000023.11:18628508:CT:
NM_001323289.2(CDKL5):c.2343del (p.Arg781fs)	CDKL5	R781fs	Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Jan 30, 2018)	criteria provided, single submitter	VCV000143801	X	18638052	X	18619932	143801	153533	rs62643614	NC_000023.11:18619931:GG:G
NM_001323289.2(CDKL5):c.1892T>C (p.Ile631Thr)	CDKL5	I631T	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2020)	criteria provided, conflicting interpretations	VCV000143786	X	18622936	X	18604816	143786	153518	rs144878564	NC_000023.11:18604815:T:C
NM_001323289.2(CDKL5):c.1767C>T (p.His589=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|not specified	Benign(Last reviewed: Aug 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143784	X	18622811	X	18604691	143784	153516	rs267608645	NC_000023.11:18604690:C:T
NM_001323289.2(CDKL5):c.175C>T (p.Arg59Ter)	CDKL5	R59*	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: May 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143783	X	18593503	X	18575383	143783	153515	rs62653623	NC_000023.11:18575382:C:T
NM_001323289.2(CDKL5):c.1675C>T (p.Arg559Ter)	CDKL5	R559*	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143781	X	18622719	X	18604599	143781	153513	rs267608395	NC_000023.11:18604598:C:T
NM_001323289.2(CDKL5):c.1648C>T (p.Arg550Ter)	CDKL5	R550*	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Pathogenic(Last reviewed: Aug 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000143780	X	18622692	X	18604572	143780	153512	rs267608643	NC_000023.11:18604571:C:T
NM_001323289.2(CDKL5):c.163_166del (p.Glu55fs)	CDKL5	E55fs	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|Early infantile epileptic encephalopathy 2	Pathogenic/Likely pathogenic(Last reviewed: Feb 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143779	X	18593488 - 18593491	X	18575368 - 18575371	143779	153511	rs267608433	NC_000023.11:18575367:AAAGAAA:AAA
NM_001323289.2(CDKL5):c.1523T>C (p.Ile508Thr)	CDKL5	I508T	Autistic disorder of childhood onset|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign/Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143778	X	18622567	X	18604447	143778	153510	rs201893287	NC_000023.11:18604446:T:C
NM_001323289.2(CDKL5):c.1382A>G (p.Asn461Ser)	CDKL5	N461S	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000143776	X	18622426	X	18604306	143776	153508	rs267608629	NC_000023.11:18604305:A:G
NM_001323289.2(CDKL5):c.1330C>T (p.Arg444Cys)	CDKL5	R444C	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|History of neurodevelopmental disorder|not specified	Benign/Likely benign(Last reviewed: Oct 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143775	X	18622374	X	18604254	143775	153507	rs61753977	NC_000023.11:18604253:C:T
NM_001323289.2(CDKL5):c.1278A>C (p.Ser426=)	CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000143773	X	18622322	X	18604202	143773	153505	rs267608620	NC_000023.11:18604201:A:C
NM_001323289.2(CDKL5):c.1196A>C (p.Asn399Thr)	CDKL5	N399T	Early infantile epileptic encephalopathy 2|Atypical Rett syndrome|CDKL5 disorder|not provided	Likely benign(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000143770	X	18622240	X	18604120	143770	153502	rs267608611	NC_000023.11:18604119:A:C
NM_000330.4(RS1):c.184+3208G>A	CDKL5|RS1		not specified|History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136716	X	18671565	X	18653445	136716	140419	rs150900695	NC_000023.11:18653444:C:T
NM_001323289.2(CDKL5):c.2409G>A (p.Thr803=)	CDKL5		History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified	Benign(Last reviewed: Oct 12, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136714	X	18643280	X	18625160	136714	140417	rs145401225	NC_000023.11:18625159:G:A
NM_001323289.2(CDKL5):c.2372A>C (p.Gln791Pro)	CDKL5	Q791P	History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2|not specified	Benign(Last reviewed: Jul 22, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136713	X	18638082	X	18619962	136713	140416	rs35478150	NC_000023.11:18619961:A:C
NM_001323289.2(CDKL5):c.1431T>C (p.Ser477=)	CDKL5		History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|not provided	Benign/Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136712	X	18622475	X	18604355	136712	140415	rs143992148	NC_000023.11:18604354:T:C
NM_001323289.2(CDKL5):c.1332C>T (p.Arg444=)	CDKL5		History of neurodevelopmental disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000136711	X	18622376	X	18604256	136711	140414	rs150844616	NC_000023.11:18604255:C:T
NM_001323289.2(CDKL5):c.93A>G (p.Arg31=)	CDKL5		not provided|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2020)	criteria provided, conflicting interpretations	VCV000094115	X	18528968	X	18510848	94115	100015	rs140332992	NC_000023.11:18510847:A:G
NM_001323289.2(CDKL5):c.555-19C>G	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094114	X	18606055	X	18587935	94114	100014	rs75057928	NC_000023.11:18587934:C:G
NM_001323289.2(CDKL5):c.533G>A (p.Arg178Gln)	CDKL5	R178Q	CDKL5 disorder|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 25, 2021)	reviewed by expert panel	VCV000094113	X	18602452	X	18584332	94113	100013	rs267606715	NC_000023.11:18584331:G:A
NM_000330.4(RS1):c.184+3118C>T	CDKL5|RS1		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|History of neurodevelopmental disorder|not specified|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000094112	X	18671655	X	18653535	94112	100012	rs139155110	NC_000023.11:18653534:G:A
NM_000330.4(RS1):c.184+3199G>A	CDKL5|RS1		not provided|not specified|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder|Early infantile epileptic encephalopathy 2	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000094111	X	18671574	X	18653454	94111	100011	rs36022183	NC_000023.11:18653453:C:T
NM_000330.4(RS1):c.184+3207C>T	CDKL5|RS1	V999M	not provided|not specified|West syndrome|Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094110	X	18671566	X	18653446	94110	100010	rs35693326	NC_000023.11:18653445:G:A
NM_001323289.2(CDKL5):c.2653G>A (p.Gly885Arg)	CDKL5	G885R	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|not provided|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094109	X	18646647	X	18628527	94109	100009	rs398123694	NC_000023.11:18628526:G:A
NM_001323289.2(CDKL5):c.2200A>G (p.Thr734Ala)	CDKL5	T734A	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 11, 2020)	criteria provided, conflicting interpretations	VCV000094108	X	18631319	X	18613199	94108	100008	rs55803460	NC_000023.11:18613198:A:G
NM_001323289.2(CDKL5):c.180G>A (p.Glu60=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|CDKL5 disorder|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000094107	X	18593508	X	18575388	94107	100007	rs148697943	NC_000023.11:18575387:G:A
NM_001323289.2(CDKL5):c.1797C>G (p.Thr599=)	CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094106	X	18622841	X	18604721	94106	100006	rs141478957	NC_000023.11:18604720:C:G
NM_001323289.2(CDKL5):c.533G>C (p.Arg178Pro)	CDKL5	R178P	Early infantile epileptic encephalopathy 2|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000018450	X	18602452	X	18584332	18450	33489	rs267606715	NC_000023.11:18584331:G:C
NM_001323289.2(CDKL5):c.872G>A (p.Cys291Tyr)	CDKL5	C291Y	Angelman syndrome-like|Early infantile epileptic encephalopathy 2|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000011505	X	18616628	X	18598508	11505	26544	rs267606714	NC_000023.11:18598507:G:A
NM_001323289.2(CDKL5):c.215T>C (p.Ile72Thr)	CDKL5	I72T	Rett syndrome|CDKL5 disorder|Angelman syndrome-like|Early infantile epileptic encephalopathy 2|not provided|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011503	X	18593543	X	18575423	11503	26542	rs62641235	NC_000023.11:18575422:T:C
NM_001323289.2(CDKL5):c.119C>T (p.Ala40Val)	CDKL5	A40V	Early infantile epileptic encephalopathy 2|not provided|CDKL5 disorder|Atypical Rett syndrome|Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Mar 30, 2021)	reviewed by expert panel	VCV000011502	X	18582616	X	18564496	11502	26541	rs122460159	NC_000023.11:18564495:C:T
GRCh37/hg19 15q11.2-13.3(chr15:22770421-32915089)x4	CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|ARHGAP11A|FAN1|CYFIP1|FAM189A1|NPAP1|KLF13|MAGEL2|MTMR10|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|SNORD115-1|GOLGA8N|GOLGA8J|GOLGA8M|GOLGA8O|GOLGA8H|PWARSN|MIR211|PWAR6|PWRN2|SNORD116-1|PWAR4|PWRN1|TJP1|APBA2|NSMCE3|ATP10A		not provided	Pathogenic(Last reviewed: Dec 2, 2018)	no assertion criteria provided	VCV000815686	15	22770421 - 32915089			815686	803895		
GRCh37/hg19 15q11.2-13.3(chr15:22382860-32396457)	CHRNA7|GABRA5|GABRB3|GABRG3|IPW|TRPM1|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|FAN1|CYFIP1|FAM189A1|NPAP1|MAGEL2|MTMR10|NSMCE3|ATP10A|NIPA2|CHRFAM7A|ARHGAP11B|TUBGCP5|NIPA1|PWAR1|OTUD7A|GOLGA6L2|OR4N4|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|MIR211|GOLGA8J|GOLGA8M|GOLGA8H|PWRN1|PWRN2|KLF13|SNORD116-1|PWAR6|TJP1|APBA2		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625712	15	22382860 - 32396457			625712	614016		
GRCh37/hg19 15q11.1-26.3(chr15:20016811-102493540)x3	CSK|CSPG4|CTSH|CYP1A1|CYP1A2|CYP11A1|CYP19A1|DUT|EPB42|ETFA|FAH|FBN1|FES|FGF7|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|PDIA3|GTF2A2|HDC|HEXA|ONECUT1|IDH2|IDH3A|IGF1R|IL16|IPW|IREB2|ISG20|ISLR|ITPKA|IVD|LIPC|LOXL1|LTK|SMAD3|SMAD6|MAN2A2|MAN2C1|MAP1A|MEF2A|MEIS2|MFAP1|MFGE8|TRPM1|MPI|MYO1E|MYO5A|MYO9A|NDN|NEDD4|NEO1|NMB|NTRK3|OAZ2|OCA2|FURIN|PCSK6|PDE8A|PKM|PLCB2|PLIN1|PML|POLG|PPIB|MAPK6|MAP2K1|MAP2K5|PSMA4|PTPN9|RAB27A|RAD51|RASGRF1|RCN2|RLBP1|RORA|RPL4|RPLP1|RPS17|RYR3|SCG5|SH3GL3|SLC12A1|SNRPA1|SNRPN|SNX1|SORD|SPINT1|SRP14|TCF12|NR2F2|THBS1|TJP1|TLE3|TP53BP1|TPM1|TYRO3|UBE3A|MKRN3|SLC30A4|AP3B2|PWAR5|ANP32A|ST8SIA2|SEMA7A|CILP|PIAS1|EIF3J|RAB11A|SNAP23|PEX11A|IQGAP1|ALDH1A2|HERC2|HERC1|SNURF|PSTPIP1|PRC1|USP8|CCNB2|SLC28A2|SLC28A1|SLC24A1|CCPG1|GCNT3|COPS2|TRIP4|TGM5|COX5A|STOML1|HOMER2|PIGB|KIF23|IGDCC3|ZNF592|PPIP5K1|AQR|SECISBP2L|PCLAF|ARHGAP11A|LCMT2|SV2B|ARNT2|USP3|SLC12A6|NR2E3|BCL2L10|HCN4|SCAMP2|SNUPN|PDCD7|TSPAN3|FEM1B|RASGRP1|SERF2|AP3S2|DENND4A|SNAPC5|HMG20A|CORO2B|SEMA4B|CIB2|CIB1|MTHFS|ARID3B|GNB5|ARPP19|CLPX|MORF4L1|SLC27A2|ABHD2|ADAMTS7|AKAP13|GPR176|CHP1|OIP5|ITGA11|CHSY1|BAHD1|FAN1|CEP152|MAPKBP1|GOLGA8A|ZNF609|TBC1D2B|RTF1|MESD|CYFIP1|ACSBG1|MINAR1|MGA|DMXL2|SYNM|VPS39|FAM189A1|TMED3|AP4E1|SEC11A|CCNDBP1|DAPK2|EID1|NPAP1|HYPK|ARIH1|SIN3A|TMEM87A|ULK3|RPAP1|GLCE|PYGO1|BLOC1S6|FBXO22|VPS33B|GREM1|MRPL46|OR4F4|RNU6-1|RNU5A-1|NPTN|FOXB1|RPUSD2|TUBGCP4|SLCO3A1|SCG3|TMOD3|TMOD2|EHD4|SCAPER|DUOX2|MYEF2|RPS27L|NDUFAF1|RSL24D1|NUSAP1|EMC4|RASL12|SPG21|SPTBN5|NGRN|RHCG|HACD3|CTDSPL2|KLF13|RAB8B|BTBD1|TM6SF1|DUOX1|CSNK1G1|ZFAND6|MAGEL2|DLL4|INO80|MINDY2|RNF111|ZNF280D|TRPM7|VPS13C|LRRC49|PAQR5|PPP1R14D|DPP8|MTMR10|RPP25|COMMD4|PARP16|TIPIN|CLN6|ZNF770|ZSCAN2|ZWILCH|DET1|UACA|HAUS2|RMDN3|LINS1|DNAJC17|FANCI|IMP3|LARP6|MNS1|DNAJA4|NOP10|MCTP2|SELENOS|GOLGA6B|MESP1|UNC45A|MYO5C|NSMCE3|FAM214A|EMC7|C15orf39|THAP10|PAK6|RGMA|WDR93|PARP6|DTWD1|KNL1|AVEN|FAM219B|ADAMTSL3|ATP10A|CEMIP|GJD2|STARD9|ALPK3|ISLR2|VPS18|IGDCC4|SQOR|ABHD17C|TLNRD1|PPCDC|CELF6|STRA6|ZNF106|KLHL25|CPEB1|AEN|CRTC3|IQCH|ISL2|RFX7|TTC23|MRPS11|SPATA5L1|CHAC1|NOX5|EFL1|NEIL1|ICE2|LRRK1|AAGAB|LMAN1L|KATNBL1|SLTM|PEAK1|SNX22|THSD4|ATP8B4|WDR76|TMEM62|SEMA6D|PIF1|CCDC33|EDC3|SPG11|TM2D3|ELL3|PLEKHO2|WDR61|CD276|STARD5|POLR2M|INTS14|NIPA2|ADPGK|APH1B|RAMAC|TLN2|CIAO2A|MEX3B|C15orf48|MEGF11|CDIN1|SPPL2A|LINGO1|ZFYVE19|WDR73|CGNL1|FRMD5|UBL7|DISP2|CHRFAM7A|ARHGAP11B|DPH6|TICRR|CCDC32|KNSTRN|BMF|SHF|DUOXA1|RCCD1|CALML4|ARRDC4|LDHAL6B|UBE2Q2|CHST14|GOLM2|LACTB|TUBGCP5|DIS3L|TGM7|CATSPER2|LEO1|C15orf40|SENP8|MTFMT|SLC51B|TARS3|LRRC28|TMEM266|NIPA1|AGBL1|HYKK|WHAMM|FSD2|PLA2G4E|ASB7|TRIM69|PWAR1|TERB2|C2CD4A|LYSMD4|FAM81A|C15orf65|PGPEP1L|C15orf61|C15orf32|HAPLN3|MESP2|TMCO5A|SPATA8|NRG4|ZSCAN29|TTBK2|CDAN1|STRC|CFAP161|TBC1D21|DNAAF4|OTUD7A|SPRED1|ODF3L1|PGBD4|ADAL|EXD1|FSIP1|ADAMTS17|RHOV|SCAMP5|FAM227B|CT62|GRAMD2A|LCTL|UBR1|PATL2|CERS3|SPESP1|LPCAT4|PLA2G4F|LRRC57|LYSMD2|NUTM1|WDR72|SNX33|SLC24A5|PRTG|REC114|GOLGA6L2|OR4N4|SAXO2|FAM98B|PLA2G4D|LINC00928|GOLGA6L1|FBXL22|SNORD115-1|TMEM202|GLDN|GOLGA6A|TMC3|ZNF774|PWAR4|PWARSN|RBPMS2|ANKDD1A|ARPIN|USP50|TEX9|KIF7|ZNF710|HDDC3|CCDC9B|TNFAIP8L3|C2CD4B|INSYN1|OR4M2|KBTBD13|UBAP1L|SKOR1|ANKRD34C|GDPGP1|OR4F6|OR4F15|SHC4|CTXN2|LINC02694|LINC02915|ST20|FAM174B|DUOXA2|MIR184|MIR211|MIR9-3|GOLGA8B|EIF2AK4|UNC13C|CKMT1A|CPLX3|SERINC4|C15orf62|GOLGA8N|PAK6-AS1|PHGR1|SH2D7|GOLGA8J|GOLGA6C|GOLGA6D|GOLGA8M|SCARNA15|FBXO22-AS1|GOLGA6L6|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|LOC100128979|ANKRD63|JMJD7|PLA2G4B|POTEB2|PWAR6|ARPIN-AP3S2|ST20-MTHFS|MYZAP|POTEB|ACTC1|ADAM10|ACAN|ALDH1A3|ANPEP|ANXA2|APBA2|AQP9|B2M|BBS4|BCL2A1|BLM|BNC1|BNIP2|BUB1B|CA12|CAPN3|CHD2|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CKMT1B|CLK3|CRABP1		not provided	Pathogenic(Last reviewed: Jan 1, 2013)	no assertion criteria provided	VCV000614519	15	20016811 - 102493540			614519	605855		
NC_000023.10:g.(?_17393881)_(20284750_?)dup	EIF1AX|NHS|PDHA1|PHKA2|PPEF1|RPS6KA3|RS1|SCML1|CDKL5|ADGRG2|SCML2|RAI2|SH3KBP1|BEND2|BCLAF3|MAP7D2|MAP3K15		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001041824	X	17393881 - 20284750			1041824	1022436		
GRCh38/hg38 15q11.2-14(chr15:23319714-38545325)x3	EMC7|FAM189A1|FAM98B|FAN1|FMN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GJD2|GJD2-DT|GOLGA6L2|GOLGA6L7|GOLGA8A|GOLGA8B|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8K|GOLGA8M|GOLGA8N|GOLGA8O|GOLGA8Q|GOLGA8R|GOLGA8S|GOLGA8T|GREM1|GREM1-AS1|HERC2|IPW|KATNBL1|KLF13|LINC00929|LINC01852|LINC02249|LINC02250|LINC02252|LINC02256|LINC02345|LINC02346|LINC02352|LINC02853|LOC100130111|LOC100132202|LOC100996413|LOC101928042|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC108004527|LOC110120842|LOC110120858|LOC110120896|LOC110120905|LOC110120936|LOC110120937|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC112272583|LOC113939943|LOC145845|LOC283710|LOC645202|LPCAT4|MAGEL2|MEIS2|MIR1233-1|MIR1233-2|MIR211|MIR3942|MIR4508|MIR4509-2|MIR4509-3|MIR4510|MIR4715|MIR8063|MKRN3|MTMR10|NANOGP8|NDN|NOP10|NPAP1|NSMCE3|NUTM1|OCA2|OTUD7A|PGBD4|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|RASGRP1|RYR3|RYR3-DT|SCG5|SCG5-AS1|SLC12A6|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|SPRED1|TJP1|TMCO5A|TRE-TTC2-2|TRPM1|UBE3A|ZNF770|ACTC1|APBA2|AQR|ARHGAP11A|ARHGAP11A-SCG5|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|AVEN|CDIN1|CHRFAM7A|CHRM5|CHRNA7|DPH6|DPH6-DT|EMC4		See cases	Pathogenic(Last reviewed: Aug 13, 2012)	no assertion criteria provided	VCV000149530	15	22765628 - 38837526	15	23319714 - 38545325	149530	159281		
NC_000023.10:g.(?_135080257)_(135292184_?)dup	FHL1|SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001036230	X	135080257 - 135292184			1036230	1022433		
NM_005249.5(FOXG1):c.177_186dup (p.Pro63fs)	FOXG1	P63fs	FOXG1 disorder|not provided|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000451937	14	29236655 - 29236656	14	28767449 - 28767450	451937	445223	rs1555321206	NC_000014.9:28767449:CCCGCCGCCGCCCGCC:CCCGCCGCCGCCCGCCGCCGCCCGCC
NM_005249.5(FOXG1):c.503G>C (p.Gly168Ala)	FOXG1	G168A	Rett syndrome, congenital variant|FOXG1 disorder|not provided|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000205474	14	29236988	14	28767782	205474	202819	rs148157138	NC_000014.9:28767781:G:C
NM_005249.5(FOXG1):c.209_232del (p.Gln70_Pro77del)	FOXG1		Rett syndrome, congenital variant|FOXG1 disorder|History of neurodevelopmental disorder|not specified|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000193308	14	29236680 - 29236703	14	28767474 - 28767497	193308	190472	rs794726920	NC_000014.9:28767473:GCCGCCGCCGCCGCAGCAGCAGCAGCCGCCGCCGCCGC:GCCGCCGCCGCCGC
NM_005249.5(FOXG1):c.256del (p.Gln86fs)	FOXG1	Q86fs	Rett syndrome, congenital variant|not provided|FOXG1 disorder	Pathogenic(Last reviewed: Mar 25, 2021)	reviewed by expert panel	VCV000189612	14	29236735	14	28767529	189612	187401	rs786205001	NC_000014.9:28767528:CCCCCCC:CCCCCC
NM_005249.5(FOXG1):c.799G>A (p.Gly267Ser)	FOXG1	G267S	not provided|FOXG1 disorder|Rett syndrome, congenital variant	Pathogenic(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000158602	14	29237284	14	28768078	158602	169061	rs587783643	NC_000014.9:28768077:G:A
NM_005249.5(FOXG1):c.489C>T (p.Gly163=)	FOXG1		FOXG1 disorder|History of neurodevelopmental disorder|Rett syndrome, congenital variant|not specified|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000137390	14	29236974	14	28767768	137390	141093	rs375378714	NC_000014.9:28767767:C:T
NM_005249.5(FOXG1):c.201G>T (p.Pro67=)	FOXG1		not provided|FOXG1 disorder|History of neurodevelopmental disorder|Rett syndrome, congenital variant|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000137388	14	29236686	14	28767480	137388	141091	rs587780944	NC_000014.9:28767479:G:T
NM_005249.5(FOXG1):c.460dup (p.Glu154fs)	FOXG1	E154fs	not provided|FOXG1 disorder|Rett syndrome, congenital variant|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000095268	14	29236938 - 29236939	14	28767732 - 28767733	95268	101167	rs398124204	NC_000014.9:28767732:GGGGGGG:GGGGGGGG
GRCh37/hg19 15q11.2-13.1(chr15:23616095-28538904)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001180527	15	23616095 - 28538904			1180527	1170075		
GRCh37/hg19 15q11.2-13.1(chr15:23208842-28525460)	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		Epileptic encephalopathy	Pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV000997087	15	23208842 - 28525460			997087	984763		
GRCh37/hg19 15q11.2-13.1(chr15:23707435-28726651)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Nov 6, 2020)	no assertion criteria provided	VCV000992644	15	23707435 - 28726651			992644	980577		
NC_000015.10:g.(?_25862297)_(26937328_?)del	GABRA5|GABRB3|ATP10A		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000833345	15	26107444 - 27182475			833345	820670		
GRCh37/hg19 15q11.2-13.1(chr15:24740574-28659911)x1	GABRA5|GABRB3|GABRG3|IPW|OCA2|SNRPN|UBE3A|PWAR5|HERC2|SNURF|NPAP1|ATP10A|PWAR1|SNORD115-1|PWAR4|PWARSN|PWRN1|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Feb 22, 2019)	no assertion criteria provided	VCV000816547	15	24740574 - 28659911			816547	804753		
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000666599	15	23810928 - 28544664			666599	654159		
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		Neurodevelopmental disorder	Pathogenic(Last reviewed: Apr 9, 2019)	no assertion criteria provided	VCV000635870	15	23699983 - 28436313			635870	623683		
GRCh37/hg19 15q11.2-13.1(chr15:23810397-28525505)	GABRA5|SNORD115-1|PWAR4|HERC2|PWARSN|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWRN1|PWRN2|SNORD116-1|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625746	15	23810397 - 28525505			625746	614050		
GRCh37/hg19 15q11.2-13.3(chr15:20848750-32925141)	GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|HERC2|IPW|KLF13|MAGEL2|MIR211|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OR4N4|OTUD7A|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TRPM1|TUBGCP5|UBE3A|APBA2|ARHGAP11A|ARHGAP11B|ATP10A|CHRFAM7A|CHRNA7|CYFIP1|FAM189A1|FAN1		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625711	15	20848750 - 32925141			625711	614015		
GRCh37/hg19 15q11.1-13.1(chr15:20102541-28535051)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|OR4N4|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|OR4M2|GOLGA8M|GOLGA6L6|PWRN1|PWRN2|SNORD116-1|POTEB2|PWAR6|POTEB		not provided	Pathogenic(Last reviewed: Sep 6, 2018)	no assertion criteria provided	VCV000617598	15	20102540 - 29031690			617598	608985		
GRCh37/hg19 15q11.2-13.1(chr15:23656946-28544359)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Jan 17, 2012)	no assertion criteria provided	VCV000614552	15	23656946 - 28544359			614552	605888		
GRCh37/hg19 15q11.2-13.1(chr15:23656946-28544359)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Oct 6, 2016)	no assertion criteria provided	VCV000614551	15	23656946 - 28544359			614551	605887		
GRCh37/hg19 15q11.2-13.1(chr15:23656946-28535266)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Aug 10, 2011)	no assertion criteria provided	VCV000614550	15	23656946 - 28535266			614550	605886		
GRCh37/hg19 15q11.2-13.1(chr15:23656946-28506450)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Oct 13, 2016)	no assertion criteria provided	VCV000614549	15	23656946 - 28506450			614549	605885		
GRCh37/hg19 15q11.2-13.1(chr15:23109890-29085893)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|GOLGA6L2|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Likely pathogenic(Last reviewed: Aug 5, 2013)	no assertion criteria provided	VCV000614545	15	23109890 - 29085893			614545	605881		
GRCh37/hg19 15q11.2-13.1(chr15:22750305-28535266)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 14, 2016)	no assertion criteria provided	VCV000614540	15	22750305 - 28535266			614540	605876		
GRCh37/hg19 15q11.2-13.1(chr15:23693406-29085893)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Mar 13, 2012)	no assertion criteria provided	VCV000602026	15	23693406 - 29085893			602026	593362		
GRCh37/hg19 15q11.2-13.1(chr15:23672782-28544359)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Aug 2, 2012)	no assertion criteria provided	VCV000602025	15	23672782 - 28544359			602025	593361		
GRCh37/hg19 15q11.2-13.1(chr15:23672782-28532120)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Jul 26, 2012)	no assertion criteria provided	VCV000602024	15	23672782 - 28532120			602024	593360		
GRCh37/hg19 15q11.2-13.1(chr15:22652330-29050198)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Sep 21, 2015)	no assertion criteria provided	VCV000602016	15	22652330 - 29050198			602016	593352		
GRCh37/hg19 15q11.2-13.1(chr15:23637603-28644578)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000564161	15	23637603 - 28644578			564161	555345		
GRCh37/hg19 15q11.2-13.1(chr15:23632677-28723454)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000564160	15	23632677 - 28723454			564160	555344		
GRCh37/hg19 15q11.2-13.1(chr15:23632677-28534458)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000564159	15	23632677 - 28534458			564159	555343		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28540415)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000564158	15	23620191 - 28540415			564158	555342		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28561671)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000564157	15	23615768 - 28561671			564157	555341		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28561671)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 1, 2019)	no assertion criteria provided	VCV000564156	15	23615768 - 28561671			564156	555340		
GRCh37/hg19 15q11.2-13.1(chr15:23290786-28560269)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|GOLGA6L2|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000564155	15	23290786 - 28560269			564155	555339		
GRCh37/hg19 15q11.2-13.1(chr15:23288374-29062203)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000564154	15	23288374 - 29062203			564154	555338		
GRCh37/hg19 15q11.2-13.1(chr15:23288374-28705281)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: May 17, 2019)	no assertion criteria provided	VCV000564153	15	23288374 - 28705281			564153	555337		
GRCh37/hg19 15q11.2-13.1(chr15:22876919-28561671)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|PWAR1|MAGEL2|ATP10A|NIPA2|NIPA1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000564151	15	22876919 - 28561671			564151	555335		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29069001)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: May 15, 2020)	no assertion criteria provided	VCV000564145	15	22770421 - 29069001			564145	555329		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28823722)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Apr 12, 2019)	no assertion criteria provided	VCV000564144	15	22770421 - 28823722			564144	555328		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28545601)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Feb 24, 2020)	no assertion criteria provided	VCV000564143	15	22770421 - 28545601			564143	555327		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28534245)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Feb 14, 2020)	no assertion criteria provided	VCV000564142	15	22770421 - 28534245			564142	555326		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28376934)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|GOLGA6L2|NIPA2|TUBGCP5|NIPA1|PWAR1|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6|MAGEL2|ATP10A		not provided	Pathogenic(Last reviewed: May 1, 2019)	no assertion criteria provided	VCV000564141	15	22770421 - 28376934			564141	555325		
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545172			15	23319712 - 28684313	545172	535436		
Single allele	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		Schizophrenia	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545171			15	23157975 - 28774125	545171	535435		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28534245)x3	GABRA5|ATP10A|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		See cases	Likely pathogenic(Last reviewed: Sep 9, 2015)	no assertion criteria provided	VCV000443750	15	23615768 - 28534245			443750	437412		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28823722)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397496	15	23615768 - 28823722			397496	384389		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28709715)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397484	15	22770421 - 28709715			397484	384377		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28958779)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397466	15	22770421 - 28958779			397466	384359		
GRCh37/hg19 15q11.2-13.1(chr15:23286571-28545355)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397443	15	23286571 - 28545355			397443	384336		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28823722)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397437	15	22770421 - 28823722			397437	384330		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28545355)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397436	15	23620191 - 28545355			397436	384329		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28823722)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397435	15	22770421 - 28823722			397435	384328		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28545355)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397386	15	22770421 - 28545355			397386	384279		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28828168)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|PWAR1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397357	15	22770421 - 28828168			397357	384250		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28419123)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397341	15	22770421 - 28419123			397341	384234		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28660038)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397312	15	22770421 - 28660038			397312	384205		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28357230)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397224	15	23620191 - 28357230			397224	384117		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29069001)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397216	15	22770421 - 29069001			397216	384109		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28534458)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|PWAR1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397109	15	22770421 - 28534458			397109	384002		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28534245)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000397083	15	22770421 - 28534245			397083	383976		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28644578)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396978	15	22770421 - 28644578			396978	383871		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28527734)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396730	15	23620191 - 28527734			396730	383623		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28527747)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396686	15	22770421 - 28527747			396686	383579		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28527747)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396685	15	22770421 - 28527747			396685	383578		
GRCh37/hg19 15q11.2-13.1(chr15:23290786-28545459)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396571	15	23290786 - 28545459			396571	383464		
GRCh37/hg19 15q11.2-13.1(chr15:23290862-28561097)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396552	15	23290862 - 28561097			396552	383445		
GRCh37/hg19 15q11.2-13.1(chr15:23290862-28534245)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396531	15	23290862 - 28534245			396531	383424		
GRCh37/hg19 15q11.2-13.1(chr15:23288374-28534245)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396479	15	23288374 - 28534245			396479	383372		
GRCh37/hg19 15q11.2-13.1(chr15:23290862-28823722)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396304	15	23290862 - 28823722			396304	383197		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28915864)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|PWAR1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396264	15	22770421 - 28915864			396264	383157		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28915864)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|PWRN1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396263	15	22770421 - 28915864			396263	383156		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28704050)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396152	15	22770421 - 28704050			396152	383045		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29021034)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|GOLGA8M|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000396092	15	22770421 - 29021034			396092	382985		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28545601)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|GOLGA6L2|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000395950	15	23620191 - 28545601			395950	382843		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28561232)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000395874	15	23620191 - 28561232			395874	382767		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-29062203)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|GOLGA8M|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000395790	15	22770421 - 29062203			395790	382683		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28545355)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000395788	15	23615768 - 28545355			395788	382681		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28437018)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		See cases	Pathogenic	no assertion criteria provided	VCV000395735	15	23620191 - 28437018			395735	382628		
GRCh37/hg19 15q11.2-12(chr15:20848460-27662530)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|OR4N4|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|OR4M2|PWRN1|PWRN2|SNORD116-1|POTEB2|PWAR6|POTEB		See cases	Pathogenic(Last reviewed: Jan 20, 2016)	criteria provided, single submitter	VCV000253587	15	20848460 - 27662530			253587	248035		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	GABRA5|GABRB3|GABRG3|IPW|NPAP1|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|GOLGA6L1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000160971	15	22698522 - 29030517	15	22358243 - 28481444	160971	170815		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275167)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000160970	15	23300238 - 28520313	15	23319714 - 28275167	160970	170814		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28446314)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000160969	15	22698522 - 28691460	15	23319714 - 28446314	160969	170813		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28275167)x1	GABRA5|GABRB3|GABRG3|IPW|SNORD108|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	VCV000160927	15	23656936 - 28520313	15	23411789 - 28275167	160927	170771		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|GOLGA6L1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000160796	15	22698522 - 29030517	15	22358243 - 28481444	160796	170640		
GRCh38/hg38 15q11.2-13.1(chr15:23454554-28280314)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000147566	15	23699701 - 28525460	15	23454554 - 28280314	147566	157317		
GRCh38/hg38 15q11.2-13.1(chr15:23462105-28290061)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Feb 16, 2011)	no assertion criteria provided	VCV000146634	15	23707252 - 28535207	15	23462105 - 28290061	146634	156385		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28446455)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059392	15	23300038 - 28691601	15	23319714 - 28446455	59392	73987		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|GOLGA6L1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059389	15	22765428 - 28940239	15	22358243 - 28481444	59389	73984		
GRCh38/hg38 15q11.1-13.1(chr15:20046515-28385894)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|LINC02203|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4508|MIR4715|MIR5701-2|MIR5701-1|SNORD116-30|SNORD115-46|POTEB|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059369	15	20251768 - 28631040	15	20046515 - 28385894	59369	73964		
GRCh38/hg38 15q11.2-13.1(chr15:23537429-28275167)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058635	15	23782576 - 28520313	15	23537429 - 28275167	58635	73230		
GRCh38/hg38 15q11.2-13.1(chr15:23537429-28269468)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058634	15	23782576 - 28514614	15	23537429 - 28269468	58634	73229		
GRCh38/hg38 15q11.2-13.1(chr15:23494211-28281294)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058633	15	23739358 - 28526440	15	23494211 - 28281294	58633	73228		
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28190742)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058631	15	23707452 - 28435888	15	23462305 - 28190742	58631	73226		
GRCh38/hg38 15q11.2-13.1(chr15:23462105-28275308)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058628	15	23707252 - 28520454	15	23462105 - 28275308	58628	73223		
GRCh38/hg38 15q11.2-13.1(chr15:23450287-28446314)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058627	15	23695434 - 28691460	15	23450287 - 28446314	58627	73222		
GRCh38/hg38 15q11.2-13.1(chr15:23398620-28446314)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058607	15	23643767 - 28691460	15	23398620 - 28446314	58607	73202		
GRCh38/hg38 15q11.2-13.1(chr15:23398620-28190742)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058606	15	23643767 - 28435888	15	23398620 - 28190742	58606	73201		
GRCh38/hg38 15q11.2-13.1(chr15:23398620-28190742)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058605	15	23643767 - 28435888	15	23398620 - 28190742	58605	73200		
GRCh38/hg38 15q11.2-13.1(chr15:23375083-28272443)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580|UBE3A|MKRN3		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058603	15	23620230 - 28517589	15	23375083 - 28272443	58603	73198		
GRCh38/hg38 15q11.2-13.1(chr15:23375083-28197267)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058601	15	23620230 - 28442413	15	23375083 - 28197267	58601	73196		
GRCh38/hg38 15q11.2-13.1(chr15:23337069-28272443)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058599	15	23582216 - 28517589	15	23337069 - 28272443	58599	73194		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28197267)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058585	15	22779922 - 28442413	15	23319714 - 28197267	58585	73180		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275167)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058584	15	22698522 - 28520313	15	23319714 - 28275167	58584	73179		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275308)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058583	15	22698322 - 28520454	15	23319714 - 28275308	58583	73178		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28190742)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058579	15	22669052 - 28435888	15	23319714 - 28190742	58579	73174		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28190742)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058578	15	22669052 - 28435888	15	23319714 - 28190742	58578	73173		
GRCh38/hg38 15q11.2-13.1(chr15:22030646-28694952)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|OR4M2|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|MIR1268A|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058574	15	22318597 - 28940098	15	22030646 - 28694952	58574	73169		
GRCh38/hg38 15q11.1-13.1(chr15:19905469-28163751)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|GOLGA6L22|LINC00929|GOLGA8S|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|LINC02203|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4508|MIR4715|MIR5701-2|MIR5701-1|SNORD116-30|SNORD115-46|POTEB|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|FAM30B|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058539	15	20110722 - 28408897	15	19905469 - 28163751	58539	73134		
GRCh38/hg38 15q11.1-13.1(chr15:19879749-28702163)x4	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD115-1|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|GOLGA6L22|LINC00929|LOC645202|GOLGA8S|GOLGA8M|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|LINC02203|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4509-2|MIR4508|MIR4509-3|MIR4715|MIR5701-2|MIR5701-1|SNORD116-30|SNORD115-46|POTEB|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|FAM30B|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058532	15	20085002 - 28947309	15	19879749 - 28702163	58532	73127		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28281294)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058075	15	23656936 - 28526440	15	23411789 - 28281294	58075	72670		
GRCh38/hg38 15q11.2-13.1(chr15:23411589-28446455)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058073	15	23656736 - 28691601	15	23411589 - 28446455	58073	72668		
GRCh38/hg38 15q11.2-13.1(chr15:23320410-28460005)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058071	15	23565551 - 28812483	15	23320410 - 28460005	58071	72666		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28681287)x3	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|GOLGA8G|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|LOC645202|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100132202|GOLGA8F|TRE-TTC2-2|PWAR6|MIR4509-2|MIR4508|MIR4509-3|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058070	15	23510051 - 28926433	15	23319714 - 28681287	58070	72665		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28314256)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057364	15	23300238 - 28557186	15	23319714 - 28314256	57364	71959		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28314256)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|SNORD107|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000057194	15	23656936 - 28557186	15	23411789 - 28314256	57194	71789		
NC_000015.9:g.(?_26792940)_(27020442_?)del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001069675	15	26792940 - 27020442			1069675	1057671		
GRCh37/hg19 15q11.2-12(chr15:23288374-27706996)x1	GABRB3|GABRG3|IPW|NDN|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|SNORD116-1|PWAR6|GABRA5|PWRN2|PWAR4|PWARSN|PWRN1		not provided	Pathogenic(Last reviewed: Mar 31, 2019)	no assertion criteria provided	VCV000815689	15	23288374 - 27706996			815689	803898		
GRCh37/hg19 15q11.2-13.1(chr15:22816713-28530182)	GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|HERC2|SNORD115-1|PWAR4|SNORD116-1|PWAR1|GOLGA6L2|PWARSN|PWRN1|PWRN2|GABRA5|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625833	15	22816713 - 28530182			625833	614137		
NC_000015.10:g.(?_26547773)_(26775295_?)del	GABRB3		Epilepsy, childhood absence 5|Epilepsy, childhood absence 1	Pathogenic(Last reviewed: Nov 11, 2019)	criteria provided, single submitter	VCV000469568			15	26547773 - 26775295	469568	464507		
GRCh37/hg19 15q11.2-13.1(chr15:23620191-28561671)x1	GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A|ATP10A|GABRA5		See cases	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000442553	15	23620191 - 28561671			442553	436215		
NM_000814.5(GABRB3):c.-114_*4247del	GABRB3		Epilepsy, childhood absence 1|Epilepsy, childhood absence 5	Uncertain significance(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000238187	15	26788693 - 27018223	15	26543546 - 26773076	238187	242024		
NM_033223.5(GABRG3):c.1125C>T (p.Asn375=)	GABRG3		Angelman syndrome	Pathogenic(Last reviewed: Mar 8, 2020)	criteria provided, single submitter	VCV000870529	15	27777748	15	27532602	870529	858691		NC_000015.10:27532601:C:T
GRCh38/hg38 15q11.2-13.1(chr15:23422864-28314256)x1	GOLGA6L2|ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jan 9, 2013)	no assertion criteria provided	VCV000148891	15	23668011 - 28557186	15	23422864 - 28314256	148891	158642		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-30386398)x4	GOLGA8M|IPW|PWAR4|PWAR5|PWAR6|PWARSN|HERC2|PWRN1|PWRN2|SNORD115-1|SNORD116-1|FAM189A1|GABRA5|GABRB3|GABRG3|GOLGA6L2|GOLGA8J|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|PWAR1|SNRPN|SNURF|TJP1|TUBGCP5|UBE3A|APBA2|ATP10A|CYFIP1		See cases	Pathogenic(Last reviewed: Mar 10, 2016)	no assertion criteria provided	VCV000441782	15	22770421 - 30386398			441782	435444		
Single allele	GOLGA8S|GOLGA8T|LOC645202|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-12|SNORD115-13|MIR4509-3|MIR4715|SNORD107|SNORD109A|SNORD109B|SNORD115-1|SNORD108|SNORD115-10|SNORD115-11|LINC02250|LINC02346|LINC02352|HERC2|IPW|KLF13|LOC100996413|LINC00929|LINC02249|LOC100130111|LOC100132202|LOC106736464|LOC106736465|LOC106736468|LOC106736476|LOC102723623|CYFIP1|FAM189A1|FAN1|PWRN2|PWRN3|PWRN4|SNHG14|APBA2|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|CHRFAM7A|CHRNA7|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8Q|GOLGA8R|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC283683|LOC283710|MAGEL2|MIR211|MIR4508|MIR4509-1|MIR4509-2|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|PWRN1|OTUD7A|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|TRPM1|TUBGCP5|UBE3A		Autistic disorder of childhood onset	Pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000545163			15	22420897 - 32130343	545163	535427		
NC_000002.12:g.(144114719_144303837)_(144566562_144681958)del	GTDC1|ZEB2|ZEB2-AS1|LINC01412|LOC105373656|LOC110120671|LOC110121209|LOC111721705|LOC112806051|TEX41		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 1, 2003)	no assertion criteria provided	VCV000004765			2	144114719 - 144681958	4765	19804		
Single allele	HERC2|MKRN3|SNURF|GABRB3|PWAR1|GABRG3|PWRN1|MAGEL2|IPW|SNRPN|PWAR6|SNORD116-1|PWARSN|OCA2|GABRA5|PWAR4|NDN|ATP10A|PWAR5|SNORD115-1|PWRN2|NPAP1|UBE3A		Prader-Willi syndrome	Pathogenic	criteria provided, single submitter	VCV000375417	15	23707435 - 28520316			375417	362184		
NM_004667.6(HERC2):c.1781C>T (p.Pro594Leu)	HERC2	P594L	Mental retardation, autosomal recessive 38	Pathogenic(Last reviewed: Feb 1, 2013)	no assertion criteria provided	VCV000088738	15	28510853	15	28265707	88738	94315	rs397518474	NC_000015.10:28265706:G:A
NM_006734.4(HIVEP2):c.2956_2957del (p.Glu986fs)	HIVEP2	E986fs	not provided|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000625161	6	143092919 - 143092920	6	142771782 - 142771783	625161	613504	rs1582843150	NC_000006.12:142771781:TCTCT:TCT
NM_006734.4(HIVEP2):c.5935C>T (p.Arg1979Ter)	HIVEP2	R1979*	not provided|Mental retardation, autosomal dominant 43|Angelman syndrome-like	Pathogenic(Last reviewed: Apr 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000523775	6	143081490	6	142760353	523775	514525	rs1554275163	NC_000006.12:142760352:G:A
Single allele	HNMT|KYNU|ARHGAP15|ZEB2|THSD7B|LRP1B|SPOPL|NXPH2|GTDC1		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000974580	2	137639637 - 146827604			974580	962877		
NC_000006.12:g.122416221_122416224del	HSF2		not provided	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666264	6	122737364 - 122737367	6	122416219 - 122416222	666264	653821	rs1582613322	NC_000006.12:122416218:AGTGAG:AG
GRCh37/hg19 15q11.2(chr15:24889575-25611877)x3	IPW|SNRPN|UBE3A|PWAR5|SNURF|NPAP1|PWAR1|SNORD115-1|PWAR4|PWARSN|SNORD116-1|PWAR6		not provided	Uncertain significance(Last reviewed: Mar 30, 2018)	no assertion criteria provided	VCV000689113	15	24889575 - 25611877			689113	676705		
GRCh37/hg19 15q11.2-12(chr15:23662481-25991024)x1	IPW|NDN|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Jul 20, 2017)	no assertion criteria provided	VCV000564162	15	23662481 - 25991024			564162	555346		
NM_004519.4(KCNQ3):c.688C>T (p.Arg230Cys)	KCNQ3	R230C, R110C	Benign familial neonatal seizures 2|Intellectual disability|Benign familial neonatal seizures|Lennox-Gastaut syndrome|Benign familial neonatal seizures|Autistic behavior|Intellectual disability|Seizures, benign familial infantile, 5|Severe neurodevelopmental delay|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000205963	8	133192493	8	132180246	205963	202181	rs796052676	NC_000008.11:132180245:G:A
NM_001244008.2(KIF1A):c.506G>C (p.Arg169Thr)	KIF1A	R169T	Intellectual disability, autosomal dominant 9	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666256	2	241725854	2	240786437	666256	653809	rs876661168	NC_000002.12:240786436:C:G
GRCh38/hg38 15q13.2-13.3(chr15:30621371-32147323)x3	KLF13|ARHGAP11B|ARHGAP11B-DT|CHRNA7|FAN1|LINC02352|LOC106736476|LOC106736477|LOC106736480|LOC106783506|LOC110121498|LOC112272582|LOC283710|MIR211|MTMR10|OTUD7A|TRPM1		See cases	conflicting data from submitters(Last reviewed: Dec 14, 2014)	no assertion criteria provided	VCV000154013	15	30913574 - 32439524	15	30621371 - 32147323	154013	163764		
NM_031206.7(LAS1L):c.1237G>A (p.Gly413Arg)	LAS1L	G396R, G413R, G354R, G94R	Wilson-Turner X-linked mental retardation syndrome	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666263	X	64743999	X	65524119	666263	653814	rs1602612611	NC_000023.11:65524118:C:T
NM_014795.4(ZEB2):c.592+6_592+7delinsAA	LOC111721705|ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001035651	2	145162396 - 145162397	2	144404829 - 144404830	1035651	1023705		NC_000002.12:144404828:GC:TT
NM_014795.4(ZEB2):c.585del (p.Glu196fs)	LOC111721705|ZEB2	E172fs, E196fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000661350	2	145162410	2	144404843	661350	628459	rs1573722122	NC_000002.12:144404842:TT:T
NM_014795.4(ZEB2):c.561C>T (p.Gly187=)	LOC111721705|ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000657407	2	145162434	2	144404867	657407	628460	rs1186904900	NC_000002.12:144404866:G:A
NM_014795.4(ZEB2):c.575A>G (p.Asn192Ser)	LOC111721705|ZEB2	N192S, N168S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000580089	2	145162420	2	144404853	580089	558729	rs779549076	NC_000002.12:144404852:T:C
NM_014795.4(ZEB2):c.502C>T (p.Gln168Ter)	LOC111721705|ZEB2	Q168*, Q144*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561146	2	145162493	2	144404926	561146	552051	rs1560609721	NC_000002.12:144404925:G:A
NM_014795.4(ZEB2):c.550_568del (p.Ser184fs)	LOC111721705|ZEB2	S160fs, S184fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160326	2	145162427 - 145162445	2	144404860 - 144404878	160326	168034	rs587784568	NC_000002.12:144404859:CTGGCGTGCCAAGGCGAGAC:C
NM_014795.4(ZEB2):c.553_554insTG (p.Arg185fs)	LOC111721705|ZEB2	R161fs, R185fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004761	2	145162441 - 145162442	2	144404874 - 144404875	4761	19800	rs587776608	NC_000002.12:144404874::CA
GRCh38/hg38 15q11.2-13.1(chr15:23370622-28414892)x1	LOC112272580|LOC645202|MAGEL2|MIR4508|MIR4715|PWAR4|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A|ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8F|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579		See cases	Pathogenic(Last reviewed: May 5, 2014)	no assertion criteria provided	VCV000153281	15	23615769 - 28660038	15	23370622 - 28414892	153281	163032		
GRCh37/hg19 15q11.2-26.3(chr15:22770422-102429112)x3	MAP2K5|MAPK6|MAPKBP1|MCTP2|MEF2A|MEGF11|MEIS2|MESD|MESP1|MESP2|MEX3B|MFAP1|MFGE8|MGA|MINAR1|MINDY2|MIR184|MIR211|MIR9-3|MTFMT|MKRN3|MNS1|MORF4L1|MPI|MRPL46|MRPS11|MTHFS|MTMR10|MYEF2|MYO1E|MYO5A|MYO5C|MYO9A|MYZAP|NDN|NDUFAF1|NEDD4|NEIL1|NEO1|NGRN|NIPA1|NIPA2|NMB|NOP10|NOX5|NPAP1|NPTN|NR2E3|NR2F2|NRG4|NSMCE3|NTRK3|NUSAP1|NUTM1|OAZ2|OCA2|ODF3L1|OIP5|ONECUT1|OR4F15|OR4F6|OTUD7A|PAK6|PAK6-AS1|PAQR5|PARP16|PARP6|PATL2|PCLAF|PCSK6|PDCD7|PDE8A|PDIA3|PEAK1|PEX11A|PGBD4|PGPEP1L|PHGR1|PIAS1|PIF1|PIGB|PKM|PLA2G4B|PLA2G4D|PLA2G4E|PLA2G4F|PLCB2|PLEKHO2|PLIN1|PML|POLG|POLR2M|PPCDC|PPIB|PPIP5K1|PPP1R14D|PRC1|PRTG|PSMA4|PSTPIP1|PTPN9|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PYGO1|RAB11A|RAB27A|RAB8B|RAD51|RAMAC|RASGRF1|RASGRP1|RASL12|RBPMS2|RCCD1|RCN2|REC114|RFX7|RGMA|RHCG|RHOV|RLBP1|RMDN3|RNF111|RNU5A-1|RNU6-1|RORA|RPAP1|RPL4|RPLP1|RPP25|RPS17|RPS27L|RPUSD2|RSL24D1|RTF1|RYR3|SAXO2|SCAMP2|SCAMP5|SCAPER|SCARNA15|SCG3|SCG5|SEC11A|SECISBP2L|SELENOS|SEMA4B|SEMA6D|SEMA7A|SENP8|SERF2|SERINC4|SH2D7|SH3GL3|SHC4|SHF|SIN3A|SKOR1|SLC12A1|SLC12A6|SLC24A1|SLC24A5|SLC27A2|SLC28A1|SLC28A2|SLC30A4|SLC51B|SLCO3A1|SLTM|SMAD3|SMAD6|SNAP23|SNAPC5|SNORD115-1|SNORD116-1|SNRPA1|SNRPN|SNUPN|SNURF|SNX1|SNX22|SNX33|SORD|SPATA5L1|SPATA8|SPESP1|SPG11|SPG21|SPINT1|SPPL2A|SPRED1|SPTBN5|SQOR|SRP14|ST20|ST20-MTHFS|ST8SIA2|STARD5|STARD9|STOML1|STRA6|STRC|SV2B|SYNM|TARS3|TBC1D21|TBC1D2B|TCF12|TERB2|TEX9|TGM5|TGM7|THAP10|THBS1|THSD4|TICRR|TIPIN|TJP1|TLE3|TLN2|TLNRD1|TM2D3|TM6SF1|TMC3|TMCO5A|TMED3|TMEM202|TMEM266|TMEM62|TMEM87A|TMOD2|TMOD3|TNFAIP8L3|TP53BP1|TPM1|TRIM69|TRIP4|TRPM1|TRPM7|TSPAN3|TTBK2|TTC23|TUBGCP4|TUBGCP5|TYRO3|UACA|UBAP1L|UBE2Q2|UBE3A|UBL7|UBR1|ULK3|UNC13C|UNC45A|USP3|USP50|USP8|VPS13C|VPS18|VPS33B|VPS39|WDR61|WDR72|WDR73|WDR76|WDR93|WHAMM|ZFAND6|ZFYVE19|ZNF106|ZNF280D|ZNF592|ZNF609|ZNF710|ZNF770|ZNF774|ZSCAN2|ZSCAN29|ZWILCH|AAGAB|ABHD17C|ABHD2|ACAN|ACSBG1|ACTC1|ADAL|ADAM10|ADAMTS17|ADAMTS7|ADAMTSL3|ADPGK|AEN|AGBL1|AKAP13|ALDH1A2|ALDH1A3|ALPK3|ANKDD1A|ANKRD34C|ANKRD63|ANP32A|ANPEP|ANXA2|AP3B2|AP3S2|AP4E1|APBA2|APH1B|AQP9|AQR|ARHGAP11A|ARHGAP11B|ARID3B|ARIH1|ARNT2|ARPIN|ARPIN-AP3S2|ARPP19|ARRDC4|ASB7|ATP10A|ATP8B4|AVEN|B2M|BAHD1|BBS4|BCL2A1|BCL2L10|BLM|BLOC1S6|BMF|BNC1|BNIP2|BTBD1|BUB1B|C15orf32|C15orf39|C15orf40|C15orf48|C15orf61|C15orf62|C15orf65|C2CD4A|C2CD4B|CA12|CALML4|CAPN3|CATSPER2|CCDC32|CCDC33|CCDC9B|CCNB2|CCNDBP1|CCPG1|CD276|CDAN1|CDIN1|CELF6|CEMIP|CEP152|CERS3|CFAP161|CGNL1|CHAC1|CHD2|CHP1|CHRFAM7A|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CHST14|CHSY1|CIAO2A|CIB1|CIB2|CILP|CKMT1A|CKMT1B|CLK3|CLN6|CLPX|COMMD4|COPS2|CORO2B|COX5A|CPEB1|CPLX3|CRABP1|CRTC3|CSK|CSNK1G1|CSPG4|CT62|CTDSPL2|CTSH|CTXN2|CYFIP1|CYP11A1|CYP19A1|CYP1A1|CYP1A2|DAPK2|DENND4A|DET1|DIS3L|DISP2|DLL4|DMXL2|DNAAF4|DNAJA4|DNAJC17|DPH6|DPP8|DTWD1|DUOX1|DUOX2|DUOXA1|DUOXA2|DUT|EDC3|EFL1|EHD4|EID1|EIF2AK4|EIF3J|ELL3|EMC4|EMC7|EPB42|ETFA|EXD1|FAH|FAM174B|FAM189A1|FAM214A|FAM219B|FAM227B|FAM81A|FAM98B|FAN1|FANCI|FBN1|FBXL22|FBXO22|FBXO22-AS1|FEM1B|FES|FGF7|FOXB1|FRMD5|FSD2|FSIP1|FURIN|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|GCNT3|GDPGP1|GJD2|GLCE|GLDN|GNB5|GOLGA6A|GOLGA6B|GOLGA6C|GOLGA6D|GOLGA6L2|GOLGA8A|GOLGA8B|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|GOLM2|GPR176|GRAMD2A|GREM1|GTF2A2|HACD3|HAPLN3|HAUS2|HCN4|HDC|HDDC3|HERC1|HERC2|HEXA|HMG20A|HOMER2|HYKK|HYPK|ICE2|IDH2|IDH3A|IGDCC3|IGDCC4|IGF1R|IL16|IMP3|INO80|INSYN1|INTS14|IPW|IQCH|IQGAP1|IREB2|ISG20|ISL2|ISLR|ISLR2|ITGA11|ITPKA|IVD|JMJD7|KATNBL1|KBTBD13|KIF23|KIF7|KLF13|KLHL25|KNL1|KNSTRN|LACTB|LARP6|LCMT2|LCTL|LDHAL6B|LEO1|LINC00928|LINC02694|LINC02915|LINGO1|LINS1|LIPC|LMAN1L|LOC100128979|LOXL1|LPCAT4|LRRC28|LRRC49|LRRC57|LRRK1|LTK|LYSMD2|LYSMD4|MAGEL2|MAN2A2|MAN2C1|MAP1A|MAP2K1		See cases	Pathogenic(Last reviewed: Dec 2, 2014)	no assertion criteria provided	VCV000442893	15	22770422 - 102429112			442893	436555		
NM_001110792.2(MECP2):c.331A>C (p.Thr111Pro)	MECP2	T111P, T6P, T99P	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000859603	X	153297740	X	154032289	859603	849791		NC_000023.11:154032288:T:G
NM_001110792.2(MECP2):c.62+2T>G	MECP2		not provided|Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000503729	X	153363059	X	154097602	503729	495805	rs1557150841	NC_000023.11:154097601:A:C
NC_000023.10:g.(?_153287264)_(153363188_?)dup	MECP2		Mental retardation, X-linked, syndromic 13|Rett syndrome|Angelman syndrome	Pathogenic(Last reviewed: Oct 27, 2016)	criteria provided, single submitter	VCV000417368	X	153287264 - 153363188			417368	404014		
NM_001110792.2(MECP2):c.414-6C>G	MECP2		Rett syndrome|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000236301	X	153296907	X	154031456	236301	237857	rs782482746	NC_000023.11:154031455:G:C
NM_001110792.2(MECP2):c.1195_1246del (p.Pro399fs)	MECP2	P387fs, P294fs, P399fs, P164fs	Angelman syndrome|Atypical Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000189662	X	153296069 - 153296120	X	154030618 - 154030669	189662	187486	rs1557135251	
NM_001110792.2(MECP2):c.1181_1207del (p.Leu394_Pro402del)	MECP2		Rett syndrome|not provided	Uncertain significance(Last reviewed: Mar 25, 2021)	reviewed by expert panel	VCV000156616	X	153296108 - 153296134	X	154030657 - 154030683	156616	166470	rs587783094	NC_000023.11:154030656:GTGGAGGTGGGGGCAGGGGTGGGAGCAGTGG:GTGG
NM_001110792.2(MECP2):c.414-3C>G	MECP2		not specified|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156068	X	153296904	X	154031453	156068	165864	rs267608465	NC_000023.11:154031452:G:C
NM_001110792.2(MECP2):c.488A>G (p.Asp163Gly)	MECP2	D151G, D163G, D58G	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000143578	X	153296827	X	154031376	143578	153310	rs61748403	NC_000023.11:154031375:T:C
NM_001110792.2(MECP2):c.338C>G (p.Pro113Arg)	MECP2	P101R, P113R, P8R	Rett syndrome|Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000143526	X	153297733	X	154032282	143526	153258	rs61754453	NC_000023.11:154032281:G:C
NM_001110792.2(MECP2):c.337C>T (p.Pro113Ser)	MECP2	P101S, P113S, P8S	Rett syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143524	X	153297734	X	154032283	143524	153256	rs61754452	NC_000023.11:154032282:G:A
NM_001110792.2(MECP2):c.1216G>A (p.Glu406Lys)	MECP2	E394K, E406K, E301K, E171K	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143421	X	153296099	X	154030648	143421	153153	rs63094662	NC_000023.11:154030647:C:T
NM_001110792.2(MECP2):c.1200_1243del (p.Pro400_Pro401insTer)	MECP2		See cases|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Rett syndrome, zappella variant|not provided|Smith-Magenis Syndrome-like|Severe neonatal-onset encephalopathy with microcephaly|not specified|Rett syndrome|Mental retardation, X-linked, syndromic 13|Syndromic X-linked intellectual disability Lubs type|Rett syndrome|Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Inborn genetic diseases|Delayed speech and language development|Delayed gross motor development|Loss of ability to walk	Pathogenic(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000143406	X	153296072 - 153296115	X	154030621 - 154030664	143406	153138	rs61752992	NC_000023.11:154030620:GGGGGCTGGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGC:GGGGGC
NM_001110792.2(MECP2):c.1197_1202del (p.Pro402_Pro403del)	MECP2		Angelman syndrome|not provided	Likely benign(Last reviewed: Dec 21, 2020)	criteria provided, single submitter	VCV000143390	X	153296113 - 153296118	X	154030662 - 154030667	143390	153122	rs267608332	NC_000023.11:154030661:GGTGGGGG:GG
NM_001110792.2(MECP2):c.1193_1236del (p.Leu398fs)	MECP2	L398fs, L293fs, L163fs	Angelman syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143372	X	153296079 - 153296122	X	154030628 - 154030671	143372	153104	rs63749748	NC_000023.11:154030627:GGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGG:GG
NM_001110792.2(MECP2):c.144_147del (p.Glu49fs)	MECP2	E37fs, E49fs	Severe neonatal-onset encephalopathy with microcephaly|Angelman syndrome|Rett syndrome|Mental retardation, X-linked, syndromic 13|Rett syndrome	Pathogenic(Last reviewed: May 1, 2016)	criteria provided, single submitter	VCV000143328	X	153297924 - 153297927	X	154032473 - 154032476	143328	153060	rs267608426	NC_000023.11:154032472:TTCTTTCTT:TTCTT
NM_001110792.2(MECP2):c.1066C>T (p.Arg356Trp)	MECP2	R344W, R356W, R251W, R121W	not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000143309	X	153296249	X	154030798	143309	153041	rs61752361	NC_000023.11:154030797:G:A
NM_001110792.2(MECP2):c.*36G>C	MECP2		not specified	Benign(Last reviewed: May 31, 2006)	no assertion criteria provided	VCV000143266	X	153295782	X	154030331	143266	152998	rs267608347	NC_000023.11:154030330:C:G
NM_001110792.2(MECP2):c.1176G>A (p.Val392=)	MECP2		not specified|Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000138194	X	153296139	X	154030688	138194	141897	rs201711454	NC_000023.11:154030687:C:T
NM_001110792.2(MECP2):c.1483G>T (p.Glu495Ter)	MECP2	E483*, E495*, E390*, E260*	Rett syndrome|Autism, susceptibility to, X-linked 3|not provided	Uncertain significance(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000133342	X	153295832	X	154030381	133342	137081	rs587777421	NC_000023.11:154030380:C:A
NM_001110792.2(MECP2):c.842del (p.Gly281fs)	MECP2	G176fs, G269fs, G281fs, G46fs	Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|Syndromic X-linked intellectual disability Lubs type|Rett syndrome|Mental retardation, X-linked, syndromic 13|not provided|Mental retardation, X-linked, syndromic 13|History of neurodevelopmental disorder|not specified	Pathogenic(Last reviewed: Mar 9, 2021)	reviewed by expert panel	VCV000095202	X	153296473	X	154031022	95202	101102	rs61750241	NC_000023.11:154031021:CCCC:CCC
NM_001110792.2(MECP2):c.644C>T (p.Thr215Met)	MECP2	T203M, T215M, T110M	History of neurodevelopmental disorder|not specified|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000095198	X	153296671	X	154031220	95198	101098	rs61749720	NC_000023.11:154031219:G:A
NM_001110792.2(MECP2):c.1162C>T (p.Pro388Ser)	MECP2	P388S, P283S, P153S	Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2020)	criteria provided, conflicting interpretations	VCV000095184	X	153296153	X	154030702	95184	101084	rs61752387	NC_000023.11:154030701:G:A
NM_001110792.2(MECP2):c.490C>G (p.Pro164Ala)	MECP2	P152A, P164A, P59A	Rett syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome, zappella variant|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Rett syndrome|Mental retardation, X-linked, syndromic 13	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011844	X	153296825	X	154031374	11844	26883	rs179363900	NC_000023.11:154031373:G:C
NM_001110792.2(MECP2):c.459C>G (p.Tyr153Ter)	MECP2	Y141*, Y153*, Y48*	Severe neonatal-onset encephalopathy with microcephaly|Atypical Rett syndrome|Rett syndrome|Inborn genetic diseases|not provided|Angelman syndrome	Pathogenic(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000011833	X	153296856	X	154031405	11833	26872	rs61748396	NC_000023.11:154031404:G:C
NM_001110792.2(MECP2):c.952C>T (p.Arg318Cys)	MECP2	R306C, R318C, R213C, R83C	none provided|Intellectual disability|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|not provided|Angelman syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011824	X	153296363	X	154030912	11824	26863	rs28935468	NC_000023.11:154030911:G:A
NM_001110792.2(MECP2):c.916C>T (p.Arg306Ter)	MECP2	R294*, R306*, R201*, R71*	Inborn genetic diseases|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|See cases|Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Rett syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000011819	X	153296399	X	154030948	11819	26858	rs61751362	NC_000023.11:154030947:G:A
NM_001110792.2(MECP2):c.203_204del (p.Pro68fs)	MECP2	P56fs, P68fs	Angelman syndrome|Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000011818	X	153297867 - 153297868	X	154032416 - 154032417	11818	26857	rs267608434	NC_000023.11:154032415:GGG:G
NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)	MECP2	T158M, T170M, T65M	not provided|Angelman syndrome|Severe neonatal-onset encephalopathy with microcephaly|Autism, susceptibility to, X-linked 3|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Autism, susceptibility to, X-linked 3|Syndromic X-linked intellectual disability Lubs type|Rett syndrome|History of neurodevelopmental disorder|Inborn genetic diseases|not specified|Rett syndrome	Pathogenic/Likely pathogenic(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011811	X	153296806	X	154031355	11811	26850	rs28934906	NC_000023.11:154031354:G:A
NM_001110792.2(MECP2):c.433C>T (p.Arg145Cys)	MECP2	R133C, R145C, R40C	Angelman syndrome|Intellectual disability|Severe neonatal-onset encephalopathy with microcephaly|Mental retardation, X-linked, syndromic 13|Rett syndrome|Rett syndrome, zappella variant|not provided|History of neurodevelopmental disorder|Inborn genetic diseases|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 10, 2021)	criteria provided, conflicting interpretations	VCV000011809	X	153296882	X	154031431	11809	26848	rs28934904	NC_000023.11:154031430:G:A
GRCh37/hg19 13q12.12(chr13:24224142-24490921)x1	MIPEP|TNFRSF19|C1QTNF9B|PCOTH		not provided	Benign(Last reviewed: Jun 12, 2015)	no assertion criteria provided	VCV000614034	13	24224142 - 24490921			614034	605370		
GRCh37/hg19 15q11.2-14(chr15:24179003-37238599)x1	MIR211|PWARSN|HERC2|PWAR5|SLC12A6|KLF13|MEIS2|GOLGA8A|GOLGA8J|CHRM5|ARHGAP11B|SNURF|TJP1|GOLGA8B|OCA2|ARHGAP11A|CHRFAM7A|PWRN1|APBA2|GOLGA8M|GREM1|FAN1|PWAR6|KATNBL1|IPW|PWAR4|ACTC1|PWRN2|ZNF770|EMC7|GOLGA8O|GOLGA8H|FAM189A1|RYR3|EMC4|LPCAT4|CHRNA7|GABRG3|PGBD4|AVEN|GABRA5|NPAP1|TRPM1|MTMR10|SNORD116-1|NUTM1|SCG5|UBE3A|GOLGA8N|SNORD115-1|DPH6|SNRPN|NOP10|GJD2|ATP10A|AQR|GABRB3|OTUD7A|NSMCE3|PWAR1|CDIN1		See cases	Pathogenic	no assertion criteria provided	VCV000396952	15	24179003 - 37238599			396952	383845		
GRCh37/hg19 15q11.1-13.1(chr15:20191652-28525310)	NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|CYFIP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|OR4N4|GOLGA6L1|GABRA5|GABRB3|SNORD115-1|PWAR4|GABRG3|IPW|NPAP1|PWARSN|OR4M2|GOLGA6L6|PWRN1|PWRN2|SNORD116-1|POTEB|POTEB2|PWAR6		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625710	15	20191652 - 28525310			625710	614014		
GRCh37/hg19 15q11.2-13.1(chr15:23286571-28823722)x1	NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6|GABRA5|GABRB3|GABRG3|IPW		not provided	Pathogenic(Last reviewed: Nov 29, 2019)	no assertion criteria provided	VCV000564152	15	23286571 - 28823722			564152	555336		
NC_000023.10:g.(?_17393861)_(18671684_?)dup	NHS|RS1|SCML1|CDKL5|SCML2|RAI2|BEND2		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV000832827	X	17393861 - 18671684			832827	821495		
NC_000023.10:g.(?_17393861)_(18671684_?)del	NHS|RS1|SCML1|CDKL5|SCML2|RAI2|BEND2		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Sep 12, 2019)	criteria provided, single submitter	VCV000584356	X	17393861 - 18671684			584356	574188		
NC_000015.9:g.(?_23730704)_(28530182_?)del	NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|SNORD115-1|SNORD116-1|SNRPN|PWRN1|PWRN2|ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|SNURF|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	VCV000209214	15	23730704 - 28530182			209214	205805		
Single allele	OCA2|SNORD115-1|SNORD116-1|GOLGA6L2|SNURF|ATP10A|PWARSN|MAGEL2|PWAR1|PWAR6|GABRA5|UBE3A|GABRG3|NPAP1|GABRB3|MKRN3|PWRN2|PWAR4|NDN|IPW|PWRN1|HERC2|SNRPN|PWAR5		Angelman syndrome	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000974578	15	23579300 - 28447626			974578	962875		
GRCh37/hg19 15q11.1-26.3(chr15:20071673-102461162)x3	OIP5|ITGA11|CHSY1|BAHD1|FAN1|CEP152|MAPKBP1|GOLGA8A|ZNF609|TBC1D2B|RTF1|MESD|CYFIP1|ACSBG1|MINAR1|MGA|DMXL2|SYNM|VPS39|FAM189A1|TMED3|AP4E1|SEC11A|CCNDBP1|DAPK2|EID1|NPAP1|HYPK|ARIH1|SIN3A|TMEM87A|ULK3|RPAP1|GLCE|PYGO1|BLOC1S6|FBXO22|VPS33B|GREM1|MRPL46|RNU6-1|RNU5A-1|NPTN|FOXB1|RPUSD2|TUBGCP4|SLCO3A1|SCG3|TMOD3|TMOD2|EHD4|SCAPER|DUOX2|MYEF2|RPS27L|NDUFAF1|RSL24D1|NUSAP1|EMC4|RASL12|SPG21|SPTBN5|NGRN|RHCG|HACD3|CTDSPL2|KLF13|RAB8B|BTBD1|TM6SF1|DUOX1|CSNK1G1|ZFAND6|MAGEL2|DLL4|INO80|MINDY2|RNF111|ZNF280D|TRPM7|VPS13C|LRRC49|PAQR5|PPP1R14D|DPP8|MTMR10|RPP25|COMMD4|PARP16|TIPIN|CLN6|ZNF770|ZSCAN2|ZWILCH|DET1|UACA|HAUS2|RMDN3|LINS1|DNAJC17|FANCI|IMP3|LARP6|MNS1|DNAJA4|NOP10|MCTP2|SELENOS|GOLGA6B|MESP1|UNC45A|MYO5C|NSMCE3|FAM214A|EMC7|C15orf39|THAP10|PAK6|RGMA|WDR93|PARP6|DTWD1|KNL1|AVEN|FAM219B|ADAMTSL3|ATP10A|CEMIP|GJD2|STARD9|ALPK3|ISLR2|VPS18|IGDCC4|SQOR|ABHD17C|TLNRD1|PPCDC|CELF6|STRA6|ZNF106|KLHL25|CPEB1|AEN|CRTC3|IQCH|ISL2|RFX7|TTC23|MRPS11|SPATA5L1|CHAC1|NOX5|EFL1|NEIL1|ICE2|LRRK1|AAGAB|LMAN1L|KATNBL1|SLTM|PEAK1|SNX22|THSD4|ATP8B4|WDR76|TMEM62|SEMA6D|PIF1|CCDC33|EDC3|SPG11|TM2D3|ELL3|PLEKHO2|WDR61|CD276|STARD5|POLR2M|INTS14|NIPA2|ADPGK|APH1B|RAMAC|TLN2|CIAO2A|MEX3B|C15orf48|MEGF11|CDIN1|SPPL2A|LINGO1|ZFYVE19|WDR73|CGNL1|FRMD5|UBL7|DISP2|CHRFAM7A|ARHGAP11B|DPH6|TICRR|CCDC32|KNSTRN|BMF|SHF|DUOXA1|RCCD1|CALML4|ARRDC4|LDHAL6B|UBE2Q2|CHST14|GOLM2|LACTB|TUBGCP5|DIS3L|TGM7|CATSPER2|LEO1|C15orf40|SENP8|MTFMT|SLC51B|TARS3|LRRC28|TMEM266|NIPA1|AGBL1|HYKK|WHAMM|FSD2|PLA2G4E|ASB7|TRIM69|PWAR1|TERB2|C2CD4A|LYSMD4|FAM81A|C15orf65|PGPEP1L|C15orf61|C15orf32|HAPLN3|MESP2|TMCO5A|SPATA8|NRG4|ZSCAN29|TTBK2|CDAN1|STRC|CFAP161|TBC1D21|DNAAF4|OTUD7A|SPRED1|ODF3L1|PGBD4|ADAL|EXD1|FSIP1|ADAMTS17|RHOV|SCAMP5|FAM227B|CT62|GRAMD2A|LCTL|UBR1|PATL2|CERS3|SPESP1|LPCAT4|PLA2G4F|LRRC57|LYSMD2|NUTM1|WDR72|SNX33|SLC24A5|PRTG|REC114|GOLGA6L2|OR4N4|SAXO2|FAM98B|PLA2G4D|LINC00928|GOLGA6L1|FBXL22|SNORD115-1|TMEM202|GLDN|GOLGA6A|TMC3|ZNF774|PWAR4|PWARSN|RBPMS2|ANKDD1A|ARPIN|USP50|TEX9|KIF7|ZNF710|HDDC3|CCDC9B|TNFAIP8L3|C2CD4B|INSYN1|OR4M2|KBTBD13|UBAP1L|SKOR1|ANKRD34C|GDPGP1|OR4F6|OR4F15|SHC4|CTXN2|LINC02694|LINC02915|ST20|FAM174B|DUOXA2|MIR184|MIR211|MIR9-3|GOLGA8B|EIF2AK4|UNC13C|CKMT1A|CPLX3|SERINC4|C15orf62|GOLGA8N|PAK6-AS1|PHGR1|SH2D7|GOLGA8J|GOLGA6C|GOLGA6D|GOLGA8M|SCARNA15|FBXO22-AS1|GOLGA6L6|GOLGA8O|GOLGA8H|PWRN1|PWRN2|SNORD116-1|LOC100128979|ANKRD63|JMJD7|PLA2G4B|POTEB2|PWAR6|ARPIN-AP3S2|ST20-MTHFS|MYZAP|POTEB|ACTC1|ADAM10|ACAN|ALDH1A3|ANPEP|ANXA2|APBA2|AQP9|B2M|BBS4|BCL2A1|BLM|BNC1|BNIP2|BUB1B|CA12|CAPN3|CHD2|CHRM5|CHRNA3|CHRNA5|CHRNA7|CHRNB4|CKMT1B|CLK3|CRABP1|CSK|CSPG4|CTSH|CYP1A1|CYP1A2|CYP11A1|CYP19A1|DUT|EPB42|ETFA|FAH|FBN1|FES|FGF7|GABPB1|GABRA5|GABRB3|GABRG3|GALK2|GANC|GATM|GCHFR|PDIA3|GTF2A2|HDC|HEXA|ONECUT1|IDH2|IDH3A|IGF1R|IL16|IPW|IREB2|ISG20|ISLR|ITPKA|IVD|LIPC|LOXL1|LTK|SMAD3|SMAD6|MAN2A2|MAN2C1|MAP1A|MEF2A|MEIS2|MFAP1|MFGE8|TRPM1|MPI|MYO1E|MYO5A|MYO9A|NDN|NEDD4|NEO1|NMB|NTRK3|OAZ2|OCA2|FURIN|PCSK6|PDE8A|PKM|PLCB2|PLIN1|PML|POLG|PPIB|MAPK6|MAP2K1|MAP2K5|PSMA4|PTPN9|RAB27A|RAD51|RASGRF1|RCN2|RLBP1|RORA|RPL4|RPLP1|RPS17|RYR3|SCG5|SH3GL3|SLC12A1|SNRPA1|SNRPN|SNX1|SORD|SPINT1|SRP14|TCF12|NR2F2|THBS1|TJP1|TLE3|TP53BP1|TPM1|TYRO3|UBE3A|MKRN3|SLC30A4|AP3B2|PWAR5|ANP32A|ST8SIA2|SEMA7A|CILP|PIAS1|EIF3J|RAB11A|SNAP23|PEX11A|IQGAP1|ALDH1A2|HERC2|HERC1|SNURF|PSTPIP1|PRC1|USP8|CCNB2|SLC28A2|SLC28A1|SLC24A1|CCPG1|GCNT3|COPS2|TRIP4|TGM5|COX5A|STOML1|HOMER2|PIGB|KIF23|IGDCC3|ZNF592|PPIP5K1|AQR|SECISBP2L|PCLAF|ARHGAP11A|LCMT2|SV2B|ARNT2|USP3|SLC12A6|NR2E3|BCL2L10|HCN4|SCAMP2|SNUPN|PDCD7|TSPAN3|FEM1B|RASGRP1|SERF2|AP3S2|DENND4A|SNAPC5|HMG20A|CORO2B|SEMA4B|CIB2|CIB1|MTHFS|ARID3B|GNB5|ARPP19|CLPX|MORF4L1|SLC27A2|ABHD2|ADAMTS7|AKAP13|GPR176|CHP1		not provided	Pathogenic(Last reviewed: Jan 5, 2017)	no assertion criteria provided	VCV000614520	15	20071673 - 102461162			614520	605856		
GRCh37/hg19 6q26(chr6:162741184-162927803)x3	PRKN		not provided	Benign(Last reviewed: Jun 12, 2015)	no assertion criteria provided	VCV000609544	6	162741184 - 162927803			609544	600880		
GRCh38/hg38 15q11.2-13.1(chr15:23411589-28275308)x1	PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058608	15	23656736 - 28520454	15	23411589 - 28275308	58608	73203		
Single allele	PWAR4|LOC645202|SNORD115-1|GOLGA8S|APBA2|GABRA5|PWAR5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3|SNURF|CYFIP1|FAM189A1|NPAP1|LINC02249|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-6|SNORD115-7|MAGEL2|NSMCE3|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|GOLGA6L1|GOLGA8J|GOLGA8T|GOLGA8M|SNORD115@|SNORD116@|SNORD116-19|LOC112272579|LOC112272580|GOLGA8G|SNORD108|LOC112272581|GOLGA6L7|SNORD116-20|SNORD116-21|SNORD115-17|SNORD115-18|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|ATP10A-DT|LOC112272575|LOC112272578|CHRFAM7A|HERC2|SNORD107|LOC100132202|LOC102723623|SNHG14|SNORD115-3|SNORD115-4|SNORD115-5|SNORD109B|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-24|SNORD116-25|MIR4508|MIR4509-3|MIR4509-2|MIR4715|SNORD116-30|SNORD115-46|GOLGA8F|TRE-TTC2-2|PWRN4|SNORD115-19|SNORD115-20|SNORD115-41|SNORD115-42|SNORD115-43|PWAR6|SNORD116-7|SNORD115-44|SNORD116-28|PWRN3|GABRG3-AS1|MIR4509-1|SNORD109A|LINC02250|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|LOC100130111|PWRN1|PWRN2|SNORD115-21|SNORD115-22|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-23|SNORD115-25|SNORD115-26|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD115-34|SNORD115-35|SNORD116-22|SNORD116-23|SNORD64|PWARSN|LINC00929		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Jun 5, 2020)	criteria provided, single submitter	VCV001098669			15	22804175 - 30375696	1098669	1087289		
GRCh37/hg19 15q11.2-13.1(chr15:23810184-29213896)	PWAR4|PWARSN|GOLGA8M|PWRN1|PWAR6|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|PWRN2|SNORD116-1|APBA2|SNORD115-1|GABRA5|HERC2		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625745	15	23810184 - 29213896			625745	614049		
NC_000015.10:g.(?_24566038)_(25781223_?)dup	PWAR5|UBE3A|IPW|PWAR6|SNRPN|SNORD116-1|PWAR1|PWARSN|PWAR4|ATP10A|SNORD115-1|NPAP1|PWRN1|SNURF		Angelman syndrome	Likely pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000832161	15	24811185 - 26026370			832161	820665		
GRCh37/hg19 15q11.2(chr15:25169355-25436179)x1	PWAR6|PWARSN|SNORD115-1|SNORD116-1|SNRPN|SNURF|IPW|PWAR1|PWAR5		See cases	Likely pathogenic(Last reviewed: Jun 16, 2014)	no assertion criteria provided	VCV000441669	15	25169355 - 25436179			441669	435331		
Single allele	PWARSN|PWAR4|GABRA5|GABRB3|CYFIP1|NIPA2|SNURF|MKRN3|PWAR1|SNORD115-1|SNORD116-1|GOLGA6L1|OCA2|MAGEL2|IPW|NIPA1|PWRN2|PWRN1|HERC2|ATP10A|PWAR5|NDN|NPAP1|UBE3A|GABRG3|PWAR6|GOLGA6L2|SNRPN|TUBGCP5|GOLGA8M		Angelman syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000974576	15	22646692 - 28964445			974576	962873		
GRCh38/hg38 15q11.2-14(chr15:23319714-38089582)x1	PWRN1|PWRN2|PWRN3|PWRN4|RYR3|RYR3-DT|SCG5|SCG5-AS1|SLC12A6|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TMCO5A|TRE-TTC2-2|TRPM1|UBE3A|ZNF770|ACTC1|APBA2|AQR|ARHGAP11A|ARHGAP11A-SCG5|ARHGAP11B|ARHGAP11B-DT|ATP10A|ATP10A-DT|AVEN|CDIN1|CHRFAM7A|CHRM5|CHRNA7|DPH6|DPH6-DT|EMC4|EMC7|FAM189A1|FAN1|FMN1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GJD2|GJD2-DT|GOLGA6L2|GOLGA6L7|GOLGA8A|GOLGA8B|GOLGA8F|GOLGA8G|GOLGA8H|GOLGA8J|GOLGA8K|GOLGA8M|GOLGA8N|GOLGA8O|GOLGA8Q|GOLGA8R|GOLGA8S|GOLGA8T|GREM1|GREM1-AS1|HERC2|IPW|KATNBL1|KLF13|LINC00929|LINC01852|LINC02249|LINC02250|LINC02252|LINC02256|LINC02345|LINC02346|LINC02352|LINC02853|LOC100130111|LOC100132202|LOC100996413|LOC101928042|LOC102723623|LOC106736464|LOC106736465|LOC106736468|LOC106736469|LOC106736476|LOC106736477|LOC106736480|LOC106736481|LOC106783506|LOC108004527|LOC110120842|LOC110120858|LOC110120896|LOC110120905|LOC110120936|LOC110120937|LOC110121498|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC112272582|LOC112272583|LOC113939943|LOC145845|LOC283710|LOC645202|LPCAT4|MAGEL2|MEIS2|MIR1233-1|MIR1233-2|MIR211|MIR3942|MIR4508|MIR4509-2|MIR4509-3|MIR4510|MIR4715|MIR8063|MKRN3|MTMR10|NANOGP8|NDN|NOP10|NPAP1|NSMCE3|NUTM1|OCA2|OTUD7A|PGBD4|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN		See cases	Pathogenic(Last reviewed: Nov 30, 2009)	no assertion criteria provided	VCV000146702	15	22698522 - 38381783	15	23319714 - 38089582	146702	156453		
GRCh37/hg19 15q11.2-12(chr15:22833525-27193380)x4	PWRN2|SNORD115-1|SNORD116-1|CYFIP1|GABRA5|ATP10A|GABRB3|GOLGA6L2|IPW|MAGEL2|NPAP1|MKRN3|NDN|NIPA1|NIPA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|SNRPN|SNURF|TUBGCP5|UBE3A		not provided	Pathogenic(Last reviewed: Aug 1, 2020)	criteria provided, single submitter	VCV001012382	15	22833525 - 27193380			1012382	1000101		
GRCh37/hg19 15q11.2-13.1(chr15:22770994-28517432)	PWRN2|SNORD116-1|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|HERC2|PWAR1|PWARSN|PWRN1|GABRA5|PWAR6|GOLGA6L2|SNORD115-1|PWAR4		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625715	15	22770994 - 28517432			625715	614019		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28314256)x4	PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A|ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000148005	15	22765628 - 28559402	15	23319714 - 28314256	148005	157756		
GRCh38/hg38 15q11.2-13.1(chr15:23328044-28315951)x1	PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A|ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2		See cases	Pathogenic(Last reviewed: Mar 10, 2014)	no assertion criteria provided	VCV000154083	15	23290786 - 28561097	15	23328044 - 28315951	154083	163834		
NM_017909.4(RMND1):c.1286A>T (p.Glu429Val)	RMND1	E259V, E429V	Combined oxidative phosphorylation deficiency 11	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666266	6	151726886	6	151405751	666266	653811	rs1582936202	NC_000006.12:151405750:T:A
NM_017909.4(RMND1):c.1049T>C (p.Met350Thr)	RMND1	M350T, M180T	Combined oxidative phosphorylation deficiency 11	Uncertain significance(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000666265	6	151742410	6	151421275	666265	653812	rs1582950315	NC_000006.12:151421274:A:G
NC_000023.10:g.(?_18582587)_(18690188_?)del	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Pathogenic(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001070858	X	18582587 - 18690188			1070858	1058212		
NC_000023.10:g.(?_18442725)_(18672749_?)dup	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Oct 10, 2020)	criteria provided, single submitter	VCV001054292	X	18442725 - 18672749			1054292	1039259		
NC_000023.10:g.(?_18525053)_(18665462_?)dup	RS1|CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Uncertain significance(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001015177	X	18525053 - 18665462			1015177	1001920		
NC_000023.10:g.(?_18668510)_(18668732_?)dup	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Mar 30, 2020)	criteria provided, single submitter	VCV001007430	X	18668510 - 18668732			1007430	986706		
NC_000023.11:g.(?_18564457)_(18653564_?)dup	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, single submitter	VCV000831636	X	18582577 - 18671684			831636	821574		
NC_000023.11:g.(?_18653412)_(18653564_?)del	RS1|CDKL5		Early infantile epileptic encephalopathy 2|Angelman syndrome-like	Uncertain significance(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000830639	X	18671532 - 18671684			830639	821577		
NC_000023.11:g.(?_18506933)_(18653564_?)del	RS1|CDKL5		Angelman syndrome-like|Early infantile epileptic encephalopathy 2	Pathogenic(Last reviewed: Aug 5, 2019)	criteria provided, single submitter	VCV000662287	X	18525053 - 18671684	X	18506933 - 18653564	662287	653384		
NM_001172509.2(SATB2):c.1826del (p.Asp609fs)	SATB2	D609fs	Chromosome 2q32-q33 deletion syndrome	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666260	2	200137310	2	199272587	666260	653808	rs1574459072	NC_000002.12:199272586:T:
NM_003042.4(SLC6A1):c.889G>A (p.Gly297Arg)	SLC6A1	G297R, G119R, G177R	not provided|Myoclonic-atonic epilepsy	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000192369	3	11067498	3	11025812	192369	190156	rs876657400	NC_000003.12:11025811:G:A
NM_001379110.1(SLC9A6):c.1922G>A (p.Arg641Gln)	SLC9A6	R579Q, R611Q, R631Q, R641Q, R663Q	Christianson syndrome	Benign(Last reviewed: Dec 3, 2019)	criteria provided, single submitter	VCV001167395	X	135126765	X	136044606	1167395	1159370		NC_000023.11:136044605:G:A
NM_001379110.1(SLC9A6):c.564G>A (p.Thr188=)	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV001164735	X	135081054	X	135998895	1164735	1159369		NC_000023.11:135998894:G:A
NM_001379110.1(SLC9A6):c.2022G>A (p.Thr674=)	SLC9A6		Christianson syndrome	Benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV001164656	X	135126865	X	136044706	1164656	1159371		NC_000023.11:136044705:G:A
NM_001379110.1(SLC9A6):c.-57+34G>C	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Apr 27, 2020)	criteria provided, single submitter	VCV001156645	X	135067670	X	135985511	1156645	1150432		NC_000023.11:135985510:G:C
NM_001379110.1(SLC9A6):c.1728A>G (p.Gly576=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001150038	X	135122301	X	136040142	1150038	1150435		NC_000023.11:136040141:A:G
NM_001379110.1(SLC9A6):c.448-9_448-8insC	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV001146037	X	135080632 - 135080633	X	135998473 - 135998474	1146037	1150434		NC_000023.11:135998473::C
NM_001379110.1(SLC9A6):c.81G>A (p.Leu27=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001143525	X	135067898	X	135985739	1143525	1150433		NC_000023.11:135985738:G:A
NM_001379110.1(SLC9A6):c.1227T>C (p.Ile409=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV001139281	X	135104777	X	136022618	1139281	1129402		NC_000023.11:136022617:T:C
NM_001379110.1(SLC9A6):c.1578C>T (p.His526=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001134224	X	135112318	X	136030159	1134224	1129403		NC_000023.11:136030158:C:T
NM_001379110.1(SLC9A6):c.630T>C (p.Thr210=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001130989	X	135081120	X	135998961	1130989	1129401		NC_000023.11:135998960:T:C
NM_001379110.1(SLC9A6):c.1839A>T (p.Gly613=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV001118274	X	135126682	X	136044523	1118274	1108028		NC_000023.11:136044522:A:T
NM_001379110.1(SLC9A6):c.1844C>T (p.Ser615Phe)	SLC9A6	S553F, S585F, S605F, S615F, S637F	Christianson syndrome	Likely benign(Last reviewed: Jun 30, 2019)	criteria provided, single submitter	VCV001117529	X	135126687	X	136044528	1117529	1108029		NC_000023.11:136044527:C:T
NM_001379110.1(SLC9A6):c.1734C>T (p.Ile578=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001110453	X	135122307	X	136040148	1110453	1108026		NC_000023.11:136040147:C:T
NM_001379110.1(SLC9A6):c.372T>A (p.Val124=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 5, 2020)	criteria provided, single submitter	VCV001110428	X	135080269	X	135998110	1110428	1108021		NC_000023.11:135998109:T:A
NM_001379110.1(SLC9A6):c.1764C>T (p.Tyr588=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV001109358	X	135122337	X	136040178	1109358	1108027		NC_000023.11:136040177:C:T
NM_001379110.1(SLC9A6):c.471G>A (p.Gly157=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001106023	X	135080664	X	135998505	1106023	1108023		NC_000023.11:135998504:G:A
NM_001379110.1(SLC9A6):c.-19C>A	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001104067	X	135067799	X	135985640	1104067	1108020		NC_000023.11:135985639:C:A
NM_001379110.1(SLC9A6):c.448-8_448-7insG	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001102761	X	135080633 - 135080634	X	135998474 - 135998475	1102761	1108022		NC_000023.11:135998474::G
NM_001379110.1(SLC9A6):c.638-8C>T	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV001101800	X	135084259	X	136002100	1101800	1108024		NC_000023.11:136002099:C:T
NM_001379110.1(SLC9A6):c.717T>C (p.Asn239=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Nov 16, 2019)	criteria provided, single submitter	VCV001100718	X	135084346	X	136002187	1100718	1108025		NC_000023.11:136002186:T:C
NM_001379110.1(SLC9A6):c.594A>G (p.Thr198=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV001096092	X	135081084	X	135998925	1096092	1086283		NC_000023.11:135998924:A:G
NM_001379110.1(SLC9A6):c.66G>A (p.Leu22=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001091661	X	135067883	X	135985724	1091661	1086280		NC_000023.11:135985723:G:A
NM_001379110.1(SLC9A6):c.504A>G (p.Ala168=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 8, 2020)	criteria provided, single submitter	VCV001089982	X	135080697	X	135998538	1089982	1086282		NC_000023.11:135998537:A:G
NM_001379110.1(SLC9A6):c.756A>G (p.Ala252=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001088012	X	135092613	X	136010454	1088012	1086284		NC_000023.11:136010453:A:G
NM_001379110.1(SLC9A6):c.-1C>T	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001083896	X	135067817	X	135985658	1083896	1086279		NC_000023.11:135985657:C:T
NM_001379110.1(SLC9A6):c.1862C>T (p.Pro621Leu)	SLC9A6	P559L, P591L, P611L, P621L, P643L	Christianson syndrome	Likely benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001079303	X	135126705	X	136044546	1079303	1086285		NC_000023.11:136044545:C:T
NM_001379110.1(SLC9A6):c.168T>C (p.Tyr56=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001077205	X	135067985	X	135985826	1077205	1086281		NC_000023.11:135985825:T:C
NC_000023.10:g.(?_135104735)_(135106652_?)del	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001074430	X	135104735 - 135106652			1074430	1058183		
NM_001379110.1(SLC9A6):c.953G>T (p.Trp318Leu)	SLC9A6	W286L, W318L, W338L, W370L	Christianson syndrome	Pathogenic(Last reviewed: Apr 14, 2018)	criteria provided, single submitter	VCV001071193	X	135095175	X	136013016	1071193	1065164		NC_000023.11:136013015:G:T
NM_001379110.1(SLC9A6):c.1958G>T (p.Arg653Leu)	SLC9A6	R591L, R623L, R643L, R653L, R675L	Christianson syndrome	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001062923	X	135126801	X	136044642	1062923	1052284		NC_000023.11:136044641:G:T
NM_001379110.1(SLC9A6):c.-56-4G>T	SLC9A6	A33S	Christianson syndrome	Uncertain significance(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001062813	X	135067758	X	135985599	1062813	1052278		NC_000023.11:135985598:G:T
NM_001379110.1(SLC9A6):c.239G>A (p.Ser80Asn)	SLC9A6	S132N, S80N	Christianson syndrome	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001061252	X	135077014	X	135994855	1061252	1052280		NC_000023.11:135994854:G:A
NM_001379110.1(SLC9A6):c.525G>A (p.Gly175=)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Aug 30, 2018)	criteria provided, single submitter	VCV001060414	X	135081015	X	135998856	1060414	1052281		NC_000023.11:135998855:G:A
NM_001379110.1(SLC9A6):c.212C>T (p.Pro71Leu)	SLC9A6	P123L, P71L	Christianson syndrome	Uncertain significance(Last reviewed: Apr 5, 2020)	criteria provided, single submitter	VCV001054385	X	135076987	X	135994828	1054385	1052279		NC_000023.11:135994827:C:T
NM_001379110.1(SLC9A6):c.1157A>G (p.Asn386Ser)	SLC9A6	N354S, N386S, N406S, N438S	Christianson syndrome	Uncertain significance(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV001052390	X	135098880	X	136016721	1052390	1052283		NC_000023.11:136016720:A:G
NM_001379110.1(SLC9A6):c.634C>G (p.Pro212Ala)	SLC9A6	P180A, P212A, P232A, P264A	Christianson syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001052092	X	135081124	X	135998965	1052092	1052282		NC_000023.11:135998964:C:G
NM_001379110.1(SLC9A6):c.-57+62C>T	SLC9A6	R13C	Christianson syndrome	Uncertain significance(Last reviewed: Jun 15, 2020)	criteria provided, single submitter	VCV001040525	X	135067698	X	135985539	1040525	1035362		NC_000023.11:135985538:C:T
NM_001379110.1(SLC9A6):c.1876G>A (p.Ala626Thr)	SLC9A6	A596T, A564T, A616T, A648T, A626T	Christianson syndrome	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, single submitter	VCV001038955	X	135126719	X	136044560	1038955	1035364		NC_000023.11:136044559:G:A
NM_001379110.1(SLC9A6):c.1420G>T (p.Gly474Cys)	SLC9A6	G474C, G442C, G526C, G494C	Christianson syndrome	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001035423	X	135106602	X	136024443	1035423	1035363		NC_000023.11:136024442:G:T
NM_001379110.1(SLC9A6):c.1080+17A>G	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Jan 18, 2018)	criteria provided, single submitter	VCV001032437	X	135095613	X	136013454	1032437	1022140		NC_000023.11:136013453:A:G
NM_001379110.1(SLC9A6):c.-57+50G>C	SLC9A6	A9P	Christianson syndrome	Uncertain significance(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV001030062	X	135067686	X	135985527	1030062	1018913		NC_000023.11:135985526:G:C
NM_001379110.1(SLC9A6):c.1711C>T (p.Leu571Phe)	SLC9A6	L509F, L541F, L561F, L571F, L593F	Christianson syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001025118	X	135122284	X	136040125	1025118	1014770		NC_000023.11:136040124:C:T
NM_001379110.1(SLC9A6):c.2018A>G (p.Asn673Ser)	SLC9A6	N611S, N643S, N663S, N673S, N695S	Christianson syndrome	Uncertain significance(Last reviewed: Mar 25, 2020)	criteria provided, single submitter	VCV001020226	X	135126861	X	136044702	1020226	1014772		NC_000023.11:136044701:A:G
NM_001379110.1(SLC9A6):c.1768A>C (p.Asn590His)	SLC9A6	N528H, N560H, N580H, N590H, N612H	Christianson syndrome	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001014938	X	135126611	X	136044452	1014938	1014771		NC_000023.11:136044451:A:C
NM_001379110.1(SLC9A6):c.461G>A (p.Arg154Gln)	SLC9A6	R122Q, R154Q, R174Q, R206Q	Christianson syndrome	Uncertain significance(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001014912	X	135080654	X	135998495	1014912	1014769		NC_000023.11:135998494:G:A
NM_001379110.1(SLC9A6):c.1765G>A (p.Glu589Lys)	SLC9A6	E527K, E559K, E579K, E589K, E611K	Christianson syndrome	Uncertain significance(Last reviewed: Jan 9, 2020)	criteria provided, single submitter	VCV001006408	X	135122338	X	136040179	1006408	999622		NC_000023.11:136040178:G:A
NM_001379110.1(SLC9A6):c.982G>A (p.Gly328Ser)	SLC9A6	G296S, G328S, G348S, G380S	Christianson syndrome	Uncertain significance(Last reviewed: May 6, 2020)	criteria provided, single submitter	VCV001005501	X	135095204	X	136013045	1005501	999621		NC_000023.11:136013044:G:A
NM_001379110.1(SLC9A6):c.885+5C>T	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Apr 14, 2020)	criteria provided, single submitter	VCV001002023	X	135092747	X	136010588	1002023	999620		NC_000023.11:136010587:C:T
NM_001379110.1(SLC9A6):c.821T>C (p.Ile274Thr)	SLC9A6	I242T, I274T, I294T, I326T	Christianson syndrome	Uncertain significance(Last reviewed: Aug 6, 2020)	no assertion criteria provided	VCV000988730	X	135092678	X	136010519	988730	976679		NC_000023.11:136010518:T:C
NM_001379110.1(SLC9A6):c.506T>A (p.Ile169Asn)	SLC9A6	I137N, I169N, I189N, I221N	Christianson syndrome	Uncertain significance(Last reviewed: Jun 3, 2020)	no assertion criteria provided	VCV000988715	X	135080699	X	135998540	988715	976678		NC_000023.11:135998539:T:A
NM_001379110.1(SLC9A6):c.992-3T>C	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Nov 15, 2019)	criteria provided, single submitter	VCV000969959	X	135095505	X	136013346	969959	960973		NC_000023.11:136013345:T:C
NM_001379110.1(SLC9A6):c.13A>C (p.Ile5Leu)	SLC9A6	I57L, I5L	Christianson syndrome	Uncertain significance(Last reviewed: Nov 6, 2019)	criteria provided, single submitter	VCV000964337	X	135067830	X	135985671	964337	951617		NC_000023.11:135985670:A:C
NM_001379110.1(SLC9A6):c.1832C>T (p.Thr611Ile)	SLC9A6	T581I, T633I, T549I, T611I, T601I	Christianson syndrome	Uncertain significance(Last reviewed: Jul 28, 2019)	criteria provided, single submitter	VCV000963236	X	135126675	X	136044516	963236	951619		NC_000023.11:136044515:C:T
NM_001379110.1(SLC9A6):c.1727G>A (p.Gly576Glu)	SLC9A6	G514E, G546E, G598E, G566E, G576E	Christianson syndrome	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV000959999	X	135122300	X	136040141	959999	951618		NC_000023.11:136040140:G:A
NM_001379110.1(SLC9A6):c.1582G>A (p.Gly528Ser)	SLC9A6	G466S, G518S, G550S, G498S, G528S	Christianson syndrome	Uncertain significance(Last reviewed: Jul 5, 2019)	criteria provided, single submitter	VCV000951462	X	135115573	X	136033414	951462	929575		NC_000023.11:136033413:G:A
NM_001379110.1(SLC9A6):c.971C>T (p.Ala324Val)	SLC9A6	A344V, A324V, A376V, A292V	Christianson syndrome	Uncertain significance(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000950702	X	135095193	X	136013034	950702	929573		NC_000023.11:136013033:C:T
NM_001379110.1(SLC9A6):c.1246_1249del (p.Leu416fs)	SLC9A6	L416fs, L436fs, L468fs, L384fs	Christianson syndrome	Pathogenic(Last reviewed: Feb 22, 2020)	criteria provided, single submitter	VCV000949999	X	135104792 - 135104795	X	136022633 - 136022636	949999	929574		NC_000023.11:136022632:CTTACTTA:CTTA
NM_001379110.1(SLC9A6):c.1996C>T (p.Pro666Ser)	SLC9A6	P636S, P656S, P604S, P688S, P666S	Christianson syndrome	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000945766	X	135126839	X	136044680	945766	929576		NC_000023.11:136044679:C:T
NM_001379110.1(SLC9A6):c.1555G>A (p.Gly519Ser)	SLC9A6	G519S, G457S, G489S, G509S, G541S	Christianson syndrome	Uncertain significance(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000943113	X	135112295	X	136030136	943113	939444		NC_000023.11:136030135:G:A
NM_001379110.1(SLC9A6):c.548C>T (p.Thr183Met)	SLC9A6	T183M, T203M, T235M, T151M	Intellectual disability|Christianson syndrome	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000942247	X	135081038	X	135998879	942247	939443		NC_000023.11:135998878:C:T
NM_001379110.1(SLC9A6):c.-56-21C>A	SLC9A6	P27H	Christianson syndrome	Uncertain significance(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV000940098	X	135067741	X	135985582	940098	939442		NC_000023.11:135985581:C:A
NM_001379110.1(SLC9A6):c.-57+26A>G	SLC9A6	M1V	Christianson syndrome|Neurodevelopmental disorder	Uncertain significance(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000853911	X	135067662	X	135985503	853911	849665		NC_000023.11:135985502:A:G
NM_001379110.1(SLC9A6):c.1934T>G (p.Phe645Cys)	SLC9A6	F583C, F635C, F667C, F615C, F645C	Christianson syndrome	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000834464	X	135126777	X	136044618	834464	849666		NC_000023.11:136044617:T:G
NC_000023.11:g.(?_135985483)_(136024503_?)dup	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Feb 8, 2019)	criteria provided, single submitter	VCV000831697	X	135067642 - 135106662			831697	821559		
NM_001379110.1(SLC9A6):c.992G>A (p.Gly331Asp)	SLC9A6	G383D, G299D, G331D, G351D	Christianson syndrome	Pathogenic(Last reviewed: Feb 24, 2017)	criteria provided, single submitter	VCV000813744	X	135095508	X	136013349	813744	802043	rs782108464	NC_000023.11:136013348:G:A
NM_001379110.1(SLC9A6):c.1599_1603del (p.Arg534fs)	SLC9A6	R472fs, R556fs, R504fs, R524fs, R534fs	Christianson syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000807688	X	135115588 - 135115592	X	136033429 - 136033433	807688	798807	rs1603219805	NC_000023.11:136033428:GAAAGGA:GA
NM_001379110.1(SLC9A6):c.524+3A>G	SLC9A6		not provided|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2020)	criteria provided, conflicting interpretations	VCV000805479	X	135080720	X	135998561	805479	794082	rs372679456	NC_000023.11:135998560:A:G
NM_001379110.1(SLC9A6):c.1080+80dup	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804088	X	135095664 - 135095665	X	136013505 - 136013506	804088	792125	rs35492327	NC_000023.11:136013505:AAAAAAAAAAAA:AAAAAAAAAAAAA
NM_001379110.1(SLC9A6):c.691CTT[1] (p.Leu232del)	SLC9A6	L284del, L232del, L252del, L200del	Christianson syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000804087	X	135084320 - 135084322	X	136002161 - 136002163	804087	792124	rs1603201557	NC_000023.11:136002160:CTTCTT:CTT
NM_001379110.1(SLC9A6):c.1566A>C (p.Ser522=)	SLC9A6		Christianson syndrome|not provided	Likely benign(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000794285	X	135112306	X	136030147	794285	786706	rs781843930	NC_000023.11:136030146:A:C
NM_001379110.1(SLC9A6):c.2031T>A (p.Gly677=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000765727	X	135126874	X	136044715	765727	773770	rs1603225948	NC_000023.11:136044714:T:A
NM_001379110.1(SLC9A6):c.549G>A (p.Thr183=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000752199	X	135081039	X	135998880	752199	773769	rs782386487	NC_000023.11:135998879:G:A
NM_001379110.1(SLC9A6):c.213G>A (p.Pro71=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000744117	X	135076988	X	135994829	744117	758301	rs782600941	NC_000023.11:135994828:G:A
NM_001379110.1(SLC9A6):c.744-7T>C	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000701274	X	135092594	X	136010435	701274	690253	rs1556618483	NC_000023.11:136010434:T:C
NM_001379110.1(SLC9A6):c.1038G>T (p.Thr346=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Feb 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000669532	X	135095554	X	136013395	669532	656732	rs782783023	NC_000023.11:136013394:G:T
NM_001379110.1(SLC9A6):c.-57+32C>T	SLC9A6	R3W	Christianson syndrome	Uncertain significance(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000657261	X	135067668	X	135985509	657261	649712	rs1556614701	NC_000023.11:135985508:C:T
NM_001379110.1(SLC9A6):c.483A>G (p.Ala161=)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000656614	X	135080676	X	135998517	656614	649715	rs781961294	NC_000023.11:135998516:A:G
NM_001379110.1(SLC9A6):c.71_88del (p.Ile24_Leu29del)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000653174	X	135067881 - 135067898	X	135985722 - 135985739	653174	649713	rs1603184929	NC_000023.11:135985721:CTGCTCATCTTCATCCTGCTGCTCA:CTGCTCA
NM_001379110.1(SLC9A6):c.393T>G (p.Phe131Leu)	SLC9A6	F183L, F131L, F151L, F99L	Christianson syndrome	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000647660	X	135080290	X	135998131	647660	649714	rs1603198044	NC_000023.11:135998130:T:G
NM_001379110.1(SLC9A6):c.652A>G (p.Ile218Val)	SLC9A6	I270V, I186V, I218V, I238V	Christianson syndrome	Uncertain significance(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000646158	X	135084281	X	136002122	646158	649716	rs782677140	NC_000023.11:136002121:A:G
NM_001379110.1(SLC9A6):c.420_421del (p.Phe141fs)	SLC9A6	F141fs, F109fs, F161fs, F193fs	Christianson syndrome	Pathogenic(Last reviewed: May 13, 2019)	criteria provided, single submitter	VCV000627623	X	135080315 - 135080316	X	135998156 - 135998157	627623	615978	rs1603198063	NC_000023.11:135998155:ATAT:AT
NM_001379110.1(SLC9A6):c.1307-1G>A	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Sep 15, 2018)	no assertion criteria provided	VCV000625179	X	135106488	X	136024329	625179	613522	rs1603215383	NC_000023.11:136024328:G:A
NM_001379110.1(SLC9A6):c.1833A>T (p.Thr611=)	SLC9A6		Christianson syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589925	X	135126676	X	136044517	589925	580775	rs782629258	NC_000023.11:136044516:A:T
NM_001379110.1(SLC9A6):c.1316G>A (p.Gly439Asp)	SLC9A6	G459D, G491D, G439D, G407D	Christianson syndrome	Likely pathogenic(Last reviewed: Jan 20, 2019)	criteria provided, single submitter	VCV000577815	X	135106498	X	136024339	577815	573553	rs1569525357	NC_000023.11:136024338:G:A
NM_001379110.1(SLC9A6):c.559G>A (p.Val187Ile)	SLC9A6	V207I, V239I, V155I, V187I	Christianson syndrome	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000575064	X	135081049	X	135998890	575064	575333	rs1556616995	NC_000023.11:135998889:G:A
NM_001379110.1(SLC9A6):c.-57+33G>T	SLC9A6	R3L	Christianson syndrome	Uncertain significance(Last reviewed: May 21, 2018)	criteria provided, single submitter	VCV000572609	X	135067669	X	135985510	572609	572224	rs1016216648	NC_000023.11:135985509:G:T
NM_001379110.1(SLC9A6):c.1873A>G (p.Ser625Gly)	SLC9A6	S647G, S615G, S563G, S595G, S625G	Christianson syndrome	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000537363	X	135126716	X	136044557	537363	534533	rs558960349	NC_000023.11:136044556:A:G
NM_001379110.1(SLC9A6):c.1460+6T>C	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516674	X	135106648	X	136024489	516674	508507	rs781963949	NC_000023.11:136024488:T:C
NM_001379110.1(SLC9A6):c.852A>T (p.Ala284=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512180	X	135092709	X	136010550	512180	507738	rs371472909	NC_000023.11:136010549:A:T
NM_001379110.1(SLC9A6):c.1038G>A (p.Thr346=)	SLC9A6		not specified|Christianson syndrome	Likely benign(Last reviewed: Jul 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000511385	X	135095554	X	136013395	511385	507852	rs782783023	NC_000023.11:136013394:G:A
NM_001379110.1(SLC9A6):c.886G>A (p.Val296Met)	SLC9A6	V316M, V348M, V296M, V264M	Christianson syndrome	Uncertain significance(Last reviewed: Jun 30, 2017)	criteria provided, single submitter	VCV000469638	X	135095108	X	136012949	469638	471285	rs1556618832	NC_000023.11:136012948:G:A
NM_001379110.1(SLC9A6):c.516C>T (p.Phe172=)	SLC9A6		not specified|Christianson syndrome	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000469637	X	135080709	X	135998550	469637	472065	rs1423014570	NC_000023.11:135998549:C:T
NM_001379110.1(SLC9A6):c.425A>G (p.Tyr142Cys)	SLC9A6	Y162C, Y194C, Y110C, Y142C	Christianson syndrome	Uncertain significance(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000469636	X	135080322	X	135998163	469636	471722	rs1556616834	NC_000023.11:135998162:A:G
NM_001379110.1(SLC9A6):c.113T>C (p.Leu38Pro)	SLC9A6	L90P, L38P	Christianson syndrome	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000469635	X	135067930	X	135985771	469635	472064	rs1556614843	NC_000023.11:135985770:T:C
NM_001379110.1(SLC9A6):c.1428C>T (p.Gly476=)	SLC9A6		Christianson syndrome	Uncertain significance(Last reviewed: May 23, 2017)	criteria provided, single submitter	VCV000469634	X	135106610	X	136024451	469634	471288	rs782370742	NC_000023.11:136024450:C:T
NM_001379110.1(SLC9A6):c.1164C>T (p.Val388=)	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000469633	X	135098887	X	136016728	469633	471736	rs1556619315	NC_000023.11:136016727:C:T
NM_001379110.1(SLC9A6):c.1083G>A (p.Leu361=)	SLC9A6		not provided|History of neurodevelopmental disorder|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000469632	X	135098806	X	136016647	469632	471733	rs151178361	NC_000023.11:136016646:G:A
NM_001379110.1(SLC9A6):c.262A>G (p.Thr88Ala)	SLC9A6	T140A, T88A	not provided|Christianson syndrome	Uncertain significance(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000450434	X	135077037	X	135994878	450434	446504	rs372003999	NC_000023.11:135994877:A:G
NM_001379110.1(SLC9A6):c.1768-6A>G	SLC9A6		Christianson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2020)	criteria provided, conflicting interpretations	VCV000436774	X	135126605	X	136044446	436774	430654	rs1556623179	NC_000023.11:136044445:A:G
NM_001379110.1(SLC9A6):c.743+1G>A	SLC9A6		Christianson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000432837	X	135084373	X	136002214	432837	426407	rs1556617455	NC_000023.11:136002213:G:A
NM_001379110.1(SLC9A6):c.-20G>A	SLC9A6	G46D	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000429629	X	135067798	X	135985639	429629	422416	rs782736274	NC_000023.11:135985638:G:A
NM_001379110.1(SLC9A6):c.1143_1144del (p.Phe382fs)	SLC9A6	F350fs, F382fs, F402fs, F434fs	Gastrostomy tube feeding in infancy|Recurrent respiratory infections|Seizures|Sleep disturbance|Scoliosis|Global developmental delay|Christianson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 6, 2015)	criteria provided, multiple submitters, no conflicts	VCV000418996	X	135098865 - 135098866	X	136016706 - 136016707	418996	411132	rs1064793575	NC_000023.11:136016705:TGT:T
NM_001379110.1(SLC9A6):c.1698G>A (p.Pro566=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Oct 24, 2016)	criteria provided, single submitter	VCV000415903	X	135122271	X	136040112	415903	404493	rs1060504687	NC_000023.11:136040111:G:A
NM_001379110.1(SLC9A6):c.228T>C (p.Asn76=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000415902	X	135077003	X	135994844	415902	404086	rs782529317	NC_000023.11:135994843:T:C
NM_001379110.1(SLC9A6):c.960C>G (p.Thr320=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000415901	X	135095182	X	136013023	415901	404491	rs1060504686	NC_000023.11:136013022:C:G
NM_001379110.1(SLC9A6):c.603A>G (p.Leu201=)	SLC9A6		not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000415900	X	135081093	X	135998934	415900	404448	rs1060504685	NC_000023.11:135998933:A:G
NM_001379110.1(SLC9A6):c.1081-8C>T	SLC9A6		Christianson syndrome	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000415899	X	135098796	X	136016637	415899	404453	rs1060504684	NC_000023.11:136016636:C:T
NM_001379110.1(SLC9A6):c.206A>G (p.His69Arg)	SLC9A6	H121R, H69R	Christianson syndrome	Uncertain significance(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000409978	X	135076981	X	135994822	409978	404120	rs1060502675	NC_000023.11:135994821:A:G
NM_001379110.1(SLC9A6):c.-4A>G	SLC9A6		not provided|not specified|Christianson syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000389505	X	135067814	X	135985655	389505	379920	rs782090744	NC_000023.11:135985654:A:G
NM_001379110.1(SLC9A6):c.1143G>A (p.Leu381=)	SLC9A6		not specified|Christianson syndrome	Likely benign(Last reviewed: Aug 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000388591	X	135098866	X	136016707	388591	378895	rs782501407	NC_000023.11:136016706:G:A
NM_001379110.1(SLC9A6):c.-57+27T>G	SLC9A6	M1R	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000383439	X	135067663	X	135985504	383439	378886	rs1006154022	NC_000023.11:135985503:T:G
NM_001379110.1(SLC9A6):c.57C>T (p.Ser19=)	SLC9A6		not provided|Christianson syndrome	Benign/Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379773	X	135067874	X	135985715	379773	378892	rs781963863	NC_000023.11:135985714:C:T
NM_001379110.1(SLC9A6):c.638-5A>G	SLC9A6		History of neurodevelopmental disorder|not specified|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 22, 2020)	criteria provided, conflicting interpretations	VCV000379485	X	135084262	X	136002103	379485	377791	rs1057520615	NC_000023.11:136002102:A:G
NM_001379110.1(SLC9A6):c.15C>G (p.Ile5Met)	SLC9A6	I57M, I5M	not provided|Christianson syndrome	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000379120	X	135067832	X	135985673	379120	377787	rs782296172	NC_000023.11:135985672:C:G
NM_001379110.1(SLC9A6):c.1434T>C (p.Thr478=)	SLC9A6		not provided|Christianson syndrome|not specified	Likely benign(Last reviewed: Sep 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000378619	X	135106616	X	136024457	378619	377800	rs1057520374	NC_000023.11:136024456:T:C
NM_001379110.1(SLC9A6):c.726del (p.Ala243fs)	SLC9A6	A243fs, A263fs, A211fs, A295fs	Christianson syndrome	Pathogenic	no assertion criteria provided	VCV000375585	X	135084354	X	136002195	375585	362395	rs1057519394	NC_000023.11:136002194:TT:T
NM_001379110.1(SLC9A6):c.2001G>A (p.Pro667=)	SLC9A6		not provided|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 3, 2020)	criteria provided, conflicting interpretations	VCV000282218	X	135126844	X	136044685	282218	266455	rs782708610	NC_000023.11:136044684:G:A
NM_001379110.1(SLC9A6):c.2021C>T (p.Thr674Met)	SLC9A6	T696M, T664M, T612M, T644M, T674M	not specified|not provided|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 22, 2020)	criteria provided, conflicting interpretations	VCV000281815	X	135126864	X	136044705	281815	266052	rs886044780	NC_000023.11:136044704:C:T
NM_001042537:c.916delC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Jan 10, 2016)	no assertion criteria provided	VCV000246605					246605	245213		
NM_001379110.1(SLC9A6):c.1588C>A (p.Pro530Thr)	SLC9A6	P520T, P552T, P468T, P500T, P530T	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Oct 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207253	X	135115579	X	136033420	207253	203997	rs782145804	NC_000023.11:136033419:C:A
NM_001379110.1(SLC9A6):c.563C>T (p.Thr188Met)	SLC9A6	T208M, T240M, T188M, T156M	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Jul 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207252	X	135081053	X	135998894	207252	203992	rs372747388	NC_000023.11:135998893:C:T
NM_001379110.1(SLC9A6):c.370-9_370-5del	SLC9A6		Intellectual disability|Christianson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 27, 2016)	criteria provided, conflicting interpretations	VCV000207248	X	135080254 - 135080258	X	135998095 - 135998099	207248	203985	rs796053290	NC_000023.11:135998094:TTTATTTTA:TTTA
NM_001379110.1(SLC9A6):c.-9G>T	SLC9A6	A50S	Christianson syndrome|not provided	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000207247	X	135067809	X	135985650	207247	203981	rs367724979	NC_000023.11:135985649:G:T
NM_001379110.1(SLC9A6):c.487G>A (p.Ala163Thr)	SLC9A6	A183T, A215T, A163T, A131T	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000207239	X	135080680	X	135998521	207239	203988	rs796053281	NC_000023.11:135998520:G:A
NM_001379110.1(SLC9A6):c.448A>G (p.Arg150Gly)	SLC9A6	R170G, R202G, R118G, R150G	Christianson syndrome|not provided	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000207238	X	135080641	X	135998482	207238	203986	rs796053280	NC_000023.11:135998481:A:G
NM_001379110.1(SLC9A6):c.1287A>G (p.Gln429=)	SLC9A6		not provided|Christianson syndrome|not specified	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000207234	X	135104837	X	136022678	207234	203996	rs142161862	NC_000023.11:136022677:A:G
NM_001379110.1(SLC9A6):c.452A>T (p.His151Leu)	SLC9A6	H171L, H203L, H151L, H119L	Christianson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2020)	criteria provided, conflicting interpretations	VCV000207233	X	135080645	X	135998486	207233	203987	rs796053275	NC_000023.11:135998485:A:T
NM_001379110.1(SLC9A6):c.825C>G (p.Phe275Leu)	SLC9A6	F327L, F295L, F243L, F275L	Christianson syndrome|not provided	Uncertain significance(Last reviewed: May 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000198540	X	135092682	X	136010523	198540	195701	rs797044779	NC_000023.11:136010522:C:G
NM_001379110.1(SLC9A6):c.448-1G>A	SLC9A6		Christianson syndrome|not provided	Pathogenic(Last reviewed: Mar 2, 2021)	reviewed by expert panel	VCV000167702	X	135080640	X	135998481	167702	178080	rs797044508	NC_000023.11:135998480:G:A
NM_001379110.1(SLC9A6):c.529A>G (p.Ile177Val)	SLC9A6	I229V, I145V, I197V, I177V	Christianson syndrome	Uncertain significance(Last reviewed: Mar 18, 2014)	criteria provided, single submitter	VCV000159936	X	135081019	X	135998860	159936	169941	rs587784402	NC_000023.11:135998859:A:G
NM_001379110.1(SLC9A6):c.256A>G (p.Ser86Gly)	SLC9A6	S138G, S86G	Christianson syndrome	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000159935	X	135077031	X	135994872	159935	169940	rs587784401	NC_000023.11:135994871:A:G
NM_001379110.1(SLC9A6):c.211C>T (p.Pro71Ser)	SLC9A6	P123S, P71S	Christianson syndrome	Uncertain significance(Last reviewed: Jul 16, 2013)	criteria provided, single submitter	VCV000159934	X	135076986	X	135994827	159934	169939	rs587784400	NC_000023.11:135994826:C:T
NM_001379110.1(SLC9A6):c.-57+50G>T	SLC9A6	A9S	not specified|not provided|Christianson syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000159933	X	135067686	X	135985527	159933	169937	rs201523857	NC_000023.11:135985526:G:T
NM_001379110.1(SLC9A6):c.2012T>G (p.Leu671Ter)	SLC9A6	L693*, L641*, L609*, L661*, L671*	Christianson syndrome	Pathogenic(Last reviewed: Dec 31, 2013)	criteria provided, single submitter	VCV000159932	X	135126855	X	136044696	159932	169942	rs587784399	NC_000023.11:136044695:T:G
NM_001379110.1(SLC9A6):c.27del (p.Lys9fs)	SLC9A6	K9fs, K61fs	Christianson syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000159931	X	135067844	X	135985685	159931	169938	rs587784398	NC_000023.11:135985684:G:
NM_001379110.1(SLC9A6):c.-16C>T	SLC9A6		not provided|not specified|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 8, 2020)	criteria provided, conflicting interpretations	VCV000139211	X	135067802	X	135985643	139211	142914	rs139299794	NC_000023.11:135985642:C:T
NM_001379110.1(SLC9A6):c.*8A>T	SLC9A6		History of neurodevelopmental disorder|Intellectual disability|not specified|Christianson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 21, 2020)	criteria provided, conflicting interpretations	VCV000139210	X	135126891	X	136044732	139210	142913	rs200171451	NC_000023.11:136044731:A:T
NM_001379110.1(SLC9A6):c.1689C>T (p.Ser563=)	SLC9A6		History of neurodevelopmental disorder|not specified|Christianson syndrome	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139209	X	135122262	X	136040103	139209	142912	rs2307131	NC_000023.11:136040102:C:T
NM_001379110.1(SLC9A6):c.1662-4G>A	SLC9A6		History of neurodevelopmental disorder|not specified|not provided|Christianson syndrome	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139208	X	135122231	X	136040072	139208	142911	rs188072063	NC_000023.11:136040071:G:A
NM_001379110.1(SLC9A6):c.1637G>A (p.Arg546Gln)	SLC9A6	R568Q, R536Q, R516Q, R484Q, R546Q	History of neurodevelopmental disorder|not specified|Intellectual disability|Christianson syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139207	X	135115628	X	136033469	139207	142910	rs146263125	NC_000023.11:136033468:G:A
NM_001379110.1(SLC9A6):c.1582-3C>T	SLC9A6		not specified|not provided|Christianson syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000139206	X	135115570	X	136033411	139206	142909	rs563279759	NC_000023.11:136033410:C:T
NM_001379110.1(SLC9A6):c.1460+10A>G	SLC9A6		not specified|Christianson syndrome	Benign(Last reviewed: Jun 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139204	X	135106652	X	136024493	139204	142907	rs185533973	NC_000023.11:136024492:A:G
NM_001379110.1(SLC9A6):c.1029A>C (p.Ala343=)	SLC9A6		History of neurodevelopmental disorder|not specified|Christianson syndrome	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139203	X	135095545	X	136013386	139203	142906	rs142049079	NC_000023.11:136013385:A:C
NM_001379110.1(SLC9A6):c.744-6C>T	SLC9A6		not specified|Christianson syndrome	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139201	X	135092595	X	136010436	139201	142904	rs17001258	NC_000023.11:136010435:C:T
NM_001379110.1(SLC9A6):c.474T>C (p.Ser158=)	SLC9A6		History of neurodevelopmental disorder|not specified|Christianson syndrome	Benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000139200	X	135080667	X	135998508	139200	142903	rs144316388	NC_000023.11:135998507:T:C
NM_001379110.1(SLC9A6):c.916C>T (p.Gln306Ter)	SLC9A6	Q326*, Q358*, Q274*, Q306*	not provided|Christianson syndrome	Pathogenic(Last reviewed: Feb 10, 2021)	reviewed by expert panel	VCV000095378	X	135095138	X	136012979	95378	101277	rs398124224	NC_000023.11:136012978:C:T
NM_001379110.1(SLC9A6):c.1460+4A>G	SLC9A6		History of neurodevelopmental disorder|not specified|Christianson syndrome|not provided	Benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095376	X	135106646	X	136024487	95376	101275	rs180727016	NC_000023.11:136024486:A:G
NM_001379110.1(SLC9A6):c.1306+8G>A	SLC9A6		Christianson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095375	X	135104864	X	136022705	95375	101274	rs6654310	NC_000023.11:136022704:G:A
NM_001379110.1(SLC9A6):c.1573G>T (p.Glu525Ter)	SLC9A6	E547*, E463*, E495*, E515*, E525*	Christianson syndrome	Pathogenic(Last reviewed: Dec 1, 2013)	no assertion criteria provided	VCV000092121	X	135112313	X	136030154	92121	97547	rs398123003	NC_000023.11:136030153:G:T
NM_001379110.1(SLC9A6):c.856_864del (p.Gly286_Ala288del)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: May 1, 2010)	no assertion criteria provided	VCV000029949	X	135092713 - 135092721	X	136010554 - 136010562	29949	38904	rs398122849	NC_000023.11:136010553:GGTGCTGCT:
NM_001379110.1(SLC9A6):c.452_453del (p.His151fs)	SLC9A6	H119fs, H151fs, H203fs, H171fs	Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011479	X	135080645 - 135080646	X	135998486 - 135998487	11479	26518	rs730882188	NC_000023.11:135998485:AT:
NM_001379110.1(SLC9A6):c.447+3_447+4delinsCC	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000011478	X	135080347 - 135080348	X	135998188 - 135998189	11478	26517	rs730882187	NC_000023.11:135998187:AA:CC
NM_001379110.1(SLC9A6):c.1342C>T (p.Arg448Ter)	SLC9A6	R468*, R448*, R500*, R416*	Christianson syndrome|not provided	Pathogenic(Last reviewed: Jan 21, 2019)	criteria provided, single submitter	VCV000011477	X	135106524	X	136024365	11477	26516	rs122461162	NC_000023.11:136024364:C:T
NM_001379110.1(SLC9A6):c.704_709del (p.Glu235_Ser236del)	SLC9A6		Christianson syndrome	Pathogenic(Last reviewed: Oct 15, 2009)	no assertion criteria provided	VCV000011476	X	135084330 - 135084335	X	136002171 - 136002176	11476	26515	rs886037619	NC_000023.11:136002170:GTGAAAGTG:GTG
NM_003079.5(SMARCE1):c.237+1G>T	SMARCE1		Coffin-Siris syndrome 5	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666261	17	38793743	17	40637491	666261	653822	rs1426841589	NC_000017.11:40637490:C:A
NM_130839.5(UBE3A):c.2547C>G (p.Tyr849Ter)	SNHG14|UBE3A	Y412*, Y432*, Y774*, Y777*, Y790*, Y797*, Y829*, Y849*, Y852*	Angelman syndrome	Likely pathogenic(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001285431	15	25584356	15	25339209	1285431	1275274		NC_000015.10:25339208:G:C
NM_130839.5(UBE3A):c.807G>A (p.Thr269=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001117017	15	25616514	15	25371367	1117017	1102754		NC_000015.10:25371366:C:T
NM_130839.5(UBE3A):c.858C>T (p.Ile286=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV001114731	15	25616463	15	25371316	1114731	1102753		NC_000015.10:25371315:G:A
NM_130839.5(UBE3A):c.2313A>G (p.Thr771=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001112990	15	25599541	15	25354394	1112990	1102750		NC_000015.10:25354393:T:C
NM_130839.5(UBE3A):c.961C>T (p.Leu321=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV001106558	15	25616360	15	25371213	1106558	1102752		NC_000015.10:25371212:G:A
NM_130839.5(UBE3A):c.303C>T (p.Pro101=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001101100	15	25620670	15	25375523	1101100	1102755		NC_000015.10:25375522:G:A
NM_130839.5(UBE3A):c.270C>T (p.Ser90=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV001093909	15	25620703	15	25375556	1093909	1080915		NC_000015.10:25375555:G:A
NM_130839.5(UBE3A):c.62+9A>G	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Mar 19, 2019)	criteria provided, single submitter	VCV001088843	15	25650599	15	25405452	1088843	1080917		NC_000015.10:25405451:T:C
NM_130839.5(UBE3A):c.81G>A (p.Lys27=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001082932	15	25620892	15	25375745	1082932	1080916		NC_000015.10:25375744:C:T
NM_130839.5(UBE3A):c.618A>G (p.Ala206=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Feb 24, 2019)	criteria provided, single submitter	VCV001081593	15	25616703	15	25371556	1081593	1080912		NC_000015.10:25371555:T:C
NM_130839.5(UBE3A):c.444T>G (p.Arg148=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001080162	15	25616877	15	25371730	1080162	1080914		NC_000015.10:25371729:A:C
NM_130839.5(UBE3A):c.2515_2531dup (p.Leu846fs)	SNHG14|UBE3A	L409fs, L429fs, L771fs, L774fs, L787fs, L794fs, L826fs, L846fs, L849fs	Angelman syndrome	Pathogenic(Last reviewed: Jul 12, 2020)	criteria provided, single submitter	VCV001073548	15	25584371 - 25584372	15	25339224 - 25339225	1073548	1063216		NC_000015.10:25339224:AGCACATTAAAGCAAGTA:AGCACATTAAAGCAAGTAGCACATTAAAGCAAGTA
NM_130839.5(UBE3A):c.2423G>A (p.Gly808Asp)	SNHG14|UBE3A	G371D, G391D, G733D, G736D, G749D, G756D, G788D, G808D, G811D	Angelman syndrome	Likely pathogenic(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001067820	15	25585307	15	25340160	1067820	1056209		NC_000015.10:25340159:C:T
NM_130839.5(UBE3A):c.238T>C (p.Cys80Arg)	SNHG14|UBE3A	C21R, C60R, C80R, C83R	Angelman syndrome	Likely pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV001066645	15	25620735	15	25375588	1066645	1056210		NC_000015.10:25375587:A:G
NM_130839.5(UBE3A):c.1960G>C (p.Val654Leu)	SNHG14|UBE3A	V217L, V237L, V595L, V634L, V654L, V657L	Angelman syndrome	Pathogenic	no assertion criteria provided	VCV001064603	15	25601203	15	25356056	1064603	1052867		NC_000015.10:25356055:C:G
NM_130839.5(UBE3A):c.361+6A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001059360	15	25620606	15	25375459	1059360	1048816		NC_000015.10:25375458:T:C
NM_130839.5(UBE3A):c.1477G>A (p.Asp493Asn)	SNHG14|UBE3A	D493N, D434N, D496N, D473N	Angelman syndrome	Uncertain significance(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001046274	15	25615844	15	25370697	1046274	1031868		NC_000015.10:25370696:C:T
NM_130839.5(UBE3A):c.2416A>G (p.Thr806Ala)	SNHG14|UBE3A	T734A, T747A, T809A, T389A, T754A, T369A, T731A, T786A, T806A	Angelman syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001043090	15	25585314	15	25340167	1043090	1031865		NC_000015.10:25340166:T:C
NM_130839.5(UBE3A):c.2181C>G (p.Phe727Leu)	SNHG14|UBE3A	F668L, F290L, F727L, F652L, F707L, F310L, F730L	Angelman syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001038124	15	25599774	15	25354627	1038124	1031866		NC_000015.10:25354626:G:C
NM_130839.5(UBE3A):c.790G>A (p.Val264Met)	SNHG14|UBE3A	V244M, V267M, V205M, V264M	Angelman syndrome	Uncertain significance(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001036134	15	25616531	15	25371384	1036134	1031869		NC_000015.10:25371383:C:T
NM_130839.5(UBE3A):c.511A>T (p.Thr171Ser)	SNHG14|UBE3A	T112S, T151S, T174S, T171S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001035320	15	25616810	15	25371663	1035320	1031870		NC_000015.10:25371662:T:A
NM_130839.5(UBE3A):c.1402del (p.Thr468fs)	SNHG14|UBE3A	T409fs, T468fs, T448fs, T471fs	Angelman syndrome	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV001032380	15	25615919	15	25370772	1032380	1021283		NC_000015.10:25370771:TTT:TT
NM_130839.5(UBE3A):c.2498+3A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001018622	15	25585229	15	25340082	1018622	1011362		NC_000015.10:25340081:T:C
NM_130839.5(UBE3A):c.1153G>T (p.Val385Leu)	SNHG14|UBE3A	V326L, V365L, V385L, V388L	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Apr 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV001018602	15	25616168	15	25371021	1018602	1011364		NC_000015.10:25371020:C:A
NM_130839.5(UBE3A):c.1221G>A (p.Gln407=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Jan 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001013058	15	25616100	15	25370953	1013058	1000886		NC_000015.10:25370952:C:T
NM_130839.5(UBE3A):c.835A>G (p.Asn279Asp)	SNHG14|UBE3A	N220D, N259D, N279D, N282D	Angelman syndrome	Uncertain significance(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001011080	15	25616486	15	25371339	1011080	996129		NC_000015.10:25371338:T:C
NM_130839.5(UBE3A):c.131A>C (p.Glu44Ala)	SNHG14|UBE3A	E24A, E44A, E47A	Angelman syndrome	Uncertain significance(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001009993	15	25620842	15	25375695	1009993	996130		NC_000015.10:25375694:T:G
NM_130839.5(UBE3A):c.853A>G (p.Ile285Val)	SNHG14|UBE3A	I226V, I265V, I285V, I288V	Angelman syndrome	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001008821	15	25616468	15	25371321	1008821	996128		NC_000015.10:25371320:T:C
NM_130839.5(UBE3A):c.1937G>T (p.Arg646Leu)	SNHG14|UBE3A	R209L, R229L, R587L, R626L, R646L, R649L	Angelman syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001007836	15	25601860	15	25356713	1007836	996126		NC_000015.10:25356712:C:A
NM_130839.5(UBE3A):c.916T>A (p.Phe306Ile)	SNHG14|UBE3A	F247I, F286I, F306I, F309I	Angelman syndrome	Uncertain significance(Last reviewed: Feb 11, 2020)	criteria provided, single submitter	VCV001006109	15	25616405	15	25371258	1006109	996127		NC_000015.10:25371257:A:T
NM_000462.3:c.2365delG	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000995996	15	25585374	15	25340227	995996	983697		NC_000015.10:25340226:CCC:CC
NM_130839.5(UBE3A):c.2033A>G (p.Gln678Arg)	SNHG14|UBE3A	Q241R, Q261R, Q619R, Q658R, Q678R, Q681R	Angelman syndrome	Likely pathogenic	criteria provided, single submitter	VCV000981483	15	25601130	15	25355983	981483	969569		NC_000015.10:25355982:T:C
NM_130839.5(UBE3A):c.826C>A (p.Arg276=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000963514	15	25616495	15	25371348	963514	948781		NC_000015.10:25371347:G:T
NM_130839.5(UBE3A):c.400C>A (p.Leu134Ile)	SNHG14|UBE3A	L134I, L114I, L137I, L75I	Angelman syndrome	Uncertain significance(Last reviewed: Sep 17, 2019)	criteria provided, single submitter	VCV000954947	15	25616921	15	25371774	954947	948783		NC_000015.10:25371773:G:T
NM_130839.5(UBE3A):c.2124+6_2124+9del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV000951417	15	25601030 - 25601033	15	25355883 - 25355886	951417	941079		NC_000015.10:25355882:ATTTATT:ATT
NM_130839.5(UBE3A):c.659A>G (p.Asn220Ser)	SNHG14|UBE3A	N161S, N223S, N200S, N220S	Angelman syndrome	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000949921	15	25616662	15	25371515	949921	927259		NC_000015.10:25371514:T:C
NM_130839.5(UBE3A):c.295G>T (p.Gly99Cys)	SNHG14|UBE3A	G40C, G99C, G79C, G102C	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Jun 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000945944	15	25620678	15	25375531	945944	927260		NC_000015.10:25375530:C:A
NM_130839.5(UBE3A):c.172C>T (p.Leu58Phe)	SNHG14|UBE3A	L38F, L58F, L61F	Angelman syndrome	Uncertain significance(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000937562	15	25620801	15	25375654	937562	936831		NC_000015.10:25375653:G:A
NM_130839.5(UBE3A):c.147G>T (p.Glu49Asp)	SNHG14|UBE3A	E49D, E52D, E29D	Angelman syndrome	Uncertain significance(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000937339	15	25620826	15	25375679	937339	936832		NC_000015.10:25375678:C:A
NM_130839.5(UBE3A):c.2344_2345del (p.Val782fs)	SNHG14|UBE3A	V345fs, V710fs, V762fs, V365fs, V707fs, V785fs, V723fs, V782fs, V730fs	Angelman syndrome	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000934588	15	25599509 - 25599510	15	25354362 - 25354363	934588	936829		NC_000015.10:25354361:ACA:A
NM_130839.5(UBE3A):c.2279G>A (p.Arg760Gln)	SNHG14|UBE3A	R323Q, R685Q, R701Q, R763Q, R343Q, R740Q, R760Q	Angelman syndrome	Uncertain significance(Last reviewed: Oct 10, 2019)	criteria provided, single submitter	VCV000934467	15	25599676	15	25354529	934467	936830		NC_000015.10:25354528:C:T
NM_130839.5(UBE3A):c.2355-3T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, single submitter	VCV000934151	15	25585378	15	25340231	934151	940321		NC_000015.10:25340230:A:G
NM_130839.5(UBE3A):c.410G>A (p.Cys137Tyr)	SNHG14|UBE3A	C117Y, C137Y, C140Y, C78Y	Angelman syndrome	Uncertain significance(Last reviewed: Apr 25, 2019)	criteria provided, single submitter	VCV000864774	15	25616911	15	25371764	864774	842088		NC_000015.10:25371763:C:T
NM_130839.5(UBE3A):c.1067G>A (p.Arg356Gln)	SNHG14|UBE3A	R297Q, R359Q, R356Q, R336Q	Angelman syndrome	Uncertain significance(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000858207	15	25616254	15	25371107	858207	842083		NC_000015.10:25371106:C:T
NM_130839.5(UBE3A):c.1006A>C (p.Met336Leu)	SNHG14|UBE3A	M277L, M336L, M316L, M339L	Angelman syndrome	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000857446	15	25616315	15	25371168	857446	842085		NC_000015.10:25371167:T:G
NM_130839.5(UBE3A):c.1568A>G (p.Lys523Arg)	SNHG14|UBE3A	K503R, K523R, K464R, K526R	Angelman syndrome	Uncertain significance(Last reviewed: Dec 19, 2019)	criteria provided, single submitter	VCV000855495	15	25615753	15	25370606	855495	842081		NC_000015.10:25370605:T:C
NM_130839.5(UBE3A):c.589G>A (p.Ala197Thr)	SNHG14|UBE3A	A138T, A197T, A177T, A200T	Angelman syndrome	Uncertain significance(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000855279	15	25616732	15	25371585	855279	842087		NC_000015.10:25371584:C:T
NM_130839.5(UBE3A):c.592G>T (p.Ala198Ser)	SNHG14|UBE3A	A178S, A201S, A139S, A198S	Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 30, 2019)	criteria provided, conflicting interpretations	VCV000850340	15	25616729	15	25371582	850340	842086		NC_000015.10:25371581:C:A
NM_130839.5(UBE3A):c.2378_2381del (p.Ser793fs)	SNHG14|UBE3A	S376fs, S721fs, S734fs, S773fs, S796fs, S356fs, S718fs, S741fs, S793fs	Angelman syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000845525	15	25585349 - 25585352	15	25340202 - 25340205	845525	842080		NC_000015.10:25340201:AATGAATGAA:AATGAA
NM_130839.5(UBE3A):c.343G>A (p.Ala115Thr)	SNHG14|UBE3A	A118T, A56T, A95T, A115T	Angelman syndrome	Uncertain significance(Last reviewed: Mar 18, 2019)	criteria provided, single submitter	VCV000845079	15	25620630	15	25375483	845079	842090		NC_000015.10:25375482:C:T
NM_130839.5(UBE3A):c.161G>A (p.Cys54Tyr)	SNHG14|UBE3A	C34Y, C54Y, C57Y	Angelman syndrome	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV000838590	15	25620812	15	25375665	838590	842092		NC_000015.10:25375664:C:T
NM_130839.5(UBE3A):c.927G>A (p.Ala309=)	SNHG14|UBE3A		not provided|Angelman syndrome	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000807191	15	25616394	15	25371247	807191	797098	rs576963061	NC_000015.10:25371246:C:T
NM_130839.5(UBE3A):c.826C>T (p.Arg276Ter)	SNHG14|UBE3A	R276*, R217*, R279*, R256*	Angelman syndrome|Intellectual disability	Pathogenic(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000803059	15	25616495	15	25371348	803059	791436	rs997044541	NC_000015.10:25371347:G:A
NM_130839.5(UBE3A):c.1405_1408del (p.Glu469fs)	SNHG14|UBE3A	E469fs, E410fs, E449fs, E472fs	Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803058	15	25615913 - 25615916	15	25370766 - 25370769	803058	791435	rs587784512	NC_000015.10:25370765:TCTCT:T
NM_130839.5(UBE3A):c.2198G>T (p.Gly733Val)	SNHG14|UBE3A	G658V, G674V, G713V, G736V, G296V, G316V, G733V	Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803056	15	25599757	15	25354610	803056	791433	rs1595572384	NC_000015.10:25354609:C:A
NM_130839.5(UBE3A):c.883A>G (p.Ser295Gly)	SNHG14|UBE3A	S295G, S236G, S298G, S275G	Angelman syndrome	Uncertain significance(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800841	15	25616438	15	25371291	800841	788886	rs1595810000	NC_000015.10:25371290:T:C
NM_130839.5(UBE3A):c.362-10G>T	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000776866	15	25616969	15	25371822	776866	778228	rs1407383738	NC_000015.10:25371821:C:A
NM_130839.5(UBE3A):c.558T>C (p.Asp186=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: May 3, 2019)	criteria provided, single submitter	VCV000765969	15	25616763	15	25371616	765969	770057	rs1595814554	NC_000015.10:25371615:A:G
NM_130839.5(UBE3A):c.1002G>A (p.Arg334=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000765373	15	25616319	15	25371172	765373	770055	rs1595808837	NC_000015.10:25371171:C:T
NM_130839.5(UBE3A):c.1273C>T (p.Leu425=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000750387	15	25616048	15	25370901	750387	754325	rs778060771	NC_000015.10:25370900:G:A
NM_130839.5(UBE3A):c.1770T>C (p.Asp590=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000711626	15	25602027	15	25356880	711626	725924	rs781556374	NC_000015.10:25356879:A:G
NM_130839.5(UBE3A):c.1428A>G (p.Thr476=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Sep 21, 2019)	criteria provided, single submitter	VCV000703061	15	25615893	15	25370746	703061	693648	rs138049263	NC_000015.10:25370745:T:C
NM_130839.5(UBE3A):c.1854G>C (p.Leu618=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000699444	15	25601943	15	25356796	699444	688393	rs370142725	NC_000015.10:25356795:C:G
NM_130839.5(UBE3A):c.211G>T (p.Glu71Ter)	SNHG14|UBE3A	E51*, E74*, E71*, E12*	Angelman syndrome	Likely pathogenic(Last reviewed: Jun 21, 2019)	criteria provided, single submitter	VCV000692239	15	25620762	15	25375615	692239	680053	rs1207660411	NC_000015.10:25375614:C:A
NM_130839.5(UBE3A):c.2426_2427del (p.Thr809fs)	SNHG14|UBE3A	T757fs, T372fs, T392fs, T734fs, T737fs, T750fs, T789fs, T809fs, T812fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000665896	15	25585303 - 25585304	15	25340156 - 25340157	665896	642995	rs1595375630	NC_000015.10:25340155:TGTG:TG
NM_130839.5(UBE3A):c.425A>C (p.Asp142Ala)	SNHG14|UBE3A	D122A, D142A, D145A, D83A	Angelman syndrome	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000661226	15	25616896	15	25371749	661226	643002	rs1595815771	NC_000015.10:25371748:T:G
NM_130839.5(UBE3A):c.2444G>A (p.Gly815Glu)	SNHG14|UBE3A	G398E, G756E, G818E, G740E, G743E, G795E, G378E, G763E, G815E	Angelman syndrome	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000654655	15	25585286	15	25340139	654655	642994	rs1595375255	NC_000015.10:25340138:C:T
NM_130839.5(UBE3A):c.986A>G (p.Asn329Ser)	SNHG14|UBE3A	N270S, N329S, N309S, N332S	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Nov 10, 2019)	criteria provided, single submitter	VCV000654347	15	25616335	15	25371188	654347	643000	rs556829175	NC_000015.10:25371187:T:C
NM_130839.5(UBE3A):c.1482T>C (p.Asn494=)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000650099	15	25615839	15	25370692	650099	642997	rs776564692	NC_000015.10:25370691:A:G
NM_130839.5(UBE3A):c.589G>T (p.Ala197Ser)	SNHG14|UBE3A	A138S, A177S, A197S, A200S	Angelman syndrome	Uncertain significance(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000650098	15	25616732	15	25371585	650098	643001	rs752711811	NC_000015.10:25371584:C:A
NM_130839.5(UBE3A):c.1060A>G (p.Asn354Asp)	SNHG14|UBE3A	N354D, N357D, N295D, N334D	Angelman syndrome	Uncertain significance(Last reviewed: Dec 12, 2018)	criteria provided, single submitter	VCV000646776	15	25616261	15	25371114	646776	642999	rs1595808009	NC_000015.10:25371113:T:C
NM_130839.5(UBE3A):c.1322del (p.Ile441fs)	SNHG14|UBE3A	I421fs, I444fs, I382fs, I441fs	Angelman syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000645339	15	25615999	15	25370852	645339	642998	rs1595804239	NC_000015.10:25370851:A:
NM_130839.5(UBE3A):c.2003A>G (p.Asn668Ser)	SNHG14|UBE3A	N671S, N231S, N251S, N609S, N648S, N668S	Angelman syndrome	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000644506	15	25601160	15	25356013	644506	642996	rs557434570	NC_000015.10:25356012:T:C
NM_130839.5(UBE3A):c.406T>C (p.Leu136=)	SNHG14|UBE3A		Angelman syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589830	15	25616915	15	25371768	589830	579932	rs1566962877	NC_000015.10:25371767:A:G
NM_130839.5(UBE3A):c.2461_2470del (p.Leu820_Lys821insTer)	SNHG14|UBE3A		History of neurodevelopmental disorder	Pathogenic(Last reviewed: Oct 4, 2016)	criteria provided, single submitter	VCV000589422	15	25585260 - 25585269	15	25340113 - 25340122	589422	580000	rs1566825063	NC_000015.10:25340112:TAATCATCTTTAAT:TAAT
NM_130839.5(UBE3A):c.2322C>T (p.Asp774=)	SNHG14|UBE3A		History of neurodevelopmental disorder|Angelman syndrome|not provided	Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000588417	15	25599532	15	25354385	588417	580004	rs759095902	NC_000015.10:25354384:G:A
NC_000015.10:g.(?_25375445)_(25375783_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000584072	15	25620592 - 25620930	15	25375445 - 25375783	584072	568563		
NC_000015.10:g.(?_25354333)_(25360547_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, single submitter	VCV000583861	15	25599480 - 25605694	15	25354333 - 25360547	583861	569188		
NC_000015.9:g.(?_25584264)_(25620930_?)dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000583426	15	25584264 - 25620930	15	25339117 - 25375783	583426	568557		
NC_000015.10:g.(?_25360363)_(25360547_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000583413	15	25605510 - 25605694	15	25360363 - 25360547	583413	569191		
NM_130839.5(UBE3A):c.342C>T (p.Gly114=)	SNHG14|UBE3A		not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	VCV000581141	15	25620631	15	25375484	581141	569224	rs142726511	NC_000015.10:25375483:G:A
NM_130839.5(UBE3A):c.2030T>C (p.Phe677Ser)	SNHG14|UBE3A	F657S, F240S, F260S, F618S, F677S, F680S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 16, 2018)	criteria provided, single submitter	VCV000577325	15	25601133	15	25355986	577325	573137	rs1566894864	NC_000015.10:25355985:A:G
NM_130839.5(UBE3A):c.854T>C (p.Ile285Thr)	SNHG14|UBE3A	I265T, I226T, I285T, I288T	Angelman syndrome	Likely pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000577015	15	25616467	15	25371320	577015	573142	rs1566959617	NC_000015.10:25371319:A:G
NM_130839.5(UBE3A):c.2604A>T (p.Gly868=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000573621	15	25584299	15	25339152	573621	573133	rs965417906	NC_000015.10:25339151:T:A
NM_130839.5(UBE3A):c.2323G>A (p.Gly775Ser)	SNHG14|UBE3A	G755S, G716S, G700S, G703S, G775S, G338S, G778S, G358S, G723S	Angelman syndrome	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, single submitter	VCV000573464	15	25599531	15	25354384	573464	568615	rs1566887391	NC_000015.10:25354383:C:T
NM_130839.5(UBE3A):c.1153G>A (p.Val385Met)	SNHG14|UBE3A	V365M, V388M, V326M, V385M	Angelman syndrome	Uncertain significance(Last reviewed: Aug 27, 2018)	criteria provided, single submitter	VCV000571708	15	25616168	15	25371021	571708	573140	rs763388142	NC_000015.10:25371020:C:T
NM_130839.5(UBE3A):c.1678_1699delinsT (p.Gln560_Val567delinsPhe)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000571267	15	25605584 - 25605605	15	25360437 - 25360458	571267	569216	rs1566912450	NC_000015.10:25360436:CACCTCCCTCATCAACTCCTTG:A
NM_130839.5(UBE3A):c.733T>G (p.Ser245Ala)	SNHG14|UBE3A	S225A, S186A, S245A, S248A	Angelman syndrome	Uncertain significance(Last reviewed: May 4, 2019)	criteria provided, single submitter	VCV000570995	15	25616588	15	25371441	570995	569220	rs760844102	NC_000015.10:25371440:A:C
NM_130839.5(UBE3A):c.647A>C (p.Gln216Pro)	SNHG14|UBE3A	Q196P, Q216P, Q219P, Q157P	Angelman syndrome	Uncertain significance(Last reviewed: Sep 8, 2019)	criteria provided, single submitter	VCV000570862	15	25616674	15	25371527	570862	566886	rs144950303	NC_000015.10:25371526:T:G
NM_130839.5(UBE3A):c.1133C>G (p.Ala378Gly)	SNHG14|UBE3A	A358G, A319G, A378G, A381G	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000569445	15	25616188	15	25371041	569445	568620	rs1219606975	NC_000015.10:25371040:G:C
NM_130839.5(UBE3A):c.1600del (p.Val535fs)	SNHG14|UBE3A	V476fs, V515fs, V538fs, V535fs	Angelman syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000568584	15	25615721	15	25370574	568584	569219	rs1566954070	NC_000015.10:25370573:G:
NM_130839.5(UBE3A):c.1207G>T (p.Glu403Ter)	SNHG14|UBE3A	E383*, E344*, E403*, E406*	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 1, 2021)	reviewed by expert panel	VCV000546267	15	25616114	15	25370967	546267	536881	rs1555400239	NC_000015.10:25370966:C:A
NM_130839.5(UBE3A):c.2355-6_2355-5insTAAT	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Oct 3, 2017)	criteria provided, single submitter	VCV000528368	15	25585380 - 25585381	15	25340233 - 25340234	528368	528969	rs1555380917	NC_000015.10:25340233::ATTA
NM_130839.5(UBE3A):c.2162A>T (p.Lys721Ile)	SNHG14|UBE3A	K701I, K284I, K304I, K646I, K721I, K724I, K662I	Angelman syndrome	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000528367	15	25599793	15	25354646	528367	528982	rs1555389881	NC_000015.10:25354645:T:A
NM_130839.5(UBE3A):c.570G>T (p.Lys190Asn)	SNHG14|UBE3A	K170N, K193N, K131N, K190N	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jun 28, 2021)	criteria provided, multiple submitters, no conflicts	VCV000528366	15	25616751	15	25371604	528366	528617	rs780715298	NC_000015.10:25371603:C:A
NM_130839.5(UBE3A):c.2354+10T>C	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Dec 13, 2017)	criteria provided, single submitter	VCV000528360	15	25599490	15	25354343	528360	528974	rs1555389575	NC_000015.10:25354342:A:G
NM_130839.5(UBE3A):c.1945G>A (p.Gly649Arg)	SNHG14|UBE3A	G629R, G590R, G652R, G232R, G649R, G212R	not provided|Angelman syndrome|Inborn genetic diseases	Uncertain significance(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000521447	15	25601852	15	25356705	521447	512117	rs747626553	NC_000015.10:25356704:C:T
NM_130839.5(UBE3A):c.1228T>C (p.Leu410=)	SNHG14|UBE3A		not provided|Angelman syndrome	Likely benign(Last reviewed: Mar 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000517984	15	25616093	15	25370946	517984	504694	rs143310195	NC_000015.10:25370945:A:G
NM_130839.5(UBE3A):c.582A>G (p.Ala194=)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2018)	criteria provided, conflicting interpretations	VCV000500854	15	25616739	15	25371592	500854	492278	rs764101035	NC_000015.10:25371591:T:C
NM_130839.5(UBE3A):c.2135A>G (p.Asn712Ser)	SNHG14|UBE3A	N692S, N295S, N637S, N712S, N653S, N715S, N275S	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Feb 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000500116	15	25599820	15	25354673	500116	491540	rs916720140	NC_000015.10:25354672:T:C
NM_130839.5(UBE3A):c.981A>G (p.Lys327=)	SNHG14|UBE3A		Angelman syndrome	Likely benign(Last reviewed: Jun 20, 2017)	criteria provided, single submitter	VCV000458667	15	25616340	15	25371193	458667	464796	rs1555400511	NC_000015.10:25371192:T:C
NM_130839.5(UBE3A):c.2406_2414del (p.Leu803_Phe805del)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000458666	15	25585316 - 25585324	15	25340169 - 25340177	458666	464802	rs1555380809	NC_000015.10:25340168:AACTGCAAGAA:AA
NC_000015.9:g.(?_25584264)_(25654274_?)dup	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 2, 2020)	criteria provided, single submitter	VCV000458664			15	25339117 - 25409127	458664	464765		
NC_000015.10:g.(?_25339117)_(25409127_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000458663			15	25339117 - 25409127	458663	464761		
NM_130839.5(UBE3A):c.1608+1G>A	SNHG14|UBE3A		not provided	Pathogenic(Last reviewed: Mar 8, 2016)	criteria provided, single submitter	VCV000449699	15	25615712	15	25370565	449699	445275	rs1555399890	NC_000015.10:25370564:C:T
NM_130839.5(UBE3A):c.1504C>T (p.Arg502Ter)	SNHG14|UBE3A	R482*, R502*, R505*, R443*	Angelman syndrome|not provided	Pathogenic(Last reviewed: Jan 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000446052	15	25615817	15	25370670	446052	439324	rs1555399937	NC_000015.10:25370669:G:A
NM_130839.5(UBE3A):c.1009A>T (p.Met337Leu)	SNHG14|UBE3A	M317L, M337L, M340L, M278L	not specified|Angelman syndrome	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000437195	15	25616312	15	25371165	437195	429628	rs368318081	NC_000015.10:25371164:T:A
NM_130839.5(UBE3A):c.1169A>G (p.Asn390Ser)	SNHG14|UBE3A	N370S, N331S, N390S, N393S	not specified|Angelman syndrome	Uncertain significance(Last reviewed: Mar 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437194	15	25616152	15	25371005	437194	429627	rs147446244	NC_000015.10:25371004:T:C
NM_130839.5(UBE3A):c.1754-4A>G	SNHG14|UBE3A		not provided|Angelman syndrome|not specified	Uncertain significance(Last reviewed: Feb 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000437190	15	25602047	15	25356900	437190	429625	rs780429591	NC_000015.10:25356899:T:C
NM_130839.5(UBE3A):c.1577G>A (p.Arg526His)	SNHG14|UBE3A	R506H, R529H, R526H, R467H	Angelman syndrome|Inborn genetic diseases|not provided	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000421257	15	25615744	15	25370597	421257	409190	rs1064795012	NC_000015.10:25370596:C:T
NM_130839.5(UBE3A):c.2125-1G>A	SNHG14|UBE3A		not provided|Angelman syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000421239	15	25599831	15	25354684	421239	409187	rs1064795001	NC_000015.10:25354683:C:T
NM_130839.5(UBE3A):c.1576C>T (p.Arg526Cys)	SNHG14|UBE3A	R506C, R529C, R467C, R526C	not provided|Angelman syndrome	Likely pathogenic(Last reviewed: Mar 25, 2021)	reviewed by expert panel	VCV000418572	15	25615745	15	25370598	418572	409191	rs1064793307	NC_000015.10:25370597:G:A
NC_000015.9:g.(?_25582396)_(25650653_?)dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000417431	15	25582396 - 25650653	15	25337249 - 25405506	417431	400846		
NM_130839.5(UBE3A):c.2535_2551del (p.Leu846fs)	SNHG14|UBE3A	L409fs, L771fs, L774fs, L429fs, L849fs, L826fs, L787fs, L794fs, L846fs	Angelman syndrome	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000408432	15	25584352 - 25584368	15	25339205 - 25339221	408432	400542	rs1064792950	NC_000015.10:25339204:TTGAGTATTCCGGAAGT:
NM_130839.5(UBE3A):c.2124+8A>G	SNHG14|UBE3A		not specified|Angelman syndrome	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386394	15	25601031	15	25355884	386394	376319	rs1057522487	NC_000015.10:25355883:T:C
NM_130839.5(UBE3A):c.141G>A (p.Thr47=)	SNHG14|UBE3A		not specified|not provided|Angelman syndrome	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386168	15	25620832	15	25375685	386168	373346	rs760283316	NC_000015.10:25375684:C:T
NM_130839.5(UBE3A):c.2592G>A (p.Thr864=)	SNHG14|UBE3A		not specified|Angelman syndrome	Benign/Likely benign(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000378845	15	25584311	15	25339164	378845	373970	rs377110924	NC_000015.10:25339163:C:T
NM_130839.5(UBE3A):c.2553_2569del (p.Ser851fs)	SNHG14|UBE3A	S414fs, S434fs, S776fs, S792fs, S831fs, S851fs, S779fs, S799fs, S854fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000375262	15	25584334 - 25584350	15	25339187 - 25339203	375262	361963	rs1057519062	NC_000015.10:25339186:CTTTAAGTTTTTCTTTGCTT:CTT
NM_130839.5(UBE3A):c.457G>A (p.Val153Ile)	SNHG14|UBE3A	V133I, V94I, V153I, V156I	not specified|Angelman syndrome	Uncertain significance(Last reviewed: Jan 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000372667	15	25616864	15	25371717	372667	360214	rs199636913	NC_000015.10:25371716:C:T
NM_130838.1(UBE3A):c.-44_*1888del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000241833	15	25582396 - 25650653	15	25337249 - 25405506	241833	242023		
NM_130839.5(UBE3A):c.1871_1872del (p.Cys624fs)	SNHG14|UBE3A	C187fs, C207fs, C565fs, C604fs, C624fs, C627fs	Inborn genetic diseases|Angelman syndrome	Pathogenic(Last reviewed: Sep 8, 2014)	criteria provided, single submitter	VCV000218320	15	25601925 - 25601926	15	25356778 - 25356779	218320	215013	rs864309508	NC_000015.10:25356777:ACA:A
NM_130839.5(UBE3A):c.1007T>C (p.Met336Thr)	SNHG14|UBE3A	M316T, M339T, M277T, M336T	not specified|Angelman syndrome	Likely pathogenic(Last reviewed: Nov 16, 2016)	criteria provided, single submitter	VCV000217366	15	25616314	15	25371167	217366	196439	rs863225071	NC_000015.10:25371166:A:G
NM_130839.5(UBE3A):c.2563_2568del (p.Leu855_Lys856del)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2019)	criteria provided, conflicting interpretations	VCV000217365	15	25584335 - 25584340	15	25339188 - 25339193	217365	196435	rs863225070	NC_000015.10:25339187:TTTAAGTTT:TTT
NM_130839.5(UBE3A):c.2535_2538del (p.Leu845fs)	SNHG14|UBE3A	L773fs, L770fs, L408fs, L428fs, L825fs, L845fs, L786fs, L793fs, L848fs	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000217026	15	25584365 - 25584368	15	25339218 - 25339221	217026	213632	rs863224940	NC_000015.10:25339217:AAGTAA:AA
NM_130839.5(UBE3A):c.2607dup (p.Gly870fs)	SNHG14|UBE3A	G795fs, G818fs, G870fs, G433fs, G453fs, G798fs, G850fs, G873fs, G811fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212536	15	25584295 - 25584296	15	25339148 - 25339149	212536	208160	rs797046088	NC_000015.10:25339148:AAA:AAAA
NM_130839.5(UBE3A):c.2563_2567dup (p.Lys856fs)	SNHG14|UBE3A	K419fs, K804fs, K781fs, K784fs, K856fs, K859fs, K439fs, K836fs, K797fs	Angelman syndrome	Pathogenic(Last reviewed: Oct 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000212535	15	25584335 - 25584336	15	25339188 - 25339189	212535	208161	rs1555379800	NC_000015.10:25339188:TTAAGTT:TTAAGTTAAGTT
NM_130839.5(UBE3A):c.2562dup (p.Leu855fs)	SNHG14|UBE3A	L418fs, L783fs, L796fs, L835fs, L438fs, L803fs, L855fs, L780fs, L858fs	Angelman syndrome	Pathogenic(Last reviewed: Jul 11, 2014)	criteria provided, single submitter	VCV000212534	15	25584340 - 25584341	15	25339193 - 25339194	212534	208163	rs797046087	NC_000015.10:25339193:TTTTT:TTTTTT
NM_130839.5(UBE3A):c.2523_2566dup (p.Lys856fs)	SNHG14|UBE3A	K781fs, K856fs, K859fs, K419fs, K784fs, K797fs, K836fs, K439fs, K804fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212533	15	25584336 - 25584337	15	25339189 - 25339190	212533	208162	rs587781230	NC_000015.10:25339189:TAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTA:TAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTATAAGTTTTTCTTTGCTTGAGTATTCCGGAAGTAAAAGCACATTA
NM_130839.5(UBE3A):c.2397_2400dup (p.Leu801fs)	SNHG14|UBE3A	L726fs, L742fs, L364fs, L781fs, L384fs, L729fs, L749fs, L804fs, L801fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212532	15	25585329 - 25585330	15	25340182 - 25340183	212532	208164	rs797046086	NC_000015.10:25340182:TCTTT:TCTTTCTTT
NM_130839.5(UBE3A):c.2238dup (p.Phe747fs)	SNHG14|UBE3A	F672fs, F310fs, F330fs, F747fs, F750fs, F688fs, F727fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212531	15	25599716 - 25599717	15	25354569 - 25354570	212531	208165	rs797046085	NC_000015.10:25354569:T:TT
NM_130839.5(UBE3A):c.62+1_62+2insAA	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000212530	15	25650606 - 25650607	15	25405459 - 25405460	212530	208169	rs797046084	NC_000015.10:25405459::TT
NM_130839.5(UBE3A):c.1338T>C (p.Phe446=)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000196572	15	25615983	15	25370836	196572	193733	rs371154816	NC_000015.10:25370835:A:G
NM_130839.5(UBE3A):c.63-14_63-7del	SNHG14|UBE3A		not provided|Angelman syndrome	Uncertain significance(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000195397	15	25620917 - 25620924	15	25375770 - 25375777	195397	192558	rs794727306	NC_000015.10:25375769:CAAACATTCAAACA:CAAACA
NM_130839.5(UBE3A):c.1024C>T (p.Gln342Ter)	SNHG14|UBE3A	Q322*, Q283*, Q345*, Q342*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160228	15	25616297	15	25371150	160228	169100	rs587784534	NC_000015.10:25371149:G:A
NM_130839.5(UBE3A):c.889G>T (p.Glu297Ter)	SNHG14|UBE3A	E277*, E300*, E238*, E297*	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2013)	criteria provided, single submitter	VCV000160227	15	25616432	15	25371285	160227	169101	rs587784533	NC_000015.10:25371284:C:A
NM_130839.5(UBE3A):c.565_571del (p.Glu189fs)	SNHG14|UBE3A	E130fs, E169fs, E189fs, E192fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	VCV000160226	15	25616750 - 25616756	15	25371603 - 25371609	160226	169102	rs587784532	NC_000015.10:25371602:CCTTTTC:
NM_130839.5(UBE3A):c.448_459del (p.Ile150_Val153del)	SNHG14|UBE3A		Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160225	15	25616862 - 25616873	15	25371715 - 25371726	160225	169103	rs587784531	NC_000015.10:25371714:AACTCTTCCAATAAC:AAC
NM_130839.5(UBE3A):c.440del (p.Ile147fs)	SNHG14|UBE3A	I127fs, I147fs, I150fs, I88fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160224	15	25616881	15	25371734	160224	169104	rs587784530	NC_000015.10:25371733:A:
NM_130839.5(UBE3A):c.377_381del (p.Thr126fs)	SNHG14|UBE3A	T129fs, T106fs, T126fs, T67fs	not provided|Angelman syndrome	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160223	15	25616940 - 25616944	15	25371793 - 25371797	160223	169105	rs587784529	NC_000015.10:25371792:TTCTGTT:TT
NM_130839.5(UBE3A):c.2609G>A (p.Gly870Asp)	SNHG14|UBE3A	G850D, G433D, G811D, G818D, G453D, G795D, G798D, G870D, G873D	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jan 15, 2014)	criteria provided, multiple submitters, no conflicts	VCV000160221	15	25584294	15	25339147	160221	169077	rs587784528	NC_000015.10:25339146:C:T
NM_130839.5(UBE3A):c.2567_2570del (p.Lys856fs)	SNHG14|UBE3A	K859fs, K419fs, K439fs, K781fs, K797fs, K784fs, K804fs, K836fs, K856fs	History of neurodevelopmental disorder|not provided|Intellectual disability|Angelman syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160220	15	25584333 - 25584336	15	25339186 - 25339189	160220	169078		NC_000015.10:25339185:TCTTT:T
NM_130839.5(UBE3A):c.2545T>C (p.Tyr849His)	SNHG14|UBE3A	Y829H, Y774H, Y852H, Y432H, Y849H, Y412H, Y777H, Y790H, Y797H	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160219	15	25584358	15	25339211	160219	169079	rs587784526	NC_000015.10:25339210:A:G
NM_130839.5(UBE3A):c.1865A>G (p.Asn622Ser)	SNHG14|UBE3A	N602S, N563S, N625S, N185S, N205S, N622S	Angelman syndrome|Inborn genetic diseases	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2016)	criteria provided, conflicting interpretations	VCV000160214	15	25601932	15	25356785	160214	169084	rs587784521	NC_000015.10:25356784:T:C
NM_130839.5(UBE3A):c.1834_1837del (p.Ile612fs)	SNHG14|UBE3A	I195fs, I612fs, I175fs, I553fs, I615fs, I592fs	Angelman syndrome|not provided	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160213	15	25601960 - 25601963	15	25356813 - 25356816	160213	169085	rs587784520	NC_000015.10:25356812:CAATCA:CA
NM_130839.5(UBE3A):c.1823A>G (p.Gln608Arg)	SNHG14|UBE3A	Q588R, Q608R, Q611R, Q171R, Q191R, Q549R	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160212	15	25601974	15	25356827	160212	169086	rs587782919	NC_000015.10:25356826:T:C
NM_130839.5(UBE3A):c.1786_1790del (p.Phe596fs)	SNHG14|UBE3A	F179fs, F159fs, F596fs, F537fs, F576fs, F599fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160211	15	25602007 - 25602011	15	25356860 - 25356864	160211	169087	rs587784519	NC_000015.10:25356859:CAAAACAA:CAA
NM_130839.5(UBE3A):c.1753+12A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160210	15	25605518	15	25360371	160210	169088	rs368720379	NC_000015.10:25360370:T:C
NM_130839.5(UBE3A):c.1748A>G (p.Asp583Gly)	SNHG14|UBE3A	D563G, D166G, D586G, D524G, D146G, D583G	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160209	15	25605535	15	25360388	160209	169089	rs587784518	NC_000015.10:25360387:T:C
NM_130839.5(UBE3A):c.1742A>G (p.Asn581Ser)	SNHG14|UBE3A	N561S, N144S, N164S, N522S, N581S, N584S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 23, 2013)	criteria provided, single submitter	VCV000160208	15	25605541	15	25360394	160208	169090	rs587784517	NC_000015.10:25360393:T:C
NM_130839.5(UBE3A):c.1694G>A (p.Gly565Glu)	SNHG14|UBE3A	G545E, G128E, G506E, G565E, G568E, G148E	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160207	15	25605589	15	25360442	160207	169091	rs587784516	NC_000015.10:25360441:C:T
NM_130839.5(UBE3A):c.1659T>A (p.Tyr553Ter)	SNHG14|UBE3A	Y533*, Y136*, Y494*, Y553*, Y556*, Y116*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160206	15	25605624	15	25360477	160206	169092	rs587784515	NC_000015.10:25360476:A:T
NM_130839.5(UBE3A):c.1627G>T (p.Glu543Ter)	SNHG14|UBE3A	E523*, E484*, E106*, E543*, E546*, E126*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160205	15	25605656	15	25360509	160205	169093	rs587784514	NC_000015.10:25360508:C:A
NM_130839.5(UBE3A):c.1521_1528del (p.Tyr508fs)	SNHG14|UBE3A	Y508fs, Y449fs, Y511fs, Y488fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160204	15	25615793 - 25615800	15	25370646 - 25370653	160204	169094	rs587784513	NC_000015.10:25370645:AGCTGTAGAG:AG
NM_130839.5(UBE3A):c.1407_1408del (p.Asn470fs)	SNHG14|UBE3A	N411fs, N470fs, N473fs, N450fs	Angelman syndrome	Pathogenic(Last reviewed: Jan 31, 2014)	criteria provided, single submitter	VCV000160203	15	25615913 - 25615914	15	25370766 - 25370767	160203	169095	rs587784512	NC_000015.10:25370765:TCTCT:TCT
NM_130839.5(UBE3A):c.1192A>C (p.Ile398Leu)	SNHG14|UBE3A	I378L, I339L, I401L, I398L	Angelman syndrome	Uncertain significance(Last reviewed: Aug 12, 2013)	criteria provided, single submitter	VCV000160201	15	25616129	15	25370982	160201	169096	rs200380619	NC_000015.10:25370981:T:G
NM_130839.5(UBE3A):c.1176A>T (p.Glu392Asp)	SNHG14|UBE3A	E372D, E392D, E395D, E333D	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000160200	15	25616145	15	25370998	160200	169097	rs587784510	NC_000015.10:25370997:T:A
NM_130839.5(UBE3A):c.1170_1173del (p.Asn390fs)	SNHG14|UBE3A	N331fs, N393fs, N370fs, N390fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160199	15	25616148 - 25616151	15	25371001 - 25371004	160199	169098	rs587784509	NC_000015.10:25371000:TTCATT:TT
NM_130839.5(UBE3A):c.1150G>T (p.Glu384Ter)	SNHG14|UBE3A	E364*, E384*, E325*, E387*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160198	15	25616171	15	25371024	160198	169099	rs587784508	NC_000015.10:25371023:C:A
NM_130839.5(UBE3A):c.2420C>T (p.Thr807Met)	SNHG14|UBE3A	T787M, T807M, T755M, T810M, T370M, T748M, T390M, T735M, T732M	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000156679	15	25585310	15	25340163	156679	166533	rs587783148	NC_000015.10:25340162:G:A
NM_130839.5(UBE3A):c.442C>T (p.Arg148Cys)	SNHG14|UBE3A	R128C, R148C, R89C, R151C	Angelman syndrome	Uncertain significance(Last reviewed: Apr 3, 2016)	criteria provided, single submitter	VCV000156624	15	25616879	15	25371732	156624	166478	rs587783101	NC_000015.10:25371731:G:A
NM_130839.5(UBE3A):c.*46del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156148	15	25584238	15	25339091	156148	165948	rs368425414	NC_000015.10:25339090:TTTTTTTTT:TTTTTTTT
NM_130839.5(UBE3A):c.*3_*7CAAAA[2] (p.Ter873=)	SNHG14|UBE3A		Angelman syndrome|not provided	Likely benign(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000156147	15	25584267 - 25584271	15	25339120 - 25339124	156147	165947	rs587782926	NC_000015.10:25339119:TTTTGTTTTGTTTTGTTTT:TTTTGTTTTGTTTT
NM_130839.5(UBE3A):c.2499-34del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156146	15	25584438	15	25339291	156146	165946	rs564915971	NC_000015.10:25339290:C:
NM_130839.5(UBE3A):c.2124+19T>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156145	15	25601020	15	25355873	156145	165945	rs587782925	NC_000015.10:25355872:A:C
NM_130839.5(UBE3A):c.2096A>C (p.Lys699Thr)	SNHG14|UBE3A	K679T, K699T, K262T, K282T, K640T, K702T	not specified|not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2021)	criteria provided, conflicting interpretations	VCV000156144	15	25601067	15	25355920	156144	165944	rs202161423	NC_000015.10:25355919:T:G
NM_130839.5(UBE3A):c.2091T>C (p.Gly697=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156143	15	25601072	15	25355925	156143	165943	rs587782924	NC_000015.10:25355924:A:G
NM_130839.5(UBE3A):c.915A>G (p.Leu305=)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156142	15	25616406	15	25371259	156142	165942	rs587782923	NC_000015.10:25371258:T:C
NM_130839.5(UBE3A):c.815A>G (p.Asn272Ser)	SNHG14|UBE3A	N252S, N213S, N272S, N275S	Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 18, 2020)	criteria provided, conflicting interpretations	VCV000156141	15	25616506	15	25371359	156141	165941	rs139928148	NC_000015.10:25371358:T:C
NM_130839.5(UBE3A):c.671T>C (p.Leu224Ser)	SNHG14|UBE3A	L204S, L165S, L224S, L227S	Angelman syndrome|not specified	Uncertain significance(Last reviewed: Feb 2, 2015)	criteria provided, single submitter	VCV000156140	15	25616650	15	25371503	156140	165940	rs587782922	NC_000015.10:25371502:A:G
NM_130839.5(UBE3A):c.63-19_63-17del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156139	15	25620927 - 25620929	15	25375780 - 25375782	156139	165939	rs587782921	NC_000015.10:25375779:AACAA:AA
NM_130839.5(UBE3A):c.2078T>G (p.Leu693Arg)	SNHG14|UBE3A	L673R, L276R, L693R, L696R, L256R, L634R	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156138	15	25601085	15	25355938	156138	165938	rs587782920	NC_000015.10:25355937:A:C
NM_130839.5(UBE3A):c.1823A>C (p.Gln608Pro)	SNHG14|UBE3A	Q588P, Q171P, Q549P, Q611P, Q191P, Q608P	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156137	15	25601974	15	25356827	156137	165937	rs587782919	NC_000015.10:25356826:T:G
NM_130839.5(UBE3A):c.1822C>G (p.Gln608Glu)	SNHG14|UBE3A	Q588E, Q608E, Q611E, Q171E, Q191E, Q549E	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156136	15	25601975	15	25356828	156136	165936	rs587782918	NC_000015.10:25356827:G:C
NM_130839.5(UBE3A):c.1753+32G>A	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156135	15	25605498	15	25360351	156135	165935	rs373746667	NC_000015.10:25360350:C:T
NM_130839.5(UBE3A):c.1608+34T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156134	15	25615679	15	25370532	156134	165934	rs587782917	NC_000015.10:25370531:A:G
NM_130839.5(UBE3A):c.1494G>A (p.Met498Ile)	SNHG14|UBE3A	M478I, M498I, M439I, M501I	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156133	15	25615827	15	25370680	156133	165933	rs587782916	NC_000015.10:25370679:C:T
NM_130839.5(UBE3A):c.1064G>C (p.Ser355Thr)	SNHG14|UBE3A	S335T, S358T, S355T, S296T	Angelman syndrome|not specified|History of neurodevelopmental disorder|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000156132	15	25616257	15	25371110	156132	165932	rs141984760	NC_000015.10:25371109:C:G
NM_130839.5(UBE3A):c.361+30G>A	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156130	15	25620582	15	25375435	156130	165930	rs367646993	NC_000015.10:25375434:C:T
NM_130839.5(UBE3A):c.361+29T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156129	15	25620583	15	25375436	156129	165929	rs587782914	NC_000015.10:25375435:A:G
NM_130839.5(UBE3A):c.2499-40C>T	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156128	15	25584444	15	25339297	156128	165928	rs373042168	NC_000015.10:25339296:G:A
NM_130839.5(UBE3A):c.2499-37dup	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156127	15	25584440 - 25584441	15	25339293 - 25339294	156127	165927	rs587782913	NC_000015.10:25339293:T:TT
NM_130839.5(UBE3A):c.2499-31T>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156126	15	25584435	15	25339288	156126	165926	rs587782912	NC_000015.10:25339287:A:C
NM_130839.5(UBE3A):c.2354+20A>G	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156125	15	25599480	15	25354333	156125	165925	rs587782911	NC_000015.10:25354332:T:C
NM_130839.5(UBE3A):c.2344G>A (p.Val782Ile)	SNHG14|UBE3A	V762I, V782I, V365I, V723I, V707I, V730I, V785I, V345I, V710I	Angelman syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 25, 2016)	criteria provided, conflicting interpretations	VCV000156124	15	25599510	15	25354363	156124	165924	rs587782910	NC_000015.10:25354362:C:T
NM_130839.5(UBE3A):c.2281-42T>C	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156123	15	25599615	15	25354468	156123	165923	rs543571933	NC_000015.10:25354467:A:G
NM_130839.5(UBE3A):c.1686TGA[1] (p.Asp563del)	SNHG14|UBE3A	D543del, D126del, D146del, D563del, D504del, D566del	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156122	15	25605592 - 25605594	15	25360445 - 25360447	156122	165922	rs587782909	NC_000015.10:25360444:TCATCA:TCA
NM_130839.5(UBE3A):c.869A>C (p.Asn290Thr)	SNHG14|UBE3A	N270T, N231T, N290T, N293T	Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156121	15	25616452	15	25371305	156121	165921	rs587782908	NC_000015.10:25371304:T:G
NM_130839.5(UBE3A):c.409T>C (p.Cys137Arg)	SNHG14|UBE3A	C117R, C137R, C140R, C78R	not provided|Angelman syndrome	Likely pathogenic(Last reviewed: May 17, 2016)	criteria provided, single submitter	VCV000156120	15	25616912	15	25371765	156120	165920	rs587782907	NC_000015.10:25371764:A:G
NM_130839.5(UBE3A):c.62+20G>A	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156119	15	25650588	15	25405441	156119	165919	rs587782906	NC_000015.10:25405440:C:T
NM_130839.5(UBE3A):c.1757T>A (p.Met586Lys)	SNHG14|UBE3A	M566K, M527K, M589K, M169K, M149K, M586K	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155998	15	25602040	15	25356893	155998	165802	rs587781244	NC_000015.10:25356892:A:T
NM_130839.5(UBE3A):c.1490G>C (p.Arg497Pro)	SNHG14|UBE3A	R477P, R497P, R500P, R438P	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155997	15	25615831	15	25370684	155997	165801	rs587781243	NC_000015.10:25370683:C:G
NM_130839.5(UBE3A):c.1364T>C (p.Leu455Pro)	SNHG14|UBE3A	L435P, L396P, L455P, L458P	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155996	15	25615957	15	25370810	155996	165800	rs587781242	NC_000015.10:25370809:A:G
NM_130839.5(UBE3A):c.770T>A (p.Leu257His)	SNHG14|UBE3A	L237H, L257H, L198H, L260H	Angelman syndrome	Likely pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155995	15	25616551	15	25371404	155995	165799	rs587780582	NC_000015.10:25371403:A:T
NM_130839.5(UBE3A):c.2547_2567dup (p.Lys856_Glu857insAsnSerSerLysGluLysLeu)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155993	15	25584335 - 25584336	15	25339188 - 25339189	155993	165797	rs587781240	NC_000015.10:25339188:TTAAGTTTTTCTTTGCTTGAGT:TTAAGTTTTTCTTTGCTTGAGTTAAGTTTTTCTTTGCTTGAGT
NM_130839.5(UBE3A):c.2540C>T (p.Pro847Leu)	SNHG14|UBE3A	P827L, P430L, P772L, P410L, P847L, P850L, P775L, P788L, P795L	Angelman syndrome	Likely pathogenic(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000155992	15	25584363	15	25339216	155992	165796	rs587781239	NC_000015.10:25339215:G:A
NM_130839.5(UBE3A):c.2129T>G (p.Phe710Cys)	SNHG14|UBE3A	F690C, F273C, F293C, F635C, F651C, F710C, F713C	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155990	15	25599826	15	25354679	155990	165794	rs587781237	NC_000015.10:25354678:A:C
NM_130839.5(UBE3A):c.2027C>T (p.Thr676Ile)	SNHG14|UBE3A	T656I, T259I, T239I, T676I, T617I, T679I	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155989	15	25601136	15	25355989	155989	165793	rs587781236	NC_000015.10:25355988:G:A
NM_130839.5(UBE3A):c.1810G>C (p.Glu604Gln)	SNHG14|UBE3A	E584Q, E604Q, E167Q, E545Q, E187Q, E607Q	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155988	15	25601987	15	25356840	155988	165792	rs587781235	NC_000015.10:25356839:C:G
NM_130839.5(UBE3A):c.1693G>A (p.Gly565Arg)	SNHG14|UBE3A	G545R, G506R, G128R, G148R, G565R, G568R	Inborn genetic diseases|Angelman syndrome	Likely pathogenic(Last reviewed: May 26, 2016)	criteria provided, single submitter	VCV000155986	15	25605590	15	25360443	155986	165790	rs587781233	NC_000015.10:25360442:C:T
NM_130839.5(UBE3A):c.2616_*6del (p.Ter873GlnextTer?)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000155985	15	25584278 - 25584287	15	25339131 - 25339140	155985	165789	rs587781232	NC_000015.10:25339130:TTTGTTTTAC:
NM_130839.5(UBE3A):c.2567_2568del (p.Lys856fs)	SNHG14|UBE3A	K439fs, K797fs, K784fs, K804fs, K836fs, K856fs, K419fs, K781fs, K859fs	Angelman syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000155984	15	25584335 - 25584336	15	25339188 - 25339189	155984	165788	rs587781231	NC_000015.10:25339187:TTT:T
NM_130839.5(UBE3A):c.2563_2566dup (p.Lys856delinsThrTer)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155983	15	25584336 - 25584337	15	25339189 - 25339190	155983	165787	rs398124440	NC_000015.10:25339189:TAAGT:TAAGTAAGT
NM_130839.5(UBE3A):c.2557_2560dup (p.Lys854fs)	SNHG14|UBE3A	K437fs, K779fs, K854fs, K795fs, K834fs, K857fs, K417fs, K782fs, K802fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155982	15	25584342 - 25584343	15	25339195 - 25339196	155982	165786	rs587781229	NC_000015.10:25339195:TTTCTTT:TTTCTTTCTTT
NM_130839.5(UBE3A):c.2549C>G (p.Ser850Ter)	SNHG14|UBE3A	S830*, S778*, S413*, S775*, S791*, S433*, S850*, S798*, S853*	Angelman syndrome	Pathogenic(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000155981	15	25584354	15	25339207	155981	165785	rs587781228	NC_000015.10:25339206:G:C
NM_130839.5(UBE3A):c.2547_2614del (p.Ser850fs)	SNHG14|UBE3A	S775fs, S778fs, S830fs, S850fs, S413fs, S433fs, S791fs, S853fs, S798fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155980	15	25584289 - 25584356	15	25339142 - 25339209	155980	165784	rs1555379684	
NM_130839.5(UBE3A):c.2538del (p.Pro847fs)	SNHG14|UBE3A	P772fs, P795fs, P847fs, P410fs, P775fs, P827fs, P788fs, P850fs, P430fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155979	15	25584365	15	25339218	155979	165783	rs587781227	NC_000015.10:25339217:AA:A
NM_130839.5(UBE3A):c.2534T>A (p.Leu845Ter)	SNHG14|UBE3A	L825*, L845*, L770*, L428*, L773*, L848*, L408*, L786*, L793*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155978	15	25584369	15	25339222	155978	165782	rs587781226	NC_000015.10:25339221:A:T
NM_130839.5(UBE3A):c.2523_2581dup (p.Lys861delinsIleMetCysPheTyrPheArgAsnThrGlnAlaLysLysAsnLeuLysArgAspCysTer)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155977	15	25584321 - 25584322	15	25339174 - 25339175	155977	165781	rs1555379745	
NM_130839.5(UBE3A):c.2430_2433del (p.Asp810fs)	SNHG14|UBE3A	D735fs, D751fs, D813fs, D393fs, D758fs, D790fs, D738fs, D810fs, D373fs	not provided|Angelman syndrome	Pathogenic(Last reviewed: Apr 1, 2019)	criteria provided, single submitter	VCV000155976	15	25585297 - 25585300	15	25340150 - 25340153	155976	165780	rs587781225	NC_000015.10:25340149:TCTGTCTGT:TCTGT
NM_130839.5(UBE3A):c.2404_2405del (p.Phe802fs)	SNHG14|UBE3A	F730fs, F750fs, F805fs, F385fs, F727fs, F743fs, F365fs, F782fs, F802fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155975	15	25585325 - 25585326	15	25340178 - 25340179	155975	165779	rs587781224	NC_000015.10:25340177:AA:
NM_130839.5(UBE3A):c.2349dup (p.Ile784fs)	SNHG14|UBE3A	I347fs, I709fs, I725fs, I764fs, I732fs, I787fs, I367fs, I712fs, I784fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155974	15	25599504 - 25599505	15	25354357 - 25354358	155974	165778	rs587781223	NC_000015.10:25354357:C:CC
NM_130839.5(UBE3A):c.2307_2311dup (p.Thr771fs)	SNHG14|UBE3A	T719fs, T771fs, T334fs, T354fs, T696fs, T699fs, T712fs, T751fs, T774fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155973	15	25599542 - 25599543	15	25354395 - 25354396	155973	165777	rs587781222	NC_000015.10:25354395:TAGTTT:TAGTTTAGTTT
NM_130839.5(UBE3A):c.2305del (p.Glu769fs)	SNHG14|UBE3A	E332fs, E769fs, E352fs, E697fs, E710fs, E717fs, E694fs, E749fs, E772fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155972	15	25599549	15	25354402	155972	165776	rs587781221	NC_000015.10:25354401:C:
NM_130839.5(UBE3A):c.2293C>T (p.Gln765Ter)	SNHG14|UBE3A	Q745*, Q693*, Q328*, Q690*, Q765*, Q768*, Q348*, Q706*, Q713*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155970	15	25599561	15	25354414	155970	165774	rs587781219	NC_000015.10:25354413:G:A
NM_130839.5(UBE3A):c.2246del (p.Pro749fs)	SNHG14|UBE3A	P674fs, P729fs, P752fs, P690fs, P312fs, P332fs, P749fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155969	15	25599709	15	25354562	155969	165773	rs587781218	NC_000015.10:25354561:GG:G
NM_130839.5(UBE3A):c.2237T>A (p.Leu746Ter)	SNHG14|UBE3A	L726*, L329*, L671*, L749*, L309*, L687*, L746*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155968	15	25599718	15	25354571	155968	165772	rs587781217	NC_000015.10:25354570:A:T
NM_130839.5(UBE3A):c.2230_2234dup (p.Tyr745Ter)	SNHG14|UBE3A	Y328*, Y725*, Y745*, Y748*, Y308*, Y670*, Y686*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155967	15	25599720 - 25599721	15	25354573 - 25354574	155967	165771	rs587781216	NC_000015.10:25354573:TACTTTA:TACTTTACTTTA
NM_130839.5(UBE3A):c.2162_2163insTATT (p.Lys721fs)	SNHG14|UBE3A	K304fs, K721fs, K284fs, K646fs, K724fs, K662fs, K701fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155966	15	25599792 - 25599793	15	25354645 - 25354646	155966	165770	rs587781215	NC_000015.10:25354645::AATA
NM_130839.5(UBE3A):c.2032del (p.Gln678fs)	SNHG14|UBE3A	Q678fs, Q681fs, Q658fs, Q241fs, Q261fs, Q619fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155965	15	25601131	15	25355984	155965	165769	rs587781214	NC_000015.10:25355983:GG:G
NM_130839.5(UBE3A):c.2032C>T (p.Gln678Ter)	SNHG14|UBE3A	Q658*, Q678*, Q681*, Q619*, Q241*, Q261*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155964	15	25601131	15	25355984	155964	165768	rs587781213	NC_000015.10:25355983:G:A
NM_130839.5(UBE3A):c.2017dup (p.Met673fs)	SNHG14|UBE3A	M673fs, M676fs, M614fs, M236fs, M256fs, M653fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155963	15	25601145 - 25601146	15	25355998 - 25355999	155963	165767	rs587781212	NC_000015.10:25355998:T:TT
NM_130839.5(UBE3A):c.2016_2023del (p.Met673fs)	SNHG14|UBE3A	M653fs, M256fs, M614fs, M673fs, M236fs, M676fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155962	15	25601140 - 25601147	15	25355993 - 25356000	155962	165766	rs587781211	NC_000015.10:25355992:TCATCATGTCATC:TCATC
NM_130839.5(UBE3A):c.1972_1973del (p.Ser658fs)	SNHG14|UBE3A	S221fs, S599fs, S661fs, S638fs, S658fs, S241fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155961	15	25601190 - 25601191	15	25356043 - 25356044	155961	165765	rs587781210	NC_000015.10:25356042:CTCT:CT
NM_130839.5(UBE3A):c.1874_1884del (p.Ile625fs)	SNHG14|UBE3A	I625fs, I566fs, I605fs, I188fs, I208fs, I628fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155960	15	25601913 - 25601923	15	25356766 - 25356776	155960	165764	rs587781209	NC_000015.10:25356765:TACATCCAGTATACA:TACA
NM_130839.5(UBE3A):c.1699_1702dup (p.Ser568fs)	SNHG14|UBE3A	S571fs, S509fs, S151fs, S548fs, S131fs, S568fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155958	15	25605580 - 25605581	15	25360433 - 25360434	155958	165762	rs587781207	NC_000015.10:25360433:AAACA:AAACAAACA
NM_130839.5(UBE3A):c.1668dup (p.Glu557Ter)	SNHG14|UBE3A	E537*, E557*, E560*, E498*, E120*, E140*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155957	15	25605614 - 25605615	15	25360467 - 25360468	155957	165761	rs587781206	NC_000015.10:25360467:AAA:AAAA
NM_130839.5(UBE3A):c.1631dup (p.Asn544fs)	SNHG14|UBE3A	N107fs, N485fs, N127fs, N544fs, N547fs, N524fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155956	15	25605651 - 25605652	15	25360504 - 25360505	155956	165760	rs587781205	NC_000015.10:25360504:TTTT:TTTTT
NM_130839.5(UBE3A):c.1597dup (p.Ala533fs)	SNHG14|UBE3A	A474fs, A533fs, A536fs, A513fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 10, 2014)	criteria provided, single submitter	VCV000155955	15	25615723 - 25615724	15	25370576 - 25370577	155955	165759	rs587781204	NC_000015.10:25370576:C:CC
NM_130839.5(UBE3A):c.1565_1566del (p.Leu522fs)	SNHG14|UBE3A	L463fs, L502fs, L522fs, L525fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155954	15	25615755 - 25615756	15	25370608 - 25370609	155954	165758	rs587781203	NC_000015.10:25370607:GAG:G
NM_130839.5(UBE3A):c.1447del (p.Ala483fs)	SNHG14|UBE3A	A424fs, A463fs, A483fs, A486fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155953	15	25615874	15	25370727	155953	165757	rs587781202	NC_000015.10:25370726:C:
NM_130839.5(UBE3A):c.1431T>A (p.Cys477Ter)	SNHG14|UBE3A	C457*, C477*, C480*, C418*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155952	15	25615890	15	25370743	155952	165756	rs587781201	NC_000015.10:25370742:A:T
NM_130839.5(UBE3A):c.1421_1422del (p.Phe474fs)	SNHG14|UBE3A	F415fs, F454fs, F474fs, F477fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155951	15	25615899 - 25615900	15	25370752 - 25370753	155951	165755	rs587781200	NC_000015.10:25370751:AAAA:AA
NM_130839.5(UBE3A):c.1415dup (p.Ser473fs)	SNHG14|UBE3A	S414fs, S473fs, S476fs, S453fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155950	15	25615905 - 25615906	15	25370758 - 25370759	155950	165754	rs587781199	NC_000015.10:25370758:AA:AAA
NM_130839.5(UBE3A):c.1345G>T (p.Glu449Ter)	SNHG14|UBE3A	E429*, E390*, E449*, E452*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155949	15	25615976	15	25370829	155949	165753	rs587781198	NC_000015.10:25370828:C:A
NM_130839.5(UBE3A):c.1330G>T (p.Glu444Ter)	SNHG14|UBE3A	E424*, E447*, E385*, E444*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155948	15	25615991	15	25370844	155948	165752	rs587781197	NC_000015.10:25370843:C:A
NM_130839.5(UBE3A):c.1261C>T (p.Arg421Ter)	SNHG14|UBE3A	R401*, R362*, R421*, R424*	Inborn genetic diseases|Angelman syndrome	Pathogenic(Last reviewed: Oct 26, 2016)	criteria provided, single submitter	VCV000155947	15	25616060	15	25370913	155947	165751	rs587781196	NC_000015.10:25370912:G:A
NM_130839.5(UBE3A):c.1174G>T (p.Glu392Ter)	SNHG14|UBE3A	E372*, E333*, E395*, E392*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155946	15	25616147	15	25371000	155946	165750	rs587781195	NC_000015.10:25370999:C:A
NM_130839.5(UBE3A):c.1136dup (p.Asn379fs)	SNHG14|UBE3A	N359fs, N379fs, N320fs, N382fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155945	15	25616184 - 25616185	15	25371037 - 25371038	155945	165749	rs587781194	NC_000015.10:25371037:TTT:TTTT
NM_130839.5(UBE3A):c.1127dup (p.Tyr376Ter)	SNHG14|UBE3A	Y317*, Y356*, Y376*, Y379*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155944	15	25616193 - 25616194	15	25371046 - 25371047	155944	165748	rs587781193	NC_000015.10:25371046:T:TT
NM_130839.5(UBE3A):c.1032_1038del (p.Thr345fs)	SNHG14|UBE3A	T286fs, T325fs, T345fs, T348fs	Inborn genetic diseases|Angelman syndrome	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000155943	15	25616283 - 25616289	15	25371136 - 25371142	155943	165747	rs587781192	NC_000015.10:25371135:ATAAGTAATAAGT:ATAAGT
NM_130839.5(UBE3A):c.1021C>T (p.Gln341Ter)	SNHG14|UBE3A	Q321*, Q282*, Q341*, Q344*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155942	15	25616300	15	25371153	155942	165746	rs587781191	NC_000015.10:25371152:G:A
NM_130839.5(UBE3A):c.810T>A (p.Tyr270Ter)	SNHG14|UBE3A	Y250*, Y211*, Y270*, Y273*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155941	15	25616511	15	25371364	155941	165745	rs587781190	NC_000015.10:25371363:A:T
NM_130839.5(UBE3A):c.2415T>C (p.Phe805=)	SNHG14|UBE3A		not provided|Angelman syndrome	Likely benign(Last reviewed: May 3, 2021)	criteria provided, multiple submitters, no conflicts	VCV000137887	15	25585315	15	25340168	137887	141590	rs587780991	NC_000015.10:25340167:A:G
NM_130839.5(UBE3A):c.1767C>T (p.Tyr589=)	SNHG14|UBE3A		History of neurodevelopmental disorder|Angelman syndrome|not provided|not specified	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137886	15	25602030	15	25356883	137886	141589	rs139082033	NC_000015.10:25356882:G:A
NM_130839.5(UBE3A):c.1404A>G (p.Thr468=)	SNHG14|UBE3A		History of neurodevelopmental disorder|Angelman syndrome|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000137885	15	25615917	15	25370770	137885	141588	rs150331504	NC_000015.10:25370769:T:C
NM_130839.5(UBE3A):c.1185A>G (p.Glu395=)	SNHG14|UBE3A		Angelman syndrome|History of neurodevelopmental disorder|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137884	15	25616136	15	25370989	137884	141587	rs114056442	NC_000015.10:25370988:T:C
NM_130839.5(UBE3A):c.1179T>C (p.Asp393=)	SNHG14|UBE3A		Angelman syndrome|not specified|not provided	Likely benign(Last reviewed: Apr 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000137883	15	25616142	15	25370995	137883	141586	rs143000400	NC_000015.10:25370994:A:G
NM_130839.5(UBE3A):c.618A>T (p.Ala206=)	SNHG14|UBE3A		Angelman syndrome|not provided|not specified	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137882	15	25616703	15	25371556	137882	141585	rs143484751	NC_000015.10:25371555:T:A
NM_130839.5(UBE3A):c.1425_1439del (p.Met475_Phe479del)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136208	15	25615882 - 25615896	15	25370735 - 25370749	136208	139912	rs587780585	NC_000015.10:25370734:ATAAAGGGACATGTCATAAA:ATAAA
NM_130839.5(UBE3A):c.1433C>T (p.Pro478Leu)	SNHG14|UBE3A	P458L, P419L, P481L, P478L	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136207	15	25615888	15	25370741	136207	139911	rs587780584	NC_000015.10:25370740:G:A
NM_130839.5(UBE3A):c.848T>G (p.Leu283Trp)	SNHG14|UBE3A	L263W, L283W, L224W, L286W	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136206	15	25616473	15	25371326	136206	139910	rs587780583	NC_000015.10:25371325:A:C
NM_130839.5(UBE3A):c.770T>C (p.Leu257Pro)	SNHG14|UBE3A	L237P, L198P, L257P, L260P	Angelman syndrome	Pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV000136205	15	25616551	15	25371404	136205	139909	rs587780582	NC_000015.10:25371403:A:G
NM_130839.5(UBE3A):c.695A>T (p.Asp232Val)	SNHG14|UBE3A	D212V, D235V, D173V, D232V	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136204	15	25616626	15	25371479	136204	139908	rs587780581	NC_000015.10:25371478:T:A
NM_130839.5(UBE3A):c.2618A>T (p.Ter873Leu)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136203	15	25584285	15	25339138	136203	139907	rs76794400	NC_000015.10:25339137:T:A
NM_130839.5(UBE3A):c.2125-2A>C	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136202	15	25599832	15	25354685	136202	139906	rs587780580	NC_000015.10:25354684:T:G
NM_130839.5(UBE3A):c.1754-2A>G	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136201	15	25602045	15	25356898	136201	139905	rs587780579	NC_000015.10:25356897:T:C
NM_130839.5(UBE3A):c.362-2A>T	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136200	15	25616961	15	25371814	136200	139904	rs587780578	NC_000015.10:25371813:T:A
NM_130839.5(UBE3A):c.777T>A (p.Tyr259Ter)	SNHG14|UBE3A	Y239*, Y200*, Y259*, Y262*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136198	15	25616544	15	25371397	136198	139902	rs587780576	NC_000015.10:25371396:A:T
NM_130839.5(UBE3A):c.748G>T (p.Glu250Ter)	SNHG14|UBE3A	E230*, E191*, E250*, E253*	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136197	15	25616573	15	25371426	136197	139901	rs587780575	NC_000015.10:25371425:C:A
NM_130839.5(UBE3A):c.640dup (p.Ser214fs)	SNHG14|UBE3A	S194fs, S217fs, S155fs, S214fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136196	15	25616680 - 25616681	15	25371533 - 25371534	136196	139900	rs587780574	NC_000015.10:25371533:T:TT
NM_130839.5(UBE3A):c.607del (p.Asp203fs)	SNHG14|UBE3A	D144fs, D203fs, D183fs, D206fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136195	15	25616714	15	25371567	136195	139899	rs587780573	NC_000015.10:25371566:C:
NM_130839.5(UBE3A):c.463dup (p.Ser155fs)	SNHG14|UBE3A	S155fs, S135fs, S158fs, S96fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136194	15	25616857 - 25616858	15	25371710 - 25371711	136194	139898	rs587780572	NC_000015.10:25371710:AAAAAA:AAAAAAA
NM_130839.5(UBE3A):c.422_423del (p.Glu141fs)	SNHG14|UBE3A	E82fs, E144fs, E121fs, E141fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136193	15	25616898 - 25616899	15	25371751 - 25371752	136193	139897	rs587780571	NC_000015.10:25371750:CTCTCT:CTCT
NM_130839.5(UBE3A):c.372_375del (p.Thr123_Tyr124insTer)	SNHG14|UBE3A		Angelman syndrome|not provided	Pathogenic(Last reviewed: Feb 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000136192	15	25616946 - 25616949	15	25371799 - 25371802	136192	139896	rs587780570	NC_000015.10:25371798:TAAGTAAGT:TAAGT
NM_130839.5(UBE3A):c.337_340del (p.Lys113fs)	SNHG14|UBE3A	K93fs, K113fs, K116fs, K54fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136191	15	25620633 - 25620636	15	25375486 - 25375489	136191	139895	rs587780569	NC_000015.10:25375485:CTTTCTT:CTT
NM_130839.5(UBE3A):c.335dup (p.Lys113fs)	SNHG14|UBE3A	K54fs, K116fs, K93fs, K113fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136190	15	25620637 - 25620638	15	25375490 - 25375491	136190	139894	rs587780568	NC_000015.10:25375490:TT:TTT
NM_130839.5(UBE3A):c.323_324del (p.Ile108fs)	SNHG14|UBE3A	I49fs, I88fs, I111fs, I108fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136189	15	25620649 - 25620650	15	25375502 - 25375503	136189	139893	rs587780567	NC_000015.10:25375501:TAT:T
NM_130839.5(UBE3A):c.259_262dup (p.Gly88fs)	SNHG14|UBE3A	G68fs, G88fs, G91fs, G29fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136188	15	25620710 - 25620711	15	25375563 - 25375564	136188	139892	rs587780566	NC_000015.10:25375563:CTTTCTT:CTTTCTTTCTT
NM_130839.5(UBE3A):c.159del (p.Cys54fs)	SNHG14|UBE3A	C34fs, C54fs, C57fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136187	15	25620814	15	25375667	136187	139891	rs587780565	NC_000015.10:25375666:GG:G
NM_130839.5(UBE3A):c.592G>A (p.Ala198Thr)	SNHG14|UBE3A	A178T, A198T, A201T, A139T	History of neurodevelopmental disorder|Angelman syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096265	15	25616729	15	25371582	96265	102159	rs147145506	NC_000015.10:25371581:C:T
NM_130839.5(UBE3A):c.477A>T (p.Ala159=)	SNHG14|UBE3A		History of neurodevelopmental disorder|not specified|Angelman syndrome	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096264	15	25616844	15	25371697	96264	102158	rs28528079	NC_000015.10:25371696:T:A
NM_130839.5(UBE3A):c.373T>C (p.Leu125=)	SNHG14|UBE3A		not specified|Angelman syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096263	15	25616948	15	25371801	96263	102157	rs61734190	NC_000015.10:25371800:A:G
NM_130839.5(UBE3A):c.2618A>G (p.Ter873=)	SNHG14|UBE3A		History of neurodevelopmental disorder|not provided|not specified|Angelman syndrome	Benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096262	15	25584285	15	25339138	96262	102156	rs76794400	NC_000015.10:25339137:T:C
NM_130839.5(UBE3A):c.2124+9T>C	SNHG14|UBE3A		not provided|not specified|Angelman syndrome	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000096260	15	25601030	15	25355883	96260	102154	rs79328837	NC_000015.10:25355882:A:G
NM_130839.5(UBE3A):c.1933T>C (p.Phe645Leu)	SNHG14|UBE3A	F625L, F208L, F586L, F228L, F645L, F648L	Angelman syndrome|not provided	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096259	15	25601864	15	25356717	96259	102153	rs398124439	NC_000015.10:25356716:A:G
NM_130839.5(UBE3A):c.1773A>G (p.Glu591=)	SNHG14|UBE3A		Angelman syndrome|not specified|not provided|History of neurodevelopmental disorder	Benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096258	15	25602024	15	25356877	96258	102152	rs34670662	NC_000015.10:25356876:T:C
NM_130839.5(UBE3A):c.1269C>T (p.Asp423=)	SNHG14|UBE3A		not provided|History of neurodevelopmental disorder|not specified|Angelman syndrome	Benign/Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096256	15	25616052	15	25370905	96256	102150	rs149506027	NC_000015.10:25370904:G:A
NM_130839.5(UBE3A):c.449T>C (p.Ile150Thr)	SNHG14|UBE3A	I130T, I91T, I150T, I153T	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007969	15	25616872	15	25371725	7969	23008	rs111033597	NC_000015.10:25371724:A:G
NM_130839.5(UBE3A):c.376A>C (p.Thr126Pro)	SNHG14|UBE3A	T106P, T67P, T126P, T129P	Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007968	15	25616945	15	25371798	7968	23007	rs111033596	NC_000015.10:25371797:T:G
NM_130839.5(UBE3A):c.1309C>T (p.Arg437Ter)	SNHG14|UBE3A	R417*, R440*, R378*, R437*	Angelman syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000007966	15	25616012	15	25370865	7966	23005		NC_000015.10:25370864:G:A
GRCh38/hg38 15q11.2-13.1(chr15:23462305-28275167)x1	SNORD109B|SNORD116-3|SNORD116-4|SNORD116-18|SNORD116-20|SNORD115-42|SNORD115-43|SNORD115-17|SNORD115-18|SNORD115-19|SNORD116-21|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-33|SNORD115-34|SNORD115-11|SNORD115-12|HERC2|SNORD107|SNORD115-7|SNORD115-8|SNORD115-31|SNORD115-32|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-35|SNORD115-36|LOC112272578|LOC112272579|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|LOC112272580|SNORD108|SNORD116-8|SNORD116-9|SNORD116-5|SNORD116-6|SNORD109A|PWRN1|SNORD116-17|SNORD116-7|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-22|SNORD116-23|SNORD116-24|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115@|SNORD116@|PWARSN|LINC00929|PWAR4|SNORD115-1|SNORD64|SNORD115-9|SNORD115-10|SNORD115-29|SNORD115-30|SNORD115-44|SNORD116-28|PWRN4|LINC02250|ATP10A-DT|GABRG3-AS1|SNHG14|SNORD116-30|SNORD115-46|PWRN3|TRE-TTC2-2|PWAR6|SNORD115-45|SNORD115-47|LINC02346|MIR4508|MIR4715|PWRN2|SNORD116-1|SNORD116-2|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|NPAP1|MAGEL2|ATP10A|SNORD116-19|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|PWAR1|GABRA5		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, multiple submitters, no conflicts	VCV000160798	15	23707452 - 28520313	15	23462305 - 28275167	160798	170642		
GRCh37/hg19 15q11.2-14(chr15:22770421-36861479)x1	SNORD115-1|RYR3|NSMCE3|APBA2|GREM1|PWARSN|GABRG3|MIR211|GOLGA8A|EMC7|MTMR10|GABRA5|NIPA2|FAN1|PWAR5|PWAR1|TJP1|ACTC1|NUTM1|NPAP1|GJD2|CHRM5|GOLGA6L2|PWRN2|SLC12A6|TUBGCP5|TRPM1|KATNBL1|GOLGA8J|MAGEL2|HERC2|DPH6|CYFIP1|FAM189A1|PWRN1|PWAR6|AQR|NIPA1|GOLGA8B|MKRN3|GABRB3|GOLGA8O|PWAR4|SNRPN|GOLGA8M|CHRFAM7A|ARHGAP11B|SNORD116-1|OTUD7A|EMC4|KLF13|SCG5|NOP10|CHRNA7|SNURF|NDN|ZNF770|GOLGA8N|IPW|ATP10A|LPCAT4|PGBD4|ARHGAP11A|UBE3A|AVEN|OCA2|GOLGA8H		not provided	Pathogenic(Last reviewed: Aug 9, 2018)	no assertion criteria provided	VCV000815687	15	22770421 - 36861479			815687	803896		
NC_000015.10:g.(?_24566038)_(25781223_?)del	SNORD115-10|SNORD115-11|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-19|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-2|SNORD115-20|SNORD115-12|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|ATP10A|IPW|LINC02250|LOC112272578|LOC112272579|NPAP1|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000584203	15	24811185 - 26026370	15	24566038 - 25781223	584203	568553		
GRCh38/hg38 15q11.2-13.1(chr15:23411789-28280314)x3	SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A|ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32		See cases	Pathogenic(Last reviewed: Oct 1, 2010)	no assertion criteria provided	VCV000147585	15	23656936 - 28525460	15	23411789 - 28280314	147585	157336		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A|ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|NPAP1|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37		See cases	Pathogenic(Last reviewed: May 30, 2010)	no assertion criteria provided	VCV000144613	15	22652047 - 28705151	15	22358243 - 28481444	144613	154364		
GRCh38/hg38 15q11.2-13.1(chr15:23422864-28280314)x1	SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A|ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MAGEL2|MIR4508|MIR4715|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6		See cases	Pathogenic(Last reviewed: Sep 26, 2012)	no assertion criteria provided	VCV000148320	15	23668011 - 28525460	15	23422864 - 28280314	148320	158071		
GRCh38/hg38 15q11.2-13.1(chr15:23319714-30073921)x4	SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TJP1|TRE-TTC2-2|UBE3A|APBA2|ATP10A|ATP10A-DT|FAM189A1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L2|GOLGA6L7|GOLGA8F|GOLGA8G|GOLGA8M|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC100130111|LOC100132202|LOC102723623|LOC112272578|LOC112272579|LOC112272580|LOC112272581|LOC645202|MAGEL2|MIR4508|MIR4509-2|MIR4509-3|MIR4715|MKRN3|NDN|NPAP1|NSMCE3|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000146449	15	22698522 - 30366124	15	23319714 - 30073921	146449	156200		
GRCh38/hg38 15q11.1-13.1(chr15:19879750-27865713)x3	SNORD116-30|SNORD115-46|POTEB|LOC101927079|PWRN3|GABRG3-AS1|LOC102723623|POTEB3|LOC102724971|MIR5701-3|SNHG14|OR4N4C|PWRN4|LINC02250|ATP10A-DT|FAM30B|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|SNORD107|TUBGCP5|NIPA1|PWAR1|LOC283683|GOLGA6L2|OR4N4|GOLGA6L1|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC01193|OR4M2|GOLGA6L22|LINC00929|GOLGA8S|FAM30C|SNORD115@|SNORD116@|SNORD116-19|GOLGA6L6|LINC02203|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|POTEB2|MIR1268A|MIR3118-3|MIR3118-4|MIR3118-2|PWAR6|MIR4509-1|MIR4508|MIR4715|MIR5701-2|MIR5701-1		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000058536	15	20085003 - 28178425	15	19879750 - 27865713	58536	73131		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x3	SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A|ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|NPAP1|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6		See cases	Pathogenic(Last reviewed: Feb 13, 2013)	no assertion criteria provided	VCV000152290	15	22765628 - 29096442	15	22358243 - 28481444	152290	162041		
GRCh37/hg19 15q11.2-13.2(chr15:22770421-30386553)x4	SNRPN|TJP1|UBE3A|MKRN3|SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA8J|GOLGA8M|PWRN1|PWRN2|SNORD116-1|HERC2|NSMCE3|ATP10A|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWAR6|PWAR5|APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2		not provided	Pathogenic(Last reviewed: Aug 30, 2018)	no assertion criteria provided	VCV000815685	15	22770421 - 30386553			815685	803894		
GRCh37/hg19 15q11.1-13.2(chr15:20190548-30300265)	SNURF|CYFIP1|FAM189A1|NPAP1|MAGEL2|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L1|SNORD115-1|PWAR4|PWARSN|OR4M2|SNORD116-1|GOLGA6L2|OR4N4|PWAR6|POTEB|PWAR5|HERC2|NSMCE3|ATP10A|GOLGA8M|POTEB2|PWRN1|PWRN2|GOLGA6L6|APBA2|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|TJP1|UBE3A|MKRN3		Chromosome 15q11-q13 duplication syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625709	15	20190548 - 30300265			625709	614013		
GRCh37/hg19 15q11.2-13.1(chr15:22770421-28928730)x1	SNURF|CYFIP1|NPAP1|MAGEL2|ATP10A|NIPA2|TUBGCP5|NIPA1|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2		See cases	Pathogenic	no assertion criteria provided	VCV000397448	15	22770421 - 28928730			397448	384341		
NM_001130438.3(SPTAN1):c.6592_6597dup (p.Leu2198_Gln2199dup)	SPTAN1		Early infantile epileptic encephalopathy 5	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666262	9	131389677 - 131389678	9	128627398 - 128627399	666262	653813	rs1589393179	NC_000009.12:128627398:AGCTGCAG:AGCTGCAGCTGCAG
NM_006772.3(SYNGAP1):c.1861C>T (p.Arg621Ter)	SYNGAP1	R621*	Complex neurodevelopmental disorder|Mental retardation, autosomal dominant 5	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000411589	6	33408690	6	33440913	411589	395450	rs1060503386	NC_000006.12:33440912:C:T
NM_024665.7(TBL1XR1):c.1043A>G (p.His348Arg)	TBL1XR1	H261R, H348R	Mental retardation, autosomal dominant 41|See cases	Likely pathogenic(Last reviewed: Apr 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000666259	3	176756105	3	177038317	666259	653815	rs1576994053	NC_000003.12:177038316:T:C
NM_024665.7(TBL1XR1):c.1000T>C (p.Cys334Arg)	TBL1XR1	C334R, C247R	Mental retardation, autosomal dominant 41	Likely pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666258	3	176756148	3	177038360	666258	653810	rs1576994101	NC_000003.12:177038359:A:G
NM_001083962.2(TCF4):c.1486G>T (p.Gly496Cys)	TCF4	G280C, G335C, G336C, G366C, G425C, G454C, G471C, G472C, G473C, G493C, G495C, G496C, G502C, G598C	Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: May 11, 2021)	reviewed by expert panel	VCV000690393	18	52901779	18	55234548	690393	678075	rs1599570613	NC_000018.10:55234547:C:A
NM_001083962.2(TCF4):c.1283G>T (p.Gly428Val)	TCF4	G428V, G267V, G357V, G386V, G427V, G212V, G403V, G404V, G405V, G425V, G530V, G268V, G298V, G434V	History of neurodevelopmental disorder|Pitt-Hopkins syndrome|not provided	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000574403	18	52921795	18	55254564	574403	572666	rs186508321	NC_000018.10:55254563:C:A
NM_001083962.2(TCF4):c.1916_1917del (p.Arg639fs)	TCF4	R564fs, R597fs, R632fs, R423fs, R479fs, R505fs, R509fs, R639fs, R474fs, R568fs, R593fs, R611fs, R616fs, R638fs, R645fs, R741fs, R475fs, R610fs, R614fs, R615fs, R634fs, R635fs	Pitt-Hopkins syndrome|not provided	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000524012	18	52895555 - 52895556	18	55228324 - 55228325	524012	514744	rs1555708227	NC_000018.10:55228323:TCT:T
NM_001083962.2(TCF4):c.759C>G (p.Ser253Arg)	TCF4	S253R, S37R, S123R, S182R, S229R, S251R, S252R, S93R, S211R, S355R, S228R, S259R	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000432062	18	52942880	18	55275649	432062	426274	rs1555796785	NC_000018.10:55275648:G:C
NM_001083962.2(TCF4):c.1826T>C (p.Leu609Pro)	TCF4	L609P, L393P, L479P, L534P, L584P, L538P, L563P, L567P, L585P, L602P, L608P, L444P, L445P, L449P, L475P, L580P, L581P, L586P, L604P, L615P, L605P, L711P	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000393171	18	52896131	18	55228900	393171	379059	rs1057524821	NC_000018.10:55228899:A:G
NM_001083962.2(TCF4):c.1727G>A (p.Arg576Gln)	TCF4	R576Q, R553Q, R360Q, R411Q, R501Q, R505Q, R530Q, R548Q, R582Q, R678Q, R416Q, R534Q, R547Q, R551Q, R552Q, R571Q, R575Q, R412Q, R442Q, R446Q, R569Q, R572Q	Inborn genetic diseases|Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000381549	18	52896230	18	55228999	381549	375991	rs1057521070	NC_000018.10:55228998:C:T
NM_001083962.2(TCF4):c.687C>A (p.Ser229=)	TCF4		not specified|Pitt-Hopkins syndrome	Likely benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000327305	18	52942952	18	55275721	327305	342039	rs200800656	NC_000018.10:55275720:G:T
NM_001083962.2(TCF4):c.1965dup (p.Gly656fs)	TCF4	G492fs, G581fs, G627fs, G632fs, G633fs, G655fs, G758fs, G491fs, G526fs, G628fs, G649fs, G522fs, G610fs, G614fs, G631fs, G652fs, G440fs, G496fs, G585fs, G651fs, G656fs, G662fs	Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000212379	18	52895506 - 52895507	18	55228275 - 55228276	212379	208455	rs797046035	NC_000018.10:55228275:GG:GGG
NM_001083962.2(TCF4):c.2010_2011del (p.Gln670fs)	TCF4	Q506fs, Q536fs, Q628fs, Q642fs, Q595fs, Q624fs, Q772fs, Q505fs, Q510fs, Q540fs, Q599fs, Q641fs, Q646fs, Q665fs, Q666fs, Q669fs, Q454fs, Q645fs, Q647fs, Q663fs, Q670fs, Q676fs	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000207545	18	52895461 - 52895462	18	55228230 - 55228231	207545	203497	rs796053429	NC_000018.10:55228229:TCT:T
NM_001083962.2(TCF4):c.269A>G (p.Asn90Ser)	TCF4|TCF4-AS1	N90S, N66S, N192S, N88S, N48S	not specified|Pitt-Hopkins syndrome|History of neurodevelopmental disorder	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000167731	18	53128285	18	55461054	167731	177427	rs143244149	NC_000018.10:55461053:T:C
NM_001083962.2(TCF4):c.990G>A (p.Ser330=)	TCF4		not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160092	18	52928697	18	55261466	160092	169445	rs587784469	NC_000018.10:55261465:C:T
NM_001083962.2(TCF4):c.944C>T (p.Ala315Val)	TCF4	A315V, A185V, A244V, A273V, A99V, A291V, A313V, A321V, A290V, A155V, A314V, A417V	not provided|History of neurodevelopmental disorder|Pitt-Hopkins syndrome|not specified	Benign(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160091	18	52928743	18	55261512	160091	169446	rs147445499	NC_000018.10:55261511:G:A
NM_001083962.2(TCF4):c.1733G>A (p.Arg578His)	TCF4	R578H, R680H, R413H, R448H, R503H, R536H, R574H, R554H, R555H, R571H, R573H, R418H, R532H, R549H, R550H, R553H, R362H, R414H, R444H, R507H, R577H, R584H	Microcephaly|not provided|Pitt-Hopkins syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000093542	18	52896224	18	55228993	93542	99447	rs121909123	NC_000018.10:55228992:C:T
NM_001083962.2(TCF4):c.1086G>A (p.Trp362Ter)	TCF4	W362*, W146*, W232*, W320*, W337*, W361*, W464*, W201*, W202*, W291*, W338*, W359*, W339*, W368*	not provided|Pitt-Hopkins syndrome	Likely pathogenic(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000093540	18	52924606	18	55257375	93540	99445	rs398123560	NC_000018.10:55257374:C:T
NM_001083962.2(TCF4):c.1739G>A (p.Arg580Gln)	TCF4	R576Q, R580Q, R446Q, R552Q, R364Q, R415Q, R450Q, R538Q, R586Q, R416Q, R420Q, R509Q, R534Q, R551Q, R556Q, R575Q, R682Q, R505Q, R555Q, R557Q, R573Q, R579Q	Pitt-Hopkins syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007371	18	52896218	18	55228987	7371	22410	rs121909121	NC_000018.10:55228986:C:T
NM_001083962.2(TCF4):c.1738C>T (p.Arg580Trp)	TCF4	R576W, R580W, R682W, R364W, R505W, R534W, R552W, R557W, R420W, R446W, R509W, R555W, R573W, R575W, R579W, R415W, R416W, R450W, R538W, R551W, R556W, R586W	not provided|Pitt-Hopkins syndrome|Inborn genetic diseases|Severe intellectual deficiency	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000007370	18	52896219	18	55228988	7370	22409	rs121909120	NC_000018.10:55228987:G:A
GRCh37/hg19 15q11.2(chr15:25582396-25684175)x1	UBE3A		Angelman syndrome	not provided	no assertion provided	VCV001177488	15	25582396 - 25684175			1177488	1166913		
NM_130839.5(UBE3A):c.1860T>A (p.Ile620=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV001158916	15	25601937	15	25356790	1158916	1145021		NC_000015.10:25356789:A:T
NM_130839.5(UBE3A):c.1800A>G (p.Pro600=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV001141879	15	25601997	15	25356850	1141879	1145022		NC_000015.10:25356849:T:C
NM_130839.5(UBE3A):c.1719G>A (p.Gln573=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001138218	15	25605564	15	25360417	1138218	1124156		NC_000015.10:25360416:C:T
NM_130839.5(UBE3A):c.1347A>G (p.Glu449=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001137592	15	25615974	15	25370827	1137592	1124158		NC_000015.10:25370826:T:C
NM_130839.5(UBE3A):c.87A>G (p.Leu29=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV001131091	15	25620886	15	25375739	1131091	1124162		NC_000015.10:25375738:T:C
NM_130839.5(UBE3A):c.861A>G (p.Val287=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV001130068	15	25616460	15	25371313	1130068	1124160		NC_000015.10:25371312:T:C
NM_130839.5(UBE3A):c.1248C>T (p.Asn416=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV001126825	15	25616073	15	25370926	1126825	1124159		NC_000015.10:25370925:G:A
NM_130839.5(UBE3A):c.2124+9_2124+10insTT	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001126495	15	25601029 - 25601030	15	25355882 - 25355883	1126495	1124155		NC_000015.10:25355882:A:AAA
NM_130839.5(UBE3A):c.1596T>C (p.Asp532=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001123889	15	25615725	15	25370578	1123889	1124157		NC_000015.10:25370577:A:G
NM_130839.5(UBE3A):c.660T>C (p.Asn220=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001123155	15	25616661	15	25371514	1123155	1124161		NC_000015.10:25371513:A:G
NM_130839.5(UBE3A):c.1764A>T (p.Thr588=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV001100353	15	25602033	15	25356886	1100353	1102751		NC_000015.10:25356885:T:A
NM_130839.5(UBE3A):c.1830T>C (p.Thr610=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Sep 30, 2020)	criteria provided, single submitter	VCV001094304	15	25601967	15	25356820	1094304	1080911		NC_000015.10:25356819:A:G
NM_130839.5(UBE3A):c.459T>G (p.Val153=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001091534	15	25616862	15	25371715	1091534	1080913		NC_000015.10:25371714:A:C
NC_000015.9:g.(?_25584273)_(25650609_?)dup	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001075074	15	25584273 - 25650609			1075074	1057670		
NC_000015.9:g.(?_25584273)_(25650609_?)del	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001069013	15	25584273 - 25650609			1069013	1057669		
NM_130839.5(UBE3A):c.580G>C (p.Ala194Pro)	UBE3A|SNHG14	A135P, A174P, A194P, A197P	Angelman syndrome	Uncertain significance(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001024047	15	25616741	15	25371594	1024047	1011365		NC_000015.10:25371593:C:G
NM_130839.5(UBE3A):c.1936C>A (p.Arg646Ser)	UBE3A|SNHG14	R209S, R229S, R587S, R626S, R646S, R649S	Angelman syndrome	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001020143	15	25601861	15	25356714	1020143	1011363		NC_000015.10:25356713:G:T
NM_130839.5(UBE3A):c.2421G>A (p.Thr807=)	UBE3A|SNHG14		Angelman syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001011641	15	25585309	15	25340162	1011641	996124		NC_000015.10:25340161:C:T
NM_130839.5(UBE3A):c.2263C>G (p.Leu755Val)	UBE3A|SNHG14	L318V, L338V, L680V, L696V, L735V, L755V, L758V	Angelman syndrome	Uncertain significance(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001008062	15	25599692	15	25354545	1008062	996125		NC_000015.10:25354544:G:C
NM_130839.5(UBE3A):c.2410C>T (p.Gln804Ter)	UBE3A|SNHG14	Q367*, Q387*, Q729*, Q732*, Q745*, Q752*, Q784*, Q804*, Q807*	Angelman syndrome	Pathogenic(Last reviewed: Apr 10, 2020)	criteria provided, single submitter	VCV000984971	15	25585320	15	25340173	984971	973104		NC_000015.10:25340172:G:A
NM_130839.5(UBE3A):c.1864A>G (p.Asn622Asp)	UBE3A|SNHG14	N185D, N205D, N563D, N602D, N622D, N625D	Angelman syndrome	Likely pathogenic(Last reviewed: Apr 3, 2020)	no assertion criteria provided	VCV000984645	15	25601933	15	25356786	984645	972727		NC_000015.10:25356785:T:C
NM_130839.5(UBE3A):c.578C>G (p.Ala193Gly)	UBE3A|SNHG14	A173G, A196G, A134G, A193G	Angelman syndrome	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000962683	15	25616743	15	25371596	962683	948782		NC_000015.10:25371595:G:C
NM_130839.5(UBE3A):c.2600_2604dup (p.Phe869fs)	UBE3A|SNHG14	F452fs, F797fs, F817fs, F869fs, F872fs, F794fs, F810fs, F849fs, F432fs	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV000961399	15	25584298 - 25584299	15	25339151 - 25339152	961399	948780		NC_000015.10:25339151:TCCTTT:TCCTTTCCTTT
NM_130839.5(UBE3A):c.167C>A (p.Thr56Asn)	UBE3A|SNHG14	T36N, T56N, T59N	Angelman syndrome	Uncertain significance(Last reviewed: Jul 21, 2019)	criteria provided, single submitter	VCV000956987	15	25620806	15	25375659	956987	948784		NC_000015.10:25375658:G:T
NM_130839.5(UBE3A):c.1012G>T (p.Glu338Ter)	UBE3A|SNHG14	E318*, E338*, E341*, E279*	Angelman syndrome	Pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV000949904	15	25616309	15	25371162	949904	927258		NC_000015.10:25371161:C:A
NM_130839.5(UBE3A):c.2198G>A (p.Gly733Asp)	UBE3A|SNHG14	G674D, G733D, G296D, G316D, G736D, G658D, G713D	not specified	Uncertain significance(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV000917692	15	25599757	15	25354610	917692	906033		NC_000015.10:25354609:C:T
NM_130839.5(UBE3A):c.1066C>T (p.Arg356Ter)	UBE3A|SNHG14	R356*, R336*, R359*, R297*	Angelman syndrome	Pathogenic(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV000864214	15	25616255	15	25371108	864214	842084		NC_000015.10:25371107:G:A
NM_130839.5(UBE3A):c.368C>G (p.Thr123Ser)	UBE3A|SNHG14	T103S, T64S, T123S, T126S	Angelman syndrome	Uncertain significance(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000860708	15	25616953	15	25371806	860708	842089		NC_000015.10:25371805:G:C
NM_130839.5(UBE3A):c.1131T>A (p.Tyr377Ter)	UBE3A|SNHG14	Y318*, Y357*, Y380*, Y377*	Angelman syndrome	Pathogenic(Last reviewed: Jun 16, 2019)	criteria provided, single submitter	VCV000846659	15	25616190	15	25371043	846659	842082		NC_000015.10:25371042:A:T
NM_130839.5(UBE3A):c.330G>C (p.Met110Ile)	UBE3A|SNHG14	M90I, M110I, M113I, M51I	Angelman syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000846201	15	25620643	15	25375496	846201	842091		NC_000015.10:25375495:C:G
NC_000015.10:g.(?_25339137)_(25405462_?)dup	UBE3A		Angelman syndrome	Likely pathogenic(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000831131	15	25584284 - 25650609			831131	820669		
NC_000015.10:g.(?_25339117)_(25360547_?)dup	UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000830404	15	25584264 - 25605694			830404	820666		
NM_130839.5(UBE3A):c.393del (p.Val130_Tyr131insTer)	UBE3A|SNHG14		not provided	Pathogenic(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000817008	15	25616928	15	25371781	817008	805816	rs1595816114	NC_000015.10:25371780:A:
NM_130839.5(UBE3A):c.2273G>A (p.Gly758Glu)	UBE3A|SNHG14	G321E, G699E, G738E, G341E, G758E, G683E, G761E	Angelman syndrome	Likely pathogenic(Last reviewed: Mar 19, 2017)	criteria provided, single submitter	VCV000813761	15	25599682	15	25354535	813761	802004		NC_000015.10:25354534:C:T
NM_130839.5(UBE3A):c.1976T>G (p.Leu659Ter)	UBE3A|SNHG14	L222*, L600*, L659*, L662*, L639*, L242*	Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803057	15	25601187	15	25356040	803057	791434	rs1595591164	NC_000015.10:25356039:A:C
NM_130839.5(UBE3A):c.2517_2553dup (p.Lys852delinsLeuLeuTer)	UBE3A|SNHG14		Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803055	15	25584349 - 25584350	15	25339202 - 25339203	803055	791432	rs1595362860	NC_000015.10:25339202:GCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAG:GCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAGCTTGAGTATTCCGGAAGTAAAAGCACATTAAAGCAAG
NM_130839.5(UBE3A):c.291G>A (p.Ser97=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV000766757	15	25620682	15	25375535	766757	770058	rs1411368065	NC_000015.10:25375534:C:T
NM_130839.5(UBE3A):c.2442G>A (p.Val814=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000764976	15	25585288	15	25340141	764976	770054	rs1595375310	NC_000015.10:25340140:C:T
NM_130839.5(UBE3A):c.873A>G (p.Arg291=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000751517	15	25616448	15	25371301	751517	770056	rs1213980033	NC_000015.10:25371300:T:C
NM_130839.5(UBE3A):c.626C>G (p.Ser209Ter)	UBE3A|SNHG14	S189*, S150*, S212*, S209*	not provided|Angelman syndrome	Pathogenic(Last reviewed: Mar 1, 2021)	reviewed by expert panel	VCV000620293	15	25616695	15	25371548	620293	611790	rs1566961418	NC_000015.10:25371547:G:C
NM_130839.5(UBE3A):c.1696G>A (p.Gly566Ser)	UBE3A|SNHG14	G546S, G149S, G507S, G566S, G129S, G569S	Angelman syndrome	Likely pathogenic(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000559871	15	25605587	15	25360440	559871	550660	rs1555393242	NC_000015.10:25360439:C:T
NM_130839.5(UBE3A):c.1876C>T (p.Leu626=)	UBE3A|SNHG14		Angelman syndrome	Likely benign(Last reviewed: Jan 1, 2020)	criteria provided, single submitter	VCV000528369	15	25601921	15	25356774	528369	529041	rs376089007	NC_000015.10:25356773:G:A
NM_130839.5(UBE3A):c.342C>A (p.Gly114=)	UBE3A|SNHG14		Angelman syndrome|not specified	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000511245	15	25620631	15	25375484	511245	504939	rs142726511	NC_000015.10:25375483:G:T
NM_130839.5(UBE3A):c.507A>G (p.Gln169=)	UBE3A|SNHG14		not specified|Angelman syndrome	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507495	15	25616814	15	25371667	507495	505609	rs1555401033	NC_000015.10:25371666:T:C
NM_130839.5(UBE3A):c.1052A>G (p.Asn351Ser)	UBE3A|SNHG14	N331S, N292S, N351S, N354S	Angelman syndrome	Uncertain significance(Last reviewed: Aug 20, 2017)	criteria provided, single submitter	VCV000458668	15	25616269	15	25371122	458668	463959	rs747932207	NC_000015.10:25371121:T:C
NM_130839.5(UBE3A):c.1196C>G (p.Pro399Arg)	UBE3A|SNHG14	P379R, P340R, P399R, P402R	Angelman syndrome	Uncertain significance(Last reviewed: Mar 5, 2017)	criteria provided, single submitter	VCV000458665	15	25616125	15	25370978	458665	464538	rs267604140	NC_000015.10:25370977:G:C
NM_130839.5(UBE3A):c.936G>A (p.Lys312=)	UBE3A|SNHG14		Angelman syndrome|not specified	Uncertain significance(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000437192	15	25616385	15	25371238	437192	429629	rs867585000	NC_000015.10:25371237:C:T
NM_130839.5(UBE3A):c.1541dup (p.Gln515fs)	UBE3A|SNHG14	Q518fs, Q456fs, Q495fs, Q515fs	not provided	Pathogenic(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000423094	15	25615779 - 25615780	15	25370632 - 25370633	423094	409192	rs1064796224	NC_000015.10:25370632:T:TT
NM_130839.5(UBE3A):c.859G>A (p.Val287Ile)	UBE3A|SNHG14	V267I, V287I, V290I, V228I	not provided|Angelman syndrome	Uncertain significance(Last reviewed: Apr 2, 2021)	reviewed by expert panel	VCV000420601	15	25616462	15	25371315	420601	409195	rs1064794579	NC_000015.10:25371314:C:T
NM_130839.5(UBE3A):c.732C>T (p.Leu244=)	UBE3A|SNHG14		Angelman syndrome|not provided	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV000414973	15	25616589	15	25371442	414973	400860	rs1060504406	NC_000015.10:25371441:G:A
NM_130839.5(UBE3A):c.1620C>T (p.Ile540=)	UBE3A|SNHG14		Angelman syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 24, 2020)	criteria provided, conflicting interpretations	VCV000390176	15	25605663	15	25360516	390176	373993	rs1057523671	NC_000015.10:25360515:G:A
NM_130839.5(UBE3A):c.1038T>C (p.Tyr346=)	UBE3A|SNHG14		not specified|Angelman syndrome|not provided	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379058	15	25616283	15	25371136	379058	374434	rs1057520481	NC_000015.10:25371135:A:G
NM_130839.5(UBE3A):c.1272C>T (p.Pro424=)	UBE3A|SNHG14		not specified|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 16, 2019)	criteria provided, conflicting interpretations	VCV000378843	15	25616049	15	25370902	378843	373336	rs1057520392	NC_000015.10:25370901:G:A
NM_130839.5(UBE3A):c.1244_1253dup (p.Gly419fs)	UBE3A|SNHG14	G399fs, G422fs, G360fs, G419fs	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 14, 2016)	criteria provided, single submitter	VCV000280389	15	25616067 - 25616068	15	25370920 - 25370921	280389	264716	rs886041603	NC_000015.10:25370920:TTCTTGTTTCTTCTT:TTCTTGTTTCTTCTTGTTTCTTCTT
NM_130839.5(UBE3A):c.153_154dup (p.Ala52fs)	UBE3A|SNHG14	A55fs, A32fs, A52fs	not provided	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000280201	15	25620818 - 25620819	15	25375671 - 25375672	280201	264617	rs886041451	NC_000015.10:25375671:CACA:CACACA
NM_130839.5(UBE3A):c.1953_1954del (p.His652fs)	UBE3A|SNHG14	H632fs, H652fs, H655fs, H215fs, H593fs, H235fs	not provided	Pathogenic(Last reviewed: Dec 4, 2015)	criteria provided, single submitter	VCV000265385	15	25601843 - 25601844	15	25356696 - 25356697	265385	260063	rs886039516	NC_000015.10:25356695:GAGAG:GAG
NM_130839.5(UBE3A):c.1521C>T (p.Leu507=)	UBE3A|SNHG14		not provided|Angelman syndrome|not specified	Likely benign(Last reviewed: May 24, 2016)	criteria provided, multiple submitters, no conflicts	VCV000241835	15	25615800	15	25370653	241835	242028	rs878855201	NC_000015.10:25370652:G:A
NM_130839.5(UBE3A):c.119G>T (p.Gly40Val)	UBE3A|SNHG14	G20V, G43V, G40V	Angelman syndrome	Pathogenic(Last reviewed: Dec 7, 2006)	no assertion criteria provided	VCV000218318	15	25620854	15	25375707	218318	215015	rs864309506	NC_000015.10:25375706:C:A
NM_130839.5(UBE3A):c.1472_1476del (p.Leu490_Tyr491insTer)	UBE3A|SNHG14		Angelman syndrome|not provided	Pathogenic(Last reviewed: May 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000217362	15	25615845 - 25615849	15	25370698 - 25370702	217362	196438	rs863225068	NC_000015.10:25370697:ATAATATAAT:ATAAT
NM_130839.5(UBE3A):c.1032T>C (p.Ile344=)	UBE3A|SNHG14		not provided|Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2019)	criteria provided, conflicting interpretations	VCV000196571	15	25616289	15	25371142	196571	193732	rs755119609	NC_000015.10:25371141:A:G
NM_130839.5(UBE3A):c.1881T>C (p.Asp627=)	UBE3A|SNHG14		Angelman syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jul 14, 2020)	criteria provided, conflicting interpretations	VCV000160215	15	25601916	15	25356769	160215	169083	rs587784522	NC_000015.10:25356768:A:G
NM_130839.5(UBE3A):c.2563C>T (p.Leu855Phe)	UBE3A|SNHG14	L835F, L855F, L418F, L796F, L783F, L438F, L780F, L803F, L858F	Angelman syndrome|not provided	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000156620	15	25584340	15	25339193	156620	166474	rs587783097	NC_000015.10:25339192:G:A
NM_130839.5(UBE3A):c.458T>G (p.Val153Gly)	UBE3A|SNHG14	V133G, V153G, V156G, V94G	Angelman syndrome	Uncertain significance(Last reviewed: Feb 22, 2013)	criteria provided, single submitter	VCV000156131	15	25616863	15	25371716	156131	165931	rs587782915	NC_000015.10:25371715:A:C
NM_130839.5(UBE3A):c.377C>A (p.Thr126Lys)	UBE3A|SNHG14	T106K, T129K, T126K, T67K	Angelman syndrome	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000155994	15	25616944	15	25371797	155994	165798	rs587781241	NC_000015.10:25371796:G:T
NM_130839.5(UBE3A):c.2463GAT[1] (p.Met822del)	UBE3A|SNHG14	M802del, M405del, M747del, M385del, M750del, M763del, M770del, M822del, M825del	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000155991	15	25585262 - 25585264	15	25340115 - 25340117	155991	165795	rs587781238	NC_000015.10:25340114:ATCATC:ATC
NM_130839.5(UBE3A):c.1802CTT[1] (p.Ser602del)	UBE3A|SNHG14	S582del, S185del, S602del, S543del, S605del, S165del	Angelman syndrome	Likely pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000155987	15	25601990 - 25601992	15	25356843 - 25356845	155987	165791	rs587781234	NC_000015.10:25356842:AAGAAGA:AAGA
NM_130839.5(UBE3A):c.2305G>T (p.Glu769Ter)	UBE3A|SNHG14	E749*, E694*, E769*, E772*, E332*, E352*, E710*, E697*, E717*	Angelman syndrome	Pathogenic(Last reviewed: Aug 14, 2013)	criteria provided, single submitter	VCV000155971	15	25599549	15	25354402	155971	165775	rs587781220	NC_000015.10:25354401:C:A
NM_130839.5(UBE3A):c.1790G>A (p.Trp597Ter)	UBE3A|SNHG14	W577*, W160*, W180*, W600*, W538*, W597*	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000155959	15	25602007	15	25356860	155959	165763	rs587781208	NC_000015.10:25356859:C:T
NM_130839.5(UBE3A):c.62T>C (p.Met21Thr)	UBE3A|SNHG14	M1T, M21T, M24T	Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000136199	15	25650608	15	25405461	136199	139903	rs587780577	NC_000015.10:25405460:A:G
GRCh38/hg38 15q11.2-13.1(chr15:23319714-28275167)x3	UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD64|PWAR4|PWARSN|LINC00929|GOLGA8S|SNORD115@|SNORD116@|SNORD116-19|PWRN1|PWRN2|SNORD116-1|SNORD116-2|SNORD116-3|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD115-2|SNORD116-26|SNORD116-27|SNORD115-3|SNORD115-4|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-25|SNORD115-26|SNORD115-29|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD116-28|SNORD116-29|SNORD115-48|SNORD115-24|SNORD115-27|SNORD115-28|SNORD115-45|SNORD115-47|LINC02346|TRE-TTC2-2|PWAR6|MIR4508|MIR4715|SNORD116-30|SNORD115-46|PWRN3|GABRG3-AS1|LOC102723623|SNHG14|PWRN4|LINC02250|ATP10A-DT|LOC112272578|LOC112272579|LOC112272580|GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|SNORD107		See cases	Pathogenic(Last reviewed: Aug 12, 2011)	criteria provided, single submitter	VCV000059390	15	22765628 - 28520313	15	23319714 - 28275167	59390	73985		
UBE3A, 15-BP DEL/7-BP INS, NT3240	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030204					30204	39160		
UBE3A, 4-BP DUP, EX10, GAGG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 15, 2004)	no assertion criteria provided	VCV000007972					7972	23011		
UBE3A, 2-BP DEL, 1930AG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007971					7971	23010		
UBE3A, 4-BP DEL, 3093AAGA	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007970					7970	23009		
NM_130839.5(UBE3A):c.2364G>A (p.Trp788Ter)	UBE3A|SNHG14	W768*, W791*, W351*, W371*, W713*, W716*, W736*, W729*, W788*	Angelman syndrome	Pathogenic(Last reviewed: Mar 1, 2021)	reviewed by expert panel	VCV000007967	15	25585366	15	25340219	7967	23006	rs111033595	NC_000015.10:25340218:C:T
UBE3A, 2-BP DEL, 1344GT	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000007965					7965	23004		
UBE3A, IVS9, A-G, -8	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007964					7964	23003		
UBE3A, 5-BP DUP	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000007963					7963	23002		
NM_014232.3(VAMP2):c.128_130del	VAMP2		Severe neurodevelopmental delay|Neurodevelopmental disorder with hypotonia and autistic features with or without hyperkinetic movements	Pathogenic(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV000666257	17	8065078 - 8065080	17	8161760 - 8161762	666257	653823	rs1598265441	NC_000017.11:8161759:CCACCACC:CCACC
NM_014795.4(ZEB2):c.2717del (p.Pro906fs)	ZEB2	P882fs, P906fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 6, 2021)	criteria provided, single submitter	VCV001172771	2	145156037	2	144398470	1172771	1161953		NC_000002.12:144398469:GGGGG:GGGG
NM_014795.4(ZEB2):c.357T>G (p.Thr119=)	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001169303	2	145182409	2	144424842	1169303	1153804		NC_000002.12:144424841:A:C
NM_014795.4(ZEB2):c.1711A>G (p.Met571Val)	ZEB2	M547V, M571V	Mowat-Wilson syndrome	Benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001167087	2	145157043	2	144399476	1167087	1153801		NC_000002.12:144399475:T:C
NM_014795.4(ZEB2):c.593-8G>A	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001166379	2	145161705	2	144404138	1166379	1153803		NC_000002.12:144404137:C:T
NM_014795.4(ZEB2):c.1361A>T (p.Asn454Ile)	ZEB2	N430I, N454I	Mowat-Wilson syndrome	Benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001164196	2	145157393	2	144399826	1164196	1153802		NC_000002.12:144399825:T:A
NM_014795.4(ZEB2):c.2622T>C (p.Asn874=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 26, 2019)	criteria provided, single submitter	VCV001158813	2	145156132	2	144398565	1158813	1131964		NC_000002.12:144398564:A:G
NM_014795.4(ZEB2):c.597G>A (p.Leu199=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001158337	2	145161693	2	144404126	1158337	1131973		NC_000002.12:144404125:C:T
NM_014795.4(ZEB2):c.1905C>T (p.Leu635=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001158320	2	145156849	2	144399282	1158320	1131967		NC_000002.12:144399281:G:A
NM_014795.4(ZEB2):c.3420C>T (p.His1140=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV001157765	2	145147243	2	144389676	1157765	1131959		NC_000002.12:144389675:G:A
NM_014795.4(ZEB2):c.2946C>T (p.Ser982=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, single submitter	VCV001157434	2	145154100	2	144396533	1157434	1131960		NC_000002.12:144396532:G:A
NM_014795.4(ZEB2):c.91G>T (p.Val31Leu)	ZEB2	V31L	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001157385	2	145187576	2	144430009	1157385	1131975		NC_000002.12:144430008:C:A
NM_014795.4(ZEB2):c.1209T>C (p.Leu403=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 26, 2019)	criteria provided, single submitter	VCV001154682	2	145157545	2	144399978	1154682	1131972		NC_000002.12:144399977:A:G
NM_014795.4(ZEB2):c.564G>T (p.Thr188=)	ZEB2|LOC111721705		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 2, 2020)	criteria provided, single submitter	VCV001154592	2	145162431	2	144404864	1154592	1131974		NC_000002.12:144404863:C:A
NM_014795.4(ZEB2):c.1875C>T (p.Ala625=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 19, 2020)	criteria provided, single submitter	VCV001153341	2	145156879	2	144399312	1153341	1131968		NC_000002.12:144399311:G:A
NM_014795.4(ZEB2):c.1803T>C (p.Arg601=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 5, 2019)	criteria provided, single submitter	VCV001152795	2	145156951	2	144399384	1152795	1131970		NC_000002.12:144399383:A:G
NM_014795.4(ZEB2):c.2133C>T (p.Ser711=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 31, 2020)	criteria provided, single submitter	VCV001150309	2	145156621	2	144399054	1150309	1131966		NC_000002.12:144399053:G:A
NM_014795.4(ZEB2):c.3466G>T (p.Gly1156Cys)	ZEB2	G1132C, G1156C	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001149290	2	145147197	2	144389630	1149290	1131958		NC_000002.12:144389629:C:A
NM_014795.4(ZEB2):c.2887-4G>C	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001149125	2	145154163	2	144396596	1149125	1131961		NC_000002.12:144396595:C:G
NM_014795.4(ZEB2):c.1830C>T (p.Ile610=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 30, 2019)	criteria provided, single submitter	VCV001148673	2	145156924	2	144399357	1148673	1131969		NC_000002.12:144399356:G:A
NM_014795.4(ZEB2):c.2742G>A (p.Gln914=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 24, 2020)	criteria provided, single submitter	VCV001145661	2	145156012	2	144398445	1145661	1131963		NC_000002.12:144398444:C:T
NM_014795.4(ZEB2):c.1482A>G (p.Pro494=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV001143256	2	145157272	2	144399705	1143256	1131971		NC_000002.12:144399704:T:C
NM_014795.4(ZEB2):c.2481C>T (p.Pro827=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 28, 2019)	criteria provided, single submitter	VCV001143013	2	145156273	2	144398706	1143013	1131965		NC_000002.12:144398705:G:A
NM_014795.4(ZEB2):c.2850G>A (p.Gln950=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 4, 2019)	criteria provided, single submitter	VCV001142001	2	145155904	2	144398337	1142001	1131962		NC_000002.12:144398336:C:T
NM_014795.4(ZEB2):c.3068-5C>T	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001140477	2	145147600	2	144390033	1140477	1111090		NC_000002.12:144390032:G:A
NM_014795.4(ZEB2):c.2304T>C (p.Asn768=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001138433	2	145156450	2	144398883	1138433	1111094		NC_000002.12:144398882:A:G
NM_014795.4(ZEB2):c.15C>T (p.Ile5=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001138263	2	145274903	2	144517336	1138263	1111101		NC_000002.12:144517335:G:A
NM_014795.4(ZEB2):c.2896C>A (p.Leu966Ile)	ZEB2	L942I, L966I	Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV001138174	2	145154150	2	144396583	1138174	1111092		NC_000002.12:144396582:G:T
NM_014795.4(ZEB2):c.2220A>T (p.Thr740=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001135964	2	145156534	2	144398967	1135964	1111095		NC_000002.12:144398966:T:A
NM_014795.4(ZEB2):c.436G>A (p.Glu146Lys)	ZEB2	E122K, E146K	Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001133054	2	145162559	2	144404992	1133054	1111100		NC_000002.12:144404991:C:T
NM_014795.4(ZEB2):c.507C>T (p.Arg169=)	ZEB2|LOC111721705		Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV001128115	2	145162488	2	144404921	1128115	1111098		NC_000002.12:144404920:G:A
NM_014795.4(ZEB2):c.624C>T (p.Ala208=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 2, 2019)	criteria provided, single submitter	VCV001125521	2	145161666	2	144404099	1125521	1111097		NC_000002.12:144404098:G:A
NM_014795.4(ZEB2):c.495G>A (p.Glu165=)	ZEB2|LOC111721705		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001124735	2	145162500	2	144404933	1124735	1111099		NC_000002.12:144404932:C:T
NM_014795.4(ZEB2):c.808-13_808-10del	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001123136	2	145158884 - 145158887	2	144401317 - 144401320	1123136	1111096		NC_000002.12:144401316:GAGA:
NM_014795.4(ZEB2):c.3006C>T (p.Asp1002=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001121311	2	145154040	2	144396473	1121311	1111091		NC_000002.12:144396472:G:A
NM_014795.4(ZEB2):c.2826A>G (p.Gly942=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001121307	2	145155928	2	144398361	1121307	1111093		NC_000002.12:144398360:T:C
NM_014795.4(ZEB2):c.1344T>G (p.Leu448=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 2, 2020)	criteria provided, single submitter	VCV001118004	2	145157410	2	144399843	1118004	1089555		NC_000002.12:144399842:A:C
NM_014795.4(ZEB2):c.3318G>T (p.Leu1106=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001115638	2	145147345	2	144389778	1115638	1089549		NC_000002.12:144389777:C:A
NM_014795.4(ZEB2):c.1407T>C (p.Asn469=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 31, 2020)	criteria provided, single submitter	VCV001106940	2	145157347	2	144399780	1106940	1089554		NC_000002.12:144399779:A:G
NM_014795.4(ZEB2):c.1728C>T (p.Asn576=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001106552	2	145157026	2	144399459	1106552	1089552		NC_000002.12:144399458:G:A
NM_014795.4(ZEB2):c.2823T>C (p.Thr941=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001106396	2	145155931	2	144398364	1106396	1089550		NC_000002.12:144398363:A:G
NM_014795.4(ZEB2):c.1305A>C (p.Pro435=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001104471	2	145157449	2	144399882	1104471	1089556		NC_000002.12:144399881:T:G
NM_014795.4(ZEB2):c.1668A>G (p.Lys556=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 8, 2020)	criteria provided, single submitter	VCV001104101	2	145157086	2	144399519	1104101	1089553		NC_000002.12:144399518:T:C
NM_014795.4(ZEB2):c.2549C>A (p.Ser850Tyr)	ZEB2	S826Y, S850Y	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001101915	2	145156205	2	144398638	1101915	1089551		NC_000002.12:144398637:G:T
NM_014795.4(ZEB2):c.912C>T (p.His304=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 5, 2020)	criteria provided, single submitter	VCV001101207	2	145158770	2	144401203	1101207	1089557		NC_000002.12:144401202:G:A
NM_014795.4(ZEB2):c.74-9C>T	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 22, 2019)	criteria provided, single submitter	VCV001099087	2	145187602	2	144430035	1099087	1089558		NC_000002.12:144430034:G:A
NM_014795.4(ZEB2):c.2223A>G (p.Ser741=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV001094860	2	145156531	2	144398964	1094860	1067825		NC_000002.12:144398963:T:C
NM_014795.4(ZEB2):c.3384G>C (p.Glu1128Asp)	ZEB2	E1104D, E1128D	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001092607	2	145147279	2	144389712	1092607	1067824		NC_000002.12:144389711:C:G
NM_014795.4(ZEB2):c.1079C>G (p.Ser360Cys)	ZEB2	S336C, S360C	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001088637	2	145157675	2	144400108	1088637	1067829		NC_000002.12:144400107:G:C
NM_014795.4(ZEB2):c.732T>C (p.Pro244=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV001082619	2	145161558	2	144403991	1082619	1067830		NC_000002.12:144403990:A:G
NM_014795.4(ZEB2):c.3557G>C (p.Gly1186Ala)	ZEB2	G1162A, G1186A	Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001082252	2	145147106	2	144389539	1082252	1067823		NC_000002.12:144389538:C:G
NM_014795.4(ZEB2):c.2148T>C (p.Ala716=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 21, 2020)	criteria provided, single submitter	VCV001081730	2	145156606	2	144399039	1081730	1067826		NC_000002.12:144399038:A:G
NM_014795.4(ZEB2):c.1944C>T (p.Pro648=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 16, 2019)	criteria provided, single submitter	VCV001081533	2	145156810	2	144399243	1081533	1067828		NC_000002.12:144399242:G:A
NM_014795.4(ZEB2):c.1950C>T (p.Asn650=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 14, 2020)	criteria provided, single submitter	VCV001080126	2	145156804	2	144399237	1080126	1067827		NC_000002.12:144399236:G:A
NM_014795.4(ZEB2):c.876dup (p.Tyr293fs)	ZEB2	Y269fs, Y293fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001076838	2	145158805 - 145158806	2	144401238 - 144401239	1076838	1058920		NC_000002.12:144401238:TTT:TTTT
NM_014795.4(ZEB2):c.696C>A (p.Tyr232Ter)	ZEB2	Y208*, Y232*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001076322	2	145161594	2	144404027	1076322	1058923		NC_000002.12:144404026:G:T
NM_014795.4(ZEB2):c.1038_1039del (p.Asn346fs)	ZEB2	N322fs, N346fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001074356	2	145157715 - 145157716	2	144400148 - 144400149	1074356	1058919		NC_000002.12:144400147:TGT:T
NM_014795.4(ZEB2):c.818_821dup (p.Gln275fs)	ZEB2	Q251fs, Q275fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001072214	2	145158860 - 145158861	2	144401293 - 144401294	1072214	1058922		NC_000002.12:144401293:GTTAG:GTTAGTTAG
NC_000002.11:g.(?_145147018)_(145753167_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001072089	2	145147018 - 145753167			1072089	1056908		
NM_014795.4(ZEB2):c.3094del (p.Cys1032fs)	ZEB2	C1008fs, C1032fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001071821	2	145147569	2	144390002	1071821	1058917		NC_000002.12:144390001:AAA:AA
NM_014795.4(ZEB2):c.2592del (p.Phe864fs)	ZEB2	F840fs, F864fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001071230	2	145156162	2	144398595	1071230	1058918		NC_000002.12:144398594:AAAA:AAA
NM_014795.4(ZEB2):c.31del (p.Arg11fs)	ZEB2	R11fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001071228	2	145274887	2	144517320	1071228	1058924		NC_000002.12:144517319:GGGGG:GGGG
NM_014795.4(ZEB2):c.874A>T (p.Lys292Ter)	ZEB2	K268*, K292*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001069634	2	145158808	2	144401241	1069634	1058921		NC_000002.12:144401240:T:A
NM_014795.4(ZEB2):c.916+1G>T	ZEB2		Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001067668	2	145158765	2	144401198	1067668	1054908		NC_000002.12:144401197:C:A
NM_014795.4(ZEB2):c.968G>T (p.Gly323Val)	ZEB2	G299V, G323V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV001065427	2	145157786	2	144400219	1065427	1053733		NC_000002.12:144400218:C:A
NM_014795.4(ZEB2):c.2380A>G (p.Lys794Glu)	ZEB2	K770E, K794E	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001064554	2	145156374	2	144398807	1064554	1052794		NC_000002.12:144398806:T:C
NM_014795.4(ZEB2):c.193G>A (p.Val65Met)	ZEB2	V65M	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 12, 2020)	criteria provided, single submitter	VCV001064340	2	145187474	2	144429907	1064340	1040541		NC_000002.12:144429906:C:T
NM_014795.4(ZEB2):c.1954T>C (p.Tyr652His)	ZEB2	Y628H, Y652H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001062186	2	145156800	2	144399233	1062186	1040539		NC_000002.12:144399232:A:G
NM_014795.4(ZEB2):c.75G>A (p.Val25=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 5, 2020)	criteria provided, single submitter	VCV001061759	2	145187592	2	144430025	1061759	1040543		NC_000002.12:144430024:C:T
NM_014795.4(ZEB2):c.2917A>G (p.Met973Val)	ZEB2	M949V, M973V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 17, 2020)	criteria provided, single submitter	VCV001055790	2	145154129	2	144396562	1055790	1040538		NC_000002.12:144396561:T:C
NM_014795.4(ZEB2):c.97G>A (p.Asp33Asn)	ZEB2	D33N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001055240	2	145187570	2	144430003	1055240	1040542		NC_000002.12:144430002:C:T
NM_014795.4(ZEB2):c.44G>T (p.Arg15Leu)	ZEB2	R15L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001053591	2	145274874	2	144517307	1053591	1040544		NC_000002.12:144517306:C:A
NM_014795.4(ZEB2):c.829G>A (p.Ala277Thr)	ZEB2	A253T, A277T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV001052110	2	145158853	2	144401286	1052110	1040540		NC_000002.12:144401285:C:T
NM_014795.4(ZEB2):c.2263G>A (p.Asp755Asn)	ZEB2	D755N, D731N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 26, 2020)	criteria provided, single submitter	VCV001047712	2	145156491	2	144398924	1047712	1023700		NC_000002.12:144398923:C:T
NM_014795.4(ZEB2):c.167T>C (p.Leu56Pro)	ZEB2	L56P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001046836	2	145187500	2	144429933	1046836	1023707		NC_000002.12:144429932:A:G
NM_014795.4(ZEB2):c.932A>T (p.Glu311Val)	ZEB2	E287V, E311V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV001046624	2	145157822	2	144400255	1046624	1023704		NC_000002.12:144400254:T:A
NM_014795.4(ZEB2):c.2764C>T (p.Pro922Ser)	ZEB2	P898S, P922S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 29, 2020)	criteria provided, single submitter	VCV001046534	2	145155990	2	144398423	1046534	1023698		NC_000002.12:144398422:G:A
NM_014795.4(ZEB2):c.370G>A (p.Ala124Thr)	ZEB2	A124T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 25, 2020)	criteria provided, single submitter	VCV001043958	2	145182396	2	144424829	1043958	1023706		NC_000002.12:144424828:C:T
NM_014795.4(ZEB2):c.2665T>C (p.Phe889Leu)	ZEB2	F865L, F889L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 6, 2020)	criteria provided, single submitter	VCV001043093	2	145156089	2	144398522	1043093	1023699		NC_000002.12:144398521:A:G
NM_014795.4(ZEB2):c.151G>A (p.Gly51Ser)	ZEB2	G51S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV001041823	2	145187516	2	144429949	1041823	1023708		NC_000002.12:144429948:C:T
NM_014795.4(ZEB2):c.2162C>G (p.Pro721Arg)	ZEB2	P721R, P697R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001041272	2	145156592	2	144399025	1041272	1023701		NC_000002.12:144399024:G:C
NM_014795.4(ZEB2):c.1850A>G (p.His617Arg)	ZEB2	H593R, H617R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV001039201	2	145156904	2	144399337	1039201	1023702		NC_000002.12:144399336:T:C
NM_014795.4(ZEB2):c.3454G>C (p.Gly1152Arg)	ZEB2	G1128R, G1152R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001036642	2	145147209	2	144389642	1036642	1023697		NC_000002.12:144389641:C:G
NM_014795.4(ZEB2):c.1286A>G (p.His429Arg)	ZEB2	H405R, H429R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 23, 2020)	criteria provided, single submitter	VCV001036414	2	145157468	2	144399901	1036414	1023703		NC_000002.12:144399900:T:C
NM_014795.4(ZEB2):c.31C>T (p.Arg11Trp)	ZEB2	R11W	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV001032637	2	145274887	2	144517320	1032637	1019456		NC_000002.12:144517319:G:A
NM_014795.4(ZEB2):c.2840C>G (p.Ala947Gly)	ZEB2	A923G, A947G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV001032636	2	145155914	2	144398347	1032636	1019455		NC_000002.12:144398346:G:C
NM_014795.4(ZEB2):c.3467G>C (p.Gly1156Ala)	ZEB2	G1156A, G1132A	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001029312	2	145147196	2	144389629	1029312	1015833		NC_000002.12:144389628:C:G
NM_014795.4(ZEB2):c.3133C>T (p.His1045Tyr)	ZEB2	H1021Y, H1045Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001029311	2	145147530	2	144389963	1029311	1015834		NC_000002.12:144389962:G:A
NM_014795.4(ZEB2):c.2944T>C (p.Ser982Pro)	ZEB2	S982P, S958P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 6, 2019)	criteria provided, single submitter	VCV001029310	2	145154102	2	144396535	1029310	1015835		NC_000002.12:144396534:A:G
NM_014795.4(ZEB2):c.2886+1G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 11, 2020)	criteria provided, single submitter	VCV001029309	2	145155867	2	144398300	1029309	1015836		NC_000002.12:144398299:C:T
NM_014795.4(ZEB2):c.2176T>C (p.Ser726Pro)	ZEB2	S726P, S702P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 21, 2020)	criteria provided, single submitter	VCV001027896	2	145156578	2	144399011	1027896	1015837		NC_000002.12:144399010:A:G
NM_014795.4(ZEB2):c.1112A>T (p.Asn371Ile)	ZEB2	N371I, N347I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 2, 2019)	criteria provided, single submitter	VCV001027895	2	145157642	2	144400075	1027895	1015838		NC_000002.12:144400074:T:A
NM_014795.4(ZEB2):c.2970G>T (p.Lys990Asn)	ZEB2	K966N, K990N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 18, 2020)	criteria provided, single submitter	VCV001027239	2	145154076	2	144396509	1027239	1003205		NC_000002.12:144396508:C:A
NM_014795.4(ZEB2):c.3146A>G (p.His1049Arg)	ZEB2	H1025R, H1049R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001026904	2	145147517	2	144389950	1026904	1003204		NC_000002.12:144389949:T:C
NM_014795.4(ZEB2):c.1466A>G (p.Tyr489Cys)	ZEB2	Y465C, Y489C	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 9, 2020)	criteria provided, single submitter	VCV001021419	2	145157288	2	144399721	1021419	1003209		NC_000002.12:144399720:T:C
NM_014795.4(ZEB2):c.422C>T (p.Thr141Ile)	ZEB2	T117I, T141I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 29, 2020)	criteria provided, single submitter	VCV001020884	2	145162573	2	144405006	1020884	1003210		NC_000002.12:144405005:G:A
NM_014795.4(ZEB2):c.50A>G (p.Gln17Arg)	ZEB2	Q17R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001020883	2	145274868	2	144517301	1020883	1003211		NC_000002.12:144517300:T:C
NM_014795.4(ZEB2):c.3400G>A (p.Gly1134Ser)	ZEB2	G1110S, G1134S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001018933	2	145147263	2	144389696	1018933	1003203		NC_000002.12:144389695:C:T
NM_014795.4(ZEB2):c.1516_1518del (p.Pro506del)	ZEB2	P482del, P506del	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 13, 2020)	criteria provided, single submitter	VCV001016600	2	145157236 - 145157238	2	144399669 - 144399671	1016600	1003208		NC_000002.12:144399668:AGGAG:AG
NM_014795.4(ZEB2):c.2150C>G (p.Pro717Arg)	ZEB2	P693R, P717R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV001016453	2	145156604	2	144399037	1016453	1003206		NC_000002.12:144399036:G:C
NM_014795.4(ZEB2):c.2093A>G (p.Tyr698Cys)	ZEB2	Y674C, Y698C	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001014021	2	145156661	2	144399094	1014021	1003207		NC_000002.12:144399093:T:C
NM_014795.4(ZEB2):c.100A>C (p.Thr34Pro)	ZEB2	T34P	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV001010313	2	145187567	2	144430000	1010313	987942		NC_000002.12:144429999:T:G
NM_014795.4(ZEB2):c.25G>A (p.Gly9Ser)	ZEB2	G9S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001008621	2	145274893	2	144517326	1008621	987943		NC_000002.12:144517325:C:T
NC_000002.11:g.(?_145182343)_(145182454_?)del	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001007970	2	145182343 - 145182454			1007970	986180		
NM_014795.4(ZEB2):c.554G>A (p.Arg185His)	ZEB2|LOC111721705	R161H, R185H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 10, 2020)	criteria provided, single submitter	VCV001005524	2	145162441	2	144404874	1005524	987940		NC_000002.12:144404873:C:T
NM_014795.4(ZEB2):c.2516C>G (p.Ala839Gly)	ZEB2	A815G, A839G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV001001252	2	145156238	2	144398671	1001252	987939		NC_000002.12:144398670:G:C
NM_014795.4(ZEB2):c.338T>C (p.Met113Thr)	ZEB2	M113T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV001000942	2	145182428	2	144424861	1000942	987941		NC_000002.12:144424860:A:G
NM_014795.4(ZEB2):c.917G>A (p.Gly306Asp)	ZEB2	G282D, G306D	Inborn genetic diseases|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 18, 2019)	criteria provided, multiple submitters, no conflicts	VCV000985660	2	145157837	2	144400270	985660	973239		NC_000002.12:144400269:C:T
NM_014795.4(ZEB2):c.2177_2178del (p.Ser726fs)	ZEB2	S702fs, S726fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV000984701	2	145156576 - 145156577	2	144399009 - 144399010	984701	972781		NC_000002.12:144399008:AGAG:AG
NM_014795.4(ZEB2):c.1309C>T (p.Gln437Ter)	ZEB2	Q413*, Q437*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000983020	2	145157445	2	144399878	983020	970711		NC_000002.12:144399877:G:A
NM_014795.4(ZEB2):c.2825G>T (p.Gly942Val)	ZEB2	G918V, G942V	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000982850	2	145155929	2	144398362	982850	970710		NC_000002.12:144398361:C:A
NM_014795.4(ZEB2):c.2973del (p.Lys992fs)	ZEB2	K968fs, K992fs	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000982817	2	145154073	2	144396506	982817	970709		NC_000002.12:144396505:G:
NM_014795.4(ZEB2):c.441C>G (p.Tyr147Ter)	ZEB2	Y123*, Y147*	Mowat-Wilson syndrome	Likely pathogenic	no assertion criteria provided	VCV000977911	2	145162554	2	144404987	977911	965956		NC_000002.12:144404986:G:C
NM_014795.4(ZEB2):c.71del (p.Asn24fs)	ZEB2	N24fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 17, 2019)	criteria provided, single submitter	VCV000976275	2	145274847	2	144517280	976275	964164		NC_000002.12:144517279:TTTTT:TTTT
NM_014795.4(ZEB2):c.331+1G>T	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000975784	2	145187335	2	144429768	975784	964019		NC_000002.12:144429767:C:A
NM_014795.4(ZEB2):c.2958_2961del (p.Ser987fs)	ZEB2	S963fs, S987fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 1, 2019)	no assertion criteria provided	VCV000975783	2	145154085 - 145154088	2	144396518 - 144396521	975783	963498		NC_000002.12:144396517:AGACAGACAG:AGACAG
NM_014795.4(ZEB2):c.1683_1689dup (p.Asp564fs)	ZEB2	D540fs, D564fs	Mowat-Wilson syndrome	Likely pathogenic	criteria provided, single submitter	VCV000974830	2	145157064 - 145157065	2	144399497 - 144399498	974830	963122		NC_000002.12:144399497:TATTAAA:TATTAAATATTAAA
NM_014795.4(ZEB2):c.851G>A (p.Cys284Tyr)	ZEB2	C260Y, C284Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV000974618	2	145158831	2	144401264	974618	962915		NC_000002.12:144401263:C:T
NM_014795.4(ZEB2):c.1541_1548del (p.Pro514fs)	ZEB2	P490fs, P514fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000973224	2	145157206 - 145157213	2	144399639 - 144399646	973224	961590		NC_000002.12:144399638:CACTACCG:
NM_014795.4(ZEB2):c.2425G>T (p.Glu809Ter)	ZEB2	E785*, E809*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000973223	2	145156329	2	144398762	973223	961589		NC_000002.12:144398761:C:A
NM_014795.4(ZEB2):c.2419T>A (p.Ser807Thr)	ZEB2	S807T, S783T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000972300	2	145156335	2	144398768	972300	952632		NC_000002.12:144398767:A:T
NM_014795.4(ZEB2):c.2204C>G (p.Pro735Arg)	ZEB2	P711R, P735R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 13, 2019)	criteria provided, single submitter	VCV000970657	2	145156550	2	144398983	970657	952633		NC_000002.12:144398982:G:C
NM_014795.4(ZEB2):c.2847G>A (p.Met949Ile)	ZEB2	M925I, M949I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV000961764	2	145155907	2	144398340	961764	942231		NC_000002.12:144398339:C:T
NM_014795.4(ZEB2):c.1354A>G (p.Thr452Ala)	ZEB2	T428A, T452A	Mowat-Wilson syndrome	Benign(Last reviewed: Oct 6, 2020)	criteria provided, single submitter	VCV000960463	2	145157400	2	144399833	960463	942236		NC_000002.12:144399832:T:C
NM_014795.4(ZEB2):c.1722C>A (p.Asn574Lys)	ZEB2	N574K, N550K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 28, 2019)	criteria provided, single submitter	VCV000959767	2	145157032	2	144399465	959767	942234		NC_000002.12:144399464:G:T
NM_014795.4(ZEB2):c.1770del (p.Pro591fs)	ZEB2	P567fs, P591fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 22, 2019)	criteria provided, single submitter	VCV000959337	2	145156984	2	144399417	959337	942233		NC_000002.12:144399416:AAAA:AAA
NM_014795.4(ZEB2):c.3610G>A (p.Asp1204Asn)	ZEB2	D1180N, D1204N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, single submitter	VCV000958873	2	145147053	2	144389486	958873	942230		NC_000002.12:144389485:C:T
NM_014795.4(ZEB2):c.1947C>G (p.Ile649Met)	ZEB2	I649M, I625M	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV000957556	2	145156807	2	144399240	957556	942232		NC_000002.12:144399239:G:C
NM_014795.4(ZEB2):c.1714A>C (p.Ile572Leu)	ZEB2	I548L, I572L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 20, 2019)	criteria provided, single submitter	VCV000957425	2	145157040	2	144399473	957425	942235		NC_000002.12:144399472:T:G
NM_014795.4(ZEB2):c.199A>C (p.Asn67His)	ZEB2	N67H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000956159	2	145187468	2	144429901	956159	942238		NC_000002.12:144429900:T:G
NM_014795.4(ZEB2):c.1028G>A (p.Arg343Gln)	ZEB2	R343Q, R319Q	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 4, 2019)	criteria provided, single submitter	VCV000955846	2	145157726	2	144400159	955846	942237		NC_000002.12:144400158:C:T
NM_014795.4(ZEB2):c.1879G>A (p.Val627Ile)	ZEB2	V603I, V627I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000952294	2	145156875	2	144399308	952294	922242		NC_000002.12:144399307:C:T
NM_014795.4(ZEB2):c.1556del (p.Asn519fs)	ZEB2	N495fs, N519fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 26, 2019)	criteria provided, single submitter	VCV000952291	2	145157198	2	144399631	952291	922245		NC_000002.12:144399630:TT:T
NM_014795.4(ZEB2):c.2993T>C (p.Met998Thr)	ZEB2	M998T, M974T	Mowat-Wilson syndrome	Benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000951741	2	145154053	2	144396486	951741	922241		NC_000002.12:144396485:A:G
NM_014795.4(ZEB2):c.1601A>G (p.Asn534Ser)	ZEB2	N534S, N510S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 10, 2019)	criteria provided, single submitter	VCV000950301	2	145157153	2	144399586	950301	922244		NC_000002.12:144399585:T:C
NM_014795.4(ZEB2):c.1077_1081del (p.Ser360fs)	ZEB2	S336fs, S360fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 19, 2019)	criteria provided, single submitter	VCV000947462	2	145157673 - 145157677	2	144400106 - 144400110	947462	922247		NC_000002.12:144400105:GAGAAGA:GA
NM_014795.4(ZEB2):c.1655G>A (p.Ser552Asn)	ZEB2	S528N, S552N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000946656	2	145157099	2	144399532	946656	922243		NC_000002.12:144399531:C:T
NM_014795.4(ZEB2):c.3430G>A (p.Gly1144Ser)	ZEB2	G1120S, G1144S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 14, 2019)	criteria provided, single submitter	VCV000946596	2	145147233	2	144389666	946596	922240		NC_000002.12:144389665:C:T
NM_014795.4(ZEB2):c.3512G>A (p.Ser1171Asn)	ZEB2	S1147N, S1171N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV000946194	2	145147151	2	144389584	946194	922239		NC_000002.12:144389583:C:T
NM_014795.4(ZEB2):c.916+5G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV000945657	2	145158761	2	144401194	945657	940654		NC_000002.12:144401193:C:T
NM_014795.4(ZEB2):c.1091C>T (p.Ser364Leu)	ZEB2	S340L, S364L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000945233	2	145157663	2	144400096	945233	922246		NC_000002.12:144400095:G:A
NM_014795.4(ZEB2):c.2124G>A (p.Leu708=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, single submitter	VCV000941757	2	145156630	2	144399063	941757	930801		NC_000002.12:144399062:C:T
NM_014795.4(ZEB2):c.1885G>C (p.Val629Leu)	ZEB2	V629L, V605L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, single submitter	VCV000939431	2	145156869	2	144399302	939431	930802		NC_000002.12:144399301:C:G
NM_014795.4(ZEB2):c.67A>T (p.Lys23Ter)	ZEB2	K23*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000937858	2	145274851	2	144517284	937858	930806		NC_000002.12:144517283:T:A
NM_014795.4(ZEB2):c.776dup (p.His259fs)	ZEB2	H235fs, H259fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000935642	2	145161513 - 145161514	2	144403946 - 144403947	935642	930804		NC_000002.12:144403946:T:TT
NM_014795.4(ZEB2):c.3527C>A (p.Pro1176His)	ZEB2	P1152H, P1176H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 11, 2019)	criteria provided, single submitter	VCV000935467	2	145147136	2	144389569	935467	930800		NC_000002.12:144389568:G:T
NM_014795.4(ZEB2):c.128A>G (p.Lys43Arg)	ZEB2	K43R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV000934845	2	145187539	2	144429972	934845	930805		NC_000002.12:144429971:T:C
NM_014795.4(ZEB2):c.1745C>T (p.Ser582Leu)	ZEB2	S582L, S558L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV000934548	2	145157009	2	144399442	934548	930803		NC_000002.12:144399441:G:A
NM_014795.4(ZEB2):c.26G>A (p.Gly9Asp)	ZEB2	G9D	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Aug 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000933393	2	145274892	2	144517325	933393	930807		NC_000002.12:144517324:C:T
NM_014795.4(ZEB2):c.2303del (p.Asn768fs)	ZEB2	N744fs, N768fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV000869448	2	145156451	2	144398884	869448	857644		NC_000002.12:144398883:TT:T
NM_014795.4(ZEB2):c.1471A>T (p.Met491Leu)	ZEB2	M467L, M491L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000862431	2	145157283	2	144399716	862431	824768		NC_000002.12:144399715:T:A
NM_014795.4(ZEB2):c.757C>A (p.Arg253Ser)	ZEB2	R229S, R253S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000861296	2	145161533	2	144403966	861296	824774		NC_000002.12:144403965:G:T
NM_014795.4(ZEB2):c.2050_2064del (p.Pro684_Val688del)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000857081	2	145156690 - 145156704	2	144399123 - 144399137	857081	824766		NC_000002.12:144399122:CACAAATTCCTGAGG:
NM_014795.4(ZEB2):c.2044G>C (p.Gly682Arg)	ZEB2	G658R, G682R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 13, 2019)	criteria provided, single submitter	VCV000857080	2	145156710	2	144399143	857080	824767		NC_000002.12:144399142:C:G
NM_014795.4(ZEB2):c.2967A>G (p.Lys989=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000856579	2	145154079	2	144396512	856579	824761		NC_000002.12:144396511:T:C
NM_014795.4(ZEB2):c.3280G>A (p.Glu1094Lys)	ZEB2	E1094K, E1070K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 21, 2019)	criteria provided, single submitter	VCV000852429	2	145147383	2	144389816	852429	824759		NC_000002.12:144389815:C:T
NM_014795.4(ZEB2):c.2619_2620delinsAT (p.Asn873_Asn874delinsLysTyr)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 15, 2019)	criteria provided, single submitter	VCV000848011	2	145156134 - 145156135	2	144398567 - 144398568	848011	824764		NC_000002.12:144398566:TA:AT
NM_014795.4(ZEB2):c.1434C>A (p.Cys478Ter)	ZEB2	C478*, C454*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV000846691	2	145157320	2	144399753	846691	824769		NC_000002.12:144399752:G:T
NM_014795.4(ZEB2):c.1277T>A (p.Leu426Ter)	ZEB2	L426*, L402*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000844347	2	145157477	2	144399910	844347	824770		NC_000002.12:144399909:A:T
NM_014795.4(ZEB2):c.785C>T (p.Thr262Ile)	ZEB2	T262I, T238I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV000844344	2	145161505	2	144403938	844344	824773		NC_000002.12:144403937:G:A
NM_014795.4(ZEB2):c.493G>T (p.Glu165Ter)	ZEB2	E141*, E165*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 4, 2019)	criteria provided, single submitter	VCV000843162	2	145162502	2	144404935	843162	824775		NC_000002.12:144404934:C:A
NM_014795.4(ZEB2):c.2707G>A (p.Ala903Thr)	ZEB2	A879T, A903T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV000841521	2	145156047	2	144398480	841521	824763		NC_000002.12:144398479:C:T
NM_014795.4(ZEB2):c.2275A>G (p.Arg759Gly)	ZEB2	R735G, R759G	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 26, 2021)	criteria provided, conflicting interpretations	VCV000841461	2	145156479	2	144398912	841461	824765		NC_000002.12:144398911:T:C
NM_014795.4(ZEB2):c.2935A>G (p.Met979Val)	ZEB2	M955V, M979V	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 18, 2019)	criteria provided, single submitter	VCV000840243	2	145154111	2	144396544	840243	824762		NC_000002.12:144396543:T:C
NM_014795.4(ZEB2):c.1130A>C (p.Lys377Thr)	ZEB2	K377T, K353T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 2, 2019)	criteria provided, single submitter	VCV000840157	2	145157624	2	144400057	840157	824772		NC_000002.12:144400056:T:G
NM_014795.4(ZEB2):c.1211T>C (p.Met404Thr)	ZEB2	M380T, M404T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000839876	2	145157543	2	144399976	839876	824771		NC_000002.12:144399975:A:G
NM_014795.4(ZEB2):c.29C>T (p.Pro10Leu)	ZEB2	P10L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV000839856	2	145274889	2	144517322	839856	824777		NC_000002.12:144517321:G:A
NM_014795.4(ZEB2):c.11C>T (p.Pro4Leu)	ZEB2	P4L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 28, 2019)	criteria provided, single submitter	VCV000839637	2	145274907	2	144517340	839637	824778		NC_000002.12:144517339:G:A
NM_014795.4(ZEB2):c.469G>A (p.Asp157Asn)	ZEB2	D133N, D157N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000838010	2	145162526	2	144404959	838010	824776		NC_000002.12:144404958:C:T
NM_014795.4(ZEB2):c.3196C>T (p.His1066Tyr)	ZEB2	H1042Y, H1066Y	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000837537	2	145147467	2	144389900	837537	824760		NC_000002.12:144389899:G:A
NM_014795.4(ZEB2):c.1387G>A (p.Val463Ile)	ZEB2	V439I, V463I	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 29, 2019)	criteria provided, single submitter	VCV000833993	2	145157367	2	144399800	833993	821848		NC_000002.12:144399799:C:T
NM_014795.4(ZEB2):c.2119T>A (p.Ser707Thr)	ZEB2	S707T, S683T	Mowat-Wilson syndrome	Benign(Last reviewed: Jun 14, 2019)	criteria provided, single submitter	VCV000833970	2	145156635	2	144399068	833970	821847		NC_000002.12:144399067:A:T
NM_014795.4(ZEB2):c.3311C>T (p.Thr1104Ile)	ZEB2	T1080I, T1104I	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 24, 2019)	criteria provided, single submitter	VCV000833882	2	145147352	2	144389785	833882	821843		NC_000002.12:144389784:G:A
NM_014795.4(ZEB2):c.2824G>A (p.Gly942Arg)	ZEB2	G918R, G942R	Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 21, 2019)	criteria provided, single submitter	VCV000833740	2	145155930	2	144398363	833740	821845		NC_000002.12:144398362:C:T
NM_014795.4(ZEB2):c.3295G>C (p.Gly1099Arg)	ZEB2	G1075R, G1099R	Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 17, 2019)	criteria provided, single submitter	VCV000833618	2	145147368	2	144389801	833618	821844		NC_000002.12:144389800:C:G
NM_014795.4(ZEB2):c.224G>A (p.Ser75Asn)	ZEB2	S75N	Mowat-Wilson syndrome	Benign(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000833588	2	145187443	2	144429876	833588	821850		NC_000002.12:144429875:C:T
NM_014795.4(ZEB2):c.242G>C (p.Arg81Thr)	ZEB2	R81T	Mowat-Wilson syndrome	Benign(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000833587	2	145187425	2	144429858	833587	821849		NC_000002.12:144429857:C:G
NM_014795.4(ZEB2):c.2374T>C (p.Ser792Pro)	ZEB2	S768P, S792P	Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 13, 2019)	criteria provided, single submitter	VCV000833534	2	145156380	2	144398813	833534	821846		NC_000002.12:144398812:A:G
NM_014795.4(ZEB2):c.899A>G (p.His300Arg)	ZEB2	H300R, H276R	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000807725	2	145158783	2	144401216	807725	798481	rs1573718595	NC_000002.12:144401215:T:C
NM_014795.4(ZEB2):c.425_429del (p.Ser142fs)	ZEB2	S142fs, S118fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 18, 2019)	criteria provided, single submitter	VCV000807525	2	145162566 - 145162570	2	144404999 - 144405003	807525	798483	rs1573722407	NC_000002.12:144404998:ATCTGAT:AT
NM_014795.4(ZEB2):c.770_771del (p.Glu257fs)	ZEB2	E233fs, E257fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000807524	2	145161519 - 145161520	2	144403952 - 144403953	807524	798482	rs1573721065	NC_000002.12:144403951:CTC:C
NM_014795.4(ZEB2):c.194_195del (p.Val65fs)	ZEB2	V65fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801757	2	145187472 - 145187473	2	144429905 - 144429906	801757	790050	rs1573743951	NC_000002.12:144429904:CACAC:CAC
NM_014795.4(ZEB2):c.244G>A (p.Glu82Lys)	ZEB2	E82K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801756	2	145187423	2	144429856	801756	790049	rs1573743847	NC_000002.12:144429855:C:T
NM_014795.4(ZEB2):c.2095C>T (p.Gln699Ter)	ZEB2	Q675*, Q699*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801755	2	145156659	2	144399092	801755	790048	rs1573716158	NC_000002.12:144399091:G:A
NM_014795.4(ZEB2):c.2996_3003del (p.Met998_Tyr999insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801754	2	145154043 - 145154050	2	144396476 - 144396483	801754	790047	rs1573713477	NC_000002.12:144396475:ACATGCATACATGC:ACATGC
NM_014795.4(ZEB2):c.3122A>G (p.His1041Arg)	ZEB2	H1017R, H1041R	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801753	2	145147541	2	144389974	801753	790046	rs1573708153	NC_000002.12:144389973:T:C
NM_014795.4(ZEB2):c.3114C>G (p.His1038Gln)	ZEB2	H1014Q, H1038Q	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 29, 2019)	no assertion criteria provided	VCV000800745	2	145147549	2	144389982	800745	788742	rs1573708173	NC_000002.12:144389981:G:C
NM_014795.4(ZEB2):c.471T>C (p.Asp157=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000797260	2	145162524	2	144404957	797260	780835	rs775694100	NC_000002.12:144404956:A:G
NM_014795.4(ZEB2):c.403+10G>A	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000795207	2	145182353	2	144424786	795207	787196	rs1573739611	NC_000002.12:144424785:C:T
NM_014795.4(ZEB2):c.2175C>T (p.Asp725=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV000794938	2	145156579	2	144399012	794938	780833	rs1184693387	NC_000002.12:144399011:G:A
NM_014795.4(ZEB2):c.3459A>G (p.Arg1153=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000794862	2	145147204	2	144389637	794862	780832	rs1573707737	NC_000002.12:144389636:T:C
NM_014795.4(ZEB2):c.3067+8T>A	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV000794443	2	145153971	2	144396404	794443	787188	rs1573713416	NC_000002.12:144396403:A:T
NM_014795.4(ZEB2):c.1965C>T (p.His655=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000765456	2	145156789	2	144399222	765456	762194	rs1290881093	NC_000002.12:144399221:G:A
NM_014795.4(ZEB2):c.1470C>T (p.His490=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 25, 2019)	criteria provided, single submitter	VCV000762704	2	145157284	2	144399717	762704	762196	rs767360787	NC_000002.12:144399716:G:A
NM_014795.4(ZEB2):c.1353C>T (p.Pro451=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Mar 6, 2020)	criteria provided, single submitter	VCV000755821	2	145157401	2	144399834	755821	762197	rs1573717237	NC_000002.12:144399833:G:A
NM_014795.4(ZEB2):c.2085A>G (p.Arg695=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000755079	2	145156669	2	144399102	755079	762193	rs1573716167	NC_000002.12:144399101:T:C
NM_014795.4(ZEB2):c.2385C>T (p.Asn795=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Jul 7, 2020)	criteria provided, single submitter	VCV000754025	2	145156369	2	144398802	754025	762192	rs759505392	NC_000002.12:144398801:G:A
NM_014795.4(ZEB2):c.1890T>C (p.Asp630=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000753258	2	145156864	2	144399297	753258	762195	rs1220461554	NC_000002.12:144399296:A:G
NM_014795.4(ZEB2):c.2547T>C (p.Val849=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 2, 2020)	criteria provided, single submitter	VCV000745011	2	145156207	2	144398640	745011	746783	rs908943407	NC_000002.12:144398639:A:G
NM_014795.4(ZEB2):c.1240C>A (p.Pro414Thr)	ZEB2	P390T, P414T	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000741718	2	145157514	2	144399947	741718	746784	rs755425183	NC_000002.12:144399946:G:T
NM_014795.4(ZEB2):c.2565C>G (p.Asn855Lys)	ZEB2	N855K, N831K	Mowat-Wilson syndrome	Benign(Last reviewed: Jun 19, 2019)	criteria provided, single submitter	VCV000719246	2	145156189	2	144398622	719246	719275	rs904620951	NC_000002.12:144398621:G:C
NM_014795.4(ZEB2):c.3495A>G (p.Glu1165=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000703403	2	145147168	2	144389601	703403	690742	rs907774736	NC_000002.12:144389600:T:C
NM_014795.4(ZEB2):c.2373A>G (p.Thr791=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000703060	2	145156381	2	144398814	703060	690743	rs775082191	NC_000002.12:144398813:T:C
NM_014795.4(ZEB2):c.180G>A (p.Thr60=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000702433	2	145187487	2	144429920	702433	690744	rs372888487	NC_000002.12:144429919:C:T
NM_014795.4(ZEB2):c.3489A>G (p.Glu1163=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 29, 2020)	criteria provided, single submitter	VCV000701712	2	145147174	2	144389607	701712	685839	rs1573707668	NC_000002.12:144389606:T:C
NM_014795.4(ZEB2):c.3285G>A (p.Ala1095=)	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: May 26, 2020)	criteria provided, single submitter	VCV000700655	2	145147378	2	144389811	700655	685840	rs201630448	NC_000002.12:144389810:C:T
NM_014795.4(ZEB2):c.2541C>T (p.Asn847=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Aug 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000698870	2	145156213	2	144398646	698870	685841	rs759097498	NC_000002.12:144398645:G:A
NM_014795.4(ZEB2):c.2342A>G (p.Asn781Ser)	ZEB2	N757S, N781S	Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV000698511	2	145156412	2	144398845	698511	685842	rs750936389	NC_000002.12:144398844:T:C
NM_014795.4(ZEB2):c.2808C>T (p.Ala936=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Mar 13, 2018)	criteria provided, single submitter	VCV000697223	2	145155946	2	144398379	697223	683391	rs749708858	NC_000002.12:144398378:G:A
NM_014795.4(ZEB2):c.2538T>A (p.His846Gln)	ZEB2	H822Q, H846Q	Mowat-Wilson syndrome|not provided	Benign(Last reviewed: Apr 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000696826	2	145156216	2	144398649	696826	683393	rs557767273	NC_000002.12:144398648:A:T
NM_014795.4(ZEB2):c.2804T>C (p.Met935Thr)	ZEB2	M911T, M935T	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000696738	2	145155950	2	144398383	696738	683392	rs201902790	NC_000002.12:144398382:A:G
NM_014795.4(ZEB2):c.1387del (p.Val463fs)	ZEB2	V439fs, V463fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 16, 2018)	criteria provided, single submitter	VCV000692022	2	145157367	2	144399800	692022	679737	rs1573717173	NC_000002.12:144399799:CC:C
NM_014795.4(ZEB2):c.656del (p.Gly219fs)	ZEB2	G195fs, G219fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 2, 2017)	criteria provided, single submitter	VCV000691991	2	145161634	2	144404067	691991	679738	rs1573721242	NC_000002.12:144404066:CCCC:CCC
NM_014795.4(ZEB2):c.2627A>G (p.Asp876Gly)	ZEB2	D876G, D852G	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 23, 2020)	criteria provided, conflicting interpretations	VCV000681961	2	145156127	2	144398560	681961	655139	rs779103467	NC_000002.12:144398559:T:C
NM_014795.4(ZEB2):c.2733A>G (p.Pro911=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Jun 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000681072	2	145156021	2	144398454	681072	655138	rs750408329	NC_000002.12:144398453:T:C
NM_014795.4(ZEB2):c.1008T>C (p.Gly336=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000671958	2	145157746	2	144400179	671958	655141	rs149510351	NC_000002.12:144400178:A:G
NM_014795.4(ZEB2):c.3308C>A (p.Pro1103His)	ZEB2	P1103H, P1079H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000665219	2	145147355	2	144389788	665219	628448	rs1385679012	NC_000002.12:144389787:G:T
NM_014795.4(ZEB2):c.2337G>C (p.Arg779Ser)	ZEB2	R779S, R755S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000661027	2	145156417	2	144398850	661027	628453	rs1573715809	NC_000002.12:144398849:C:G
NM_014795.4(ZEB2):c.933G>T (p.Glu311Asp)	ZEB2	E287D, E311D	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000660079	2	145157821	2	144400254	660079	628456	rs1573717761	NC_000002.12:144400253:C:A
NM_014795.4(ZEB2):c.2239C>T (p.Leu747Phe)	ZEB2	L723F, L747F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000659354	2	145156515	2	144398948	659354	628454	rs1160664411	NC_000002.12:144398947:G:A
NM_014795.4(ZEB2):c.3070A>G (p.Lys1024Glu)	ZEB2	K1000E, K1024E	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 23, 2018)	criteria provided, single submitter	VCV000657836	2	145147593	2	144390026	657836	628450	rs1573708232	NC_000002.12:144390025:T:C
NM_014795.4(ZEB2):c.751G>A (p.Ala251Thr)	ZEB2	A227T, A251T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000657562	2	145161539	2	144403972	657562	628458	rs1437414345	NC_000002.12:144403971:C:T
NM_014795.4(ZEB2):c.1017del (p.Ser339_Val340insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 9, 2018)	criteria provided, single submitter	VCV000650576	2	145157737	2	144400170	650576	628455	rs1573717685	NC_000002.12:144400169:A:
NM_014795.4(ZEB2):c.364C>T (p.Pro122Ser)	ZEB2	P122S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 8, 2018)	criteria provided, single submitter	VCV000645462	2	145182402	2	144424835	645462	628461	rs1573739706	NC_000002.12:144424834:G:A
NM_014795.4(ZEB2):c.3298C>T (p.His1100Tyr)	ZEB2	H1100Y, H1076Y	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 4, 2018)	criteria provided, single submitter	VCV000645103	2	145147365	2	144389798	645103	628449	rs1573707949	NC_000002.12:144389797:G:A
NM_014795.4(ZEB2):c.2647G>A (p.Val883Met)	ZEB2	V883M, V859M	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Dec 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000644069	2	145156107	2	144398540	644069	628452	rs550047043	NC_000002.12:144398539:C:T
NM_014795.4(ZEB2):c.857_858del (p.Glu286fs)	ZEB2	E262fs, E286fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000641571	2	145158824 - 145158825	2	144401257 - 144401258	641571	628457	rs1573718630	NC_000002.12:144401256:CTCT:CT
NM_014795.4(ZEB2):c.2692C>T (p.Leu898Phe)	ZEB2	L874F, L898F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 13, 2018)	criteria provided, single submitter	VCV000640254	2	145156062	2	144398495	640254	628451	rs1573715321	NC_000002.12:144398494:G:A
NM_014795.4(ZEB2):c.703G>T (p.Glu235Ter)	ZEB2	E235*, E211*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV000619079	2	145161587	2	144404020	619079	610477	rs1553962069	NC_000002.12:144404019:C:A
NM_014795.4(ZEB2):c.1554T>C (p.His518=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome	Likely benign(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000590043	2	145157200	2	144399633	590043	578911	rs1431508601	NC_000002.12:144399632:A:G
NM_014795.4(ZEB2):c.2589T>C (p.Thr863=)	ZEB2		Mowat-Wilson syndrome|History of neurodevelopmental disorder	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589784	2	145156165	2	144398598	589784	578929	rs985918539	NC_000002.12:144398597:A:G
NM_014795.4(ZEB2):c.1049C>T (p.Thr350Met)	ZEB2	T350M, T326M	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000589364	2	145157705	2	144400138	589364	578917	rs975397942	NC_000002.12:144400137:G:A
NM_014795.4(ZEB2):c.1956C>A (p.Tyr652Ter)	ZEB2	Y652*, Y628*	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Pathogenic(Last reviewed: Jul 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000589324	2	145156798	2	144399231	589324	578959	rs587784563	NC_000002.12:144399230:G:T
NM_014795.4(ZEB2):c.2886+4_2886+5del	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000583029	2	145155863 - 145155864	2	144398296 - 144398297	583029	557561	rs1560605795	NC_000002.12:144398295:TTT:T
NM_014795.4(ZEB2):c.2774G>A (p.Gly925Glu)	ZEB2	G925E, G901E	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000580028	2	145155980	2	144398413	580028	559210	rs1408659659	NC_000002.12:144398412:C:T
NM_014795.4(ZEB2):c.2418C>A (p.Phe806Leu)	ZEB2	F806L, F782L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, single submitter	VCV000575923	2	145156336	2	144398769	575923	557514	rs770951243	NC_000002.12:144398768:G:T
NM_014795.4(ZEB2):c.2541C>A (p.Asn847Lys)	ZEB2	N847K, N823K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 21, 2018)	criteria provided, single submitter	VCV000575296	2	145156213	2	144398646	575296	558721	rs759097498	NC_000002.12:144398645:G:T
NM_014795.4(ZEB2):c.2354C>G (p.Pro785Arg)	ZEB2	P785R, P761R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, single submitter	VCV000574367	2	145156400	2	144398833	574367	557518	rs1560606278	NC_000002.12:144398832:G:C
NM_014795.4(ZEB2):c.3599A>G (p.Glu1200Gly)	ZEB2	E1200G, E1176G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000574019	2	145147064	2	144389497	574019	558719	rs1273805127	NC_000002.12:144389496:T:C
NM_014795.4(ZEB2):c.1222G>A (p.Gly408Arg)	ZEB2	G408R, G384R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 4, 2020)	criteria provided, single submitter	VCV000572911	2	145157532	2	144399965	572911	558727	rs770190727	NC_000002.12:144399964:C:T
NM_014795.4(ZEB2):c.432dup (p.Glu145Ter)	ZEB2	E145*, E121*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000572710	2	145162562 - 145162563	2	144404995 - 144404996	572710	557524	rs1560609810	NC_000002.12:144404995:AAAA:AAAAA
NM_014795.4(ZEB2):c.3538C>G (p.Arg1180Gly)	ZEB2	R1180G, R1156G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000572414	2	145147125	2	144389558	572414	559206	rs756424812	NC_000002.12:144389557:G:C
NM_014795.4(ZEB2):c.3025C>T (p.Gln1009Ter)	ZEB2	Q1009*, Q985*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2018)	criteria provided, single submitter	VCV000572098	2	145154021	2	144396454	572098	559208	rs1560604977	NC_000002.12:144396453:G:A
NM_014795.4(ZEB2):c.1570dup (p.Ser524fs)	ZEB2	S524fs, S500fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 10, 2018)	criteria provided, single submitter	VCV000571056	2	145157183 - 145157184	2	144399616 - 144399617	571056	558725	rs1560606974	NC_000002.12:144399616:TTTT:TTTTT
NM_014795.4(ZEB2):c.2390A>G (p.His797Arg)	ZEB2	H797R, H773R	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000569903	2	145156364	2	144398797	569903	557516	rs201227541	NC_000002.12:144398796:T:C
NM_014795.4(ZEB2):c.236_239del (p.Leu78_Leu79insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000569754	2	145187428 - 145187431	2	144429861 - 144429864	569754	557567	rs1560620837	NC_000002.12:144429860:GGCA:
NM_014795.4(ZEB2):c.2337del (p.Ser780fs)	ZEB2	S756fs, S780fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 15, 2018)	criteria provided, single submitter	VCV000569753	2	145156417	2	144398850	569753	559212	rs1560606294	NC_000002.12:144398849:CC:C
NM_014795.4(ZEB2):c.808-2A>G	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000569478	2	145158876	2	144401309	569478	557565	rs1560607925	NC_000002.12:144401308:T:C
NM_014795.4(ZEB2):c.2545G>A (p.Val849Ile)	ZEB2	V849I, V825I	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000569360	2	145156209	2	144398642	569360	557563	rs1560606101	NC_000002.12:144398641:C:T
NM_014795.4(ZEB2):c.1845G>T (p.Gln615His)	ZEB2	Q615H, Q591H	Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV000568984	2	145156909	2	144399342	568984	557522	rs757485792	NC_000002.12:144399341:C:A
NM_014795.4(ZEB2):c.1975C>T (p.Leu659Phe)	ZEB2	L659F, L635F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000568915	2	145156779	2	144399212	568915	557520	rs1560606673	NC_000002.12:144399211:G:A
NM_014795.4(ZEB2):c.351T>A (p.Tyr117Ter)	ZEB2	Y117*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000567647	2	145182415	2	144424848	567647	557526	rs1560618505	NC_000002.12:144424847:A:T
NM_014795.4(ZEB2):c.1571G>A (p.Ser524Asn)	ZEB2	S524N, S500N	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000566943	2	145157183	2	144399616	566943	558723	rs1560606972	NC_000002.12:144399615:C:T
NM_014795.4(ZEB2):c.2757del (p.Leu920fs)	ZEB2	L896fs, L920fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561145	2	145155997	2	144398430	561145	552050	rs1560605892	NC_000002.12:144398429:CCC:CC
NM_014795.4(ZEB2):c.71dup (p.Asn24fs)	ZEB2	N24fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 22, 2018)	no assertion criteria provided	VCV000559637	2	145274846 - 145274847	2	144517279 - 144517280	559637	550349	rs1553971826	NC_000002.12:144517279:TTTTT:TTTTTT
NM_014795.4(ZEB2):c.3200C>A (p.Ser1067Ter)	ZEB2	S1067*, S1043*	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547837	2	145147463	2	144389896	547837	537690	rs1423851170	NC_000002.12:144389895:G:T
NM_014795.4(ZEB2):c.3023T>G (p.Phe1008Cys)	ZEB2	F1008C, F984C	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547836	2	145154023	2	144396456	547836	537691	rs1553961332	NC_000002.12:144396455:A:C
NM_014795.4(ZEB2):c.2227del (p.Ser743fs)	ZEB2	S719fs, S743fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547835	2	145156527	2	144398960	547835	537692	rs1553961580	NC_000002.12:144398959:A:
NM_014795.4(ZEB2):c.1168del (p.Ile390fs)	ZEB2	I366fs, I390fs	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547834	2	145157586	2	144400019	547834	537693	rs1553961747	NC_000002.12:144400018:TTTT:TTT
NM_014795.4(ZEB2):c.1162C>T (p.Leu388Phe)	ZEB2	L388F, L364F	Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547833	2	145157592	2	144400025	547833	537694	rs1553961748	NC_000002.12:144400024:G:A
NM_014795.4(ZEB2):c.247dup (p.Glu83fs)	ZEB2	E83fs	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Nov 1, 2016)	criteria provided, single submitter	VCV000547832	2	145187419 - 145187420	2	144429852 - 144429853	547832	537695	rs1553964145	NC_000002.12:144429852:CC:CCC
NM_014795.4(ZEB2):c.216A>C (p.Pro72=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000534646	2	145187451	2	144429884	534646	516360	rs764560219	NC_000002.12:144429883:T:G
NM_014795.4(ZEB2):c.2120C>T (p.Ser707Phe)	ZEB2	S707F, S683F	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000534645	2	145156634	2	144399067	534645	516426	rs1174325176	NC_000002.12:144399066:G:A
NM_014795.4(ZEB2):c.807+3G>A	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000534644	2	145161480	2	144403913	534644	516344	rs144925893	NC_000002.12:144403912:C:T
NM_014795.4(ZEB2):c.168G>C (p.Leu56=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 8, 2017)	criteria provided, single submitter	VCV000534643	2	145187499	2	144429932	534643	516456	rs1553964156	NC_000002.12:144429931:C:G
NM_014795.4(ZEB2):c.1426A>C (p.Met476Leu)	ZEB2	M476L, M452L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 4, 2017)	criteria provided, single submitter	VCV000534642	2	145157328	2	144399761	534642	516454	rs778246270	NC_000002.12:144399760:T:G
NM_014795.4(ZEB2):c.1491A>C (p.Gln497His)	ZEB2	Q497H, Q473H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 19, 2017)	criteria provided, single submitter	VCV000534641	2	145157263	2	144399696	534641	516446	rs200378546	NC_000002.12:144399695:T:G
NM_014795.4(ZEB2):c.3202_3207del (p.Gly1068_Ser1069del)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000534640	2	145147456 - 145147461	2	144389889 - 144389894	534640	516420	rs1553960777	NC_000002.12:144389888:CGAGCCCGAG:CGAG
NM_014795.4(ZEB2):c.3357G>C (p.Gln1119His)	ZEB2	Q1119H, Q1095H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 18, 2019)	criteria provided, single submitter	VCV000534639	2	145147306	2	144389739	534639	516436	rs1332911302	NC_000002.12:144389738:C:G
NM_014795.4(ZEB2):c.1880T>A (p.Val627Asp)	ZEB2	V627D, V603D	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000534638	2	145156874	2	144399307	534638	516357	rs730881176	NC_000002.12:144399306:A:T
NM_014795.4(ZEB2):c.467G>A (p.Arg156His)	ZEB2	R156H, R132H	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 17, 2020)	criteria provided, single submitter	VCV000534637	2	145162528	2	144404961	534637	516437	rs1250217464	NC_000002.12:144404960:C:T
NM_014795.4(ZEB2):c.3575A>C (p.Asp1192Ala)	ZEB2	D1192A, D1168A	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000534636	2	145147088	2	144389521	534636	516411	rs752093966	NC_000002.12:144389520:T:G
NM_014795.4(ZEB2):c.3267A>C (p.Glu1089Asp)	ZEB2	E1089D, E1065D	Mowat-Wilson syndrome|Lennox-Gastaut syndrome	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000534635	2	145147396	2	144389829	534635	516418	rs1553960775	NC_000002.12:144389828:T:G
NM_014795.4(ZEB2):c.703G>A (p.Glu235Lys)	ZEB2	E235K, E211K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 25, 2017)	criteria provided, single submitter	VCV000534634	2	145161587	2	144404020	534634	516428	rs1553962069	NC_000002.12:144404019:C:T
NM_014795.4(ZEB2):c.2621A>C (p.Asn874Thr)	ZEB2	N874T, N850T	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000534633	2	145156133	2	144398566	534633	516423	rs1477010525	NC_000002.12:144398565:T:G
NM_014795.4(ZEB2):c.2806del (p.Ala936fs)	ZEB2	A936fs, A912fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 3, 2019)	criteria provided, single submitter	VCV000534632	2	145155948	2	144398381	534632	516342	rs1553961487	NC_000002.12:144398380:CC:C
NM_014795.4(ZEB2):c.234_235del (p.Leu79fs)	ZEB2	L79fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000534631	2	145187432 - 145187433	2	144429865 - 144429866	534631	516345	rs1553964147	NC_000002.12:144429864:ACA:A
NM_014795.4(ZEB2):c.2327A>G (p.Asp776Gly)	ZEB2	D776G, D752G	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000534630	2	145156427	2	144398860	534630	516355	rs1553961558	NC_000002.12:144398859:T:C
NM_014795.4(ZEB2):c.1527G>A (p.Pro509=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516856	2	145157227	2	144399660	516856	498656	rs759999662	NC_000002.12:144399659:C:T
NM_014795.4(ZEB2):c.1336C>T (p.Pro446Ser)	ZEB2	P446S, P422S	Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516349	2	145157418	2	144399851	516349	498659	rs1435380197	NC_000002.12:144399850:G:A
NM_014795.4(ZEB2):c.384C>T (p.Thr128=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000514330	2	145182382	2	144424815	514330	498668	rs573552493	NC_000002.12:144424814:G:A
NM_014795.4(ZEB2):c.2300C>T (p.Thr767Ile)	ZEB2	T767I, T743I	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 7, 2020)	criteria provided, conflicting interpretations	VCV000513556	2	145156454	2	144398887	513556	498911	rs755233964	NC_000002.12:144398886:G:A
NM_014795.4(ZEB2):c.3057C>T (p.Tyr1019=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512784	2	145153989	2	144396422	512784	498643	rs541915540	NC_000002.12:144396421:G:A
NM_014795.4(ZEB2):c.2226A>T (p.Pro742=)	ZEB2		not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 30, 2020)	criteria provided, conflicting interpretations	VCV000511735	2	145156528	2	144398961	511735	498654	rs540345773	NC_000002.12:144398960:T:A
NM_014795.4(ZEB2):c.720C>T (p.Asn240=)	ZEB2		Mowat-Wilson syndrome|not specified|not provided	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000510555	2	145161570	2	144404003	510555	498660	rs1022840384	NC_000002.12:144404002:G:A
NM_014795.4(ZEB2):c.981G>A (p.Ser327=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign(Last reviewed: Oct 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000510410	2	145157773	2	144400206	510410	498875	rs201579452	NC_000002.12:144400205:C:T
NM_014795.4(ZEB2):c.828A>G (p.Gly276=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000509911	2	145158854	2	144401287	509911	498876	rs1161704021	NC_000002.12:144401286:T:C
NM_014795.4(ZEB2):c.2855G>C (p.Arg952Thr)	ZEB2	R952T, R928T	not specified|not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 19, 2018)	criteria provided, conflicting interpretations	VCV000506473	2	145155899	2	144398332	506473	498650	rs151256895	NC_000002.12:144398331:C:G
NM_014795.4(ZEB2):c.3118C>T (p.His1040Tyr)	ZEB2	H1016Y, H1040Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000496685	2	145147545	2	144389978	496685	488152	rs1553960788	NC_000002.12:144389977:G:A
NM_014795.4(ZEB2):c.807+8G>A	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000466291	2	145161475	2	144403908	466291	448710	rs367991951	NC_000002.12:144403907:C:T
NM_014795.4(ZEB2):c.593-9C>T	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466290	2	145161706	2	144404139	466290	448726	rs372216323	NC_000002.12:144404138:G:A
NM_014795.4(ZEB2):c.481del (p.Val161fs)	ZEB2	V161fs, V137fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, single submitter	VCV000466289	2	145162514	2	144404947	466289	448735	rs1553962198	NC_000002.12:144404946:C:
NM_014795.4(ZEB2):c.3451C>A (p.Leu1151Met)	ZEB2	L1151M, L1127M	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Dec 6, 2019)	criteria provided, single submitter	VCV000466288	2	145147212	2	144389645	466288	448789	rs772764893	NC_000002.12:144389644:G:T
NM_014795.4(ZEB2):c.3327C>A (p.Asn1109Lys)	ZEB2	N1109K, N1085K	not provided|Mowat-Wilson syndrome	Benign(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000466287	2	145147336	2	144389769	466287	448790	rs1288140327	NC_000002.12:144389768:G:T
NM_014795.4(ZEB2):c.324T>C (p.Asp108=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 12, 2017)	criteria provided, single submitter	VCV000466286	2	145187343	2	144429776	466286	448797	rs148117680	NC_000002.12:144429775:A:G
NM_014795.4(ZEB2):c.30C>T (p.Pro10=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: May 31, 2017)	criteria provided, single submitter	VCV000466285	2	145274888	2	144517321	466285	448713	rs747483109	NC_000002.12:144517320:G:A
NM_014795.4(ZEB2):c.2951C>T (p.Ser984Phe)	ZEB2	S984F, S960F	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Apr 28, 2017)	criteria provided, single submitter	VCV000466284	2	145154095	2	144396528	466284	448695	rs143474223	NC_000002.12:144396527:G:A
NM_014795.4(ZEB2):c.2869C>T (p.Arg957Trp)	ZEB2	R957W, R933W	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Feb 27, 2017)	criteria provided, single submitter	VCV000466283	2	145155885	2	144398318	466283	448699	rs1354236085	NC_000002.12:144398317:G:A
NM_014795.4(ZEB2):c.2762G>A (p.Arg921Gln)	ZEB2	R921Q, R897Q	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000466282	2	145155992	2	144398425	466282	448703	rs147716561	NC_000002.12:144398424:C:T
NM_014795.4(ZEB2):c.2688dup (p.Ala897fs)	ZEB2	A873fs, A897fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000466281	2	145156065 - 145156066	2	144398498 - 144398499	466281	448708	rs1553961510	NC_000002.12:144398498:T:TT
NM_014795.4(ZEB2):c.2325G>A (p.Leu775=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 26, 2020)	criteria provided, single submitter	VCV000466280	2	145156429	2	144398862	466280	448572	rs1553961560	NC_000002.12:144398861:C:T
NM_014795.4(ZEB2):c.2038_2152dup (p.Asn718delinsSerCysGlyProSerSerGlyIleCysGluGlyMetValTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000466279	2	145156601 - 145156602	2	144399034 - 144399035	466279	448705	rs1553961598	
NM_014795.4(ZEB2):c.1993A>G (p.Met665Val)	ZEB2	M665V, M641V	Mowat-Wilson syndrome|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2019)	criteria provided, conflicting interpretations	VCV000466278	2	145156761	2	144399194	466278	448712	rs1388932284	NC_000002.12:144399193:T:C
NM_014795.4(ZEB2):c.1836G>A (p.Ala612=)	ZEB2		Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466277	2	145156918	2	144399351	466277	448792	rs754916469	NC_000002.12:144399350:C:T
NM_014795.4(ZEB2):c.1503A>G (p.Gln501=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000466276	2	145157251	2	144399684	466276	448714	rs1269576350	NC_000002.12:144399683:T:C
NM_014795.4(ZEB2):c.1309C>A (p.Gln437Lys)	ZEB2	Q437K, Q413K	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV000466275	2	145157445	2	144399878	466275	448706	rs760437173	NC_000002.12:144399877:G:T
NM_014795.4(ZEB2):c.1221C>T (p.His407=)	ZEB2		Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: Nov 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000466274	2	145157533	2	144399966	466274	448717	rs144613207	NC_000002.12:144399965:G:A
NM_014795.4(ZEB2):c.1053T>C (p.Gly351=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000466273	2	145157701	2	144400134	466273	448718	rs1553961766	NC_000002.12:144400133:A:G
NC_000002.12:g.(?_144517258)_(144517420_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 13, 2017)	criteria provided, single submitter	VCV000466272			2	144517258 - 144517420	466272	448525		
NM_014795.4(ZEB2):c.2471T>C (p.Met824Thr)	ZEB2	M824T, M800T	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000450276	2	145156283	2	144398716	450276	442923	rs1553961536	NC_000002.12:144398715:A:G
NM_014795.4(ZEB2):c.2211_2214dup (p.Ile739fs)	ZEB2	I715fs, I739fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 16, 2017)	criteria provided, single submitter	VCV000448970	2	145156539 - 145156540	2	144398972 - 144398973	448970	442547	rs1553961585	NC_000002.12:144398972:GGAG:GGAGGGAG
NM_014795.4(ZEB2):c.74-3C>T	ZEB2		not specified|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448886	2	145187596	2	144430029	448886	440523	rs984545941	NC_000002.12:144430028:G:A
NM_014795.4(ZEB2):c.1489C>T (p.Gln497Ter)	ZEB2	Q497*, Q473*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000437333	2	145157265	2	144399698	437333	427889	rs1553961702	NC_000002.12:144399697:G:A
NM_014795.4(ZEB2):c.2072G>A (p.Trp691Ter)	ZEB2	W691*, W667*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 2, 2015)	criteria provided, single submitter	VCV000437332	2	145156682	2	144399115	437332	427887	rs1553961610	NC_000002.12:144399114:C:T
NM_014795.4(ZEB2):c.220G>A (p.Val74Met)	ZEB2	V74M	not specified|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000437331	2	145187447	2	144429880	437331	427895	rs767169568	NC_000002.12:144429879:C:T
NM_014795.4(ZEB2):c.466C>T (p.Arg156Cys)	ZEB2	R156C, R132C	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 19, 2019)	criteria provided, conflicting interpretations	VCV000437330	2	145162529	2	144404962	437330	427893	rs147021269	NC_000002.12:144404961:G:A
NM_014795.4(ZEB2):c.2497A>G (p.Thr833Ala)	ZEB2	T833A, T809A	not specified|Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000437325	2	145156257	2	144398690	437325	427885	rs1490526407	NC_000002.12:144398689:T:C
NM_014795.4(ZEB2):c.3109A>T (p.Lys1037Ter)	ZEB2	K1037*, K1013*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 21, 2015)	criteria provided, single submitter	VCV000437324	2	145147554	2	144389987	437324	427883	rs1553960793	NC_000002.12:144389986:T:A
NM_014795.4(ZEB2):c.3164A>G (p.Tyr1055Cys)	ZEB2	Y1055C, Y1031C	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jun 8, 2017)	criteria provided, single submitter	VCV000431481	2	145147499	2	144389932	431481	424988	rs1135402759	NC_000002.12:144389931:T:C
NM_014795.4(ZEB2):c.3170G>A (p.Cys1057Tyr)	ZEB2	C1057Y, C1033Y	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 6, 2017)	criteria provided, single submitter	VCV000431116	2	145147493	2	144389926	431116	424640	rs1135401790	NC_000002.12:144389925:C:T
NM_014795.4(ZEB2):c.593-18_593-17insTG	ZEB2		not specified|Mowat-Wilson syndrome	Benign(Last reviewed: Mar 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000418552	2	145161714 - 145161715	2	144404147 - 144404148	418552	405296	rs776927209	NC_000002.12:144404147:A:ACA
NC_000002.12:g.(?_144517278)_(144517419_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 3, 2016)	criteria provided, single submitter	VCV000417344	2	145274845 - 145274986	2	144517278 - 144517419	417344	391349		
NM_014795.4(ZEB2):c.1315T>C (p.Leu439=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Apr 29, 2016)	criteria provided, single submitter	VCV000413313	2	145157439	2	144399872	413313	391506	rs1060503991	NC_000002.12:144399871:A:G
NM_014795.4(ZEB2):c.702C>T (p.His234=)	ZEB2		not provided|History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Feb 7, 2021)	criteria provided, multiple submitters, no conflicts	VCV000413312	2	145161588	2	144404021	413312	391419	rs140169964	NC_000002.12:144404020:G:A
NM_014795.4(ZEB2):c.1386G>C (p.Lys462Asn)	ZEB2	K462N, K438N	not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV000413311	2	145157368	2	144399801	413311	391364	rs780523431	NC_000002.12:144399800:C:G
NM_014795.4(ZEB2):c.696C>T (p.Tyr232=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Sep 23, 2016)	criteria provided, single submitter	VCV000413310	2	145161594	2	144404027	413310	391421	rs1060503990	NC_000002.12:144404026:G:A
NM_014795.4(ZEB2):c.1071T>G (p.Val357=)	ZEB2		not provided|Mowat-Wilson syndrome	Likely benign(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000413309	2	145157683	2	144400116	413309	391508	rs200510665	NC_000002.12:144400115:A:C
NM_014795.4(ZEB2):c.3408C>G (p.Ser1136Arg)	ZEB2	S1136R, S1112R	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Sep 1, 2018)	criteria provided, single submitter	VCV000405333	2	145147255	2	144389688	405333	391602	rs1060500655	NC_000002.12:144389687:G:C
NM_014795.4(ZEB2):c.2205_2206delinsCG (p.Met736Val)	ZEB2	M712V, M736V	Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000405332	2	145156548 - 145156549	2	144398981 - 144398982	405332	391604	rs1060500654	NC_000002.12:144398980:TA:CG
NM_014795.4(ZEB2):c.3095del (p.Cys1032fs)	ZEB2	C1032fs, C1008fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Oct 13, 2016)	criteria provided, single submitter	VCV000405331	2	145147568	2	144390001	405331	391416	rs1060500653	NC_000002.12:144390000:C:
NM_014795.4(ZEB2):c.2622T>A (p.Asn874Lys)	ZEB2	N874K, N850K	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Mar 28, 2018)	criteria provided, conflicting interpretations	VCV000392737	2	145156132	2	144398565	392737	365558	rs745927130	NC_000002.12:144398564:A:T
NM_014795.4(ZEB2):c.621T>C (p.Phe207=)	ZEB2		Mowat-Wilson syndrome|not specified|not provided	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391948	2	145161669	2	144404102	391948	365575	rs934470843	NC_000002.12:144404101:A:G
NM_014795.4(ZEB2):c.396T>C (p.Asn132=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: May 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391187	2	145182370	2	144424803	391187	365390	rs147072510	NC_000002.12:144424802:A:G
NM_014795.4(ZEB2):c.3557G>T (p.Gly1186Val)	ZEB2	G1186V, G1162V	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 11, 2019)	criteria provided, conflicting interpretations	VCV000391143	2	145147106	2	144389539	391143	365376	rs748213160	NC_000002.12:144389538:C:A
NM_014795.4(ZEB2):c.1534G>A (p.Gly512Ser)	ZEB2	G512S, G488S	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 1, 2020)	criteria provided, conflicting interpretations	VCV000390228	2	145157220	2	144399653	390228	365562	rs141781307	NC_000002.12:144399652:C:T
NM_014795.4(ZEB2):c.564G>A (p.Thr188=)	ZEB2|LOC111721705		not specified|History of neurodevelopmental disorder|Mowat-Wilson syndrome	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000389320	2	145162431	2	144404864	389320	365771	rs747482254	NC_000002.12:144404863:C:T
NM_014795.4(ZEB2):c.395A>G (p.Asn132Ser)	ZEB2	N132S	not provided|Mowat-Wilson syndrome	Benign(Last reviewed: Aug 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000388778	2	145182371	2	144424804	388778	365576	rs369622877	NC_000002.12:144424803:T:C
NM_014795.4(ZEB2):c.1288C>T (p.Pro430Ser)	ZEB2	P430S, P406S	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2018)	criteria provided, conflicting interpretations	VCV000388030	2	145157466	2	144399899	388030	365759	rs753804606	NC_000002.12:144399898:G:A
NM_014795.4(ZEB2):c.73+6A>C	ZEB2		not provided|Mowat-Wilson syndrome	Benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000387907	2	145274839	2	144517272	387907	365590	rs756924190	NC_000002.12:144517271:T:G
NM_014795.4(ZEB2):c.2016T>C (p.Asp672=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000386556	2	145156738	2	144399171	386556	365545	rs1057522531	NC_000002.12:144399170:A:G
NM_014795.4(ZEB2):c.797G>A (p.Gly266Glu)	ZEB2	G266E, G242E	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2019)	criteria provided, conflicting interpretations	VCV000385903	2	145161493	2	144403926	385903	365553	rs1057522361	NC_000002.12:144403925:C:T
NM_014795.4(ZEB2):c.2646A>G (p.Pro882=)	ZEB2		Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000385085	2	145156108	2	144398541	385085	365543	rs372224804	NC_000002.12:144398540:T:C
NM_014795.4(ZEB2):c.349T>C (p.Tyr117His)	ZEB2	Y117H	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2020)	criteria provided, conflicting interpretations	VCV000385055	2	145182417	2	144424850	385055	365578	rs1057522108	NC_000002.12:144424849:A:G
NM_014795.4(ZEB2):c.295A>G (p.Asn99Asp)	ZEB2	N99D	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 15, 2019)	criteria provided, conflicting interpretations	VCV000381504	2	145187372	2	144429805	381504	365581	rs150665982	NC_000002.12:144429804:T:C
NM_014795.4(ZEB2):c.225C>T (p.Ser75=)	ZEB2		Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000381140	2	145187442	2	144429875	381140	365583	rs754754722	NC_000002.12:144429874:G:A
NM_014795.4(ZEB2):c.1526C>T (p.Pro509Leu)	ZEB2	P509L, P485L	Mowat-Wilson syndrome|not provided	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000380262	2	145157228	2	144399661	380262	365386	rs1051563603	NC_000002.12:144399660:G:A
NM_014795.4(ZEB2):c.3432C>T (p.Gly1144=)	ZEB2		Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379072	2	145147231	2	144389664	379072	365377	rs768007761	NC_000002.12:144389663:G:A
NM_014795.4(ZEB2):c.2457A>G (p.Ser819=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Jan 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000378870	2	145156297	2	144398730	378870	365757	rs144184948	NC_000002.12:144398729:T:C
NM_014795.4(ZEB2):c.2256G>A (p.Thr752=)	ZEB2		not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Nov 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000378869	2	145156498	2	144398931	378869	365379	rs772121083	NC_000002.12:144398930:C:T
NM_014795.4(ZEB2):c.179C>T (p.Thr60Met)	ZEB2	T60M	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 3, 2021)	criteria provided, conflicting interpretations	VCV000378868	2	145187488	2	144429921	378868	365568	rs780890592	NC_000002.12:144429920:G:A
NM_014795.4(ZEB2):c.388A>G (p.Ile130Val)	ZEB2	I130V	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 13, 2019)	criteria provided, conflicting interpretations	VCV000377259	2	145182378	2	144424811	377259	364137	rs1057520175	NC_000002.12:144424810:T:C
NM_014795.4(ZEB2):c.1542G>T (p.Pro514=)	ZEB2		not specified|Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000374622	2	145157212	2	144399645	374622	361508	rs141674976	NC_000002.12:144399644:C:A
NM_014795.4(ZEB2):c.430T>A (p.Phe144Ile)	ZEB2	F144I, F120I	not specified|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000373361	2	145162565	2	144404998	373361	359383	rs1057518371	NC_000002.12:144404997:A:T
NM_014795.4(ZEB2):c.297C>T (p.Asn99=)	ZEB2		Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Aug 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000331302	2	145187370	2	144429803	331302	281984	rs147603619	NC_000002.12:144429802:G:A
NM_014795.4(ZEB2):c.1410T>C (p.Thr470=)	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000331300	2	145157344	2	144399777	331300	284522	rs34890427	NC_000002.12:144399776:A:G
NM_014795.4(ZEB2):c.3640A>G (p.Met1214Val)	ZEB2	M1214V, M1190V	Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: Sep 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000331298	2	145147023	2	144389456	331298	284291	rs199951665	NC_000002.12:144389455:T:C
NM_014795.4(ZEB2):c.*35dup	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331297	2	145146982 - 145146983	2	144389415 - 144389416	331297	282627	rs567229506	NC_000002.12:144389415:AAAAAAAAA:AAAAAAAAAA
NM_014795.4(ZEB2):c.*514del	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331292	2	145146504	2	144388937	331292	281977	rs558553086	NC_000002.12:144388936:AAAAAAAAAA:AAAAAAAAA
NM_014795.4(ZEB2):c.*514dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331291	2	145146503 - 145146504	2	144388936 - 144388937	331291	281983	rs558553086	NC_000002.12:144388936:AAAAAAAAAA:AAAAAAAAAAA
NM_014795.4(ZEB2):c.*560del	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331290	2	145146458	2	144388891	331290	282609	rs533637050	NC_000002.12:144388890:AAAAAAAAAAAAA:AAAAAAAAAAAA
NM_014795.4(ZEB2):c.*560dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331289	2	145146457 - 145146458	2	144388890 - 144388891	331289	281976	rs533637050	NC_000002.12:144388890:AAAAAAAAAAAAA:AAAAAAAAAAAAAA
NM_014795.4(ZEB2):c.*1110_*1114AAGAG[1]	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331286	2	145145899 - 145145903	2	144388332 - 144388336	331286	284510	rs534438826	NC_000002.12:144388331:CTCTTCTCTT:CTCTT
NM_014795.4(ZEB2):c.*1796dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331278	2	145145221 - 145145222	2	144387654 - 144387655	331278	282607	rs886054890	NC_000002.12:144387654:TTTTTTTT:TTTTTTTTT
NM_014795.4(ZEB2):c.*1945del	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331274	2	145145073	2	144387506	331274	281948	rs886054888	NC_000002.12:144387505:TTTT:TTT
NM_014795.4(ZEB2):c.*1984del	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331271	2	145145034	2	144387467	331271	281946	rs771457697	NC_000002.12:144387466:A:
NM_014795.4(ZEB2):c.*2377_*2378GT[7]	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331265	2	145144629 - 145144630	2	144387062 - 144387063	331265	281938	rs886054884	NC_000002.12:144387062:ACACACACACACA:ACACACACACACACA
NM_014795.4(ZEB2):c.*2396_*2397insGT	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331263	2	145144621 - 145144622	2	144387054 - 144387055	331263	284272	rs886054883	NC_000002.12:144387054:A:ACA
NM_014795.4(ZEB2):c.*2388_*2389TA[8]	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331262	2	145144613 - 145144614	2	144387046 - 144387047	331262	284496	rs143648355	NC_000002.12:144387045:TATATATATATATATATA:TATATATATATATATA
NM_014795.4(ZEB2):c.*2388_*2389TA[12]	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331261	2	145144612 - 145144613	2	144387045 - 144387046	331261	281934	rs143648355	NC_000002.12:144387045:TATATATATATATATATA:TATATATATATATATATATATATA
NM_014795.4(ZEB2):c.*2388_*2389TA[11]	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331260	2	145144612 - 145144613	2	144387045 - 144387046	331260	282563	rs143648355	NC_000002.12:144387045:TATATATATATATATATA:TATATATATATATATATATATA
NM_014795.4(ZEB2):c.*2388_*2389TA[10]	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331259	2	145144612 - 145144613	2	144387045 - 144387046	331259	282557	rs143648355	NC_000002.12:144387045:TATATATATATATATATA:TATATATATATATATATATA
NM_014795.4(ZEB2):c.*2516del	ZEB2		Mowat-Wilson syndrome	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331258	2	145144502	2	144386935	331258	281933	rs566578258	NC_000002.12:144386934:CCCCC:CCCC
NM_014795.4(ZEB2):c.*2525dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331256	2	145144492 - 145144493	2	144386925 - 144386926	331256	284268	rs886054882	NC_000002.12:144386925:CCCCCCCC:CCCCCCCCC
NM_014795.4(ZEB2):c.*4845del	ZEB2		Mowat-Wilson syndrome	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331230	2	145142173	2	144384606	331230	284224	rs201661554	NC_000002.12:144384605:TTTTTTTTTTTT:TTTTTTTTTTT
NM_014795.4(ZEB2):c.*4844_*4845dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331229	2	145142172 - 145142173	2	144384605 - 144384606	331229	284214	rs201661554	NC_000002.12:144384605:TTTTTTTTTTTT:TTTTTTTTTTTTTT
NM_014795.4(ZEB2):c.*4845dup	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000331228	2	145142172 - 145142173	2	144384605 - 144384606	331228	282545	rs201661554	NC_000002.12:144384605:TTTTTTTTTTTT:TTTTTTTTTTTTT
NM_014795.4(ZEB2):c.1446A>C (p.Glu482Asp)	ZEB2	E482D, E458D	not provided|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000287267	2	145157308	2	144399741	287267	271504	rs886043609	NC_000002.12:144399740:T:G
NM_014795.4(ZEB2):c.2281A>T (p.Thr761Ser)	ZEB2	T761S, T737S	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Mar 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000281635	2	145156473	2	144398906	281635	265872	rs867243713	NC_000002.12:144398905:T:A
NM_014795.4(ZEB2):c.2886+4A>C	ZEB2		not provided|Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jul 16, 2020)	criteria provided, conflicting interpretations	VCV000281633	2	145155864	2	144398297	281633	265870	rs754532627	NC_000002.12:144398296:T:G
NM_014795.4(ZEB2):c.3046C>T (p.Arg1016Ter)	ZEB2	R1016*, R992*	Intellectual disability|Mowat-Wilson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 15, 2021)	criteria provided, multiple submitters, no conflicts	VCV000280856	2	145154000	2	144396433	280856	264012	rs886041989	NC_000002.12:144396432:G:A
NM_014795.4(ZEB2):c.2672_2678del (p.Ala891fs)	ZEB2	A867fs, A891fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000242351	2	145156076 - 145156082	2	144398509 - 144398515	242351	243902	rs878855329	NC_000002.12:144398508:GGTTTGG:
NM_014795.4(ZEB2):c.2180del (p.Leu727fs)	ZEB2	L727fs, L703fs	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Dec 10, 2013)	criteria provided, single submitter	VCV000217030	2	145156574	2	144399007	217030	213525	rs786204810	NC_000002.12:144399006:AAA:AA
NM_014795.4(ZEB2):c.2932G>T (p.Asp978Tyr)	ZEB2	D978Y, D954Y	Mowat-Wilson syndrome	Likely pathogenic(Last reviewed: Jul 17, 2012)	criteria provided, single submitter	VCV000217029	2	145154114	2	144396547	217029	213524	rs863224942	NC_000002.12:144396546:C:A
NM_014795.4(ZEB2):c.674C>A (p.Ser225Ter)	ZEB2	S225*, S201*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 29, 2016)	criteria provided, multiple submitters, no conflicts	VCV000212637	2	145161616	2	144404049	212637	206852	rs797046122	NC_000002.12:144404048:G:T
NM_014795.4(ZEB2):c.3137C>A (p.Ser1046Ter)	ZEB2	S1046*, S1022*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 3, 2015)	criteria provided, single submitter	VCV000212636	2	145147526	2	144389959	212636	206846	rs797046121	NC_000002.12:144389958:G:T
NM_014795.4(ZEB2):c.2894T>A (p.Leu965Ter)	ZEB2	L965*, L941*	Inborn genetic diseases|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000212635	2	145154152	2	144396585	212635	206847	rs797046120	NC_000002.12:144396584:A:T
NM_014795.4(ZEB2):c.2404_2407del (p.Thr802fs)	ZEB2	T778fs, T802fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 9, 2015)	criteria provided, single submitter	VCV000212634	2	145156347 - 145156350	2	144398780 - 144398783	212634	206848	rs797046119	NC_000002.12:144398779:GAGTG:G
NM_014795.4(ZEB2):c.2061del (p.Phe687fs)	ZEB2	F663fs, F687fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 31, 2014)	criteria provided, single submitter	VCV000212633	2	145156693	2	144399126	212633	206849	rs797046118	NC_000002.12:144399125:AAA:AA
NM_014795.4(ZEB2):c.1106T>A (p.Leu369Ter)	ZEB2	L369*, L345*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 24, 2014)	criteria provided, single submitter	VCV000212632	2	145157648	2	144400081	212632	206850	rs797046117	NC_000002.12:144400080:A:T
NM_014795.4(ZEB2):c.1877G>A (p.Gly626Glu)	ZEB2	G626E, G602E	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Apr 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000198863	2	145156877	2	144399310	198863	196023	rs794727923	NC_000002.12:144399309:C:T
NM_014795.4(ZEB2):c.2641A>C (p.Asn881His)	ZEB2	N881H, N857H	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Dec 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000198861	2	145156113	2	144398546	198861	196021	rs794727922	NC_000002.12:144398545:T:G
NM_014795.4(ZEB2):c.219C>T (p.His73=)	ZEB2		not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000196468	2	145187448	2	144429881	196468	193629	rs778851716	NC_000002.12:144429880:G:A
NM_014795.4(ZEB2):c.3219C>T (p.His1073=)	ZEB2		Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 3, 2019)	criteria provided, conflicting interpretations	VCV000193714	2	145147444	2	144389877	193714	190877	rs139944383	NC_000002.12:144389876:G:A
NM_014795.4(ZEB2):c.2177_2180del (p.Ser726fs)	ZEB2	S726fs, S702fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189288	2	145156574 - 145156577	2	144399007 - 144399010	189288	187153	rs786204821	NC_000002.12:144399006:AAAGA:A
NM_014795.4(ZEB2):c.1653del (p.Ser552fs)	ZEB2	S552fs, S528fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000189287	2	145157101	2	144399534	189287	187160	rs786204820	NC_000002.12:144399533:G:
NM_014795.4(ZEB2):c.1687del (p.Leu562_Ile563insTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189286	2	145157067	2	144399500	189286	187159	rs786204819	NC_000002.12:144399499:TT:T
NM_014795.4(ZEB2):c.1966_1967del (p.Met656fs)	ZEB2	M632fs, M656fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189285	2	145156787 - 145156788	2	144399220 - 144399221	189285	187154	rs786204818	NC_000002.12:144399219:AT:
NM_014795.3(ZEB2):c.3068-?_(*5076_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189284					189284	187148		
NM_014795.4(ZEB2):c.460del (p.Glu154fs)	ZEB2	E154fs, E130fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189283	2	145162535	2	144404968	189283	187169	rs786204817	NC_000002.12:144404967:CC:C
NM_014795.4(ZEB2):c.3391_3400del (p.Pro1131fs)	ZEB2	P1131fs, P1107fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189282	2	145147263 - 145147272	2	144389696 - 144389705	189282	187150	rs786204816	NC_000002.12:144389695:CATCCCTCGGCAT:CAT
NM_014795.4(ZEB2):c.1027C>T (p.Arg343Ter)	ZEB2	R343*, R319*	Inborn genetic diseases|Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000189281	2	145157727	2	144400160	189281	187166	rs786204815	NC_000002.12:144400159:G:A
NM_014795.4(ZEB2):c.1416_1420del (p.Arg473fs)	ZEB2	R473fs, R449fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189280	2	145157334 - 145157338	2	144399767 - 144399771	189280	187162	rs786204814	NC_000002.12:144399766:GCCTGG:G
NM_014795.4(ZEB2):c.73+1del	ZEB2		not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 5, 2015)	criteria provided, single submitter	VCV000189279	2	145274844	2	144517277	189279	187171	rs786204813	NC_000002.12:144517276:CC:C
NM_014795.4(ZEB2):c.227_233del (p.Gln76fs)	ZEB2	Q76fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189278	2	145187434 - 145187440	2	144429867 - 144429873	189278	187170	rs786204812	NC_000002.12:144429866:AGAGCTT:
NM_014795.4(ZEB2):c.1884del (p.Phe628fs)	ZEB2	F604fs, F628fs	Mowat-Wilson syndrome	Pathogenic/Likely pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189277	2	145156870	2	144399303	189277	187156	rs786204811	NC_000002.12:144399302:AAAAA:AAAA
NM_014795.4(ZEB2):c.2179_2180del (p.Leu727fs)	ZEB2	L727fs, L703fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189276	2	145156574 - 145156575	2	144399007 - 144399008	189276	187152	rs786204810	NC_000002.12:144399006:AAA:A
NM_014795.4(ZEB2):c.1754del (p.Phe585fs)	ZEB2	F585fs, F561fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189275	2	145157000	2	144399433	189275	187157	rs786204809	NC_000002.12:144399432:AA:A
NM_014795.4(ZEB2):c.1749C>A (p.Cys583Ter)	ZEB2	C583*, C559*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189274	2	145157005	2	144399438	189274	187158	rs786204808	NC_000002.12:144399437:G:T
NM_014795.4(ZEB2):c.1277T>G (p.Leu426Ter)	ZEB2	L426*, L402*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189273	2	145157477	2	144399910	189273	187163	rs786204807	NC_000002.12:144399909:A:C
NM_014795.4(ZEB2):c.703del (p.Glu235fs)	ZEB2	E211fs, E235fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189272	2	145161587	2	144404020	189272	187167	rs786204806	NC_000002.12:144404019:C:
NM_014795.4(ZEB2):c.1541_1542insA (p.Val515fs)	ZEB2	V515fs, V491fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189271	2	145157212 - 145157213	2	144399645 - 144399646	189271	187161	rs1553961695	NC_000002.12:144399645::T
NM_014795.3(ZEB2):c.(?_-522)_(*5076_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189270					189270	187173		
NM_014795.4(ZEB2):c.660C>G (p.Tyr220Ter)	ZEB2	Y220*, Y196*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189269	2	145161630	2	144404063	189269	187168	rs111724246	NC_000002.12:144404062:G:C
NM_014795.3(ZEB2):c.404-?_(*5076_?)del	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189268					189268	187149		
NM_014795.4(ZEB2):c.1172_1182delinsTGACTTAAAATTAATG (p.Lys391_Pro394delinsMetThrTer)	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189267	2	145157572 - 145157582	2	144400005 - 144400015	189267	187165	rs786204805	NC_000002.12:144400004:TGGTTCTGTTT:CATTAATTTTAAGTCA
NM_014795.4(ZEB2):c.2687_2688dup (p.Ala897fs)	ZEB2	A873fs, A897fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189266	2	145156065 - 145156066	2	144398498 - 144398499	189266	187151	rs786204804	NC_000002.12:144398498:TGTGT:TGTGTGT
NM_014795.4(ZEB2):c.1944del (p.Ile649fs)	ZEB2	I625fs, I649fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189265	2	145156810	2	144399243	189265	187155	rs786204803	NC_000002.12:144399242:GGGG:GGG
NM_014795.4(ZEB2):c.20_21insT (p.Asp8fs)	ZEB2	D8fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189264	2	145274897 - 145274898	2	144517330 - 144517331	189264	187172	rs786204802	NC_000002.12:144517330::A
NM_014795.4(ZEB2):c.1257del (p.Gly421fs)	ZEB2	G421fs, G397fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 2, 2015)	no assertion criteria provided	VCV000189263	2	145157497	2	144399930	189263	187164	rs786204801	NC_000002.12:144399929:CCC:CC
NM_014795.4(ZEB2):c.2004G>T (p.Glu668Asp)	ZEB2	E668D, E644D	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Apr 23, 2021)	criteria provided, multiple submitters, no conflicts	VCV000187816	2	145156750	2	144399183	187816	185720	rs767506087	NC_000002.12:144399182:C:A
NM_014795.4(ZEB2):c.3499del (p.Ser1167fs)	ZEB2	S1143fs, S1167fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000181763	2	145147164	2	144389597	181763	178960	rs730881218	NC_000002.12:144389596:TTT:TT
NM_014795.4(ZEB2):c.3073del (p.Arg1025fs)	ZEB2	R1001fs, R1025fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 18, 2014)	criteria provided, single submitter	VCV000181762	2	145147590	2	144390023	181762	178968	rs730881217	NC_000002.12:144390022:TTTTT:TTTT
NM_014795.4(ZEB2):c.10C>G (p.Pro4Ala)	ZEB2	P4A	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181761	2	145274908	2	144517341	181761	179013	rs146394306	NC_000002.12:144517340:G:C
NM_014795.4(ZEB2):c.178_190delinsGTT (p.Thr60fs)	ZEB2	T60fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 11, 2014)	criteria provided, single submitter	VCV000181758	2	145187477 - 145187489	2	144429910 - 144429922	181758	179008	rs730881215	NC_000002.12:144429909:TAGCTGGACTCGT:AAC
NM_014795.4(ZEB2):c.82_87del (p.Tyr28_Asp29del)	ZEB2		Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)	criteria provided, conflicting interpretations	VCV000181757	2	145187580 - 145187585	2	144430013 - 144430018	181757	179011	rs730881214	NC_000002.12:144430012:GTCATAGT:GT
NM_014795.4(ZEB2):c.3195dup (p.His1066fs)	ZEB2	H1042fs, H1066fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 11, 2013)	criteria provided, single submitter	VCV000181756	2	145147467 - 145147468	2	144389900 - 144389901	181756	178965	rs730881213	NC_000002.12:144389900:T:TT
NM_014795.4(ZEB2):c.3002del (p.Cys1001fs)	ZEB2	C1001fs, C977fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 4, 2013)	criteria provided, single submitter	VCV000181755	2	145154044	2	144396477	181755	178969	rs730881212	NC_000002.12:144396476:C:
NM_014795.4(ZEB2):c.2228_2229del (p.Ser743fs)	ZEB2	S719fs, S743fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 3, 2014)	criteria provided, single submitter	VCV000181754	2	145156525 - 145156526	2	144398958 - 144398959	181754	178980	rs730881211	NC_000002.12:144398957:AGA:A
NM_014795.4(ZEB2):c.999del (p.Lys333fs)	ZEB2	K309fs, K333fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 31, 2014)	criteria provided, single submitter	VCV000181751	2	145157755	2	144400188	181751	178996	rs730881208	NC_000002.12:144400187:TTT:TT
NM_014795.4(ZEB2):c.314C>T (p.Ala105Val)	ZEB2	A105V	not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Feb 2, 2020)	criteria provided, conflicting interpretations	VCV000181750	2	145187353	2	144429786	181750	179006	rs730881207	NC_000002.12:144429785:G:A
NM_014795.4(ZEB2):c.59C>T (p.Pro20Leu)	ZEB2	P20L	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000181749	2	145274859	2	144517292	181749	179012	rs730881206	NC_000002.12:144517291:G:A
NM_014795.4(ZEB2):c.3337T>A (p.Leu1113Met)	ZEB2	L1113M, L1089M	Mowat-Wilson syndrome|not specified	Likely benign(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181747	2	145147326	2	144389759	181747	178962	rs730881204	NC_000002.12:144389758:A:T
NM_014795.4(ZEB2):c.2870G>A (p.Arg957Gln)	ZEB2	R957Q, R933Q	Mowat-Wilson syndrome|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2018)	criteria provided, conflicting interpretations	VCV000181744	2	145155884	2	144398317	181744	178970	rs371509136	NC_000002.12:144398316:C:T
NM_014795.4(ZEB2):c.2707G>T (p.Ala903Ser)	ZEB2	A903S, A879S	not provided|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181742	2	145156047	2	144398480	181742	178972	rs730881200	NC_000002.12:144398479:C:A
NM_014795.4(ZEB2):c.2486G>A (p.Ser829Asn)	ZEB2	S829N, S805N	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000181740	2	145156268	2	144398701	181740	178976	rs730881198	NC_000002.12:144398700:C:T
NM_014795.4(ZEB2):c.2248A>G (p.Ser750Gly)	ZEB2	S750G, S726G	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Mar 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000181738	2	145156506	2	144398939	181738	178979	rs730881196	NC_000002.12:144398938:T:C
NM_014795.4(ZEB2):c.2084G>A (p.Arg695Gln)	ZEB2	R695Q, R671Q	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2020)	criteria provided, conflicting interpretations	VCV000181737	2	145156670	2	144399103	181737	178982	rs147693839	NC_000002.12:144399102:C:T
NM_014795.4(ZEB2):c.1876G>A (p.Gly626Arg)	ZEB2	G626R, G602R	not provided|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Oct 26, 2020)	criteria provided, conflicting interpretations	VCV000181736	2	145156878	2	144399311	181736	178987	rs727504224	NC_000002.12:144399310:C:T
NM_014795.4(ZEB2):c.1735A>G (p.Thr579Ala)	ZEB2	T579A, T555A	Mowat-Wilson syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181735	2	145157019	2	144399452	181735	178988	rs140593583	NC_000002.12:144399451:T:C
NM_014795.4(ZEB2):c.1678C>T (p.Arg560Cys)	ZEB2	R560C, R536C	not specified|Mowat-Wilson syndrome	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181733	2	145157076	2	144399509	181733	178990	rs730881194	NC_000002.12:144399508:G:A
NM_014795.4(ZEB2):c.1565C>G (p.Thr522Ser)	ZEB2	T522S, T498S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV000181732	2	145157189	2	144399622	181732	178992	rs730881193	NC_000002.12:144399621:G:C
NM_014795.4(ZEB2):c.1283T>C (p.Val428Ala)	ZEB2	V428A, V404A	Mowat-Wilson syndrome|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000181731	2	145157471	2	144399904	181731	178993	rs730881192	NC_000002.12:144399903:A:G
NM_014795.4(ZEB2):c.385G>A (p.Ala129Thr)	ZEB2	A129T	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2018)	criteria provided, conflicting interpretations	VCV000181726	2	145182381	2	144424814	181726	179004	rs730881187	NC_000002.12:144424813:C:T
NM_014795.4(ZEB2):c.332-6C>T	ZEB2		not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: May 20, 2020)	criteria provided, conflicting interpretations	VCV000181725	2	145182440	2	144424873	181725	179005	rs730881186	NC_000002.12:144424872:G:A
NM_014795.4(ZEB2):c.304A>T (p.Ile102Phe)	ZEB2	I102F	not specified|History of neurodevelopmental disorder|Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000181724	2	145187363	2	144429796	181724	179007	rs201109457	NC_000002.12:144429795:T:A
NM_014795.4(ZEB2):c.139G>T (p.Ala47Ser)	ZEB2	A47S	Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181722	2	145187528	2	144429961	181722	179010	rs730881184	NC_000002.12:144429960:C:A
NM_014795.4(ZEB2):c.2495C>A (p.Ala832Asp)	ZEB2	A832D, A808D	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 11, 2021)	criteria provided, conflicting interpretations	VCV000181717	2	145156259	2	144398692	181717	178975	rs730881179	NC_000002.12:144398691:G:T
NM_014795.4(ZEB2):c.2255C>G (p.Thr752Arg)	ZEB2	T752R, T728R	Mowat-Wilson syndrome|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jan 31, 2020)	criteria provided, conflicting interpretations	VCV000181716	2	145156499	2	144398932	181716	178978	rs143438888	NC_000002.12:144398931:G:C
NM_014795.4(ZEB2):c.2215A>G (p.Ile739Val)	ZEB2	I739V, I715V	not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181715	2	145156539	2	144398972	181715	178981	rs730881178	NC_000002.12:144398971:T:C
NM_014795.4(ZEB2):c.1638C>T (p.Asp546=)	ZEB2		Mowat-Wilson syndrome|not specified	Likely benign(Last reviewed: Sep 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181712	2	145157116	2	144399549	181712	178991	rs149035844	NC_000002.12:144399548:G:A
NM_014795.4(ZEB2):c.1276T>A (p.Leu426Ile)	ZEB2	L426I, L402I	Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder|not provided	Benign/Likely benign(Last reviewed: May 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000181711	2	145157478	2	144399911	181711	178994	rs201881288	NC_000002.12:144399910:A:T
NM_014795.4(ZEB2):c.905G>A (p.Arg302Gln)	ZEB2	R302Q, R278Q	not provided|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Uncertain significance(Last reviewed: Mar 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181709	2	145158777	2	144401210	181709	178998	rs730881174	NC_000002.12:144401209:C:T
NM_014795.4(ZEB2):c.768C>T (p.Leu256=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000181707	2	145161522	2	144403955	181707	179000	rs370751674	NC_000002.12:144403954:G:A
NM_014795.4(ZEB2):c.289del (p.Trp97fs)	ZEB2	W97fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000180207	2	145187378	2	144429811	180207	178387	rs727503784	NC_000002.12:144429810:A:
NM_014795.4(ZEB2):c.374C>T (p.Thr125Met)	ZEB2	T125M	Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2021)	criteria provided, conflicting interpretations	VCV000167858	2	145182392	2	144424825	167858	176934	rs727504227	NC_000002.12:144424824:G:A
NM_014795.4(ZEB2):c.1218del (p.His407fs)	ZEB2	H383fs, H407fs	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jan 22, 2014)	criteria provided, single submitter	VCV000167856	2	145157536	2	144399969	167856	178161	rs727504226	NC_000002.12:144399968:T:
NM_014795.4(ZEB2):c.1876G>T (p.Gly626Ter)	ZEB2	G626*, G602*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Apr 18, 2014)	criteria provided, single submitter	VCV000167854	2	145156878	2	144399311	167854	177329	rs727504224	NC_000002.12:144399310:C:A
NM_014795.4(ZEB2):c.2206A>G (p.Met736Val)	ZEB2	M736V, M712V	not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Apr 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000167853	2	145156548	2	144398981	167853	177065	rs139191491	NC_000002.12:144398980:T:C
NM_014795.4(ZEB2):c.9G>C (p.Gln3His)	ZEB2	Q3H	Mowat-Wilson syndrome|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)	criteria provided, conflicting interpretations	VCV000160332	2	145274909	2	144517342	160332	168035	rs149882004	NC_000002.12:144517341:C:G
NM_014795.4(ZEB2):c.9G>A (p.Gln3=)	ZEB2		Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 9, 2021)	criteria provided, conflicting interpretations	VCV000160331	2	145274909	2	144517342	160331	168036	rs149882004	NC_000002.12:144517341:C:T
NM_014795.4(ZEB2):c.904C>T (p.Arg302Ter)	ZEB2	R302*, R278*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Nov 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160329	2	145158778	2	144401211	160329	168031	rs587784571	NC_000002.12:144401210:G:A
NM_014795.4(ZEB2):c.823C>T (p.Gln275Ter)	ZEB2	Q275*, Q251*	Inborn genetic diseases|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jan 18, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160328	2	145158859	2	144401292	160328	168032	rs587784570	NC_000002.12:144401291:G:A
NM_014795.4(ZEB2):c.747G>A (p.Thr249=)	ZEB2		Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 12, 2013)	criteria provided, single submitter	VCV000160327	2	145161543	2	144403976	160327	168033	rs587784569	NC_000002.12:144403975:C:T
NM_014795.4(ZEB2):c.3444C>T (p.Tyr1148=)	ZEB2		Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 18, 2018)	criteria provided, conflicting interpretations	VCV000160325	2	145147219	2	144389652	160325	168021	rs374141392	NC_000002.12:144389651:G:A
NM_014795.4(ZEB2):c.3141G>C (p.Arg1047Ser)	ZEB2	R1047S, R1023S	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jun 16, 2014)	criteria provided, single submitter	VCV000160324	2	145147522	2	144389955	160324	168022	rs587784567	NC_000002.12:144389954:C:G
NM_014795.4(ZEB2):c.2761C>T (p.Arg921Ter)	ZEB2	R921*, R897*	Intellectual disability|not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: May 21, 2021)	criteria provided, multiple submitters, no conflicts	VCV000160323	2	145155993	2	144398426	160323	168023	rs587784566	NC_000002.12:144398425:G:A
NM_014795.4(ZEB2):c.2501del (p.Lys834fs)	ZEB2	K810fs, K834fs	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000160322	2	145156253	2	144398686	160322	168024	rs587784565	NC_000002.12:144398685:TTT:TT
NM_014795.4(ZEB2):c.2352T>C (p.Ser784=)	ZEB2		not specified|Mowat-Wilson syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2020)	criteria provided, conflicting interpretations	VCV000160321	2	145156402	2	144398835	160321	168025	rs201990887	NC_000002.12:144398834:A:G
NM_014795.4(ZEB2):c.2329C>T (p.His777Tyr)	ZEB2	H777Y, H753Y	Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jan 23, 2014)	criteria provided, single submitter	VCV000160320	2	145156425	2	144398858	160320	168026	rs587784564	NC_000002.12:144398857:G:A
NM_014795.4(ZEB2):c.1542G>A (p.Pro514=)	ZEB2		not provided|not specified|Mowat-Wilson syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 15, 2020)	criteria provided, conflicting interpretations	VCV000160318	2	145157212	2	144399645	160318	168028	rs141674976	NC_000002.12:144399644:C:T
NM_014795.4(ZEB2):c.1438G>T (p.Ala480Ser)	ZEB2	A480S, A456S	not specified|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000160317	2	145157316	2	144399749	160317	168029	rs143854197	NC_000002.12:144399748:C:A
NM_014795.4(ZEB2):c.375G>A (p.Thr125=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137956	2	145182391	2	144424824	137956	141659	rs138389836	NC_000002.12:144424823:C:T
NM_014795.4(ZEB2):c.150C>T (p.Asp50=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137955	2	145187517	2	144429950	137955	141658	rs587780996	NC_000002.12:144429949:G:A
NM_014795.4(ZEB2):c.2973C>T (p.Ile991=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137954	2	145154073	2	144396506	137954	141657	rs572507342	NC_000002.12:144396505:G:A
NM_014795.4(ZEB2):c.2766A>T (p.Pro922=)	ZEB2		Mowat-Wilson syndrome|not provided|not specified|History of neurodevelopmental disorder	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000137952	2	145155988	2	144398421	137952	141655	rs185223937	NC_000002.12:144398420:T:A
NM_014795.4(ZEB2):c.2601G>A (p.Lys867=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137951	2	145156153	2	144398586	137951	141654	rs139369265	NC_000002.12:144398585:C:T
NM_014795.4(ZEB2):c.2361T>C (p.Asn787=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137950	2	145156393	2	144398826	137950	141653	rs201567433	NC_000002.12:144398825:A:G
NM_014795.4(ZEB2):c.2205T>C (p.Pro735=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137949	2	145156549	2	144398982	137949	141652	rs149964599	NC_000002.12:144398981:A:G
NM_014795.4(ZEB2):c.2142G>A (p.Pro714=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137948	2	145156612	2	144399045	137948	141651	rs201180901	NC_000002.12:144399044:C:T
NM_014795.4(ZEB2):c.1840C>T (p.Leu614=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Jun 22, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137947	2	145156914	2	144399347	137947	141650	rs145201706	NC_000002.12:144399346:G:A
NM_014795.4(ZEB2):c.1587G>A (p.Thr529=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137946	2	145157167	2	144399600	137946	141649	rs148709333	NC_000002.12:144399599:C:T
NM_014795.4(ZEB2):c.1533C>T (p.Val511=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Apr 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137945	2	145157221	2	144399654	137945	141648	rs587780994	NC_000002.12:144399653:G:A
NM_014795.4(ZEB2):c.798G>C (p.Gly266=)	ZEB2		not specified|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137944	2	145161492	2	144403925	137944	141647	rs34961586	NC_000002.12:144403924:C:G
NM_014795.4(ZEB2):c.759C>T (p.Arg253=)	ZEB2		not specified|not provided|Mowat-Wilson syndrome|History of neurodevelopmental disorder	Benign/Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137943	2	145161531	2	144403964	137943	141646	rs150853991	NC_000002.12:144403963:G:A
NM_014795.4(ZEB2):c.462G>A (p.Glu154=)	ZEB2		Mowat-Wilson syndrome|not specified	Benign/Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137942	2	145162533	2	144404966	137942	141645	rs372940559	NC_000002.12:144404965:C:T
NM_014795.4(ZEB2):c.930C>T (p.Tyr310=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not provided|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095643	2	145157824	2	144400257	95643	101541	rs6711223	NC_000002.12:144400256:G:A
NM_014795.4(ZEB2):c.807+3G>C	ZEB2		Mowat-Wilson syndrome|History of neurodevelopmental disorder|not provided|not specified	Benign/Likely benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095642	2	145161480	2	144403913	95642	101540	rs144925893	NC_000002.12:144403912:C:G
NM_014795.4(ZEB2):c.73+2T>C	ZEB2		Mowat-Wilson syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 29, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095639	2	145274843	2	144517276	95639	101537	rs398124282	NC_000002.12:144517275:A:G
NM_014795.4(ZEB2):c.643_659del (p.Tyr215fs)	ZEB2	Y215fs, Y191fs	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Dec 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095638	2	145161631 - 145161647	2	144404064 - 144404080	95638	101536	rs398124281	NC_000002.12:144404063:TAGCCCCGGTCGCAGTA:
NM_014795.4(ZEB2):c.489C>T (p.Ile163=)	ZEB2		History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095637	2	145162506	2	144404939	95637	101535	rs138859323	NC_000002.12:144404938:G:A
NM_014795.4(ZEB2):c.3471C>T (p.Asp1157=)	ZEB2		History of neurodevelopmental disorder|Mowat-Wilson syndrome|not specified	Benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095636	2	145147192	2	144389625	95636	101534	rs149526010	NC_000002.12:144389624:G:A
NM_014795.4(ZEB2):c.3359_3364delinsTAATG (p.Gly1120fs)	ZEB2	G1096fs, G1120fs	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Feb 25, 2013)	criteria provided, single submitter	VCV000095635	2	145147299 - 145147304	2	144389732 - 144389737	95635	101533	rs398124280	NC_000002.12:144389731:AGTACC:CATTA
NM_014795.4(ZEB2):c.3067+6A>T	ZEB2		Mowat-Wilson syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095633	2	145153973	2	144396406	95633	101531	rs143450927	NC_000002.12:144396405:T:A
NM_014795.4(ZEB2):c.2887-4G>A	ZEB2		History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095632	2	145154163	2	144396596	95632	101530	rs147972125	NC_000002.12:144396595:C:T
NM_014795.4(ZEB2):c.2255C>T (p.Thr752Met)	ZEB2	T752M, T728M	Mowat-Wilson syndrome|not specified|not provided	Benign/Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095631	2	145156499	2	144398932	95631	101529	rs143438888	NC_000002.12:144398931:G:A
NM_014795.4(ZEB2):c.2230A>G (p.Ile744Val)	ZEB2	I744V, I720V	History of neurodevelopmental disorder|not specified|not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095630	2	145156524	2	144398957	95630	101528	rs112005830	NC_000002.12:144398956:T:C
NM_014795.4(ZEB2):c.2203C>T (p.Pro735Ser)	ZEB2	P735S, P711S	History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome	Benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095629	2	145156551	2	144398984	95629	101527	rs144154908	NC_000002.12:144398983:G:A
NM_014795.4(ZEB2):c.2141C>T (p.Pro714Leu)	ZEB2	P714L, P690L	not provided|not specified|History of neurodevelopmental disorder|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095627	2	145156613	2	144399046	95627	101525	rs112581563	NC_000002.12:144399045:G:A
NM_014795.4(ZEB2):c.1848T>G (p.Pro616=)	ZEB2		not specified|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095625	2	145156906	2	144399339	95625	101523	rs144835963	NC_000002.12:144399338:A:C
NM_014795.4(ZEB2):c.1480C>T (p.Pro494Ser)	ZEB2	P494S, P470S	History of neurodevelopmental disorder|not provided|not specified|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095622	2	145157274	2	144399707	95622	101520	rs144952836	NC_000002.12:144399706:G:A
NM_014795.4(ZEB2):c.1410T>A (p.Thr470=)	ZEB2		History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095621	2	145157344	2	144399777	95621	101519	rs34890427	NC_000002.12:144399776:A:T
NM_014795.4(ZEB2):c.1381C>T (p.Gln461Ter)	ZEB2	Q461*, Q437*	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jan 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095620	2	145157373	2	144399806	95620	101518	rs398124274	NC_000002.12:144399805:G:A
NM_014795.4(ZEB2):c.1306A>G (p.Met436Val)	ZEB2	M436V, M412V	History of neurodevelopmental disorder|not specified|Mowat-Wilson syndrome|not provided	Benign/Likely benign(Last reviewed: Sep 10, 2020)	criteria provided, multiple submitters, no conflicts	VCV000095619	2	145157448	2	144399881	95619	101517	rs145812868	NC_000002.12:144399880:T:C
NM_014795.4(ZEB2):c.1161A>G (p.Leu387=)	ZEB2		History of neurodevelopmental disorder|not specified|not provided|Mowat-Wilson syndrome	Benign/Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095618	2	145157593	2	144400026	95618	101516	rs146673563	NC_000002.12:144400025:T:C
NM_014795.4(ZEB2):c.3134A>G (p.His1045Arg)	ZEB2	H1045R, H1021R	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056827	2	145147529	2	144389962	56827	71450	rs397515449	NC_000002.12:144389961:T:C
NM_014795.4(ZEB2):c.3211T>C (p.Ser1071Pro)	ZEB2	S1071P, S1047P	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000056826	2	145147452	2	144389885	56826	71449	rs397515448	NC_000002.12:144389884:A:G
NM_014795.4(ZEB2):c.3356A>G (p.Gln1119Arg)	ZEB2	Q1119R, Q1095R	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Jun 1, 2006)	no assertion criteria provided	VCV000004768	2	145147307	2	144389740	4768	19807	rs137852983	NC_000002.12:144389739:T:C
NM_014795.4(ZEB2):c.-69-1G>A	ZEB2		Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 15, 2008)	no assertion criteria provided	VCV000004767	2	145274987	2	144517420	4767	19806	rs587776612	NC_000002.12:144517419:C:T
NM_014795.4(ZEB2):c.1862del (p.Val621fs)	ZEB2	V621fs, V597fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Sep 1, 2005)	no assertion criteria provided	VCV000004766	2	145156892	2	144399325	4766	19805	rs587776611	NC_000002.12:144399324:A:
NM_014795.4(ZEB2):c.295AAC[1] (p.Asn100del)	ZEB2	N100del	Hirschsprung disease-mental retardation syndrome, late infantile|Mowat-Wilson syndrome	Uncertain significance(Last reviewed: Jul 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004764	2	145187367 - 145187369	2	144429800 - 144429802	4764	19803	rs587776610	NC_000002.12:144429799:GTTGTTGT:GTTGT
NM_014795.4(ZEB2):c.3566_3567dup (p.Met1190fs)	ZEB2	M1166fs, M1190fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004763	2	145147095 - 145147096	2	144389528 - 144389529	4763	19802	rs587776609	NC_000002.12:144389528:GG:GGGG
NM_014795.4(ZEB2):c.2555C>G (p.Ser852Ter)	ZEB2	S852*, S828*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004762	2	145156199	2	144398632	4762	19801	rs137852982	NC_000002.12:144398631:G:C
NM_014795.4(ZEB2):c.1892del (p.Asn631fs)	ZEB2	N607fs, N631fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Mar 15, 2002)	no assertion criteria provided	VCV000004760	2	145156862	2	144399295	4760	19799	rs587776607	NC_000002.12:144399294:TT:T
NM_014795.4(ZEB2):c.2453dup (p.Leu818fs)	ZEB2	L794fs, L818fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004759	2	145156300 - 145156301	2	144398733 - 144398734	4759	19798	rs587776606	NC_000002.12:144398733:AA:AAA
NM_014795.4(ZEB2):c.760_761dup (p.Gln255fs)	ZEB2	Q231fs, Q255fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Dec 1, 2001)	no assertion criteria provided	VCV000004758	2	145161528 - 145161529	2	144403961 - 144403962	4758	19797	rs587776605	NC_000002.12:144403961:GTG:GTGTG
NM_014795.4(ZEB2):c.1426dup (p.Met476fs)	ZEB2	M476fs, M452fs	Mowat-Wilson syndrome|not provided	Pathogenic(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000004757	2	145157327 - 145157328	2	144399760 - 144399761	4757	19796	rs587776604	NC_000002.12:144399760:TTTTTT:TTTTTTT
NM_014795.4(ZEB2):c.1173_1176del (p.Thr392fs)	ZEB2	T392fs, T368fs	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004756	2	145157578 - 145157581	2	144400011 - 144400014	4756	19795	rs587776603	NC_000002.12:144400010:TGTTT:T
NM_014795.4(ZEB2):c.2083C>T (p.Arg695Ter)	ZEB2	R695*, R671*	not provided|Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000004755	2	145156671	2	144399104	4755	19794	rs137852981	NC_000002.12:144399103:G:A
NM_014795.4(ZEB2):c.1645A>T (p.Arg549Ter)	ZEB2	R549*, R525*	Mowat-Wilson syndrome	Pathogenic(Last reviewed: Apr 1, 2001)	no assertion criteria provided	VCV000004754	2	145157109	2	144399542	4754	19793	rs137852980	NC_000002.12:144399541:T:A
